Datasets:

ZixuanKe

/

nickmuchi-trade-the-event

like 0

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: PORTSMOUTH, Va., Oct. 27, 2020 /PRNewswire/ --Right now, our country is looking for solutions on how to unite the community and its law enforcement agencies. The Portsmouth Police Department (PPD) is taking bold new steps to meet the challenges of recruiting and retaining the best and brightest Virginia has to offer.Beginning November 2, the city will launch an aggressive marketing police recruitment campaign with outreach focused on local individuals while also reaching out to possible candidates around the region and the nation. Continue Reading (PRNewsfoto/Portsmouth VA Police Department) Upon being sworn in as a Portsmouth officer, applicants are eligible for a sign-on bonus. In addition, police employees who recommend/refer a candidatewho becomes a sworn officer will be eligible for a one-time incentive bonus. \"Portsmouth's Police Department is a small, family-based environment with a good solid foundation,\" said Michael Floriano, public safety recruiter based in the city's Human Resource Management Department. \"Existing police officers and even city residents will be involved in this effort and may also receive bonuses for recruiting.\" The police department is also working with information technology and a team of web designers to overhaul the department's website. It will improve our communication with recruits and the general public. \"We are looking for men and women who reflect the values of the Portsmouth community, including selfless public service, integrity, teamwork, cooperation, and the ability to continue growing and improving,\" Floriano said.The recruitment campaign will utilize a multi-media strategy, including implementing a more concerted effort on social media to tell stories that demonstrate the diversity in the types of work performed in law enforcement. The department's social media sites will be updated and used to reach out and maintain connections with interested individuals. Recruitment materials will also outline other employment benefits, including paid annual leave, paid holidays, retirement plans, and the opportunity for promotion after two years at the Portsmouth Police Department.Over the next few weeks, the public will see billboards, television advertising, social media ads, and more. If you or someone you know is interested in working for the Portsmouth Police Department, reach out to our recruiter at [emailprotected]. Or, visit http://www.portsmouthpd.us/recruiting/ for more information.CONTACT:Victoria VernedoePublic Information Officer Portsmouth Police Department 757-393-8257 [emailprotected]SOURCE Portsmouth VA Police Department", "role": "user" }, { "content": "Portsmouth, VA, Announces Police Department Recruitment Initiative", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: STERLING, Va.--(BUSINESS WIRE)--Neustar Inc., a global information services and technology company and leader in identity resolution, today announced the launch of Neustar Unified Identity, the only end-to-end identity management solution that enables resolution of offline to online identifiers by responsibly connecting people, location, and device data. The new solution powered by Neustars unrivaled identity graph platform, OneID, transforms data management to enable better data-driven decision making and outcomes for brands by supporting data onboarding, linking, enrichment, and validation. According to a recent study by Forrester Consulting that evaluated how brands are adjusting their customer data strategies in the face of shifts in the marketing landscape, brands struggle to meet the moment with comprehensive, identity-based strategies that would let them simultaneously tackle issues of privacy management, data governance, and marketing management.i Neustar Unified Identity enables brands to develop identity-based, privacy-forward approaches that improve omnichannel customer data quality, management, and governance across marketing, analytics, and technology use cases. Our goal with Unified Identity is to bring simplicity and order back to customer data management helping our clients to better manage data between departments and partners using a single, unassailable source of truth, said Michael Schoen, Senior Vice President and General Manager of Marketing Solutions at Neustar. Data chaos kills organizational efficiencies, strategic clarity, and ultimately business growth. Unified Identity is the high-value currency that provides brands the privacy-centric data quality they need, while eliminating the data fragmentation and organizational pains many brands struggle with. Unified Identity is a core offering part of Fabrick, Neustars next generation Customer Identity Platform. It provides the identity data, machine-learning, and cross-channel linkages brands need to power advanced CRM data hygiene and enrichment, onboarding, omnichannel media planning, and audience targeting use cases. Unified Identity connects and augments online and offline data via a single next-generation identity infrastructure that has built in linkages across the marketing technology, data science, and CRM-technology worlds. For more than five years, Neustar has provided Allstate a solid foundation of identity-based solutions allowing us to better control and improve business performance, said David Schroeder, Digital Marketing Solutions, Allstate. We rely on Neustar for anonymized household-level measurement and analytics, offline data enrichment, digital audience syndication to our demand side platforms and the ability to control household impression frequency. We appreciate the continued partnership. Unified Identity also integrates with Neustars Unified Analytics, powering predictive analytics at the user-level across all channels including linear and connected-TV and walled garden ecosystems. This enables brands to make critical, on-the-fly optimizations to their marketing mix, campaign tactics, and audience targets to maximize return on ad spend. According to a 2021 Forrester Total Economic Impact Study commissioned by Neustar, After using Neustar, companies and executives had a single source of truth instead of conflicting numbers and reports. The analysis and advice provided by Neustar centralized and unified the data among the brand, agencies, and corporate marketing team. According to a marketing effectiveness manager at a multi-national automaker, Our online budget has been reduced by about 250 million dollars, and were getting more out of it now than we ever had. ii Built to be platform agnostic, Unified Identity is a powerful addition to existing brand and agency marketing and analytics stacks including customer data platforms (CDPs) such as Treasure Data, as well as data and cloud services like PreciseTarget and data sharing platform, Snowflake Data Marketplace. Whether its for upsell, customer acquisition, or retention, identity drives consistent and relevant customer experiences, said Rob Parrish, Vice President of Product at Treasure Data. Treasure Data is excited to incorporate Neustar Unified Identity into our customer data platform to help solve the challenge of identity resolution across an increasingly complex world of customer behaviors online and offline. Our partnership with Neustar will add a new dimension to our datas precision and effectiveness and will offer the retail and apparel industry much-needed assistance to capture lost revenue from the disruption of the past two quarters, said Rob McGovern, Founder and CEO at PreciseTarget. Neustar is one of the most respected companies in the industry: their data and identity resolution are known for their accuracy, and their strict standards on data privacy are second to none. Neustar is solving some of the biggest customer data challenges marketers face today by unifying the offline and online data worlds in a single identity infrastructure, said Vince Trotta, Head of Snowflake Data Marketplace at Snowflake. Snowflake Data Marketplace makes it easy to unify data from multiple sources on Snowflakes single, integrated platform. Were excited to have Neustar provide joint customers with cutting-edge data and identity capabilities. The Unified Identity suite of products will go live on Snowflake Data Marketplace in a phased approach, from March to April 2021. About Neustar Fabrick Neustar Fabrick is a next generation customer identity platform powering identity management, cross-channel planning, marketing activation, audience syndication, and analytics in a post-device ID world. This integrated set of identity management and marketing solutions connects Neustars unique identity assets and capabilities with brand, publisher, and technology-partner data to provide a sustainable means of managing and mobilizing customer data across marketing, technology, and analytics use cases. Neustars identity-based marketing and measurement solutions free advertisers and publishers from reliance on device IDs like third-party cookies and mobile ad IDs (MAIDs). This enables clients and partners to better acquire, enrich, manage, and activate customer data to improve engagement across channels, analyze marketing contribution to sales, and optimize return on investment. About Neustar Neustar is an information services and technology company and a leader in identity resolution providing the data and technology that enable trusted connections between companies and people at the moments that matter most. Neustar offers industry-leading solutions in marketing, risk, communications, and security that responsibly connect data on people, devices and locations, continuously corroborated through billions of transactions. Neustar serves more than 8,000 clients worldwide, including 60 of the Fortune 100. Learn how your company can benefit from the power of trusted connections here: home.neustar. i A Forrester Consulting Study, Transforming Customer Data Management, Bridging the Gap Between Consumer Privacy and People-Based Marketing (Forrester Research, Inc., 2021), Page 3. ii A Forrester Total Economic Impact Study, The Total Economic Impact of Neustar Unified Analytics, Cost Savings and Business Benefits Enable by Unified Analytics (Forrester Research, Inc., 2021), Page 3.", "role": "user" }, { "content": "Neustar Launches Unified Identity Transforming the Future of Customer Data Management Announces the first customer data solution to connect, validate, and enrich customer data from all offline and online sources, improving customer relationship management (CRM), marketing, and analytics outcomes for brands.", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: LONDON--(BUSINESS WIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the Code) 1. KEY INFORMATION (a) Full name of discloser: NATIXIS (Natixis SA and its affiliate Harris Associates LP) (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree G4S Plc (d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: (e) Date position held/dealing undertaken: For an opening position disclosure, state the latest practicable date prior to the disclosure 16th December 2020 (f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state N/A NO 2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security. (a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any) Class of relevant security: 25p ordinary Interests Short positions Number % Number % (1) Relevant securities owned and/or controlled: 102 312 806 6,59 (2) Cash-settled derivatives: 6 090 000 0,39 (3) Stock-settled derivatives (including options) and agreements to purchase/sell: TOTAL: 108 496 908 6,98 All interests and all short positions should be disclosed. Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions). (b) Rights to subscribe for new securities (including directors and other employee options) Class of relevant security in relation to which subscription right exists: Details, including nature of the rights concerned and relevant percentages: 3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in. The currency of all prices and other monetary amounts should be stated. (a) Purchases and sales Class of relevant security Purchase/sale Number of securities Price per unit 25p ordinary Sale 22 600 GBP 2,5498 25p ordinary Sale 289 300 GBP 2,5508 25p ordinary Sale 141 100 GBP 2,5500 25p ordinary Sale 139 800 GBP 2,5420 25p ordinary Sale 110 300 GBP 2,5380 25p ordinary Sale 700 GBP 2,5498 25p ordinary Sale 9 500 GBP 2,5508 25p ordinary Sale 4 500 GBP 2,5500 25p ordinary Sale 4 600 GBP 2,5420 25p ordinary Sale 3 600 GBP 2,5380 25p ordinary Sale 2 900 GBP 2,5508 25p ordinary Sale 1 100 GBP 2,5500 25p ordinary Sale 1 300 GBP 2,5420 25p ordinary Sale 1 000 GBP 2,5380 25p ordinary Sale 2 700 GBP 2,5508 25p ordinary Sale 1 300 GBP 2,5500 25p ordinary Sale 1 300 GBP 2,5420 25p ordinary Sale 1 000 GBP 2,5380 25p ordinary Sale 3 300 GBP 2,5498 25p ordinary Sale 36 900 GBP 2,5508 25p ordinary Sale 18 000 GBP 2,5500 25p ordinary Sale 18 100 GBP 2,5420 25p ordinary Sale 14 100 GBP 2,5380 25p ordinary Sale 3 200 GBP 2,5508 25p ordinary Sale 1 500 GBP 2,5500 25p ordinary Sale 1 400 GBP 2,5420 25p ordinary Sale 1 200 GBP 2,5380 25p ordinary Sale 5 950 GBP 2,5498 25p ordinary Sale 19 900 GBP 2,5508 25p ordinary Sale 9 800 GBP 2,5500 25p ordinary Sale 9 800 GBP 2,5420 25p ordinary Sale 7 600 GBP 2,5380 25p ordinary Sale 1 900 GBP 2,5508 25p ordinary Sale 800 GBP 2,5500 25p ordinary Sale 1 000 GBP 2,5420 25p ordinary Sale 600 GBP 2,5380 25p ordinary Sale 500 GBP 2,5498 25p ordinary Sale 500 GBP 2,5420 25p ordinary Sale 600 GBP 2,5498 25p ordinary Sale 6 200 GBP 2,5508 25p ordinary Sale 3 000 GBP 2,5500 25p ordinary Sale 3 000 GBP 2,5420 25p ordinary Sale 2 400 GBP 2,5380 25p ordinary Sale 1 200 GBP 2,5498 25p ordinary Sale 12 400 GBP 2,5508 25p ordinary Sale 5 900 GBP 2,5500 25p ordinary Sale 6 100 GBP 2,5420 25p ordinary Sale 4 700 GBP 2,5380 25p ordinary Sale 2 300 GBP 2,5508 25p ordinary Sale 1 600 GBP 2,5500 25p ordinary Sale 800 GBP 2,5420 25p ordinary Sale 1 200 GBP 2,5380 25p ordinary Sale 600 GBP 2,5508 25p ordinary Sale 500 GBP 2,5500 25p ordinary Sale 818 GBP 2,5420 25p ordinary Sale 503 GBP 2,5508 25p ordinary Sale 1 500 GBP 2,5508 25p ordinary Sale 1 300 GBP 2,5500 25p ordinary Sale 900 GBP 2,5420 25p ordinary Sale 600 GBP 2,5380 25p ordinary Sale 600 GBP 2,5508 25p ordinary Sale 500 GBP 2,5380 25p ordinary Sale 2 400 GBP 2,5508 25p ordinary Sale 1 000 GBP 2,5500 25p ordinary Sale 1 200 GBP 2,5420 25p ordinary Sale 800 GBP 2,5380 25p ordinary Sale 1 200 GBP 2,5508 25p ordinary Sale 600 GBP 2,5500 25p ordinary Sale 800 GBP 2,5380 25p ordinary Sale 3 200 GBP 2,5508 25p ordinary Sale 1 700 GBP 2,5500 25p ordinary Sale 1 700 GBP 2,5420 25p ordinary Sale 1 100 GBP 2,5380 25p ordinary Sale 5 400 GBP 2,5508 25p ordinary Sale 2 600 GBP 2,5500 25p ordinary Sale 2 600 GBP 2,5420 25p ordinary Sale 1 900 GBP 2,5380 25p ordinary Sale 3 900 GBP 2,5508 25p ordinary Sale 1 700 GBP 2,5500 25p ordinary Sale 1 500 GBP 2,5420 25p ordinary Sale 1 500 GBP 2,5380 25p ordinary Sale 1 000 GBP 2,5508 25p ordinary Sale 500 GBP 2,5500 25p ordinary Sale 1 100 GBP 2,5420 25p ordinary Sale 3 200 GBP 2,5508 25p ordinary Sale 1 500 GBP 2,5500 25p ordinary Sale 1 500 GBP 2,5420 25p ordinary Sale 1 100 GBP 2,5380 25p ordinary Sale 9 GBP 2,5380 (b) Cash-settled derivative transactions Class of relevant security Product description e.g. CFD Nature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short position Number of reference securities Price per unit (c) Stock-settled derivative transactions (including options) (i) Writing, selling, purchasing or varying Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type e.g. American, European etc. Expiry date Option money paid/ received per unit (ii) Exercise Class of relevant security Product description e.g. call option Exercising/ exercised against Number of securities Exercise price per unit (d) Other dealings (including subscribing for new securities) Class of relevant security Nature of dealing e.g. subscription, conversion Details Price per unit (if applicable) 4. OTHER INFORMATION (a) Indemnity and other dealing arrangements Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer: Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state none NONE (b) Agreements, arrangements or understandings relating to options or derivatives Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state none NONE (c) Attachments Is a Supplemental Form 8 (Open Positions) attached? NO Date of disclosure: 17th December 2020 Contact name: Carole Sign Telephone number*: +33 1 58 32 17 94 Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service. The Panels Market Surveillance Unit is available for consultation in relation to the Codes disclosure requirements on +44 (0)20 7638 0129. *If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panels Market Surveillance Unit. The Code can be viewed on the Panels website at www.thetakeoverpanel.org.uk.", "role": "user" }, { "content": "Form 8.3 - G4S Plc", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: CINCINNATI and INDIANAPOLIS, Oct. 8, 2020 /PRNewswire/ --The Kroger Co. (NYSE: KR), America's largest grocery retailer, today announced the launch of two on-premise kitchens, respectively at stores in Metro Indianapolis, IN and Metro Columbus, OH. Developed in partnership with ClusterTruck, a technology start-up that operates delivery-only restaurants, the kitchens will provide a variety of freshly prepared meals on-demand with no service or delivery fees. Kroger launches on-premise ghost kitchens in partnership with Midwest start-up ClusterTruck. The first location opens today in Fishers, Indiana. (PRNewsfoto/The Kroger Co.) \"Kroger remains focused on providing our customers with fresh food and experiences enabled by industry-leading insights\" Tweet this Kroger and ClusterTruck's on-premise kitchens were developed from the momentum and insights of an informative pilotlaunched in December 2019 in Carmel and Indianapolis, Indiana and Columbus, Ohio. Different from the off-premise concept, the new concept will repurpose approximately 1,000 square feet at each participating storeto create a culinary space for ClusterTruck staff to prepare meals for quick delivery and in-store pickup. Customers can order from a menu of more than 80 meals, spanning a variety of ingredients and best characterized as food quality you can get at a sit-down restaurant with the personality of street food. \"Kroger remains focused on providing our customers with fresh food and experiences enabled by industry-leading insights and transformative technology,\" said Dan De La Rosa, Kroger's group vice president of fresh merchandising. \"The new on-premise kitchen, in partnership with ClusterTruck, is an innovation that streamlines ordering, preparation and delivery, supporting Kroger as we meet the sustained customer demand for quick, fresh restaurant-quality meals, especially as we navigate an unprecedented health crisis that has affected every aspect of our lives, including mealtime.\" The expansion of Kroger's relationship with ClusterTruck reflects the retailer's ongoing investments in providing a variety of prepared fresh food options and creating a seamless experience for customers. Kroger experienced a 127% digital sales lift in second quarter 2020, as customers continued to use digital ordering options, including pickup, delivery, and ship to home.Indianapolis-based ClusterTruck is a pioneer in the ghost kitchen space, building a proprietary software system that creates custom algorithms to optimize kitchen and delivery operations and removes the pain points of the third-party delivery model. ClusterTruck's systematic approach to meal delivery allows the company to ensure all orders are delivered to the customer within just 7 minutes of preparation and on average, less than 30 minutes of ordering. The combination of ClusterTruck's innovative technology platform, optimization of meal delivery, and launch at Kroger stores has the potential to create a new and more sustainable model.\"ClusterTruck combines leading software, high-quality ingredients, and delicious variety to elevate the prepared food delivery experience,\" said Chris Baggott, ClusterTruck co-founder and CEO. \"As the prepared food delivery category continues to explode, we're thrilled to play such a pivotal role in Kroger's fresh and forward-thinking meal delivery strategy.\"Kroger's first on-premise kitchen is now open in Fishers, IN (9799 East 116th Street). Later this year, the second location will open in Dublin, Ohio (7625 Sawmill Road). Media AssetsTo download photography of the on-premise kitchen, please visit here.About The Kroger Co.At The Kroger Co. (NYSE:KR), we are Fresh for Everyone and dedicated to our Purpose: ToFeed the Human Spirit. We are, across our family of companies, nearly half a million associates who serve over 11 million customers daily through a seamless shopping experience under a variety ofbanner names. We are committed to creating #ZeroHungerZeroWaste communities by 2025. To learn more about us, visit ournewsroomand investor relationssite.About ClusterTruckCo-founded in 2015,ClusterTrucklaunched its first kitchen in Indianapolis in 2016.ClusterTruckis a software platform that drives profitable, vertically integrated delivery-only kitchens. With locations in Indianapolis, Carmel, Broad Ripple and Fishers, Indiana; Columbus and Dublin, Ohio; and Kansas City, Missouri,ClusterTruckis revolutionizing prepared food delivery from click, to cook, to curb. Get more information and see the menu at ClusterTruck.com.SOURCE The Kroger Co. Related Links http://www.kroger.com", "role": "user" }, { "content": "Kroger Launches On-Premise Ghost Kitchens in Partnership with ClusterTruck Retailer expands relationship with Midwest start-up to provide customers with an on-demand meal ordering option", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: IRVING, Texas--(BUSINESS WIRE)--ExxonMobil has completed a review of its forward business plans and will prioritize near-term capital spending on advantaged assets with the highest potential future value, including developments in Guyana and the U.S. Permian Basin, targeted exploration in Brazil and Chemicals projects to grow high-value performance products. Recent exploration success and reductions in development costs of strategic investments have further enhanced the value of our industry-leading investment portfolio, said Darren Woods, chairman and chief executive officer for Exxon Mobil Corporation. Continued emphasis on high-grading the asset base - through exploration, divestment and prioritization of advantaged development opportunities - will improve earnings power and cash generation, and rebuild balance sheet capacity to manage future commodity price cycles while working to maintain a reliable dividend. The company said its annual business plan focused on the following priorities and actions: Woods said the business environment in the fourth quarter is showing signs of improvement despite the resurgence in COVID-19 cases and accompanying economic restrictions. Prices and margins for many of our businesses have improved from the third quarter and when coupled with continuing efforts to reduce spending and capture additional efficiencies, quarter-to-date cash flow has improved versus our plan assumptions, he said. About ExxonMobil ExxonMobil, one of the largest publicly traded international energy companies, uses technology and innovation to help meet the worlds growing energy needs. ExxonMobil holds an industry-leading inventory of resources, is one of the largest refiners and marketers of petroleum products, and its chemical company is one of the largest in the world. To learn more, visit exxonmobil.com and the Energy Factor. Follow us on Twitter and LinkedIn. Cautionary Statement Statements related to outlooks, projections, goals, accounting estimates, descriptions of strategic plans and objectives, and other statements of future events or conditions are forward-looking statements. Actual future results, including financial and operating performance; future earnings growth; the impact of the COVID-19 pandemic on results; planned capital and cash operating expenses for future years and the ability to meet or exceed announced reductions against prior plans; total capital expenditures and mix; cash flow; capital allocation and debt levels; dividend and shareholder returns; business and project plans, timing, costs and capacities; accounting and financial reporting effects, including potential impairment charges resulting from changes in current development plan strategy or divestment plans; and the pace and outcome of divestments, could differ materially due to a number of factors. These include global or regional changes in the supply and demand for oil, natural gas, petrochemicals, and feedstocks and other market conditions that impact prices and differentials; the outcome of government policies and actions, including actions taken to address COVID-19 and to maintain the functioning of national and global economies and markets; the impact of company actions to protect the health and safety of employees, vendors, customers, and communities; the severity, length and ultimate impact of COVID-19 on people and economies, including the nature and pace of economic recovery as well as the ability of ExxonMobil and its vendors and contractors to maintain operations while taking appropriate health protective measures for employees and others; reservoir performance; the outcome of exploration projects and timely completion of development and construction projects; changes in law, taxes, or regulation including environmental regulations, and timely granting of governmental permits; war, trade agreements and patterns, shipping blockades or harassment, and other political or security disturbances; opportunities for and regulatory approval of potential investments or divestments; the capture of efficiencies within and between business lines and the ability to maintain near-term cost reductions as ongoing efficiencies while maintaining future competitive positioning; general economic conditions including the occurrence and duration of economic recessions; and other factors discussed under the heading Factors Affecting Future Results on the Investors page of our website at www.exxonmobil.com and in Item 1A of ExxonMobils 2019 Form 10-K and subsequent Forms 10-Q for the quarters ended March 31, 2020, June 30, 2020, and September 30, 2020. Statements regarding plans or potential outcomes for the fourth quarter 2020 and for 2021 through 2027 remain subject to final assessments and analysis based on the company plan approved by the Board of Directors in November 2020. We assume no duty to update these statements as of any future date. Forward-looking statements contained in this release regarding the potential for future earnings growth potential are not forecasts of actual future results. These figures are provided to help quantify the potential future results and goals of currently-contemplated management plans and objectives including planned project investments, plans to grow Upstream production volumes, plans to increase sales in our Downstream and Chemical segments and to shift our Downstream product mix toward higher-value products, continued highgrading of ExxonMobils portfolio through our ongoing asset management program, initiatives to improve efficiencies and reduce costs, capital expenditures and cash management, and other efforts within managements control to impact future results. These figures are intended to quantify for illustrative purposes managements view of the potentials for these efforts and the potential to achieve these results subject to a timeframe of 2027 in comparison to the 2025 time frame previously communicated at our 2020 Investor Day as a result of the impacts of COVID and related events. These prices are not intended to reflect managements forecasts for future prices or the prices we use for internal planning purposes. The reference to the potential for doubling of earnings by 2027 is in comparison to 2017 adjusted earnings, i.e., reported earnings of $19.7 billion excluding the effects of U.S. tax reform and impairments resulting in adjusted 2017 earnings of $15.3 billion. Future growth potential as presented at the companys 2020 Investor Day was based on pre-COVID assumptions including $60 real prices for Brent crude, $3/mbtu Henry Hub prices for natural gas, and historical Downstream and Chemical margins over the 2015-2019 time period, and no significant changes in applicable laws or regulations or fiscal terms vs the environment at that time. Updated assumptions supporting the companys future view of growth potential will be discussed at the companys next Investor Day scheduled for March 2021. References to the resource base and other quantities of oil, natural gas or condensate may include estimated amounts that are not yet classified as proved reserves under SEC definitions, but which are expected to be ultimately recoverable. The term project as used in this report can refer to a variety of different activities and does not necessarily have the same meaning as in any government payment transparency reports.", "role": "user" }, { "content": "ExxonMobil to Prioritize Capital Investments on High-Value Assets Capital and exploration investments of $16-$19 billion in 2021; $20 billion to $25 billion annually to 2025 Near-term investment priorities: Guyana, Permian, Brazil, Chemicals performance products Certain dry gas assets removed from development plan; after-tax impairment of $17 billion to $20 billion Commitment to cost reduction, reliable dividend remains unchanged", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: BOULDER, Colo., June 25, 2020 /PRNewswire/ --IDmission, LLC, a global leader in biometric and AI technology that reduces risk associated with false identities, has announced the appointment of Miles Busby as chief revenue officer. Busby, a former managing partner at IronPoint Financial, was brought in to oversee all revenue operations and lead IDmission executives as they prepare to scale the business in the United States and abroad. An accomplished entrepreneurial executive, Busby has a proven track record of success in leading high-performing sales teams to revenue growth in a variety of highly specialized tech industries. With 30 years' leadership experience, Busby brings IDmission a wealth of knowledge in business growth strategy, strategic revenue planning, and fluency in technical sales. \"We look forward to having Miles' forward-thinking business approaches, which have earned his former businesses much success, including recognition by the Inc. 500 three consecutive years for Fastest Growing US-based Companies and his selection by Ernst & Young as Entrepreneur of the Year (National Finalist),\" said Ashim Banerjee, president and CEO of IDmission. \"IDmission is one of few global companies to reach the prestigious ISO 30107-2 compliance rating, so I am eager to work alongside Mr. Banerjee to scale IDmission as a global leader in biometric and AI technology,\" Busby said. \"We have exciting plans to grow our strategic sales and marketing staff in the US and abroad.\" About IDmission IDmission, a global leader in biometric and AI technology, reduces risk associated with false identities. It is one of only two U.S. based biotech providers, and the sole provider of a proprietary, end-to-end biotech solution for identity theft, through a comprehensive \"Know Your Customer\" (KYC) platform and automatic ID document analysis across 200 countries and four categories of biometrics: face, fingerprint, iris, and voice. For more information, visit https://www.idmission.com/homepage-en/. @IDmissionLLC #KYC #identitytheftprotection #biometrics #biotech *PHOTO link for media: https://www.Send2Press.com/300dpi/20-0625s2p-miles-busby-300dpi.jpg This release was issued through Send2Press, a unit of Neotrope. For more information, visit Send2Press Newswire at https://www.Send2Press.com SOURCE IDmission, LLC", "role": "user" }, { "content": "IDmission, LLC Names Entrepreneurial Executive Miles Busby as New Chief Revenue Officer Global leader in biometric and AI technology to reduce false identities risk has achieved prestigious ISO 30107-2 compliance rating", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: SEOUL, South Korea, June 4, 2020 /PRNewswire/ -- MagnaChip Semiconductor Corporation (\"MagnaChip\" or \"Company\") (NYSE: MX) today announced the appointment of Camillo Martino as its new nonexecutive Chairman of the Board of Directors (the \"Board\"), effective June 11, 2020, immediately following MagnaChip's upcoming Annual Meeting of Stockholders. Mr.Martino succeeds Nader Tavakoli as the Company's Chairman. Mr.Tavakoli will remain a director on the Company's Board and continue to serve as a member of the Audit, Compensation and Risk Committees. Mr.Tavakoli joined MagnaChip's Board in 2009 and has served as its nonexecutive Chairman since late 2018, shortly before the Company's announcement that it would undertake a strategic review. The strategic review process was successfully completed with the Company's announcement in March 2020 of a definitive agreement to sell its Foundry business and Fab 4 to a special purpose company in South Korea established by Alchemist Capital Partners Korea Co., Ltd. and Credian Partners, Inc. for a transaction value of approximately $435 million. Following the completion of the sale, MagnaChip will be a pure-play products company focused on the attractive highgrowth opportunities in the Display and Power market segments. \"It was an honor to have served as Chairman of the Board of Directors of MagnaChip,\" said Mr.Tavakoli. \"When I assumed the role, my goal was to help unlock the significant shareholder value at the Company and position it for future success by deleveraging the balance sheet, while at the same time making it a more streamlined pure-play product company. The announced transaction is expected to close in the September-October timeframe and will fully achieve that objective. I firmly believe Camillo is the right person to be appointed as the new Chairman, allowing me to devote more of my time to new initiatives and opportunities related to the current business environment in corporate credit and restructurings.\" \"The Board thanks Nader for his leadership as Chairman,\" said Mr.Martino. \"I am thankful for the opportunity to serve as Chairman and look forward to working with the entire Board of Directors and the management team to transform MagnaChip into a pure-play products company to drive sustainable and profitable growth.\" \"The Company and the management team would like to express their appreciation to Nader for his dedicated service as Chairman and for his leadership during the important strategic review process,\" said YJ Kim, MagnaChip's Chief Executive Officer and a member of the Board of Directors. \"I also look forward to working with Camillo and drawing upon his vast knowledge and experience in the semiconductor industry. His decades of expertise, particularly in semiconductor products, will play a vital role as we enter an exciting new chapter.\" Mr.Martino has served on MagnaChip's Board since 2016and is also currently serving on the board of directors of Sensera Limited. Mr.Martino also serves on the board of directors of several privately held companies, including VVDN Technologies, Keracel and CyberForza. Mr.Martino previously served as a director of Cypress Semiconductor until the closing of its sale to Infineon in April 2020 and was also the Chief Executive Officer and director of Silicon Image until it was acquired by Lattice Semiconductor in 2015. His semiconductor experience also includes the position of Chief Operating Officer at Zoran Corporation, and earlier in his career, he served at National Semiconductor in four different countries including Japan and China over a nearly 14-year period. Mr. Tavakoli has served as an investor, executive and advisor in complex corporate financial and operational restructurings for more than 30 years. Over the last year, Mr.Tavakoli has been engaged in senior executive and consulting roles in a number of large restructurings, including Cobalt International Energy, MF Global Inc., Sears and Toys \"R\" Us. Mr.Tavakoli is the Founder and CEO of EagleRock Capital Management and has recently formed Global Restructuring Advisors to assist creditors and boards of directors with the restructuring and winddown of unprofitable businesses. The following link provides additional information on each of the directors who serve on the Company's Board of Directors: http://investors.magnachip.com/corporate-governance/board-of-directors. About MagnaChip Semiconductor MagnaChip is a designer and manufacturer of analog and mixed-signal semiconductor platform solutions for communications, IoT, consumer, industrial and automotive applications. The Company's Standard Products Group and Foundry Services Group provide a broad range of standard products and manufacturing services to customers worldwide. MagnaChip, with more than 40 years of operating history, owns a portfolio of approximately 2,950 registered patents and pending applications, and has extensive engineering, design and manufacturing process expertise. For more information, please visit www.magnachip.com. Information on or accessible through MagnaChip's website is not a part of, and is not incorporated into, this release. CONTACTS: In the United States:So-Yeon JeongInvestor RelationsTel: +1.408-712-6151[emailprotected] In Korea:Chankeun ParkDirector, Public RelationsTel. +82.2.6903.3195[emailprotected] SOURCE MagnaChip Semiconductor Corporation Related Links http://www.magnachip.com", "role": "user" }, { "content": "Camillo Martino Succeeds Nader Tavakoli as Chairman of the Board of MagnaChip Semiconductor Mr. Tavakoli to Remain a Member of the Board", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: QUINCY, Ill., March 31, 2021 /PRNewswire/ --Titan International, Inc. (\"Titan\") announced today that Laura K. Thompson, 56, has been appointed to Titan's Board of Directors (the \"Board\"), effective April 1, 2021. Ms. Thompson was also appointed to serve on the Audit, Nomination, and Compensation Committees of the Board. Ms. Thompson is a global business executive with deep financial and business expertise established over a 35-year career with The Goodyear Tire & Rubber Company. Ms. Thompson served as Executive Vice President of Goodyear until her retirement in March 2019, and from 2013 to 2018 she served as Executive Vice President and Chief Financial Officer. She also served in various finance and business roles including Vice President Finance North America, Vice President Business Development and Director Investor Relations. Ms. Thompson is also a Director at Parker Hannifin Corporation and WESCO International Inc. Ms. Thompson earned an undergraduate degree in Accounting and an MBA in Finance from the University of Akron. Morry Taylor, Chairman of the Board stated \"Titan International is very pleased to have Laura Thompson join Titan's Board of Directors. I have known Laura for years and have had the pleasure of working with her on business dealings between Titan and Goodyear. Paul Reitz, Titan's CEO/President and Board Member, has also worked with Laura and is excited to have her on Titan's team. Laura not only has great financial experience, but she also has invaluable work experience in tire manufacturing. There is no question she will make great contributions to Titan as a new chapter in the company's history begins.\" About Titan: Titan International, Inc. (NYSE: TWI) is a leading global manufacturer of off-highway wheels, tires, assemblies, and undercarriage products. Headquartered in Illinois, the Company globally produces a broad range of products to meet the specifications of original equipment manufacturers (OEMs) and aftermarket customers in the agricultural, earthmoving/construction, and consumer markets. For more information, visit www.titan-intl.com. SOURCE Titan International, Inc. Related Links http://www.titan-intl.com", "role": "user" }, { "content": "Titan International, Inc. Announces Appointment of Laura K. Thompson, Former Executive Vice President of The Goodyear Tire & Rubber Company, to Board of Directors", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: --(BUSINESS WIRE)-- -- EESAIBISTelBISTelligence Japan 2020BISTelligence Japan 2020AIBISTelligence JapanBISTelISSM 2020 2021BISTelligence JapanAIISSMBISTellignce Japan 2020BISTel3 ISSM 2020ISSMBISTelligence Japan 2020BISTelCEOW.K. Choi BISTelligence Japan 20205 1) FDC 2) BISTeleDatalyzer 3) GrandView APMRUL 4) DFDFDC1 5) BISTel 20 20BISTel2001BISTelEESBISTelligence Japan 2020 BISTelligence Japan 2020BISTelligence Japan 20201210202012152020115BISTelligence Japan 20201230 BISTel BISTelEESA.I.https://www.bistel.com", "role": "user" }, { "content": "BISTelBISTelligence Japan 2020 ISSM 2020121516BISTelligence 2020AI", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: DUBLIN, Nov. 23, 2020 /PRNewswire/ -- The \"Immuno-Oncology Diagnostics Market Forecasts for Immuno-Oncology Diagnostics with COVID-19 Impact and Updates. Including Executive/Consultant Guides and Customized Forecasting/Analysis. 2021 to 2025\" report has been added to ResearchAndMarkets.com's offering. Revolution in cancer therapy to be driven by new diagnostics: Histology, genomics and liquid biopsy converge - COVID-19 changes the focus of research. This is a complex area but this readable report will bring the entire management team up to speed, on both the technology and the opportunity and the surprising impact of COVID-19 on what might seem to be an unrelated area. A revolution in cancer therapy is underway. New therapy based on using the body's natural immune defenses is having unprecedented success. But diagnostics, especially biomarkers are desperately needed to help select the right therapy. The technology is moving faster than the market. The impact on the health care industry is enormous. Tumor Mutational Burden? Checkpoint Inhibitors? Cytokines? Find out about the technology in readily understood terms that explain the jargon. Find the opportunities and the pitfalls. Understand growth expectations and the ultimate potential market size. Key Topics Covered: Market Guides Situation Analysis & Impact of COVID-19 Pandemic Guide for Executives and Marketing Staff Guide for Investment Analysts and Management Consultants 1. Introduction and Market Definition 1.1 What are Immuno-Oncology Diagnostics? 1.2 Immuno-oncology - the looming cure 1.2.1 Immuno-oncology Diagnostics Takes a Leading Role1.3 Market Definition 1.4 Methodology 1.5 U.S. Medical Market and laboratory Testing - Perspective 1.5.1 U.S. Medicare Expenditures for Laboratory Testing 2. Immunotherapy - Guide to Immune Technologies 2.0 The Immune System2.0.1 Innate immune system 2.0.1.1 Surface barriers 2.0.1.2 Inflammation 2.0.1.3 Complement system 2.0.1.4 Cellular barriers2.0.1.5 Natural killer cells2.0.2 Adaptive immune system 2.0.2.1 Lymphocytes 2.0.2.2 Killer T cells 2.0.2.3 Helper T cells 2.0.2.4 Gamma delta T cells 2.0.2.5 B lymphocytes and antibodies2.0.3 Tumor immunology - the immune surveillance system 2.1 Immuno Oncology Diagnostics2.1.1 Checkpoint Assays 2.1.2 Cytokine Assays 2.1.3 Genomic Germline2.1.4 Genomic Tumour 2.1.5 Tumor Microenviroment 2.1.6 Others 3. Industry Overview 3.1 Players in a Dynamic Market 3.1.1 Academic Research Lab3.1.2 Diagnostic Test Developer 3.1.3 Genomic Instrumentation Supplier 3.1.3.1 Cell Separation and Viewing Instrumentation Supplier 3.1.4 Pharmaceutical/Reagent Supplier 3.1.5 Independent Testing Lab3.1.6 Public National/regional lab 3.1.7 Hospital lab3.1.8 Physician Lab 3.1.9 Audit Body 3.1.10 Certification Body 4. Market Trends4.1 Factors Driving Growth4.1.1 Outcome potential 4.1.2 Companion Diagnostics 4.1.3 Funding 4.1.4 Technology Environment 4.1.5 Target Solutions 4.2 Factors Limiting Growth 4.2.1 Complex Role of Diagnostics 4.2.2 Clinical Trials Role4.2.3 Protocols 4.3 Diagnostic Technology Development 4.3.1 Combinations - Issues and Complexity 4.3.2 Shifting Role of Diagnostics 4.3.3 Multiplexing and Foundation One 4.3.4 The Disruption Dynamic 4.3.5 The Race for Biomarkers 4.3.6 The Next Five Years 5. Cancer Immuno-Oncology Diagnostics Recent Developments 5.1 Recent Developments - Importance and How to Use This Section 5.1.1 Importance of These Developments 5.1.2 How to Use This Section Qiagen Expands Immuno-Oncology Portfolio Immune Profiling System Redirected to Fight COVID-19 IncellDx Awarded PD-L1 Detection Patent FDA Approves CDx for Trastuzumab Promega Nabs CE Mark for Microsatellite Instability IVD ArcherDx partners with AstraZeneca for Immuno-Oncology Germline Results Guides Precision Therapy Agilent PD-L1 Assay Gets FDA Approval Bayer, OrigiMed Form Companion Diagnostic Development Alliance Bio-Me to Develop Microbiome Biomarker Test for Cancer Immunotherapy SkylineDx, BioInvent Collaborate to Characterize Predictive Immunological Signatures Biocare Medical Launches 7 Novel IVD Antibodies Oncocyte to Acquire Insight Genetics for $12M Novigenix and BioLizard to develop NGS Based Diagnostic Algorithm Biodesix and Immodulon Collaborate for Pancreatic Cancer Treatment Generex to Merge with NuGenerex Immuno-Oncology Cellgen Diagnostics and Genomic Testing Cooperative Partner to Develop Companion Diagnostics for Cancer Therapies Hematogenix Launches FDA Approved Immuno-oncology Test for Triple-Negative Breast Cancer Icon Acquires MolecularMD Guardant Health to Develop Companion Diagnostic Tests for AstraZeneca Tumor Mutational Burden as Predictor of Immunotherapy Success 6. Profiles of Key Immunotherapy Companies Genomics Abbott Laboratories Abcam Adaptive Biotechnologies Aethlon Medical Agena Bioscience Angle plc Apocell ARUP Laboratories Beckman Coulter Becton Dickinson Bioarray Genetics BioCartis Biocept Biodesix Inc BioFluidica BioGenex 38 bioMerieux Bio-Rad Bio-Techne Bristol-Myers Squibb Cancer Genetics Caris Molecular Diagnostics CellMax Life Charles River Laboratories Chronix Biomedical Circulogene Clearbridge BioMedics Clinical Genomics Cynvenio Cytolumina Technologies Corp CytoTrack Dako (Agilent) Diagnologix LLC Epic Sciences Exosome Diagnostics Fluidigm Corp Fluxion Biosciences Foundation Medicine Freenome Genomic Health GenomOncology GRAIL Guardant Health HalioDx Horizon Discovery HTG Molecular Diagnostics iCellate Illumina Incell Dx Inivata Integrated Diagnostics Invivoscribe Leica Biosystems Luminex MDx Health Merck & Co., Inc MIODx Molecular MD MRM Proteomics Inc Myriad Genetics/Myriad RBM Nanostring Natera Neogenomics New Oncology Oncocyte Ortho Clinical Diagnostics Perkin Elmer Personal Genome Diagnostics Pfizer Promega Protagen Diagnostics Qiagen Quanterix Rarecells SAS Roche Diagnostics Siemens Silicon Biosystems SkylineDx SRI International Sysmex Thermo Fisher Trovagene Vortex Biosciences 7. The Global Market for Immuno-Oncology Diagnostics 7.1 Global Market Overview by Country 7.1.1 Global Market by Country7.1.2 Global Market by Country 7.2 Global Market by Assay Type - Overview 7.2.1 Global Market by Assay Type 7.2.2 Global Market by Assay Type - Base/Final Year Comparison7.2.3 Global Market by Assay Type - Base Year 7.2.4 Global Market by Assay Type - End Year7.2.5 Global Market by Assay Type - Share by Year 7.2.6 Global Market by Assay Type - Segments Growth 8. Global Immuno-Oncology Diagnostic Markets - By Assay Type8.1 Checkpoint 8.2 Cytokine 8.3 Germline Genetic 8.4 Genetic Tumor 8.5 Tumor Microenvironment8.6 Other 9. Appendices9.1 FDA Cancer Drug Approvals by Year9.2 Clinical Trials Started 2010 to 2016 9.3 Prevalence of Cancer Treatments For more information about this report visit https://www.researchandmarkets.com/r/fexj3e Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. Media Contact: Research and Markets Laura Wood, Senior Manager [emailprotected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 SOURCE Research and Markets Related Links http://www.researchandmarkets.com", "role": "user" }, { "content": "Global Immuno-Oncology Diagnostics Market Report 2020: Forecasts for 2021-2025 - Genomics and Liquid Biopsy Converge", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: LAKE FOREST, Calif.--(BUSINESS WIRE)--Toshiba America Business Solutions commemorates Earth Day 2021 while continuing its commitment to a more sustainable planet through ongoing recycling and reforesting initiatives. This focus led to the recycling of more than 68 U.S. tons of used toner consumables and reforesting of 21,422 trees in 2020. Recycling Preserves Open Space Preventing more than 1,610 tons of e-waste from entering landfills since 2008 is the result of Toshiba's EcoSmart Toner Recycling Program in partnership with the internationally recognized recycler, Close the Loop. This weight is equivalent to 501 of the latest Zamboni ice resurfacing machines. Toshibas EcoSmart Toner Recycling Program ensures the transformation of the companys spent toner cartridges for reuse. Many of the components convert into new products including an asphalt material for resurfacing roads. Global Reforestation Toshiba has facilitated the replanting of 99,736 trees across global reforestation projects in Madagascar, Dominican Republic, United States, Mexico, Ireland, Canada, Brazil and India since partnering with PrintReleaf in 2016. Toshiba customers choose the specific areas they want to reforest per recommendations of the World Resources Institutes Global Forest Watch initiative. A new tree is planted once a Toshiba customer prints 8,333 sheets. SGS International, a world-leading inspection, verification, testing and certification organization, certifies the global reforestation partners while verifying the 100 percent net survival of the trees. \"Establishing a more sustainable and healthier planet through our day-to-day efforts is a primary focus of our Toshiba workforce,\" stated Toshiba America Business Solutions President and Chief Executive Officer Scott Maccabe. \"While pleased with our current accomplishments in this area, we assertively strive to improve upon and surpass these achievements in 2021 and beyond.\" Click-to-Tweet: Toshiba Commemorates Earth Day Through Yearlong Recycling & Reforesting About Close the Loop Close the Loop (CtL) provides best-in-class sustainability solutions to help companies enhance corporate social responsibility programs. Trusted by the global imaging industry, CtL designs and manages high efficient ink and toner take-back, recovery and reuse programs. Working throughout North America, Australia and Europe, CtL works towards a circular economy keeping items that would normally end up in landfills and oceans and turning them into useful commodities. To learn more, please visit www.closetheloopusa.com or follow Close the Loop on Facebook and LinkedIn. About PrintReleaf PrintReleaf creates a global sustainability standard by certifiably guaranteeing to releaf the paper consumption of PrintReleaf customers. PrintReleaf is the only technology platform that measures customers paper usage and certifiably reforests that usage on an equivalent basis. The patented PrintReleaf technology not only tracks paper consumption, but also monitors PrintReleaf reforestation partners to ensure fulfillment. Market-leading companies with a passion for the environment and a progressive concern for advancing environmental stewardship, together with their customers, rely on PrintReleaf to provide a nexus of partnerships involving forestry, technology, and business. For more information, please visit http://www.printreleaf.com. About Toshiba America Business Solutions, Inc. Toshiba America Business Solutions (TABS) is a workplace solutions provider delivering an extensive portfolio of industry-recognized workflow and document management products for businesses of all sizes across the United States, Mexico, and Central and South America. TABS supports the diverse needs of todays professionals through award-winning eSTUDIO multifunction printers, label and receipt printers, digital signage, managed print services, and cloud solutions. Toshiba continuously focuses on the clients and communities it serves, is committed to sustainability and is recognized as a Wall Street Journal Top 100 Sustainable Company. To learn more, please visit business.toshiba.com. Follow TABS on Facebook, Twitter, LinkedIn and YouTube.", "role": "user" }, { "content": "Toshiba Commemorates Earth Day Through Yearlong Recycling & Reforesting Company Recycles More Than 68 Tons & Replants 21,422 Trees Across the Globe in 2020", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: LOS ANGELES, March 20, 2020 /PRNewswire/ --From Refuge Recovery: In the next 12 months, at least 158,000 people are expected to die in the United States, not from the coronavirus outbreak, but from the scourge of addiction. Drug overdose deaths in the U.S. have reached 70,000 per year, while another 88,000 people are dying each year from alcohol abuse. Study after study shows that isolation and loneliness are among the main causes. It is not surprising then, that connection and community have been proven by most studies to be among the most critical factors in recovery. With the social distancing and isolation required by the onslaught of the coronavirus, addiction recovery organizations have been forced to adapt to the challenge, to try to avoid the death toll from addiction climbing much higher. Non-profit organizations such as Refuge Recovery, Alcoholics Anonymous, Narcotics Anonymous, Smart Recovery, and others rapidly have moved most, if not all of their recovery meetings -- the heart of the recovery process -- to online platforms. Peer-led Refuge Recovery meetings in particular, which are critical to that organization's mindfulness meditation-based approach to recovery, are now available for free online, around the clock, at www.refugerecovery.org. In those meetings, as in all Refuge Recovery meetings, participants are offered guided meditation, a reading from the Harper Collins book, \"Refuge Recovery: A Buddhist Path to Recovery from Addiction,\" and perhaps most importantly, an opportunity to share their personal accounts from the front lines of the battle for recovery. Smaller Refuge Recovery meetings are continuing in person, in compliance with government guidelines regarding social distancing. But many are too large, so they've gone online. Ironically, by forcing thousands of recovery meetings online, the coronavirus might be opening the addiction recovery process to millions of people who, for whatever reason, did not or could not attend in-person meetings. ABOUT REFUGE RECOVERY: Refuge Recovery, a non-profit organization, is grounded in the belief, based on over a decade of its own experience, and 2,600 years of Buddhist practice in general, that Buddhist principles and practices can create a strong foundation for the addiction recovery process, especially for addicts who have difficulty with other programs. Wisdom and compassion enable those struggling with any form of addiction to become more mindful of their mental processes, while also developing a deep understanding of the suffering that addiction has created, and compassion for their own pain. We foster free-of-charge meetings and communities that practice regular meditation, offer mentorship, and use Refuge Recovery literature to educate and provide free, Buddhist-inspired guidance for anyone seeking recovery from addiction. The international network of hundreds of Refuge Recovery meetings is strong and growing every week. More information is available on our website at www.refugerecovery.org, and on our two main Facebook pages with the @refugerecovery handle. Press Contact:Joseph Souhrada, Refuge Recovery World ServicesSeattle, Washington+1 (206) 913-9625[emailprotected] SOURCE Refuge Recovery Related Links https://www.refugerecovery.org", "role": "user" }, { "content": "Recovery Community Combats Isolation Of Social Distancing English USA - espaol Online meetings are providing a life-line to addicts of all kinds, in this time of global pandemic", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: BALTIMORE, April 9, 2021 /PRNewswire/ -- The American Urological Association (AUA) is pleased to announceDr. Ashish Jha, Dean of Brown University School of Public Health and globally recognized expert on the COVID-19 pandemic preparedness and response, will deliver the keynote address at the 2021 Annual Urology Advocacy Summit. In his keynote, Dr. Jha will discuss the public policy response to the pandemic, as well priorities in the coming months. Dr. Jha's presentation will take place virtually Wednesday, July 21st. \"Dr. Jha serves as a most compelling keynote speaker for this year's Annual Urology Advocacy Summit in July,\" said Dr. Eugene Rhee, Chair of the AUA Public Policy Council. \"His deep perspectives as a public policy authority on the pandemic and how it impacts advocacy in urology will highlight a resurgence of public interest in healthcare delivery across this nation.\" Dr. Jha received his M.D. from Harvard Medical School and then trained in Internal Medicine at the University of California in San Francisco. He completed his General Medicine fellowship at Brigham & Women's Hospital at Harvard Medical School and received his M.P.H. from Harvard T.H. Chan School of Public Health. His research endeavors focus on improving the quality and costs of healthcare systems with a specialized focus on the impact of public health policies nationally and globally. Dr. Jha has published over two hundred various papers in prestigious journals and heads a personal blog that focuses on using statistical data research to improve health quality. Prior to his role as Dean of Public Health at Brown University, he was faculty member at the Harvard T.H. Chan School of Public Health and Faculty Director of the Harvard Global Health Institute and Dean of Global Strategy. Dr. Jha is a member of the Institute of Medicine at the National Academies of Sciences, Engineering, and Medicine and continues his practice at the Providence VA Medical Center. He is a frequent medical contributor on CNN, NBC, MSNBC and other top news outlets discussing the impact of the global pandemic, vaccine distribution and health outcomes. The AUA Summit provides an opportunity for those in urology to advocate directly with lawmakers for policies that impact their work and the lives of their patients. To learn more about the AUA Summit and to register to attend, visitwww.AUASummit.org. About the American Urological Association:Founded in 1902 and headquartered nearBaltimore, Maryland, the American Urological Association is a leading advocate for the specialty of urology and has nearly 23,000 members throughout the world. The AUA is a premier urologic association, providing invaluable support to the urologic community as it pursues its mission of fostering the highest standards of urologic care through education, research and the formulation of health policy. Media Contact:Teri Arnold, Corporate Communications and Media Relations ManagerCell: 757-272-7002, [emailprotected] SOURCE American Urological Association Related Links www.auanet.org", "role": "user" }, { "content": "Dr. Ashish Jha to Keynote American Urological Association's Annual Urology Advocacy Summit", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: NEW YORK, April 7, 2021 /PRNewswire/ --OTC Markets Group Inc.(OTCQX: OTCM), operator of financial markets for 11,000 U.S. and global securities, today announced Tiger Brokers, a leading stock brokerage in Asia that allows customers to buy and sell stocks from all over the world, as a new distributor of OTC Markets' Real-Time Level 2+ Quotes. With this agreement, Tiger Broker's clients now have convenient access to real-time depth of book pricing for OTCQX, OTCQB and Pink market securities to assist in trading and investment decision-making. This agreement increases the availability of data on OTC equity securities to Tiger Broker's platform of investors. \"We are pleased that Tiger Broker's trading platform now provides customers the benefit of additional access to real-time data on over 11,000 OTCQX, OTCQB and Pink securities,\" said Matthew Fuchs, Executive Vice President of Market Data and Strategy at OTC Markets Group. \"Providing key real-time data points to analyze, value and trade the expansive roster of OTC equities increases subscriber options and further supports Tiger Broker's mission of leveraging technology to encourage participation in the financial markets.\" \"At Tiger Brokers, we are dedicated to providing the best trading experience to our customers,\" stated Mr. Wu Tianhua, the company's founder and CEO. \"Our alliance with OTC Markets Group will give our customers an edge with detailed insights into the OTC market, assisting them to make more informed trading decisions.\" OTC Markets Group's Market Data provides mission-critical data tobroker-dealers, compliance, and risk management teams. As the primary market operator, we deliver the most comprehensive, contextual, real-time and analytical data on OTCQX, OTCQB and Pink securities. For more about OTC Markets Group's market data products, including connectivity information, visit https://www.otcmarkets.com/market-data/overview. To contact OTC Markets Market Data, call +1 (212) 220-2166 or e-mail [emailprotected]. About Tiger Brokers Foundedin2014,TigerBrokers (NASDAQ:TIGR)isa leading global online broker. Tiger uses its next generation technology to enable clients to trade a wide range of securities across multiple global markets and currencies. Clients may use Tiger's flagship mobile trading APP, Tiger Trade, to trade equities in The U.S., Hong Kong, Singapore, and Australia as well as futures, options, and funds. Tiger Brokers has offices in Singapore, New York, Beijing, Auckland, and Sydney and employees over 800 people. The firm presently holds brokerage licenses in Singapore, The U.S., New Zealand, and Australia. To learn more about the company, please go to www.itiger.com About OTC Markets Group Inc.OTC Markets Group Inc.(OTCQX: OTCM) operates the OTCQX Best Market, the OTCQB Venture Market and the Pink Open Market for over 11,000 U.S. and global securities. Through OTC Link ATS and OTC Link ECN, we connect a diverse network of broker-dealers that provide liquidity and execution services. We enable investors to easily trade through the broker of their choice and empower companies to improve the quality of information available for investors. To learn more about how we create better informed and more efficient markets, visit www.otcmarkets.com. OTC Link ATS and OTC Link ECN are SEC regulated ATSs, operated by OTC Link LLC, member FINRA/SIPC. Subscribe to the OTC Markets RSS Feed Media Contact: OTC Markets Group Inc., +1 (212) 896-4428,[emailprotected] SOURCE OTC Markets Group Inc. Related Links http://www.otcmarkets.com", "role": "user" }, { "content": "OTC Markets Group Adds Tiger Brokers as Distributor of Real-Time Level 2+ Quotes", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: BANGKOK--(BUSINESS WIRE)--Novo Nordisk Thailand, an affiliate of the global healthcare company with more than 90 years of innovation and leadership in diabetes care, has been recognized as one of the best companies to work in Thailand in 2020. The company offers an award-winning culture, advancement opportunities, career training, high-level mentoring, wellness initiatives and competitive benefits resulting in its recognition among the employers of choice in Thailand. According to the company results, 92% of the employees said it's a great workplace compared to 80% in a typical Thai organization. \"We're honored to be among the best companies to work for in Thailand,\" said John Dawber, Novo Nordisks GM for Thailand. \"I am truly humbled by this result because this is based on anonymous responses collected from our valued employees. We work hard every day to ensure that we are providing an environment where our people can enjoy where they work and be successful. This award recognizes the contribution of every single one of our employees We strive to create a family culture where all of our employees flourish. Participation in the program was important because it provided us valuable feedback in terms of what we are doing right as well as the areas where we can evolve to continue to meet our employees needs. Our employees are the backbone to our success and we thank them all for their immense contribution to our company culture said Vera Bakirova, HR Director for Novo Nordisk Thailand. \"Despite the disruption brought about by the pandemic, Novo Nordisk Thailand succeeded in earning the trust of their employees, creating a great workplace culture that delivers outstanding business results said Hamza Idrissi, Program Manager for APAC. ABOUT BEST PLACES TO WORK PROGRAM Best Places To Work is a global certification program that recognizes leading workplaces in many countries around the world. Our proprietary assessment analyzes a companys attractiveness through a two-step process focusing on 8 Workplace factors including culture, leadership, opportunities for growth and people practices. Beside the employee satisfaction survey, we conduct an HR assessment focusing on HR practices implemented in the organization against our people framework standard proven to deliver market-leading revenue and increased innovation. For more information, please visit www.bestplacestoworkfor.org", "role": "user" }, { "content": "Novo Nordisk Thailand certified as a Best Place To Work in 2020", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: WICHITA, Kan.--(BUSINESS WIRE)--CURO Group Holdings Corp. (NYSE: CURO) (CURO or the Company), a tech-enabled, multi-channel and multi-product consumer finance company serving a wide range of non-prime and prime consumers in the U.S. and Canada and a market leader in the industry based on revenue, today announced financial results for its first quarter ended March 31, 2021. We are pleased to report very strong earnings as the credit quality of our loan portfolio continued to remain at historically strong levels in the first quarter of 2021, said Don Gayhardt, CURO's Chief Executive Officer. While we typically experience normal seasonal loan balance declines across all products in the first quarter, our Canada Direct Lending segment delivered sequential loan growth of $13.4 million, or 4.1%, and year-over-year loan growth of 24.4%. U.S. results continue to be affected by COVID-19, mainly the third government stimulus payments in March 2021. While stimulus and U.S. federal income tax refunds reduce loan demand, they also drive exceptional credit performance and payment rates. Also, we closed our acquisition of Flexiti on March 10, 2021. Flexiti grew originations 69.0% year-over-year in the first quarter and added several new merchant partnerships. The combination of CUROs and Flexitis complementary, market-leading businesses in Canada position us well to drive revenue growth and create long-term shareholder value. We expect to see the Katapult and FinServ merger close by the end of the second quarter and we continue to be excited about the benefits of this merger, which will increase our balance sheet flexibility while maintaining a meaningful representation on Katapults board. The total value of our stake, before taxes and based on FinServs stock price as of April 30, 2021, is approximately $445 million, including earn-out shares. Finally, we are very pleased to announce that Philip Gitler has joined us as EVP and Chief Strategy Officer. Phil has a long career in corporate and asset-backed finance and he has deep familiarity with our company and our industry. We think that he is very well-suited to help us execute on our strategic priorities, particularly as it relates to M&A, strategic investments and organic growth opportunities. Consolidated Summary Results - Unaudited Three Months Ended March 31, (in millions, except per share data) 2021 2020 Variance Revenue $ 196.6 $ 280.8 (30.0) % Net Revenue 160.4 167.3 (4.1) % Company Owned gross loans receivable 731.0 564.4 29.5 % Unrestricted Cash 135.4 138.7 (2.4) % Net income 25.7 36.3 (29.2) % Adjusted Net Income (1) 30.1 32.3 (6.8) % Diluted Earnings per Share from continuing operations $ 0.59 $ 0.86 (31.4) % Adjusted Diluted Earnings per Share from continuing operations (1) $ 0.69 $ 0.77 (10.4) % EBITDA (1) 58.7 59.8 (1.8) % Adjusted EBITDA (1) 63.8 65.8 (3.0) % Weighted Average Shares diluted 43.6 41.9 (1) These are non-GAAP metrics. For a reconciliation of each non-GAAP metric to the nearest GAAP metric, see the applicable reconciliations contained under \"Results of Operations.\" For a description of each non-GAAP metric, see \"Non-GAAP Financial Measures.\" First quarter 2021 and recent developments include: Tables throughout this release may not foot or cross-foot due to rounding. Consolidated Revenue by Product and Segment The following table summarizes revenue by product, including credit services organization (\"CSO\") fees, for the period indicated: Three Months Ended March 31, 2021 March 31, 2020 (in millions, unaudited) U.S. Canada Direct Lending Canada POS Lending Total % of Total U.S. Canada Direct Lending Canada POS Lending Total % of Total Revolving LOC $ 26.9 $ 34.4 $ 1.4 $ 62.7 31.9 % $ 42.0 $ 29.0 $ $ 71.0 25.3 % Installment 105.9 10.4 116.4 59.2 % 175.3 18.6 193.9 69.0 % Ancillary 3.6 13.6 0.2 17.5 8.9 % 4.5 11.5 16.0 5.7 % Total revenue $ 136.5 $ 58.4 $ 1.6 $ 196.6 100.0 % $ 221.8 $ 59.0 $ $ 280.8 100.0 % During the three months ended March 31, 2021, total revenues declined $84.3 million, or 30.0%, to $196.6 million, compared to the prior-year period. U.S. and Canada Direct Lending revenues declined 38.5% and 1.0%, respectively. Since the onset of COVID-19, we have experienced lower customer demand and favorable credit performance, including increased or accelerated repayments and favorable payment trends as customers benefited from government stimulus programs (collectively \"COVID-19 Impacts\"). COVID-19 Impacts on U.S. results for the current quarter were more pronounced due to additional government stimulus programs in late March 2021 and slower reopening of major markets during 2020. In Canada, effects of the pandemic and related government responses were mitigated by the growth and maturation of Revolving LOC products and more focused and limited stimulus. Canada Direct Lending Revolving LOC gross loans receivable grew $79.0 million, or 32.9%, year over year, contributing to related revenue growth of $5.4 million, or 18.5% for the three months ended March 31, 2021 compared to the three months ended March 31, 2020. We recognized $1.6 million of Canada POS Lending revenue for the Flexiti post-acquisition period of March 10, 2021 to March 31, 2021. Canada POS Lending revenue includes merchant discount revenue, which is unearned when received and recognized over the life of the credit card loan term. Unearned revenue is not recognized in purchase accounting and, therefore, merchant discount revenue recognized as of March 31, 2021 relates to merchant fees received after the acquisition of Flexiti. From a product perspective, Revolving LOC revenue for the three months ended March 31, 2021 decreased $8.3 million, or 11.7%, year over year, primarily driven by a decline in U.S. revenue, partially offset by growth in Canada Direct Lending revenue of $5.4 million, or 18.5%, and Canada POS lending of $1.4 million. For the three months ended March 31, 2021, Installment revenue decreased $77.5 million, or 40.0%, compared to the prior-year period, as a result of COVID-19 impacts and normal seasonality. Ancillary revenue increased $1.5 million, or 9.5% versus the prior-year period, primarily due to the sale of insurance products to Revolving LOC and Installment loan customers in Canada. The following table presents online revenue and online transaction compositions, including CSO fees, of the products and services that we currently offer within the U.S. and Canada Direct Lending segments: Three Months Ended March 31, 2021 2020 Online revenues as a percentage of consolidated revenue 50.9 % 47.5 % Online transactions as a percentage of consolidated transactions 60.2 % 48.2 % Online revenue as a percentage of consolidated revenue increased during the three months ended March 31, 2021 due to COVID-19 Impacts and the resulting transition of customers using our online channel which allows for a safe and contactless option. Consolidated Loans Receivable The following table reconciles Company Owned gross loans receivable, a GAAP-basis balance sheet measure, to Gross combined loans receivable, a non-GAAP measure(1). Gross combined loans receivable includes loans originated by third-party lenders through CSO programs, which are not included in the Condensed Consolidated Financial Statements but from which we earn revenue by providing a guarantee to the unaffiliated lender. As of (in millions, unaudited) March 31, 2021 December 31, 2020 September 30, 2020 June 30, 2020 March 31, 2020 U.S. Revolving LOC $ 43.4 $ 55.6 $ 56.7 $ 52.2 $ 73.7 Installment - Company Owned 142.4 167.9 148.6 146.5 214.4 Canada Direct Lending Revolving LOC 319.3 303.3 265.5 231.9 240.3 Installment 24.4 26.9 26.6 24.9 36.0 Canada POS Lending Revolving LOC 201.5 Company Owned gross loans receivable $ 731.0 $ 553.7 $ 497.4 $ 455.5 $ 564.4 Gross loans receivable Guaranteed by the Company 32.4 44.1 39.8 34.1 55.9 Gross combined loans receivable (1) $ 763.5 $ 597.8 $ 537.2 $ 489.6 $ 620.4 (1) See \"Non-GAAP Financial Measures\" at the end of this release for definition and more information. Gross combined loans receivable increased $143.1 million, or 23.1%, to $763.5 million as of March 31, 2021, from $620.4 million as of March 31, 2020. The increase was driven by Canada Direct Lending growth of $67.4 million, or 24.4%, and Canada POS Lending gross loans receivables of $201.5 million related to the acquisition of Flexiti. Excluding Flexiti loan balances, gross combined loans receivable were down 9.4% year over year. U.S. gross combined loans receivable declined $125.8 million, or 36.6%, due to COVID-19 Impacts and additional government stimulus in the first quarter of 2021. Excluding Flexiti loans, gross loans receivable decreased sequentially $35.9 million, or 6.0%, with Canada Direct Lending growing $13.4 million, or 4.1%, and the U.S. declining $49.3 million, or 18.4%, as a result of U.S. government stimulus in the first quarter of 2021 and federal income tax seasonality. Gross combined loans receivable performance by product is described further in the following sections. Results of Consolidated Operations Condensed Consolidated Statements of Operations (in millions, unaudited) Three Months Ended March 31, 2021 2020 Change $ Change % Revenue $ 196.6 $ 280.8 ($ 84.3 ) (30.0 )% Provision for losses 36.1 113.5 (77.4 ) (68.2 )% Net revenue 160.4 167.3 (6.9 ) (4.1 )% Advertising 8.1 12.2 (4.1 ) (33.8 )% Non-advertising costs of providing services 50.3 55.4 (5.0 ) (9.1 )% Total cost of providing services 58.4 67.6 (9.2 ) (13.6 )% Gross margin 102.0 99.7 2.3 2.3 % Operating expense Corporate, district and other expenses 48.8 42.8 6.0 14.1 % Interest expense 19.5 17.3 2.2 12.8 % (Income) loss from equity method investment (0.5 ) 1.6 (2.2 ) # Total operating expense 67.8 61.7 6.1 9.9 % Income from continuing operations before income taxes 34.2 38.0 (3.8 ) (9.9 )% Provision for income taxes 8.4 1.9 6.5 # Net income from continuing operations 25.7 36.0 (10.3 ) (28.5 )% Net income from discontinued operations, net of tax 0.3 (0.3 ) # Net income $ 25.7 $ 36.3 ($ 10.6 ) (29.1 )% # - Variance greater than 100% or not meaningful Reconciliation of Net Income from Continuing Operations and Diluted Earnings per Share to Adjusted Net Income and Adjusted Diluted Earnings per Share, non-GAAP measures (in millions, except per share data, unaudited) Three Months Ended March 31, 2021 2020 Change $ Change % Net income from continuing operations $ 25.7 $ 36.0 ($ 10.3 ) (28.5 )% Adjustments: Legal and other costs (1) 0.9 (Income) loss from equity method investment (2) (0.5 ) 1.6 Transaction costs (3) 3.2 0.2 Share-based compensation (4) 2.7 3.2 Intangible asset amortization (5) 0.8 0.7 Impact of tax law changes (6) (9.1 ) Cumulative tax effect of adjustments (7) (1.7 ) (1.3 ) Adjusted Net Income $ 30.1 $ 32.3 ($ 2.1 ) (6.7 )% Net income from continuing operations $ 25.7 $ 36.0 Diluted Weighted Average Shares Outstanding 43.6 41.9 Diluted Earnings per Share from continuing operations $ 0.59 $ 0.86 ($ 0.27 ) (31.4 )% Per Share impact of adjustments to Net income from continuing operations 0.10 (0.09 ) Adjusted Diluted Earnings per Share $ 0.69 $ 0.77 ($ 0.08 ) (10.4 )% Note: Footnotes follow Reconciliation of Net income table immediately below Reconciliation of Net Income from Continuing Operations to EBITDA and Adjusted EBITDA, Non-GAAP Measures (in millions, unaudited) Three Months Ended March 31, 2021 2020 Change $ Change % Net income from continuing operations $ 25.7 $ 36.0 ($ 10.3 ) (28.5 )% Provision for income taxes 8.4 1.9 6.5 # Interest expense 19.5 17.3 2.2 12.8 % Depreciation and amortization 5.0 4.5 0.4 9.4 % EBITDA 58.7 59.8 (1.1 ) (1.9 )% Legal and other costs (1) 0.9 (Income) loss from equity method investment (2) (0.5 ) 1.6 Transaction costs (3) 3.2 0.2 Share-based compensation (4) 2.7 3.2 Other adjustments (8) (0.2 ) Adjusted EBITDA $ 63.8 $ 65.8 ($ 2.0 ) (3.1 )% Adjusted EBITDA Margin 32.4 % 23.4 % (1) Legal and other costs for the three months ended March 31, 2020 included (i) costs for certain securities litigation and related matters and (ii) severance costs for certain corporate employees. (2) The amounts reported includes our share of the estimated U.S. GAAP net (income) loss of Katapult. (3) Transaction costs for the three months ended March 31, 2021 relate to the acquisition of Flexiti and for the three months ended March 31, 2020 relate to the acquisition of Ad Astra. (4) The estimated fair value of share-based awards is recognized as non-cash compensation expense on a straight-line basis over the vesting period. (5) The amortization expense on intangible assets is recognized on a straight-line basis over the life of the intangible asset. (6) On March 27, 2020, the Coronavirus Aid, Relief and Economic Security Act (\"CARES Act\") was enacted by the U.S. Federal government in response to the COVID-19 pandemic. The CARES Act, among other things, allows NOLs incurred in 2018, 2019 and 2020 to be carried back to each of the five preceding taxable years to generate a refund of previously paid income taxes. For the three months ended March 31, 2020, we recorded an income tax benefit of $9.1 million related to the carryback of NOL from tax years 2018 and 2019. (7) Cumulative tax effect of adjustments included in Reconciliation of Net income from continuing operations to EBITDA and Adjusted EBITDA table is calculated using the estimated incremental tax rate by country. (8) Other adjustments primarily include the intercompany foreign-currency exchange impact. For the Three Months Ended March 31, 2021 and 2020 Revenue and Net Revenue Revenue decreased 30.0% to $196.6 million for the three months ended March 31, 2021, from $280.8 million for the three months ended March 31, 2020, as a result of the decline in U.S. and Canada Direct Lending gross loan receivables discussed previously. Year over year, U.S. and Canada Direct Lending revenues decreased 38.5% and 1.0% (6.6% on a constant-currency basis), respectively, partially offset by $1.6 million of Canada POS Lending revenue from Flexiti after closing the acquisition. As previously mentioned, COVID-19 Impacts on year over year results for Canada were less pronounced compared to the U.S. due to continued growth of our Revolving LOC loans in Canada. Provision for losses decreased by $77.4 million, or 68.2%, for the three months ended March 31, 2021 compared to the prior-year period. The decrease in provision for loan losses was due to lower loan balances in the U.S. in 2021, resulting from COVID-19 Impacts, compared to 2020 and significantly improved NCO rates year over year in both the U.S. and Canada Direct Lending segments as discussed in more detail in the \"Segment Analysis\" sections. Cost of Providing Services Non-advertising costs of providing services decreased $5.0 million, or 9.1%, to $50.3 million in the three months ended March 31, 2021, compared to $55.4 million in the three months ended March 31, 2020. The decrease was due to lower underwriting and other variable costs as a result of lower volume and lower collection costs stemming from stimulus-related repayments. Advertising costs decreased $4.1 million, or 33.8%, year over year in response to product demand changes resulting from COVID-19. Corporate, District and Other Expenses Corporate, district and other expenses were $48.8 million for the three months ended March 31, 2021, an increase of $6.0 million, or 14.1%, compared to the three months ended March 31, 2020. The increase year over year was primarily due to (i) transaction costs related to the acquisition of Flexiti, (ii) $2.6 million of Flexiti operating expenses post-closing, and (iii) the timing and extent of variable compensation compared to the prior-year period. These expenses were partially offset by travel and other cost reductions, including work-from-home initiatives. Refer to the \"Segment Analysis\" sections below for further details. Equity Method Investment Refer to the \"Katapult Update for the Three Months Ended March 31, 2021 and 2020\" below for details. Interest Expense Interest expense for the three months ended March 31, 2021 increased $2.2 million, or 12.8%, on higher year-over-year borrowings. Provision for Income Taxes The effective income tax rate for the three months ended March 31, 2021 was 24.7%. The effective income tax rate was slightly lower than the federal and state/provincial statutory rates of approximately 26% primarily as the result of several non-taxable events. Refer to the \"Reconciliation of Net Income from Continuing Operations and Diluted Earnings per Share to Adjusted Net Income and Adjusted Diluted Earnings per Share, non-GAAP measures\" for additional information. The effective income tax rate of adjusted tax expense included in the Adjusted Net Income for the three months ended March 31, 2021 was 25.5%. Katapult Update for the Three Months Ended March 31, 2021 and 2020 A portion of our investment in Katapult is accounted for using the equity method of accounting and is included in \"Investments in Katapult\" on the unaudited Condensed Consolidated Balance Sheet. Our recognized share of Katapult's earnings was $0.5 million for the first quarter of 2021 compared to losses of $1.6 million for the three months ended March 31, 2020. We recognize our share of Katapults earnings on a one-quarter lag. In December 2020, we announced that Katapult and FinServ entered into a merger agreement that, when completed, we expect will provide consideration to us in a combination of cash and stock. Based on market prices as of the date of this release, we expect to receive consideration with a total value of approximately $445 million. To date, our total cash investment in Katapult is $27.5 million. Upon closing of the merger, we anticipate receiving cash of up to $130 million while maintaining at least a 21% ownership, on a fully-diluted basis, in the newly formed public company. The transaction is expected to close by the end of the second quarter and remains subject to approval by FinServ's stockholders and other customary closing conditions. The transaction will result in both a cash tax liability and deferred tax liability, with the cash tax liability dependent upon cash received at closing. Assuming cash proceeds to us of $130 million, our estimated cash tax liability would be approximately $35 million. The table below presents select financial information for Katapult for the periods presented: For the Year Ended December 31, (1) (in millions) 2020 2019 Revenue $ 247.2 $ 91.9 Cost of revenue 167.4 71.2 Gross profit 79.8 20.7 Operating expenses 42.9 30.0 Interest and loss on extinguishment of debt 13.9 9.4 Income before income taxes 23.0 (18.8 ) Net income $ 22.5 ($ 18.8 ) Originations $ 192.1 $ 87.7 Cash and restricted cash $ 69.6 $ 12.2 Gross property held for lease $ 213.8 $ 110.4 (1) Source: FinServ's Registration Statement on Form S-4, pages F-24, F-28, F-36 and 98, filed with the SEC on April 2, 2021. Segment Analysis Following the acquisition of Flexiti on March 10, 2021, we report financial results for three reportable segments: U.S., Canada Direct Lending and Canada POS Lending, instead of our prior U.S. and Canada segments. Following is a summary of portfolio performance and results of operations for the segment and period indicated. U.S. Portfolio Performance (in millions, except percentages) Q1 2021 Q4 2020 Q3 2020 Q2 2020 Q1 2020 Gross combined loans receivable (1) Revolving LOC $ 43.4 $ 55.6 $ 56.7 $ 53.2 $ 73.7 Installment loans - Company Owned 142.4 167.9 148.6 146.5 214.4 Total U.S. Company Owned gross loans receivable 185.8 223.5 205.3 199.7 288.1 Installment loans - Guaranteed by the Company (2) 32.4 44.1 39.8 34.1 55.9 Total U.S. gross combined loans receivable (1) $ 218.2 $ 267.6 $ 245.1 $ 233.8 $ 344.0 Lending Revenue: Revolving LOC $ 26.9 $ 31.1 $ 30.4 $ 30.9 $ 42.0 Installment loans - Company Owned 64.5 68.9 62.2 65.1 107.2 Installment loans - Guaranteed by the Company (2) 41.4 43.0 36.7 37.8 68.1 Total U.S. lending revenue $ 132.9 $ 143.0 $ 129.4 $ 133.8 $ 217.3 Lending Provision: Revolving LOC $ 5.0 $ 11.6 $ 11.9 $ 12.0 $ 19.3 Installment loans - Company Owned 11.2 24.6 16.3 17.6 39.8 Installment loans - Guaranteed by the Company (2) 9.6 22.6 14.9 11.7 26.4 Total U.S. lending provision $ 25.8 $ 58.8 $ 43.1 $ 41.2 $ 85.5 Lending Net Revenue Revolving LOC $ 21.9 $ 19.5 $ 18.5 $ 18.9 $ 22.7 Installment loans - Company Owned 53.4 44.3 46.0 47.6 67.4 Installment loans - Guaranteed by the Company (2) 31.8 20.4 21.8 26.0 41.7 Total U.S. lending net revenue $ 107.0 $ 84.2 $ 86.3 $ 92.5 $ 131.8 NCOs Revolving LOC $ 9.9 $ 12.5 $ 10.6 $ 20.1 $ 21.2 Installment loans - Company Owned 17.3 19.6 16.8 29.9 47.7 Installment loans - Guaranteed by the Company (2) 12.2 21.6 13.9 15.7 27.8 Total U.S. NCOs $ 39.4 $ 53.7 $ 41.3 $ 65.7 $ 96.8 NCO rate (3) Revolving LOC 20.0% 22.3% 19.3% 31.7% 27.0% Installment loans - Company Owned 11.2% 12.4% 11.4% 16.6% 19.3% Total U.S. Company Owned NCO rate 13.3% 15.0% 13.5% 20.5% 21.2% Installment loans - Guaranteed by the Company (2) 31.7% 51.5% 37.6% 35.0% 42.0% Total U.S. NCO rate 16.2% 21.0% 17.2% 22.8% 24.7% ALL and CSO Liability for Losses (4) Revolving LOC $ 14.3 $ 19.2 $ 20.1 $ 18.8 $ 26.9 Installment loans - Company Owned 25.8 32.0 27.0 27.1 39.8 Installment loans - Guaranteed by the Company (2) 4.7 7.2 6.2 5.2 9.2 Total U.S. ALL and CSO Liability for Losses $ 44.9 $ 58.4 $ 53.3 $ 51.1 $ 75.9 ALL and CSO Liability for Losses rate (5) Revolving LOC 33.0% 34.5% 35.4% 35.3% 36.5% Installment loans - Company Owned 18.1% 19.0% 18.1% 18.5% 18.6% Total U.S. Company Owned ALL rate 21.6% 22.9% 22.9% 23.0% 23.2% Installment loans - Guaranteed by the Company (2) 14.6% 16.4% 15.6% 15.1% 16.4% Total ALL and CSO Liability for Losses rate 20.6% 21.8% 21.7% 21.8% 22.1% Past-due rate (5) Revolving LOC 26.3% 30.7% 27.9% 26.6% 36.2% Installment loans - Company Owned 18.0% 19.0% 16.6% 17.6% 22.7% Total U.S. Company Owned past-due rate 19.9% 21.9% 19.8% 20.0% 26.2% Installment loans - Guaranteed by the Company (2) 12.8% 14.1% 15.4% 12.1% 17.1% (1) Non-GAAP measure. For a description of each non-GAAP metric, see \"Non-GAAP Financial Measures.\" (2) Includes loans originated by third-party lenders through CSO programs. Installment gross loans receivable Guaranteed by the Company are not included in the Condensed Consolidated Financial Statements. (3) We calculate NCO rate as total NCOs divided by Average gross loans receivables. (4) We report allowance for loan losses (\"ALL\") as a contra-asset reducing gross loans receivable and the CSO Liability for Losses as a liability on the Condensed Consolidated Balance Sheets. (5) We calculate (i) ALL and CSO Liability for losses rate and (ii) past-due rate as the respective totals divided by gross loans receivable at each respective quarter end. U.S. Net Revenue U.S. revenues decreased by $85.3 million, or 38.5%, to $136.5 million, compared to the prior-year period for the three months ended March 31, 2021, as a result of the COVID-19 related declines in gross combined loans receivable and normal seasonality. See the loan performance discussions below for further details on regulatory impacts. The provision for losses decreased $60.0 million, or 69.7%, primarily as a result of lower loan volume and lower NCOs from COVID-19 Impacts as previously described. U.S. NCOs, including loans Guaranteed by the Company, decreased by $57.4 million, or 59.3% year over year, and the U.S. NCO rate improved from 24.7% in the prior year to 16.2% for the three months ended March 31, 2021. U.S. Revolving LOC loan performance U.S. Revolving LOC loan balances as of March 31, 2021 decreased $30.3 million, or 41.1%, compared to the prior year, resulting in a related revenue decrease of $15.1 million, or 35.9%, primarily due to COVID-19 Impacts and the conversion of Virginia Revolving LOC loans to Installment loans in response to regulatory changes effective January 1, 2021. The Revolving LOC ALL as a percentage of Revolving LOC gross loans receivable (\"allowance coverage\") decreased year over year from 36.5% to 33.0% for the three months ended March 31, 2021. The decrease was due to sustained favorable trends in NCOs throughout 2020 and the first quarter of 2021, and lower past-due rates compared to historical trends. Year over year, NCO rates improved 700 bps and past-due rates improved 990 bps. Sequentially, NCO rates improved by 225 bps, or 10.1%, and past-due rates improved by 440 bps, or 14.5%. U.S. Installment loan performance - Company Owned U.S. Installment loan balances as of March 31, 2021 decreased $72.0 million, or 33.6%, and revenue decreased $42.7 million, or 39.8%, compared to the prior year, primarily due to COVID-19 Impacts and regulatory changes in California, effective January 1, 2020 that affected multi-pay installment products. Excluding the impacted California loans, U.S. Installment loans decreased $24.6 million, or 18.3%, year over year. The Installment loans allowance coverage decreased from 18.6% in the prior year to 18.1% as of March 31, 2021, largely due to sustained favorable trends in NCOs and lower past-due rates, partially offset by growth in the Verge Credit brand. We launched Verge installment loans originated by Stride Bank in the fourth quarter of 2019 and have executed pilot programs in several states. After testing various offers, rates, terms and approval criteria, Stride has informed us that it plans to focus on near-prime loans as they represent a larger addressable market and offer greater opportunity to scale. As a result, Stride has decided to discontinue new Verge Credit loans. Verge loan balances totaled $29.7 million as of March 31, 2021. We expect an orderly run-off of these balances over the next 24 months. We continue to maintain various relationships with Stride and are working together to develop additional products that meet customer needs. Year over year, NCO rates and past-due rates improved by 800 bps and 475 bps, respectively. Sequentially, allowance coverage decreased from 19.0% to 18.1% primarily from (i) lower NCOs, (ii) a decline in TDR loans as a percentage of total gross loans receivable, and (iii) lower past-due gross loans receivable as a percentage of total gross loans receivable compared to historical trends. U.S. Installment loan performance - Guaranteed by the Company U.S. Installment loans Guaranteed by the Company declined $23.5 million, or 42.0%, year over year, primarily due to COVID-19 Impacts, which includes effects of the government stimulus in the first quarter of 2021. The allowance rate decreased 180 bps year over year due to sustained favorable NCO trends and lower past-due gross loans receivable compared to historical trends. Sequentially, allowance coverage and past-due balances declined from 16.4% to 14.6% and from 14.1% to 12.8%, respectively, for the three months ended March 31, 2021. NCO rates improved year over year from 42.0% to 31.7%, and sequentially from 51.5% to 31.7%, as a result of government stimulus-related pay-downs during the first quarter of 2021. Following is a summary of results of operations for the U.S. segment for the periods indicated. U.S. Results of Operations (dollars in millions, unaudited) Three Months Ended March 31, 2021 2020 Change $ Change % Revenue $ 136.5 $ 221.8 ($ 85.3 ) (38.5 )% Provision for losses 26.1 86.0 (60.0 ) (69.7 )% Net revenue 110.4 135.7 (25.3 ) (18.6 )% Advertising 7.1 10.9 (3.8 ) (34.8 )% Non-advertising costs of providing services 32.2 37.2 (5.1 ) (13.7 )% Total cost of providing services 39.3 48.2 (8.9 ) (18.5 )% Gross margin 71.1 87.5 (16.4 ) (18.7 )% Corporate, district and other expenses 40.6 37.7 2.9 7.8 % Interest expense 16.4 14.8 1.5 10.2 % (Income) loss from equity method investment (0.5 ) 1.6 (2.2 ) # Total operating expense 56.4 54.1 2.3 4.2 % Segment operating income 14.7 33.4 (18.7 ) (55.9 )% Interest expense 16.4 14.8 1.5 10.2 % Depreciation and amortization 3.1 3.4 (0.3 ) (7.4 )% EBITDA (1) 34.2 51.6 (17.4 ) (33.8 )% Legal and other costs 0.9 (0.9 ) Transaction costs 3.2 0.2 2.9 (Income) loss from equity method investment (0.5 ) 1.6 (2.2 ) Share-based compensation 2.7 3.2 (0.5 ) Other adjustments (0.2 ) (0.1 ) (0.1 ) Adjusted EBITDA (1) $ 39.3 $ 57.5 ($ 18.2 ) (31.7 )% (1) These are non-GAAP metrics. For a description of each non-GAAP addback, see the applicable reconciliations contained under \"Results of Consolidated Operations.\" For a description of each non-GAAP metric, see \"Non-GAAP Financial Measures.\" # - Variance greater than 100% or not meaningful. U.S. Segment Results - For the Three Months Ended March 31, 2021 and 2020 For a discussion of revenue, provision for losses and related gross combined loans receivables, see \"U.S. Portfolio Performance,\" above. Non-advertising costs of providing services for the three months ended March 31, 2021 were $32.2 million, a decrease of $5.1 million, or 13.7%, compared to $37.2 million for the three months ended March 31, 2020. The decrease was primarily driven by (i) lower underwriting and other variable costs as a result of COVID-19 related demand constraints and (ii) lower collection costs resulting from government stimulus-related repayments. Advertising costs decreased $3.8 million, or 34.8%, year over year in response to demand changes resulting from COVID-19. Corporate, district and other expenses were $40.6 million for the three months ended March 31, 2021, an increase of $2.9 million, or 7.8%, compared to the prior-year period. The year-over-year increase was primarily due to transaction costs related to the acquisition of Flexiti and the timing and extent of variable compensation compared to the prior-year period. These expenses were partially offset by certain cost reductions, including work-from-home initiatives. U.S. interest expense for the three months ended March 31, 2021 increased $1.5 million, or 10.2%, primarily related to the Non-Recourse U.S. SPV Facility, which we closed in April 2020. As previously described, we recognize our share of Katapults income on a one-quarter lag and recorded income of $0.5 million for the three months ended March 31, 2021. Canada Direct Lending and Canada POS Lending Portfolio Performance (in millions, except percentages) Q1 2021 Q4 2020 Q3 2020 Q2 2020 Q1 2020 Gross loans receivable Canada Direct Lending Revolving LOC $ 319.3 $ 303.3 $ 265.5 $ 231.9 $ 240.3 Canada Direct Lending Installment loans 24.4 26.9 26.6 24.9 36.0 Total Canada Direct Lending gross loans receivable $ 343.7 $ 330.2 $ 292.1 $ 256.8 $ 276.3 Total Canada POS Lending gross loans receivable $ 201.5 $ $ $ $ Lending Revenue: Canada Direct Lending Revolving LOC $ 34.4 $ 32.0 $ 28.3 $ 25.8 $ 29.0 Canada Direct Lending Installment loans 10.4 11.1 10.2 9.7 18.6 Total Canada Direct Lending - lending revenue $ 44.8 $ 43.1 $ 38.5 $ 35.5 $ 47.6 Canada POS Lending - lending revenue $ 1.4 $ $ $ $ Lending Provision: Canada Direct Lending Revolving LOC $ 7.9 $ 8.7 $ 9.8 $ 9.4 $ 21.7 Canada Direct Lending Installment loans 1.2 2.0 1.4 (0.3 ) 5.7 Total Canada Direct Lending - lending provision $ 9.1 $ 10.7 $ 11.2 $ 9.1 $ 27.4 Canada POS Lending - lending provision $ 0.9 $ $ $ $ Lending Net Revenue Canada Direct Lending Revolving LOC $ 26.5 $ 23.3 $ 18.5 $ 16.5 $ 7.3 Canada Direct Lending Installment loans 9.2 9.1 8.8 10.0 12.9 Total Canada Direct Lending - lending net revenue $ 35.7 $ 32.4 $ 27.3 $ 26.5 $ 20.2 Canada POS Lending - lending net revenue $ 0.5 $ $ $ $ NCOs Canada Direct Lending Revolving LOC $ 11.1 $ 8.9 $ 7.6 $ 11.6 $ 15.9 Canada Direct Lending Installment loans 1.7 2.1 1.3 1.4 5.8 Total Canada Direct Lending NCOs $ 12.8 $ 11.0 $ 8.9 $ 13.0 $ 21.7 Canada POS Lending NCOs $ 0.2 $ $ $ $ NCO rate (1) Canada Direct Lending Revolving LOC 3.6 % 3.1 % 3.0 % 4.9 % 6.4 % Canada Direct Lending Installment loans 6.5 % 7.7 % 5.0 % 4.6 % 13.5 % Total Canada Direct Lending NCO rate 3.8 % 3.5 % 3.2 % 4.9 % 7.5 % Canada POS Lending NCO rate NM (2) % % % % ALL (3) Canada Direct Lending Revolving LOC $ 29.9 $ 32.8 $ 31.3 $ 28.5 $ 29.6 Canada Direct Lending Installment loans 1.8 2.2 2.2 2.0 3.6 Total Canada Direct Lending ALL $ 31.7 $ 35.0 $ 33.5 $ 30.5 $ 33.2 Canada POS Lending ALL (4) $ 0.5 $ $ $ $ ALL rate (5) Canada Direct Lending Revolving LOC 9.4 % 10.8 % 11.8 % 12.3 % 12.3 % Canada Direct Lending Installment loans 7.5 % 8.3 % 8.3 % 8.1 % 9.9 % Total Canada Direct Lending ALL rate 9.2 % 10.6 % 11.5 % 11.9 % 12.0 % Canada POS Lending ALL rate 0.3 % % % % % Past-due rate (5) Canada Direct Lending Revolving LOC 6.4 % 6.8 % 6.0 % 7.3 % 9.7 % Canada Direct Lending Installment loans 2.1 % 2.1 % 2.9 % 3.7 % 4.1 % Total Canada Direct Lending past-due rate 6.1 % 6.4 % 5.7 % 7.0 % 9.0 % Canada POS Lending past-due rate 5.7 % % % % % (1) We calculate NCO rate as total NCOs divided by Average gross loans receivables. (2) Not material or not meaningful. (3) We report ALL as a contra-asset reducing gross loans receivable on the Condensed Consolidated Balance Sheets. (4) Loans originated pre-acquisition have been adjusted to fair value at the acquisition date and included estimates of future losses. The ALL represents estimated incurred losses for loans originated after acquisition plus an incurred losses for acquired loans in excess of the remaining fair value discount. (5) We calculate ALL rate and past-due rate as the respective totals divided by gross loans receivable at each respective quarter end. Canada Direct Lending Net Revenue Canada Direct Lending revenue declined year over year by $1.0 million, or 1.7%, ($3.9 million, or 6.6%, on a constant-currency basis), for the three months ended March 31, 2021, as a result of COVID-19 Impacts on Installment gross loans receivable, offset by increases in Revolving LOC gross loans receivable. Sequentially, Canada Direct Lending revenue increased $3.0 million, or 5.3%, driven by increases in Revolving LOC and ancillary revenue, partially offset by a decrease in Installment revenue. The provision for losses decreased $18.3 million, or 66.4%, ($18.7 million, or 68.2%, on a constant-currency basis), to $9.2 million for the three months ended March 31, 2021, compared to $27.5 million in the prior-year period. The decrease in provision for loan losses was the result of lower NCOs and the related impact of changes in allowance coverage due to an increase in credit quality for Revolving LOC loans. As of March 31, 2021, allowance coverage decreased sequentially by 135 basis points, or 12.9%, compared to a sequential increase of 200 bps, or 19.8%, as of March 31, 2020. On a quarterly basis, loss rates improved approximately 370 bps, or 49.4%, year over year due to COVID-19 Impacts and overall seasoning of the Revolving LOC loan portfolio. Canada Direct Lending Revolving LOC loan performance Canada Direct Lending Revolving LOC gross loans receivable increased $79.0 million, or 32.9%, ($41.7 million, or 17.4%, on a constant-currency basis) year over year and $16.0 million, or 5.3% ($13.0 million, or 4.3%, on a constant-currency basis) sequentially. Revolving LOC revenue increased $5.4 million, or 18.5%, year over year and $2.4 million, or 7.5%, sequentially ($3.4 million, or 11.9%, and $1.4 million, or 4.5%, respectively, on a constant-currency basis). The allowance coverage decreased year over year from 12.3% to 9.4% as of March 31, 2021 due to sustained favorable trends in NCOs and continued lower past-due balances. The year-over-year NCO rate and past-due rate for Revolving LOC gross loans receivable improved by 290 bps and 325 bps, respectively. Canada Direct Lending Installment loan performance Installment revenues decreased $8.1 million, or 43.8%, ($8.7 million, or 46.9%, on a constant-currency basis) as a result of a year over year decline in Installment gross loans receivable of $11.6 million, or 32.3% ($14.5 million, or 40.2%, on a constant-currency basis). The decreases in Installment loans and related revenue were due to a continued shift to Revolving LOC loans, as well as COVID-19 related constraints on demand, particularly as related to store-driven Installment loans. The Installment allowance coverage decreased year over year from 9.9% to 7.5% as a result of sustained favorable trends in NCOs and past-due balances stemming from COVID-19 Impacts. The year-over-year NCO rate and past-due rate for Installment loans improved by 695 bps and 200 bps, respectively. Sequentially, Installment gross loans receivable decreased $2.6 million, or 9.5%, ($2.8 million, or 10.4%, on a constant-currency basis) and related revenue decreased $0.7 million, or 5.9% ($1.0 million, or 8.6%, on a constant-currency basis). Canada POS Lending Revolving LOC loan performance Canada POS Lending Revolving LOC gross loans receivable as of March 31, 2021 were $201.5 million, which generated $1.4 million of interest revenue for the period of acquisition through quarter end. Revolving LOC gross loans receivable charge-off at 180 days past due, or in some instances earlier, when specific criteria are met. NCOs were $0.2 million from March 10, 2021 (the acquisition date) through March 31, 2021. Originations for the three months ended March 31, 2021 were $85.0 million in Canadian dollars (\"C$\"), an increase of C$34.7 million, or 69.0%, from the prior-year period of C$50.3 million. Canada Direct Lending and Canada POS Lending Results of Operations Three Months Ended March 31, 2021 2020 (dollars in millions, unaudited) Canada Direct Lending Canada POS Lending Consolidated Canada Canada Direct Lending Canada POS Lending Consolidated Canada Consolidated Canada Change $ Change % Revenue $ 58.4 $ 1.6 $ 60.1 $ 59.0 $ $ 59.0 $ 1.0 1.7 % Provision for losses 9.2 0.9 10.1 27.5 27.5 ($ 17.4 ) (63.3 )% Net revenue 49.2 0.8 50.0 31.5 31.5 $ 18.4 58.4 % Advertising 0.9 0.9 1.3 1.3 ($ 0.3 ) (26.0 )% Non-advertising costs of providing services 18.1 0.1 18.2 18.1 18.1 $ 0.2 % Total cost of providing services 19.0 0.1 19.1 19.4 19.4 ($ 0.3 ) (1.5 )% Gross margin 30.2 0.7 30.9 12.2 12.2 $ 18.7 # Corporate, district and other expenses 5.6 2.6 8.2 5.2 5.2 $ 3.1 59.8 % Interest expense 2.4 0.8 3.2 2.5 2.5 $ 0.7 28.4 % Total operating expense 8.0 3.5 11.4 7.6 7.6 $ 3.8 49.6 % Segment operating income 22.2 (2.8 ) 19.4 4.5 4.5 $ 14.9 # Interest expense 2.4 0.8 3.2 2.5 2.5 $ 0.7 28.4 % Depreciation and amortization 1.1 0.7 1.8 1.2 1.2 $ 0.7 58.5 % EBITDA (1) 25.7 (1.3 ) 24.5 8.2 8.2 $ 16.3 # Other adjustments 0.2 0.2 ($ 0.1 ) Adjusted EBITDA (1) $ 25.8 ($ 1.3 ) $ 24.5 $ 8.3 $ $ 8.3 $ 16.2 # # - Variance greater than 100% or not meaningful. (1) These are non-GAAP metrics. For a description of each non-GAAP addback, see the applicable reconciliations contained under \"Results of Consolidated Operations.\" For a description of each non-GAAP metric, see \"Non-GAAP Financial Measures.\" Canada Direct Lending Segment Results - For the Three Months Ended March 31, 2021 and 2020 For a discussion of revenue, provision for losses and related gross combined loans receivables, see \"Canada Direct Lending Portfolio Performance,\" above. Canada cost of providing services were consistent to the prior-year period at $19.0 million for the three months ended March 31, 2021 compared to $19.4 million for the three months ended March 31, 2020. Canada operating expenses were consistent to the prior-year period at $8.0 million for the three months ended March 31, 2021 compared to $7.6 million for the three months ended March 31, 2020. Canada POS Lending Segment Results - For the Three Months Ended March 31, 2021 For a discussion of revenue, provision for losses and related gross combined loans receivables, see the \"Canada POS Lending Portfolio Performance,\" above. Canada POS Lending segment revenue also includes revenue from merchant discounts and ancillary products. Merchant discount revenue represents the fee charged to merchant partners to help facilitate customer credit card purchases at merchant locations. The fee is recognized over the credit card loan term, which ranges from three to 72 months. Ancillary revenue includes administrative fees, annual fees, insurance product fees and other fees charged to customers. CURO GROUP HOLDINGS CORP. AND SUBSIDIARIES CONDENSED CONSOLIDATED BALANCE SHEETS (in millions) March 31, 2021 (unaudited) December 31, 2020 ASSETS Cash and cash equivalents $ 135.4 $ 213.3 Restricted cash (includes restricted cash of consolidated VIEs of $47.6 million and $32.0 million as of March 31, 2021 and December 31, 2020, respectively) 80.4 54.8 Gross loans receivable (includes loans of consolidated VIEs of $554.6 million and $360.4 million as of March 31, 2021 and December 31, 2020, respectively) 731.0 553.7 Less: Allowance for loan losses (includes allowance for losses of consolidated VIEs of $44.9 million and $54.1 million as of March 31, 2021 and December 31, 2020, respectively) (72.4 ) (86.2 ) Loans receivable, net 658.6 467.6 Income taxes receivable 24.1 32.1 Prepaid expenses and other (includes prepaid expenses and other of consolidated VIEs of $0 and $0.4 million as of March 31, 2021 and December 31, 2020, respectively) 26.8 28.0 Property and equipment, net 57.6 59.7 Investment in Katapult 27.9 27.4 Right of use asset - operating leases 112.3 115.0 Deferred tax assets 1.5 Goodwill and Intangibles, net 273.9 176.5 Other assets 9.1 8.6 Total Assets $ 1,407.6 $ 1,183.0 LIABILITIES AND STOCKHOLDERS' EQUITY Liabilities Accounts payable and accrued liabilities (includes accounts payable and accrued liabilities of consolidated VIEs of $8.0 million and $34.1 million as of March 31, 2021 and December 31, 2020, respectively) $ 67.6 $ 49.6 Deferred revenue 5.5 5.4 Lease liability - operating leases 119.1 122.6 Contingent consideration related to acquisition 20.6 Income taxes payable 0.3 Accrued interest (includes accrued interest of consolidated VIEs of $1.2 million and $1.1 million as of March 31, 2021 and December 31, 2020, respectively) 5.9 20.1 Liability for losses on CSO lender-owned consumer loans 4.7 7.2 Debt (includes debt and issuance costs of consolidated VIEs of $331.9 million and $12.2 million as of March 31, 2021 and $147.4 million and $7.8 million as of December 31, 2020, respectively) 1,000.2 819.7 Other long-term liabilities 15.2 15.4 Deferred tax liabilities 8.3 11.0 Total Liabilities $ 1,247.5 $ 1,051.1 Stockholders' Equity Total Stockholders' Equity $ 160.2 $ 131.9 Total Liabilities and Stockholders' Equity $ 1,407.6 $ 1,183.0 Balance Sheet Changes - March 31, 2021 Compared to December 31, 2020 Cash and cash equivalents - The decrease in Cash from December 31, 2020 was primarily due to the acquisition of Flexiti, partially offset by lower demand for loan products due to seasonality and impacts from COVID-19, including the first quarter U.S. government stimulus. Restricted cash - The increase in Restricted cash from December 31, 2020 was primarily due to our Non-Recourse U.S. SPV Facility, our new Non-Recourse Flexiti SPE Facility entered into as part of our acquisition in March 2021, and growth in Revolve and Opt+ products. Gross loans receivable and Allowance for loan losses - The increase in Gross loans receivable from December 31, 2020 was primarily due to the acquisition of Flexiti, which accounted for $201.5 million of gross loans receivable as of March 31, 2021, and growth in the Canada Direct Lending Revolving LOC loans. The increase was partially offset by a decline in the U.S. As noted in \"Consolidated Loans Receivable\" and \"Portfolio Performance Analysis\" above, changes in Gross loans receivable and related ALL were due to expected lower customer demand and loan origination volumes as a result of COVID-19 impacts, including the 2021 U.S. government stimulus. Goodwill and Intangible Assets - The increases in Goodwill and Intangible assets from December 31, 2020 were due to our acquisition of Flexiti on March 10, 2021, which resulted in $95.5 million of goodwill and intangible assets as of March 31, 2021. Accrued Interest - The decrease in accrued interest from December 31, 2020 is primarily due to interest payments on our 8.25% Senior Secured Notes, which are due semi-annually on September 1 and March 1. Contingent Consideration related to acquisition - The acquisition of Flexiti on March 10, 2021 included an up-front purchase price as well as a cash earn-out of up to approximately $32.8 million. The cash earn-out is recorded at fair value based on discounted expected cash flows and remeasured quarterly. Liability for losses on CSO lender-owned consumer loans - As noted in \"U.S. Portfolio Performance Analysis\" above, changes in Liability for losses on CSO lender-owned consumer loans were due to expected lower customer demand and loan origination volumes as a result of COVID-19. Debt Capitalization Summary (in millions, net of deferred financing costs) Capacity Interest Rate Maturity Counter-parties Balance as of March 31, 2021 (in USD) Non-Recourse Canada SPV Facility (1) C$175.0 million 3-Mo CDOR + 6.75% September 2, 2023 Waterfall Asset Management $ 97.3 Senior Secured Revolving Credit Facility $50.0 million 1-Mo LIBOR + 5.00% June 30, 2021 BayCoast Bank; Stride Bank; Hancock-Whitney Bank; Metropolitan Commercial Bank Non-Recourse U.S. SPV Facility $200.0 million 1-Mo LIBOR + 6.25%(2) April 8, 2024 Atalaya Capital Management, MetaBank 44.0 Non-Recourse Flexiti SPE Facility (1)(3) C$500.0 million 3-Mo CDOR + 4.40% March 10, 2024 Credit Suisse (Class A); SPF (Class B) 178.4 Cash Money Revolving Credit Facility (1) C$10.0 million Canada Prime Rate +1.95% On-demand Royal Bank of Canada 8.25% Senior Secured Notes (due 2025) $690.0 million 8.25% September 1, 2025 680.4 (1) Capacity amounts are denominated in Canadian dollars, while outstanding balances as of March 31, 2021 are denominated in U.S. dollars. (2) The Non-Recourse U.S. SPV Facility initially provided for $100.0 million of borrowing capacity, which increased to $200.0 million on July 31, 2020 following additional commitments. As a result of the increase in commitments, interest now accrues at an annual rate of one-month LIBOR (with a floor of 1.65%) plus the lesser of (i) 6.95% and (ii) the sum of (a) 6.25% on balances up to $145.5 million and (b) 9.75% on balances greater than $145.5 million. (3) The current Non-Recourse Flexiti SPE Facility was entered into concurrent with the Flexiti acquisition. Interest accrues at an annual rate of three-month CDOR plus 4.40%. Non-GAAP Financial Measures In addition to the financial information prepared in conformity with U.S. GAAP, we provide certain non-GAAP financial measures, including: We believe that presentation of non-GAAP financial information is meaningful and useful in understanding the activities and business metrics of the Company's operations. We believe that these non-GAAP financial measures reflect an additional way of viewing aspects of the business that, when viewed with the Company's U.S. GAAP results, provide a more complete understanding of factors and trends affecting the business. We believe that investors regularly rely on non-GAAP financial measures, such as Adjusted Net Income, Adjusted Earnings per Share, EBITDA and Adjusted EBITDA, to assess operating performance and that such measures may highlight trends in the business that may not otherwise be apparent when relying on financial measures calculated in accordance with U.S. GAAP. In addition, we believe that the adjustments shown above are useful to investors in order to allow them to compare our financial results during the periods shown without the effect of each of these income or expense items. In addition, we believe that Adjusted Net Income, Adjusted Earnings per Share, EBITDA and Adjusted EBITDA are frequently used by securities analysts, investors and other interested parties in the evaluation of public companies in our industry, many of which present Adjusted Net Income, Adjusted Earnings per Share, EBITDA and/or Adjusted EBITDA when reporting their results. In addition to reporting loans receivable information in accordance with U.S. GAAP, we provide Gross Combined Loans Receivable consisting of owned loans receivable plus loans originated by third-party lenders through the CSO programs, which we guarantee but do not include in the Condensed Consolidated Financial Statements. Management believes this analysis provides investors with important information needed to evaluate overall lending performance. We provide non-GAAP financial information for informational purposes and to enhance understanding of the U.S. GAAP Consolidated Financial Statements. Adjusted Net Income, Adjusted Earnings per Share, EBITDA, Adjusted EBITDA and Gross Combined Loans Receivable should not be considered as alternatives to income from continuing operations, segment operating income, or any other performance measure derived in accordance with U.S. GAAP, or as an alternative to cash flows from operating activities or any other liquidity measure derived in accordance with U.S. GAAP. Readers should consider the information in addition to, but not instead of or superior to, the financial statements prepared in accordance with U.S. GAAP. This non-GAAP financial information may be determined or calculated differently by other companies, limiting the usefulness of those measures for comparative purposes. Description and Reconciliations of Non-GAAP Financial Measures Adjusted Net Income, Adjusted Earnings per Share, EBITDA and Adjusted EBITDA Measures have limitations as analytical tools, and you should not consider these measures in isolation or as a substitute for analysis of our income or cash flows as reported under U.S. GAAP. Some of these limitations are: We calculate Adjusted Earnings per Share utilizing diluted shares outstanding at year-end. If the Company records a loss from continuing operations under U.S. GAAP, shares outstanding utilized to calculate Diluted Earnings per Share from continuing operations are equivalent to basic shares outstanding. Shares outstanding utilized to calculate Adjusted Earnings per Share from continuing operations reflect the number of diluted shares the Company would have reported if reporting net income from continuing operations under U.S. GAAP. As noted above, Gross Combined Loans Receivable includes loans originated by third-party lenders through CSO programs which are not included in the consolidated financial statements but from which we earn revenue and for which we provide a guarantee to the lender. Management believes this analysis provides investors with important information needed to evaluate overall lending performance. We believe Adjusted Net Income, Adjusted Earnings per Share, EBITDA and Adjusted EBITDA are used by investors to analyze operating performance and to evaluate our ability to incur and service debt and the capacity for making capital expenditures. Adjusted EBITDA is also useful to investors to help assess our estimated enterprise value. The computation of Adjusted EBITDA as presented in this release may differ from the computation of similarly-titled measures provided by other companies. Forward-Looking Statements This press release contains forward-looking statements. These forward-looking statements include projections, estimates and assumptions about our ability to drive revenue growth and create long-term shareholder value; the expected timing impact of the Katapult merger and its impact on us, including the potential value we expect to receive, the mix of cash and stock, potential earn out, and resulting ownership position and our cash tax liability; the expected timing of the Katapult merger; the expected financial and operational benefits of our acquisition of Flexiti Financial; the run-off of Verge loan balances and our belief in the usefulness of the various non-GAAP financial measures used in this release. In addition, words such as guidance, estimate, anticipate, believe, forecast, step, plan, predict, focused, project, is likely, expect, intend, should, will, confident, variations of such words and similar expressions are intended to identify forward-looking statements. Our ability to achieve these forward-looking statements is based on certain assumptions, judgments and other factors, both within and outside of our control, that could cause actual results to differ materially from those in the forward-looking statements, including: the inability of the parties to the Katapult transaction to successfully or timely consummate the proposed business combination, including the risk that any required regulatory approvals are not obtained, are delayed or are subject to unanticipated conditions that could adversely affect the combined company or the expected benefits of the proposed transaction or that the approval of FinServ stockholders is not obtained; failure to realize the anticipated benefits of the proposed Katapult transaction; risks relating to the uncertainty of projected financial information with respect to Katapult; the effects of competition on Katapults future business; Katapults the ability to attract and retain customers; market, financial, political and legal conditions; the impact of COVID-19 pandemic on us, our investments Katapults and our business and the global economy; risks related to the concentration of Katapults business among a relatively small number of merchants; the ability of FinServ or the combined company to issue equity or equity-linked securities or obtain debt financing in connection with the proposed business combination or in the future; our dependence on third-party lenders to provide the cash we need to fund our loans and our ability to affordably access third-party financing; errors in our internal forecasts; our level of indebtedness; our ability to integrate acquired businesses; our dependence on third-party lenders to provide the cash we need to fund our loans and our ability to affordably access third-party financing; actions of regulators and the negative impact of those actions on our business; our ability to protect our proprietary technology and analytics and keep up with that of our competitors; disruption of our information technology systems that adversely affect our business operations; ineffective pricing of the credit risk of our prospective or existing customers; inaccurate information supplied by customers or third parties that could lead to errors in judging customers qualifications to receive loans; improper disclosure of customer personal data; failure of third parties who provide products, services or support to us; any failure of third-party lenders upon whom we rely to conduct business in certain states; disruption to our relationships with banks and other third-party electronic payment solutions providers; disruption caused by employee or third-party theft and errors in our stores as well as other factors discussed in our filings with the Securities and Exchange Commission. These projections, estimates and assumptions may prove to be inaccurate in the future. These forward-looking statements are not guarantees of future performance and involve known and unknown risks and uncertainties that are difficult to predict with regard to timing, extent, likelihood and degree of occurrence. There may be additional risks that CURO presently does not know or that it currently believes are immaterial that could also cause actual results to differ from those contained in the forward-looking statements. Given these risks and uncertainties, investors should not place undue reliance on forward-looking statements as a prediction of actual future results. We undertake no obligation to update, amend or clarify any forward-looking statement for any reason. About CURO CURO Group Holdings Corp. (NYSE: CURO), serves the evolving needs of the financial consumer. In 1997, the Company was founded in Riverside, California by three Wichita, Kansas childhood friends to meet the growing consumer need for short-term loans. Their success led to opening stores across the United States, later expanding to offer online loans and financial services in the United States and Canada and now broadening into a full-spectrum consumer lender through the point-of-sale / buy-now-pay-later channel. CURO combines its market expertise with a fully integrated technology platforms, an omni-channel approach and advanced credit decisioning to provide an array of credit products across all mediums. CURO operates under a number of brands including Speedy Cash, Rapid Cash, Cash Money, LendDirect, Flexiti, Avo Credit, Opt+ and Revolve Finance. With over 20 years of operating experience, CURO provides financial freedom to non-prime consumers. Conference Call CURO will host a conference call to discuss these results at 8:15 a.m. Eastern Time on Tuesday, May 4, 2021. The live webcast of the call can be accessed at the CURO Investor Relations website at http://ir.curo.com/. You may access the call at 1-866-807-9684 (1-412-317-5415 for international callers). Please ask to join the CURO Group Holdings call. A replay of the conference call will be available until May 11, 2021, at 8:15 a.m. Eastern Time. An archived version of the webcast will be available on the CURO Investors website for 90 days. You may access the conference call replay at 1-877-344-7529 (1-412-317-0088 for international callers). The replay access code is 10155812. Final Results The financial results presented and discussed herein are on a preliminary and unaudited basis; final unaudited data will be included in the Companys Quarterly Report on Form 10-Q for the three months ended March 31, 2021. (CURO-NWS)", "role": "user" }, { "content": "CURO Group Holdings Corp. Announces First Quarter 2021 Financial Results Doubled quarterly dividend Authorized $50 million share repurchase program Added Philip Gitler as Executive Vice President and Chief Strategy Officer", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: ROCKLAND, Mass.--(BUSINESS WIRE)--Christopher Oddleifson, President and Chief Executive Officer, Robert D. Cozzone, Executive Vice President and Chief Operating Officer, Mark J. Ruggiero, Chief Financial Officer and Chief Accounting Officer and Gerard Nadeau, Chief Commercial Banking Officer of Independent Bank Corp. (NASDAQ Global Select Market: INDB) will participate in the 2021 Virtual KBW Winter Financial Services Symposium on February 11, 2021. The conference will be held virtually. Independent Bank Corp. (NASDAQ Global Select Market: INDB) is the holding company for Rockland Trust Company, a full-service commercial bank headquartered in Massachusetts. Rockland Trust was named to The Boston Globe's \"Top Places to Work\" 2020 list, an honor earned for the 12th consecutive year. In 2020, Rockland Trust was ranked the #1 Bank in Massachusetts according to Forbes World's Best Banks list. Rockland Trust has a longstanding commitment to equity and inclusion. This commitment is underscored by initiatives such as Diversity and Inclusion leadership training, a colleague Allyship mentoring program, numerous Employee Resource Groups focused on providing colleague support and education, reinforcing a culture of mutual respect and advancing professional development, and Rockland Trusts sponsorship of diverse community organizations through charitable giving and employee-based volunteerism. Rockland Trust is deeply committed to the communities it serves, as reflected in the overall \"Outstanding\" rating received in its most recent Community Reinvestment Act performance evaluation. Rockland Trust offers a wide range of banking, investment, and insurance services. The Bank serves businesses and individuals through approximately 100 retail branches, commercial and residential lending centers, and investment management offices in eastern Massachusetts, including Greater Boston, the South Shore, Cape Cod and Islands, Worcester County, and Rhode Island. Rockland Trust also offers a full suite of mobile, online, and telephone banking services. Rockland Trust is an FDIC member and an Equal Housing Lender. To find out why Rockland Trust is the bank \"Where Each Relationship Matters,\" please visit RocklandTrust.com. Category: Conference Announcements", "role": "user" }, { "content": "Independent Bank Corp. CEO Christopher Oddleifson, COO Robert D. Cozzone, CFO Mark J. Ruggiero and Chief Commercial Banking Officer Gerard Nadeau to Participate in the 2021 Virtual KBW Winter Financial Services Symposium", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: NEW YORK, March 18, 2021 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against AgEagle Aerial Systems, Inc. (\"AgEagle\" or the \"Company\") (NYSE: UAVS) and certain of its officers.The class action, filed in the United States District Court for the Central District of California, and docketed under 21-cv-01991, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise, acquired publicly traded AgEagle securities between September 3, 2019 and February 18, 2021, inclusive (the \"Class Period\").Plaintiff seeks to recover compensable damages caused by Defendants' violations of the federal securities laws under the Securities Exchange Act of 1934 (the \"Exchange Act\"). If you are a shareholder who purchased AgEagle securities during the Class Period, you have until April 27, 2021to ask the Court to appoint you as Lead Plaintiff for the class.A copy of the Complaint can be obtained at www.pomerantzlaw.com.To discuss this action, contact Robert S. Willoughby at [emailprotected]or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased. [Click here for information about joining the class action] AgEagle purports to be a commercial drone company.According to AgEagle's website, the Company is engaged in the design, engineering, and manufacturing of commercial drones, as well as in providing drone services and solutions to the agriculture industry. The Complaint alleges that throughout the Class Period, Defendants made materially false and/or misleading because they misrepresented and failed to disclose the following adverse facts pertaining to the Company's business, operations and prospects, which were known to Defendants or recklessly disregarded by them.Specifically, Defendants made false and/or misleading statements and/or failed to disclose that: (1) AgEagle did not have a partnership with Amazon and in fact never had any relationship with Amazon; (2) rather than correct the public's understanding about a partnership with Amazon, Defendants were actively contributing to the rumor that AgEagle had a partnership with Amazon; and (3) as a result, Defendants' statements about AgEagle's business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times. On October 14, 2020, news broke that Amazon did not have a partnership agreement with AgEagle, and in fact never did.The Wichita Business Journal published a story with the headline: \"Exclusive: Who's AgEagle's big customer? We now know who it's not.\"The articlereported that AgEagle was not partnering with Amazon. On February 18, 2021, Bonitas Research published a report revealing that AgEagle \"was a pump & dump scheme orchestrated by . . . AgEagle founder and former chairman Bret Chilcott and other UAVS insiders to defraud US investors.\" On this news, shares of AgEagle, fell $5.13, or 36.4%, to close at $8.96 on February 18, 2021, damaging investors. The Pomerantz Firm, with offices in New York, Chicago, Los Angeles, and Paris is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 80 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com CONTACT:Robert S. WilloughbyPomerantz LLP[emailprotected]888-476-6529 ext. 7980 SOURCE Pomerantz LLP Related Links www.pomerantzlaw.com", "role": "user" }, { "content": "Pomerantz Law Firm Announces the Filing of a Class Action against AgEagle Aerial Systems, Inc. and Certain Officers - UAVS", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: STOCKHOLM and COPENHAGEN, Denmark, July 10, 2020 /PRNewswire/ -- Eir Ventures, a Nordic Life Science Venture Fund, today announced a first close of its new fund of EUR76 million. With a strong base in the Nordic region and a team of experienced life science investors, Eir Ventures will invest in innovative companies with products and technologies addressing significant unmet medical need and a potential to improve the life of patients. The fund is launched with support from a strong investor syndicate comprising Saminvest, the European Investment Fund (EIF), Vkstfonden, Novo Holdings, as well as additional private investors. Eir Ventures has been set up by an experienced and successful team of life science investors: Dr Magnus Persson, Stephan Christgau, Andreas Segerros are the Managing Partners, and Amanda Hayward is Special Partner. It has offices in Stockholm and Copenhagen. Eir Ventures will invest in high return potential opportunities in the Nordics, Europe and the US. The fund will have a particular focus on innovations from the leading universities and incubators in the Nordics and has established collaborations with select Nordic Universities. Dr Magnus Persson, Managing Partner of Eir Ventures, commented,\"In the current environment, where financing has become even more sparse and startups are struggling to fund development, healthcare innovation is more important than ever. We see great potential to bring some of the highly innovative treatments to patients with underserved medical needs, while also bringing outstanding returns to our investors.\" Stephan Christgau, Managing Partner of Eir Ventures, added,\"The Nordic region is ranked year after year as one of the most innovative areas in Europe, with a stable business environment and a successful track record of medical innovation and world-class science. However, the region is severely underserved with professional venture capital. Eir Ventures sees this as a unique opportunity that it will leverage.\" Eir Ventures is backed by a strong investor syndicate of Swedish and Danish institutions including: Saminvest, a venture capital company founded by the Swedish Government, Vkstfonden, the Danish state's investment fund, Novo Holdings, as well as the European Investment Fund. \"We are very pleased to see a new life science fund that focuses on early stage companies in the Swedish ecosystem, in close contact with the university sector. We firmly believe Eir Ventures is well positioned to take advantage of investment opportunities in the innovative life science sector in Scandinavia,\" commented Peder Hasslev, Chief Executive Officer at Saminvest. \"The COVID-19 pandemic has been a powerful illustration that healthcare is a truly global issue, and that there is a constant need for new treatments and therapies. Hence, it is essential that we invest in emerging companies that develop new treatments from Danish and Nordic University innovation and life science entrepreneurs in the region. I am thrilled that Vkstfonden can help launch and fund Eir Ventures,\" added Simon Kollerup, Danish Minister for Industry, Business and Financial affairs. \"This EIF investment reflects the importance of sustaining innovative players in this sector, made all the more crucial by the ongoing situation. Eir Ventures has a strong founding team and the fund will be well-positioned to find and further develop companies that solve tomorrow's health challenges,\" said Alain Godard, Chief Executive at the European Investment Fund. \"Novo Seeds has been investing in the Nordic life science industry for more than 10 years, and we have seen steady growth in number and quality of investment opportunities. We are therefore very excited to be one of the founding investors of Eir Ventures. In addition to making a profitable fund investment, we look forward to working with the team to translate more Nordic innovation into startups,\" added Sren Mller, Managing Partner for Novo Seeds, the early stage investment arm of Novo Holdings. About Eir Ventures Eir Ventures is a Life science focused venture fund, that with a strong foundation in the Nordic Biotech ecosystem will invest in early stage as well as more mature opportunities. The fund initiates investment activities in 2020 and will seek opportunities addressing significant unmet medical needs for new therapies, medical technology and digital health. Eir Ventures is founded by a team of experienced life science investors, and backed by a strong investor syndicate comprising Saminvest, the European Investment Fund (EIF), Vkstfonden, Novo Holdings, as well as additional private investors. Eir Ventures I AB is a registered alternative investment fund, under the Swedish Alternative Investment Funds Managers Act. http://www.eirventures.eu About Saminvest Saminvest is a venture capital company, founded by the Swedish Government in 2016. Saminvest works actively for the establishment of new venture capital funds with sufficient qualities and long-term ability to develop the Swedish venture capital market, giving innovative and fast-growing companies access to both capital and ownership skills. https://www.saminvest.se/ About EIF The European Investment Fund (EIF) is part of the European Investment Bank Group. Its central mission is to support Europe's micro, small and medium-sized businesses (SMEs) by helping them to access finance. EIF designs and develops venture and growth capital, guarantees and microfinance instruments which specifically target this market segment. In this role, EIF fosters EU objectives in support of innovation, research and development, entrepreneurship, growth, and employment. https://www.eif.org/ About Vaekstfonden In close collaboration with banks and domestic and international private investors, we discover and develop the companies that Denmark cannot afford to miss out on. We carry the experience and the expertise that make businesses grow from digitalizing a carpenter's business in small town Sallingsund to the launching of a robotic arm in Silicon Valley. The power of innovation, yield to society and responsibility are the three signposts that guide us in finding and choosing new projects. Since 1992, Vaekstfonden has co-financed growth in over 8,500 companies for a total commitment of more than DKK 27.3 billion. kr. https://vaekstfonden.com/ About Novo Holdings A/S Novo Holdings A/S is a private limited liability company wholly owned by the Novo Nordisk Foundation. It is the holding and investment company of the Novo Group, comprising Novo Nordisk A/S and Novozymes A/S, and is responsible for managing the Novo Nordisk Foundation's assets. Novo Holdings is recognized as a leading international life science investor, with a focus on creating long-term value. As a life science investor, Novo Holdings provides seed and venture capital to development-stage companies and takes significant ownership positions in growth and well-established companies. Novo Holdings also manages a broad portfolio of diversified financial assets. Further information: http://www.novoholdings.dk For further information, please contact: Eir VenturesMagnus Persson, +46-737314146, [emailprotected]Stephan Christgau, +45-30674790, [emailprotected] Optimum Strategic Communications Mary Clark, Supriya Mathur, Manel Mateus+44-(0)-20-8148-3040, [emailprotected] SOURCE Eir Ventures", "role": "user" }, { "content": "New Nordic Life Science Venture Fund, Eir Ventures, Launched to Leverage the Untapped Potential of Health Care Innovation Life sciences focused fund also announces first close of EUR76 million", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: Designed to deliver both value and performance, the Swoop Portable MRI system maximizes operational efficiencies and enables cost-effective quality careLONDON, Oct. 14, 2020 /PRNewswire/ --Based on its recent analysis of the global portable magnetic resonance imaging (MRI) market, Frost & Sullivan recognizes HyperfineResearch with the 2020 Global New Product Innovation Award for its category-defining Swoop portable MRI system. Lightweight, compact, and easily maneuverable, the first-of-its-kind 0.064 Tesla MRI on wheels enables imaging at the point of care (POC) and delivers preliminary results within minutes so that clinicians can make evidence-based decisions at the patient's bedside. Hyperfine Hyperfine's Swoop can be wheeled to the patient's bedside, plugged into a standard wall outlet, and operated wirelessly via an iPad. A user-friendly interface allows healthcare professionals (HCPs) to choose MR imaging sequences and protocols easily from a simple list and start scanning in less than two minutes, using 20 times less power than traditional fixed MRI systems. Besides, at 5 feet, 3 inches tall and 1,400 pounds, it is 10 times lighter and substantially smaller than fixed MRI systems, does not need liquid cryogens for operation, and averts projectile risks from ferromagnetic objects. \"Hyperfine's portable MRI technology renders DICOM images that integrate with the hospital's PACS systems. The company also offers Hyperfine Cloud PACS solutions for hospitals without PACS, extending healthcare practitioners access to patient information as well as traditional PACS tools and applications,\" said Poornima Srinivasan, Consultant at Frost & Sullivan. \"Suitable for use in neuro ICUs, emergency departments, urgent care facilities, neurosurgery outpatient clinics, rehabilitation hospitals, and pediatric departments, it enhances patient care quality and safety while improving overall operational efficiencies.\" Furthermore, Swoop offers padding, some even inflatable, for patients who are unable to remain still, ensuring correct positioning and patient comfort. Unlike traditional fixed MRIs, if the patient is in the incorrect position when the scan begins, HCPs can stop the procedure and reposition them to scan the right area. It enables them to prioritize scan orders from a set of protocols for different indications to provide evidence-based, quality care decisions throughout the hospital setting.\"Hyperfine's Swoop Portable MRI system incorporates progressive image reconstruction while the scan is in progress to display images on the screen after just 10% of the scan completes. The low-field MRI system allows family members to comfort patientsmainly childrenduring the scanning procedure, reducing the need for sedation,\" noted Srinivasan. \"By helping detect anomalies and regions of interest quickly, it saves critical time in identifying life-threatening abnormalities and improves patient outcomes. It also allows hospitals to scale up procedural volumes, thereby delivering exceptional value all around.\"Each year, Frost & Sullivan presents this award to the company that develops an innovative element in a product by leveraging leading-edge technologies. The award recognizes the value-added features/benefits of the product and the increased return on investment it gives customers, which, in turn, raises customer acquisition and overall market penetration potential.Frost & Sullivan Best Practices awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analyses, and extensive secondary research to identify best practices in the industry.About Frost & SullivanFor over five decades, Frost & Sullivan has become world-renowned for its role in helping investors, corporate leaders, and governments navigate economic changes and identify disruptive technologies, Mega Trends, new business models, and companies to action, resulting in a continuous flow of growth opportunities to drive future success. Contact us: Start the discussion.Contact:Lindsey WhitakerP: +1 (210) 477-8457E: [emailprotected]About Hyperfine ResearchHyperfine lives to make MR imaging available to everyone. The Swoop Portable MR Imaging System is the result of a total rethink of MR's potential in the healthcare landscape. What if MR imaging didn't require a dedicated suite, extensive training or expensive upkeep?Let's use the wonders of high-field MRI for the appropriate patients, and deploy Swoop system at the point-of-care for everyone else. Hyperfine received market-ready FDA clearance for its portable MR imaging for the brain and head of patientsof all ages in August 2020. Hyperfine is part of 4Catalyzer, a health technology incubator with facilities in CT, NY, CA and Taiwan.www.hyperfine.io.Contact: Chris WardP: (203) 905-0412E: Chris Ward, [emailprotected]SOURCE Frost & Sullivan", "role": "user" }, { "content": "Hyperfine Lauded by Frost & Sullivan for Developing the World's Only Portable MRI System for Point of Care USA - English USA - English", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: TROY, Mich.--(BUSINESS WIRE)--Electric Last Mile, Inc. (ELMS), a commercial electric vehicle company focused on last-mile delivery solutions, and Geotab Inc. (Geotab), a global leader in IoT and connected transportation, today announced their partnership to deliver a factory-installed connectivity solution that will equip ELMS customers with the data they need to help manage and optimize their vehicles. As part of the collaboration, ELMS plans to integrate Geotabs GO9+ telematics solution into its Urban Delivery vehicle, which is anticipated to be the first Class 1 commercial electric vehicle (EV) available in the U.S. market. Ideal for fleet managers, the factory-installed addition of Geotabs telematics offering will help provide ELMS customers with centralized access to their connected vehicle data via the MyGeotab platform. Specifically, Geotabs GO9+ device will help enable high-speed connectivity and allow fleet managers access to ELMS AIR, ELMS in-development connectivity and data analytics suite, which is anticipated to provide fleets with full visibility of their Urban Delivery vehicles in near real time. The GO9+ is also expected to allow users to turn each Urban Delivery vehicle into a Wi-Fi hotspot where possible and when needed. Powered by Geotab, ELMS AIR will provide fleet managers with a single view of their entire fleet to help better analyze fleet-generated data, from GPS tracking, road speed and charging status to battery state of charge and more, which can be used to help reduce fleet costs, increase productivity and efficiency, improve safety and strengthen compliance. Geotab and ELMS are further collaborating on technology that is focused on enabling the GO9+ to assist fleet managers with access to the ELMS AIR over-the-air (OTA) technology solution, aimed at one day providing software updates and upgrades to fleets via a secured cellular connection intended to help maximize vehicle uptime and ensure that vehicle software is up to date. The Urban Delivery is expected to be the first Class 1 OTA-enabled EV in the U.S. Factory-installation of Geotabs GO9+ device is expected to begin at the start of Urban Delivery vehicle production. ELMS is not just a vehicle company but a technology and solutions company, said ELMS CTO, Kev Adjemian. This exciting collaboration with Geotab is a part of ELMS commitment to delivering powerful telematics, data and real-time visibility solutions that fleet managers need to help improve their operating efficiency and reduce costs. By integrating Geotabs solutions, we will work closely together to eventually provide Urban Delivery customers with in-house OTA technology, which we believe will help to significantly reduce service downtime and maximize vehicle efficiency. With sustainability at the forefront of Geotab's innovations, we are excited to collaborate with innovative OEM partners like ELMS to equip customers with the technology needed to help achieve their fleet electrification goals, said Rob Minton, Associate Vice President, Connected Car Business Development at Geotab. By combining the power of Geotab's telematics technology with ELMS, this partnership will equip Urban Delivery customers with a turnkey connectivity solution that can help maximize electric vehicle efficiency, reduce downtime and increase productivity. Forward-Looking Statements This press release includes forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forum Merger III Corporations (Forum) and ELMSs actual results may differ from their expectations, estimates and projections and consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as expect, estimate, project, budget, forecast, anticipate, intend, plan, may, will, could, should, believes, predicts, potential, continue, and similar expressions are intended to identify such forward-looking statements. These forward-looking statements include, without limitation, Forums and ELMSs expectations with respect to future performance and anticipated financial impacts of the previously announced business combination of Forum and ELMS (the business combination), the satisfaction of the closing conditions to the business combination, the size, demands and growth potential of the markets for ELMSs products and ELMSs ability to serve those markets, ELMSs ability to develop innovative products and compete with other companies engaged in the commercial delivery vehicle industry and/or the electric vehicle industry, ELMSs ability to attract and retain customers, the estimated go to market timing and cost for ELMSs products, the implied valuation of ELMS and the timing of the completion of the business combination. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results. Most of these factors are outside Forums and ELMSs control and are difficult to predict. Factors that may cause such differences include, but are not limited to: (1) the occurrence of any event, change or other circumstances that could give rise to the termination of the agreement and plan of merger (Merger Agreement) relating to the business combination or could otherwise cause the business combination to fail to close; (2) the inability of ELMS to (x) execute the transaction agreements for the Carveout Transaction (as defined below) that are in form and substance acceptable to Forum (at Forums sole discretion), (y) acquire a leasehold interest or fee simple title to the Indiana manufacturing facility or (z) secure key intellectual property rights related to its proposed business; (3) the outcome of any legal proceedings that may be instituted against Forum or ELMS following the announcement of the business combination; (4) the inability to complete the business combination, including due to failure to obtain approval of the stockholders of Forum or other conditions to closing in the Merger Agreement; (5) the receipt of an unsolicited offer from another party for an alternative business transaction that could interfere with the business combination; (6) the inability to obtain the listing of the common stock of the post-acquisition company on the Nasdaq Stock Market or any alternative national securities exchange following the business combination; (7) the risk that the announcement and consummation of the business combination disrupts current plans and operations; (8) the inability to recognize the anticipated benefits of the business combination, which may be affected by, among other things, competition and the ability of the combined company to grow and manage growth profitably and retain its key employees; (9) costs related to the business combination; (10) changes in applicable laws or regulations; (11) the possibility that ELMS may be adversely affected by other economic, business, and/or competitive factors; (12) the impact of COVID-19 on the combined companys business; and (13) other risks and uncertainties indicated from time to time in the proxy statement filed relating to the business combination, including those under the Risk Factors section therein, and in Forums other filings with the SEC. Some of these risks and uncertainties may in the future be amplified by the COVID-19 outbreak and there may be additional risks that Forum and ELMS consider immaterial or which are unknown. Forum and ELMS caution that the foregoing list of factors is not exclusive. Forum and ELMS caution readers not to place undue reliance upon any forward-looking statements, which speak only as of the date made. ELMS is currently engaged in limited operations only and its ability to carry out its business plans and strategies in the future are contingent upon the closing of the proposed business combination. The consummation of the business combination is subject to, among other conditions, (i) the execution and effectiveness of transaction agreements by ELMS with SF Motors, Inc. (d/b/a SERES) (SERES), including as contemplated by the term sheet entered into by ELMS and SERES, that are each in form and substance acceptable to Forum (at Forums sole discretion), (ii) the acquisition by ELMS of a leasehold interest or fee simple title to the Indiana manufacturing facility prior to the business combination, and (iii) the securing by ELMS of key intellectual property rights related to its proposed business (collectively, the Carveout Transaction). All statements herein regarding ELMSs anticipated business assume the completion of the Carveout Transaction. Forum and ELMS do not undertake or accept any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect any change in their expectations or any change in events, conditions or circumstances on which any such statement is based. Important Information About the Business Combination and Where to Find It In connection with the proposed business combination with ELMS, Forum filed a preliminary proxy statement with the U.S. Securities and Exchange Commission (SEC) and intends to file a definitive proxy statement with the SEC. Forums stockholders and other interested persons are advised to read the preliminary proxy statement and any amendments thereto and, when available, the definitive proxy statement, in connection with Forums solicitation of proxies for its special meeting of stockholders to be held to approve, among other things, the proposed business combination, because these documents contain important information about Forum, ELMS and the proposed business combination. When available, the definitive proxy statement for the proposed business combination will be mailed to stockholders of Forum as of a record date to be established for voting on the proposed business combination. Forums stockholders may also obtain a copy of the preliminary proxy statement and the definitive proxy statement, once available, as well as other documents filed with the SEC by Forum, without charge, at the SECs website located at www.sec.gov or by directing a request to: Forum Merger III Corporation, 1615 South Congress Avenue, Suite 103, Delray Beach, FL 33445. The information contained on, or that may be accessed through, the websites referenced in this press release is not incorporated by reference into, and is not a part of, this press release. Participants in the Solicitation Forum and its directors and executive officers may be considered participants in the solicitation of proxies with respect to the business combination. Information about the directors and executive officers of Forum and a description of their interests in Forum are set forth in the preliminary proxy statement, which was filed on February 16, 2021 with the SEC, and definitive proxy statement, when it is filed with the SEC, in connection with the proposed business combination. These documents can be obtained free of charge from the sources indicated above. ELMS and its directors and executive officers may also be deemed to be participants in the solicitation of proxies from the stockholders of Forum in connection with the business combination. A list of the names of such directors and executive officers and information regarding their interests in the business combination are set forth in the preliminary proxy statement, which was filed on February 16, 2021 with the SEC, and definitive proxy statement, when it is filed with the SEC, in connection with the proposed business combination. These documents can be obtained free of charge from the sources indicated above. No Offer or Solicitation This press release shall not constitute a solicitation of a proxy, consent or authorization with respect to any securities or in respect of the business combination. This press release shall also not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of securities in any states or jurisdictions in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. About Electric Last Mile, Inc. ELMS is focused on redefining the last mile with efficient, customizable and sustainable solutions. ELMS first vehicle, the Urban Delivery, is anticipated to be the first Class 1 electric vehicle in the U.S. market. The company is headquartered in Troy, Michigan. For more information, please visit www.electriclastmile.com. About Geotab Inc. Geotab is advancing security, connecting commercial vehicles to the internet and providing web-based analytics to help customers better manage their fleets. Geotabs open platform and Marketplace, offering hundreds of third-party solution options, allows both small and large businesses to automate operations by integrating vehicle data with their other data assets. As an IoT hub, the in-vehicle device provides additional functionality through IOX Add-Ons. Processing billions of data points a day, Geotab leverages data analytics and machine learning to help customers improve productivity, optimize fleets through the reduction of fuel consumption, enhance driver safety, and achieve strong compliance to regulatory changes. Geotabs products are represented and sold worldwide through Authorized Geotab Resellers. To learn more, please visit www.geotab.com and follow us @GEOTAB and on LinkedIn.", "role": "user" }, { "content": "Electric Last Mile and Geotab Inc. Announce Partnership Partnership to support rollout of ELMS AIR connectivity suite and deliver advanced, turnkey telematics solutions to fleet managers", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: SEOUL, South Korea, June 4, 2020 /PRNewswire/ -- In celebration of World Environment Day (June 5), Amorepacific announced its plan to install an upcycled bench made from recycled cosmetic bottles in public facilities for citizens. The bench is a co-creation with environmental startup TerraCycle and environmental design startup Radio-B. Amorepacific's upcycled bench made from empty cosmetic bottles To make the bench, Amorepacific developed a terrazzo for the first time in the industry by mixing plastic cosmetic bottle powder with ultra-high performance concrete (UHPC). The bench's design highlights the importance of recycling with 1,400 empty bottles used in its production. The project also includes some unique ideas to promote distancing in daily life as part of preventing the spread of COVID-19. A pot of plants is placed in the middle of the bench as well as the 1m mark to help people maintain social distancing when sitting. Amorepacific Communication Executive Director Howard Lee explained, \"This upcycled bench project shows how we can extend the lifecycles of products. It is meaningful that we actively spread a positive message of overcoming social issues together. Amorepacific is proud to work as a global corporate citizen discovering sustainable and innovative ways to contribute to society.\"The recycled cosmetics bottle terrazzo will be further used in Amorepacific stores and in 'GREENCYCLE' campaign, a corporate social responsibility activity, dedicated to recycling and upcycling.The company plans to reduce its use of plastic up to 700 tons by 2022. To help with this, it is switching to colorless PET to help increase its use of recyclable packaging. In June 2019, Amorepacific signed an agreement of cooperation with TerraCycle to recycle used bottles. Their goal included collecting 100 tons of used plastic cosmetic bottles each year and aiming for a 100% recycle rate. The company plans to continue its environmental commitment by increasing its use of PCR (post-consumer recycled) plastic and through ongoing research on eco-friendly packaging.SOURCE Amorepacific", "role": "user" }, { "content": "Amorepacific makes upcycled bench made from empty cosmetic bottles in celebration of World Environment Day English English English English", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: REDWOOD CITY, Calif.--(BUSINESS WIRE)--i2c Inc., a leading provider of digital payment and banking technology, will be joining host Visas webinar on demystifying the fintech enablement ecosystem on March 10th, 2021. i2c CEO and founder, Amir Wain, joins the conversation along with client and strategic partner, Car IQ CEO, Sterling Pratz, to discuss how partnerships simplify company roadmaps for up-and-coming fintech startups and how integrating different components of payments infrastructures can power sustainable and scalable growth. The live discussion will feature a panel of industry experts aiming to help up-level audience knowledge on the fintech enablement ecosystem, discussing its current state and where its heading. A live Q&A session will be open to participants at the end of the webinar. Join the one-hour webinar on Wednesday, March 10th, 2021 (9:00AM PST/12:00PM EST) to: Panelists: Register for the webinar at: Demystifying the Fintech Enablement Ecosystem. About i2c Inc. i2c is a global provider of highly-configurable payment and banking solutions. Using i2c's proprietary \"building block\" technology, clients can easily create and manage a comprehensive set of solutions for credit, debit, prepaid, lending and more, quickly and cost-effectively. i2c delivers unparalleled flexibility, agility, security and reliability from a single global SaaS platform. Founded in 2001, and headquartered in Silicon Valley, i2c's next-generation technology supports millions of users in more than 200 countries/ territories and across all time zones. For more information, visit www.i2cinc.com and follow us at @i2cinc.", "role": "user" }, { "content": "Webinar: Demystifying the Fintech Enablement Ecosystem i2c Joins Visa and Car IQ to Discuss Enabling Partnerships Through Modern Payments Infrastructure Stacks", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: ROCKVILLE, Md.--(BUSINESS WIRE)--Immunomic Therapeutics, Inc., (ITI), a privately-held clinical-stage biotechnology company pioneering the study of nucleic acid immunotherapy platforms, and WhyWeVax (WWV), a non-profit organization dedicated to building vaccine confidence, workforce security and countering vaccine misinformation, announced that executives from both organizations recently made public comments discussing the science of COVID-19 vaccines and the challenges of vaccine hesitancy and distribution. Sia Anagnostou, Senior Director of Corporate Development for ITI and WWV Board Secretary, recently made public comments during the ACIP emergency meeting in support of the CDCs recommendation to allocate the initial COVID vaccine doses expected late Dec 2020 - Jan 2021 to health care workers and people living in long-term care facilities. In addition to the ACIP discussion, Dr. William Hearl, CEO of ITI and Chairman of WWV, was interviewed on Fox News 29 in Philadelphia to amplify the commentary on these topics. It is important that leaders in the biotechnology community speak out wherever possible to effectively communicate the value, safety and efficacy of vaccines for COVID-19 and other infectious diseases, said Dr. Hearl. Participation in immunization education and support of Public Health efforts is of the utmost importance as we face the global challenge of this pandemic. The public comments at ACIP and on Fox News are available here: https://vimeo.com/489026826 https://www.fox29.com/video/876822.amp About Immunomic Therapeutics, Inc. Immunomic Therapeutics, Inc. (ITI) is a privately-held, clinical stage biotechnology company pioneering the development of vaccines through its investigational proprietary technology platform, UNiversal Intracellular Targeted Expression (UNITE), which is designed to utilize the bodys natural biochemistry to develop vaccines that have the potential to generate broad immune responses. The UNITE platform has a robust history of applications in various therapeutic areas, including infectious diseases, oncology, allergy and autoimmune diseases. ITI is primarily focused on applying the UNITE platform to oncology, where it could potentially have broad applications, including targeting viral antigens, cancer antigens, neoantigens and producing antigen-derived antibodies as biologics. In early 2020, an investment of over $60M by HLB Co., LTD, a global pharmaceutical company, enabled ITI to accelerate application of its immuno-oncology platform, in particular to glioblastoma multiforme, and rapidly advance other key candidates in the pipeline, including the most recent initiative into infectious diseases with development of its vaccine candidate for COVID-19. The Company has built a large pipeline from UNITE with eight oncology programs, multiple animal health programs and a SARS-CoV-2 program to prevent and treat COVID-19. ITI has entered into a significant allergy partnership with Astellas Pharma and has formed several academic collaborations with leading Immuno-oncology researchers at Duke University and the University of Florida. ITI maintains its headquarters in Rockville, Maryland. For more information, please visit www.immunomix.com. About Why We Vaccinate, Inc. WhyWeVax - www.whywevax.org - is a 501(3)(c) educational organization dedicated to provide a credible and trusted source for honest and factual information on vaccines, their efficacy, safety and importance to public health. WhyWeVax works to counter the misinformation, anti-science rhetoric and virulent fake news dissemination that question the safety and efficacy of vaccines for preventable infectious diseases. The development of a safe and effective vaccine for COVID-19 and its ultimate manufacture and distribution through the healthcare system will require a concerted effort by the biotechnology, academic, medical and scientific communities to meet the challenge of vaccine hesitancy and refusal. WhyWeVax will support educate the population to the value of vaccines to protect the health and safety of their families, their friends, their communities and our way of life.", "role": "user" }, { "content": "Immunomic Therapeutics Executives and Board Members of WhyWeVax Discuss COVID-19 Vaccine Issues with Fox News and CDCs ACIP Committee", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: NEW YORK, Aug. 26, 2020 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors ofAnaplan, Inc. (\"Anaplan\" or the \"Company\")(NYSE:PLAN). Such investors are advised to contact Robert S. Willoughby at [emailprotected]or 888-476-6529, ext. 7980. The investigation concerns whether Anaplan and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about joining the class action] On February 27, 2020, Anaplan announced that, although it slightly exceeded revenue guidance for the quarter, which grew at a rate of 42% year-over-year, its calculated billings for the fourth quarter fell short of consensus. Specifically, billings were only $126 million, representing a growth rate of 25%, which was well below consensus estimates of $138 million, and roughly half of the Company's historical growth rates of 46% to 59%, and significantly less than the Company's rate of revenue growth of over 40%. These reported earnings contrasted management's previous representation that calculated billings growth rate would track the revenue growth rate. In explaining this shortfall, the Company cited \"management changes,\" which resulted in the inability to close some large deals at the end of the quarter, and also announced that its Chief Growth Officer was leaving after only a few months on the job. Analysts immediately pointed out that the billings growth rate had fallen to half its historical rate, and that the \"significant drop\" in billings was a strong sign of a business in trouble. On this news, Anaplan's stock price fell $14.06 per share, or 24.20%, to close at $44.03 per share on February 27, 2020. The Pomerantz Firm, with offices in New York, Chicago, Los Angeles, and Paris is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 80 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com. CONTACT:Robert S. WilloughbyPomerantz LLP[emailprotected]888-476-6529 ext. 7980 SOURCE Pomerantz LLP Related Links www.pomerantzlaw.com", "role": "user" }, { "content": "SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anaplan, Inc. - PLAN", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: NEW YORK, Nov. 2, 2020 /PRNewswire/ --Infortoday announcedInfor OrderNow, a new contactless ordering solution to help the hospitality industry better navigate the operational challenges that the current pandemic presents, while supporting the dining revenue stream in the future. An extension of Infor POS, Infor's powerful cloud-based point-of-sale solution, Infor OrderNow is a new solution released as an adaptation to changes in customer purchase behavior that also provides organizations with a tool to address declining revenue challenges. The hospitality industry, including hotels, restaurants, campus cafeterias, etc., stand to benefit from greater customer satisfaction, increased order accuracy and higher average check totals. \"As apprehensiveness about dining out continues to linger, it's more important than ever to provide the hospitality industry with tools to help regain revenue during a culturally changing landscape while adhering to changing virus prevention guidelines,\" said Rick Kuhlmann, Infor director of product development. \"In response to this and the needs of our customers, Infor developed this contactless ordering mobile web application that will provide a frictionless and contactless user experience to give guests the peace of mind of ordering directly from their phone.\" Infor OrderNow is a responsive web application that is easy to deploy in a wide variety of hospitality industry segments. For on-premises restaurants and food services, it supports BYOD mobile kiosk functionality, providing an alternative to counter-based ordering. In hotels and resorts, it supports full-service restaurant and room service ordering. Infor OrderNow is easily embeddable in a customer's own web environment, and because an app download is not required, it is quickly and easily adopted by guests for immediate uptake. Part of the Infor Hospitality suite, Infor POS helps operators in hotels, food services, restaurant chains, and other hospitality locations control incoming data from multiple revenue centers. Transactions are securely integrated to leading payment platforms, meal plan solutions, and loyalty applications, making for an easy-to-use, operationally versatile solution. With Infor POS, organizations can manage all restaurants from one central point, and replicate parameters such as menu items, prices, and touch-screen configurations, without having to input the criteria separately for each outlet. The centralized management structure allows users to analyze performance at a group or property level in real-time, allowing for greater efficiency and more informed decision making. \"We've seen this over and over again on the news, and online, but offering contactless solutions to guests and employees is key. Being able to provide the same level of service through different means or outlets is what is setting organizations apart from their competitors right now, and allowing them remain resilient in a changing market,\" said Jason Floyd, general manager, Infor Hospitality. \"During this pandemic Infor is not sitting stagnant like many of our competitors. We are innovating within our solution suites, and creating new products based on customer needs and feedback, to keep our customers running, and give them tools that will help them better manage the needs of right now, but be able to adapt and scale for their needs in the coming months.\" About Infor Infor is a global leader in business cloud software specialized by industry. Providing mission-critical enterprise applications to 67,000 customers in more than 175 countries, Infor software is designed to deliver more value and less risk, with more sustainable operational advantages. We empower our 17,000 employees to leverage their deep industry expertise and use data-driven insights to create, learn and adapt quickly to solve emerging business and industry challenges. Infor is committed to providing our customers with modern tools to transform their business and accelerate their own path to innovation. To learn more, please visitwww.infor.com. For more information:Christina Ledger Infor 312-662-2135 [emailprotected] SOURCE Infor Related Links www.infor.com", "role": "user" }, { "content": "Infor Develops Contactless Ordering Solution for Hospitality Industry Cloud-based Infor OrderNow provides new contactless ordering capabilities for hospitality and food service leaders", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: SO PAULO, Jan. 15, 2021 /PRNewswire/ --Companhia de Saneamento Bsico do Estado de So Paulo Sabesp (\"Sabesp\" or \"Company\"), in compliance with the provisions of Article 157, Paragraph 4, of Law 6,404/76 and the provisions of Instruction 358 of the Brazilian Securities and Exchange Commission (\"CVM\"), dated January 3, 2002, as amended, hereby informs its shareholders and the market in general that the So Paulo State Energy and Sanitation Regulatory Agency (ARSESP - Agncia Reguladora de Saneamento e Energia do Estado de So Paulo) published Resolutions N 1,114 and N 1,115: (i) changing the schedule of the Third Ordinary Tariff Revision of Sabesp; and (ii) changing to the Tariff Structure schedule, as follows: Resolution N 1,114 - Third Ordinary Tariff Revision Stage Event Period 9 Disclosure of the Preliminary Technical Note - Calculation of P0 January 28, 2021 10 Public consultation and public hearing - Calculation of P0 January 29, to March 1, 2021 11 Disclosure of the Detailed Report, Final Technical Note and Resolution regarding P0 April 9, 2021 Resolution N 1,115 - Tariff Structure Schedule Stage Event Period* 4 Disclosure of the Preliminary Technical Note with the proposal for the new tariff structure and the respective implementation plan Up to January 28, 2021 5 Hold of the public consultation and public hearing on the Preliminary Technical Note published according to Stage 4 From January 29 to March 8, 2021 6 Analysis of the contributions received, publication of the Final Technical Note, of the Detailed Report and of the Resolution on the tariff structure approved by Arsesp Up to April 9, 2021 *The indicated periods (except for stage 5) may be anticipated as the technical work progresses. The Resolutions mentioned are available on ARSESP's and Sabesp's websites, in the Investor Relations page. The Company will keep the market informed on the developments concerning this matter. IR Contacts: Mario Arruda Sampaio (55 11) 3388-8664 ([emailprotected]) Angela Beatriz Airoldi (55 11) 3388-8793 ([emailprotected]) SOURCE Sabesp Related Links http://www.sabesp.com.br", "role": "user" }, { "content": "Sabesp - Material Fact USA - English Brazil - Portugus", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: PITTSBURGH, Jan. 21, 2021 /PRNewswire/ -- \"My dog's dry food would get soggy from water or drool that would accumulate in the food dish,\" said an inventor, from Ogden, Utah, \"so I invented the DRY MUTT FOOD BOWL. My design helps to prevent soggy food, waste and bacteria that builds up in a dog food dish.\" The patent-pending invention provides an improved food and water bowl set for pet dogs. In doing so, it ensures that the supply of dry food remains dry and free from water or drool. It also helps to prevent messes and it could provide added comfort, safety and convenience. The invention features a practical design that is easy to use so it is ideal for pet owners. Additionally, it is producible in design variations and a prototype is available. The original design was submitted to the Salt Lake City sales office of InventHelp. It is currently available for licensing or sale to manufacturers or marketers. For more information, write Dept. 19-STU-2404, InventHelp, 217 Ninth Street, Pittsburgh, PA 15222, or call (412) 288-1300 ext. 1368. Learn more about InventHelp's Invention Submission Services at http://www.InventHelp.com. SOURCE InventHelp Related Links http://www.inventhelp.com", "role": "user" }, { "content": "InventHelp Inventor Develops Improved Food and Water Bowl Set for Dogs (STU-2404)", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: BEIJING, March 24, 2021 /PRNewswire/ -- Innovator and leader in China's online travel industry - Tongcheng-Elong Holdings Limited (\"Tongcheng-Elong\" or the \"Company\", together with its subsidiaries, the \"Group\", stock code: 0780) announces the audited consolidated results for the year ended December 31, 2020 (the \"Reporting Period\"). The Company's operation and performance were inevitably disrupted by the COVID-19 outbreak since January 2020. Due to the decreased demands in our travel business, resulting from the implementation of travel restrictions and lockdown policies imposed by governments around the world. However, the Company's business continues improving quarter by quarter and has achieved an impressive recovery which outpaced the average industry. Through the continuous operation of diversified traffic channels, expanding the coverage of low-line cities and other strategic guidelines, the company is pleased to record some key metrics that showed a strong recovery trend during the Reporting Period. Results Review Although the pandemic caused an unavoidable impact on the business and financial performance, we managed to remain profitable and outperform the industry with our advantages in market position, operations and cost control. For the fourth quarter of 2020, thecompanyachieved four consecutive quarters of profitability. In the fourth quarter of 2020, ouradjusted profit net margin has recovered 92.8% to RMB307.3 million. Adjusted net profit margin was 16.9%, which has fully recovered to the level in 2019. Adjusted EBITDA increased from RMB415.1 million in the fourth quarter of 2019 to RMB441.0 million in the same period of 2020. On a year-to-year basis, adjusted EBITDA in the fourth quarter of 2020 increased for the first time in year 2020 by 6.2%. In the fourth quarter of 2020, adjusted EBITDA margin increased to 24.3% from 21.2% in the fourth quarter of 2019. For the fourth quarter of 2020, the revenue was RMB1,812.9 million, which has decreased by 7.3% compared to RMB1,956.5 million for the same period in 2019. Our APU in 2020 increased by 1.8% from 152.4 million in 2019 to 155.2 million amid the challenging market situation during the pandemic. For the fourth quarter of 2020, our average MPUs increased by 5.9% year-to-year from 27.1 million to 28.7 million. Our paying ratio increased from 13.2% to 14.6%. With our strategic focus on lower-tier cities, effective traffic sources and advanced innovation capability, we have successfully captured the rebound opportunities in the lower-tier cities market and further reinforced our leading position in China's OTA market, and the business performance outpaced the industry average. For the year ended December 31, 2020, approximately 61.7% of our new paying users on the WeChat platform were from tier-3 or below cities in China. Currently, the online penetration rate of travel business in lower-tier cities is relatively low, signifying immense opportunities for us. As of December 31, 2020, our registered users residing in non-first-tier cities in China accounted for approximately 86.3% of the total registered users. We reacted swiftly to market changes and adopted a flexible operations strategy, stringent cost control and light operating model, which helped us overcome challenges and seize market opportunities. Our efforts have also brought us market recognition during the year. It is worth mentioning that the company achieved excellent growth and excellent business performance in the fourth quarter of 2020 We have registered year over year growth of 21% in our room nights sold, with of more than 30% increase year-to-year in lower-tier cities, around 5% year-to-year increase in domestic air ticketing volume, and nearly 180% year-to-year increase in bus ticketing volume. 2020 Business Review Supported by the diverse and effective traffic channels both online and offline, the Company's competitive advantage in lower-tier cities, as well as the Company's comprehensive products and services, the Company have obtained solid amount of active users and paying users. The Company's APU in 2020 increased by 1.8% from 152.4 million in 2019 to 155.2 million amid the challenging market situation during the pandemic. On a yearly basis, the Company's average MAUs only slightly decreased by 6.7% year-to-year from 205.2 million in 2019 to 191.4 million in 2020. Our average MPUs decreased by 14.5% year-to-year from 26.9 million in 2019 to 23.0 million in 2020 as travel demand was hindered by travel restrictions and pandemic control measures. \"Together, let's go!\". We are committed to the principle of assisting and protecting the responsibility of our users, and we will provide full support to our stakeholders and the travel industry during the outbreak. During the period under review, We designed a self-service online cancellation function as well as co-establishing an emergency fund to guarantee well-timed refund. At the same time, we embedded our advanced technology in an enquiry platform for users to trace possible exposures to virus in their travel histories and help them understand the quarantine and travel policies in different regions of China. Furthermore, we worked with Tencent Map to provide users with locational information of COVID-19 nucleic acid test availability. To help our suppliers to capture the market rebound opportunities, we developed Ark Alliance program and actively promoted tourist sightseeing spots through online marketing for free. We also offered \"Hit the Road\" initiative to facilitate users' travel plans and to help revitalize the travel industry by providing travelers with more safety assurance. We also joined hands with local governments to promote tourist destinations and distribute consumer vouchers so as to help stimulate domestic consumption. During the period under review, we enhanced diversification of our traffic channels by exploring and further penetrating alternative online traffic sources. We maintained stable and effective traffic channels from Weixin mini program and continued to deepen cooperation with Tencent by further exploring the potential of the \"Search+Travel\" ecosystem. During the period under review, about 80.9% of our average MAUs was contributed from Weixin mini program. As Tencent's first partner in the OTA industry, we also expanded our cooperation with Tencent by launching various marketing campaigns with its online games platform to enhance interactions with our younger users. This has helped to increase our advertising efficiency significantly. During the period under review, we actively expanded its traffic diversification and have successfully captured the rebound opportunities in lower-tier cities market and have gained more market shares in our major business segments, including accommodation and transportation. We cooperated with several handset vendors and designed various initiatives which provided users with direct booking and itinerary reminders functions through our quick APPs on mobile phones and other mobile devices. To grasp opportunities driven by the upswing of short videos, we strategically cooperated with one of the leading short video platforms and improve brand recognition. We commenced our offline user acquisition initiatives in bus ticketing, attraction ticketing and accommodation businesses in the second quarter of 2020 to capture market recovery opportunities, especially in lower-tier cities. We forged sustainable relationships with various TSPs to offer one-stop-shop products and services to users throughout their journeys. During the period under review, our online platforms offered over 7,600 domestic routes operated by over 820 airlines and agencies, around 2.2 million hotels selections and alternative accommodation options, nearly 390,000 bus routes, over 670 ferry routes and approximately 8,000 domestic tourist attractions ticketing services. Furthermore, we continued to elevate our cross-selling strategies, resulting in continuous improvement in our cross-selling rate. In late 2020, we also combined the accommodation and the tourist attraction business segment, so as to achieve better synergy and further improve cross-selling. The Company is committed to transforming from OTA to ITA (Intelligent Travel Assistant), with an aim to benefit the whole industry. During the Reporting Period, the Company further ripened the Huixing system by optimizing the layout to users and better integrating supply chain resources to provide more combinations in different scenarios to meet various demands. Simultaneously, the Company successfully developed our own intelligent robot for customer service, which benefited our customer service efficiency and reduced our operational costs. During the Reporting Period, the Company have developed comprehensive Software-as-a-service (SaaS) solutions to assist individual and small hotel chains in the management of their daily operations as well as for the management of inventory, revenue and marketing, which better integrated supply chain resources and enhanced our operations and profitability. Business Outlook and Strategies With the effective control of the pandemic in China and as efficacious vaccines emerge, the Company are optimistic about the recovery of the travel industry in China in 2021. The Company are confident to continuously outperform the industry with the Company's competitive advantages in traffic sources, market position and operation strategies. With the government's support to develop and to digitalize travel industry, we will leverage our advanced technology to improve value proposition to our suppliers and business partners and create sustainable cooperation in the long run. We will further explore local travel opportunities with local governments, travel bureaus and upstream suppliers to provide comprehensive local travel recommendations and solutions to users. This has granted us great opportunities to leverage our strong traffic to cultivate untapped travel destinations as well as enhancing the digitalization and the efficiency of the travel industry in China. In the long run, the Company believe the online penetration of travel industry will accelerate and more opportunities for OTAs will appear. To fulfill the Company's mission and reinforce the Company's leadership in the market, the Company will continue to execute the Company's key business strategies. The Company will not only further penetrate the travel market leveraging on stable and cost-effective traffic sources but also further enhance products and services with technological innovations. The Company will continue to excel in the industry with the Company's ambition to transform from OTA to ITA. The Company will also continue to seek merger and acquisition opportunities to boost future growth of the Company's business. Appendix Key Financial Metrics for the year ended December 31, 2020 Year endedDecember 31, Year-to-year 2020 2019 change (in RMB' 000) Revenue 5,932,591 7,392,932 (19.8)% Adjusted EBITDA 1,366,484 2,018,532 (32.3)% Adjusted profit for the year 953,972 1,544,320 (38.2)% Revenue (decrease)/growth (year-to-year) (19.8)% 21.4% Adjusted EBITDA margin 23.0% 27.3% Adjusted net margin 16.1% 20.9% SOURCE Tongcheng-Elong Holdings Limited", "role": "user" }, { "content": "Tongcheng-Elong Announces 2020 Annual Results", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: SEATTLE, Aug. 25, 2020 /PRNewswire/ --Milliman, Inc., a premier global consulting and actuarial firm, is pleased to announce the recipients of this year's Opportunity Scholarship program. The program was created to assist students from ethnic groups and races that are under-represented in the fields of actuarial science, data science, computer science, economics, programming, mathematics, statistics, data analytics, or finance. This year, Opportunity Scholarship recipients include 17 students from colleges and universities across the United States, Australia, South Africa, and the United Kingdom who have demonstrated academic excellence and plan to pursue a career in actuarial science or related fields. \"We are pleased to support these outstanding students, and recognize their accomplishments to date,\" said Milliman Chief Executive Officer Steve White. \"Our professions will benefit from their diverse backgrounds and perspectives. Our hope is that this financial support will be a small step on their path to future success and leadership.\" 2020 Opportunity Scholarship recipients: Aleesha Chavez, Computer Science, Northwest Nazarene University, Nampa, IdahoMicalyia Douglas, Actuarial Science, Central Connecticut State University, New Britain, ConnecticutHerman A. Gonzalez, Computer Science, University of Florida, Gainesville, FloridaJoelle Hardy, Finance, Emory University, Atlanta, GeorgiaMichaela Henry, Mathematics, California State University, San Bernardino, CAJordan Howell, Actuarial Science, Kettering University, Flint, MichiganRachael King, Mathematics, Macquarie University, Ryde, NSW, AustraliaRichard Machivenyika, Actuarial Science, University of Cape Town, Rondebosch, South AfricaTreasure Z. Mdhluli, Actuarial Science, University of the Witwatersrand, Johannesburg, South AfricaSibonakaliso Mkandla, Actuarial Science, University of Cape Town, Rondebosch, South AfricaJorge Morejon, Actuarial Science, Michigan State University, East LansingGenius Mukuka, Economics, University of Birmingham, United KingdomEldaleona Odole, Data Science, University of Iowa, Iowa CityJulie E. Orellana, Computer Science, Oklahoma State University Institute of Technology, OkmulgeeJacqueline Pina Perez, Mathematics, Hamilton College, Clinton, New York Present Rikhotso, Actuarial Science, University of Pretoria, South AfricaMattie Zimmer, Mathematics, University of New Orleans, Louisiana Eight of this year's recipients also received Opportunity Scholarships last year. Repeat recipients are Aleesha Chavez, Herman Gonzalez, Jordan Howell, Rachael King, Richard Machivenyika, Treasure Mdhluli, Julie Orellana, and Mattie Zimmer. Since it began in 2017, the Opportunity Scholarship program has awarded 61 scholarships. About Milliman Milliman is among the world's largest providers of actuarial and related products and services. The firm has consulting practices in healthcare, property & casualty insurance, life insurance and financial services, and employee benefits. Founded in 1947, Milliman is an independent firm with offices in major cities around the globe. For further information, visit milliman.com. SOURCE Milliman, Inc. Related Links www.milliman.com", "role": "user" }, { "content": "Milliman Awards 17 Opportunity Scholarships In Program's Fourth Year", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: DALLAS--(BUSINESS WIRE)--AIS Healthcare is committed to doing more of what matters, not only to improve quality in healthcare but also to improve lives in our communities. Now, were honoring this commitment by supporting two organizations dedicated to increasing opportunity and reducing inequality: The Breonna Taylor Memorial Scholarship Fund in Nursing and Feeding America. AIS Healthcare is matching all employee donations to each organization, up to $50,000 total, for a potential $100,000 impact. These two partnerships are just the beginning, said Simon Castellanos, Chief Executive Officer of AIS Healthcare. We will continue to find ways to help create a more just, more equitable world. We will continue to do whats right, not just whats expected, at a time when doing whats right is more important than ever. The Breonna Taylor Memorial Scholarship Fund in Nursing In March 2020, Breonna Taylor, an emergency room technician at University of Louisville Health, was killed by police officers serving a no-knock warrant at her home. To honor her memory, UofL Health has created a nursing scholarship in her name. The Breonna Taylor Memorial Scholarship Fund in Nursing will cover four years of tuition and fees. Preference will be given to Black female residents of Kentucky. More than 325 patients in Kentucky receive in-home nursing care from AIS Healthcare. We are proud to increase access to nursing education in this community while remembering the life of a dedicated healthcare worker. Feeding America More and more Americans are going hungry due to the COVID-19 pandemic. Feeding America, a national network of food banks, estimates that more than 50 million people across the country may experience food insecurity this year, including 17 million children. Every dollar donated to Feeding America helps provide at least 10 meals. AIS Healthcares efforts could give half a million meals to Americans in need. About AIS Healthcare Advancing quality. Improving lives. As the leading provider of targeted drug delivery (TDD), infusion care and ophthalmic solutions, AIS Healthcare is committed to doing more of what matters. From pharmacies that put patient safety first to comprehensive services that enhance the entire care experience, we go beyond the expected in everything we do. Learn more at aiscaregroup.com", "role": "user" }, { "content": "AIS Healthcare Donations Address Social Inequities and Advance Social Justice", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: SHENZHEN, China, April 27, 2020 /PRNewswire/ -- Tencent Music Entertainment (TME) (NYSE: TME) announced it has completed an equity investment in Radio Music Warehouse, a leading music company that provides music streaming solutions to business use in China, on April 27. TME has also obtained a right to further increase its shareholdings to controlling stake in the company. Upon completion of the transaction, TME will provide Radio Music with access to a rich and diversified music library to meet the personalized demands of its customers. At the same time, TME will promote and distribute its high quality music content, via the hundreds of thousand offline spots in China that is using Radio Music's in-store music solutions. Through business investments and other methods, TME is contributing to the recovery of normal business operations in China from the COVID-19 pandemic. \"Radio Music has a professional music-for-business service system and comprehensive offline coverage resources. Through this investment, we will jointly explore music-for-business market to add value to our music ecosystem,\" said Tony Yip, Chief Strategy Officer of TME. \"TME will offer more diversified music content to resolve the challenge of a shortage of content for music solutions to business, and develop brand-new content promotion and distribution models in to provide a stage for artists and high-quality work everywhere. We also look forward to a strong synergy between music-for-business service and our existing online music and social entertainment services, to bring users a more professional, immersive music experience that drives the healthy development of the music-for-business industry and the music industry as a whole. \" SOURCE Tencent Music Entertainment Group Related Links https://ir.tencentmusic.com/", "role": "user" }, { "content": "Tencent Music Completed Investment in Radio Music, a Leading Music-for-business Provider in China", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: DENVER--(BUSINESS WIRE)--HempFusion Wellness Inc. (TSX:CBD.U) (OTCQX:CBDHF) (FWB:8OO) (\"HempFusion\" or the \"Company\"), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, is pleased to announce that it has submitted its dossier to the United Kingdom's Regulatory Food Safety Agency (the \"FSA\"). HempFusion, in conjunction with its strategic and exclusive supply chain partner, has submitted its novel foods application to the FSA with the coordination of a leading regulatory agency in Europe. This submission represents the first step in the United Kingdoms (the UK) regulatory approval process required to allow products that contain CBD to be sold on the shelves of retailers in the UK. The submission includes a detailed analysis of the quality, stability and safety of HempFusion's raw ingredients and many unique product formulations. In addition to proprietary heirloom hemp-sourcing and state-of-the-art low pressure and low-temperature C02 extraction methods, the submission also includes compliant labeling and testing requirements and complete toxicology data. The Company's focus on compliance and sourcing premium raw materials further substantiates the quality of HempFusion's exclusive Organic Panoramic Hemp Extract and strategically positions HempFusion for continued sales within one of the largest markets in Europe, the UK. HempFusion believes the submission is an essential step in preparing for anticipated European Union (the EU) regulations. \"We believe the UK's decision to allow CBD companies to obtain a Novel Food Authorization from the FSA is a tremendous step forward for the global CBD industry,\" commented Jason Mitchell, N.D., HempFusion's Co-Founder and Chief Executive Officer. \"HempFusion was built on the pillars of regulatory compliance. We have invested significant time, resources, and energy to ensure our products meet the highest standards, and we are pleased to report our submission includes completed toxicology data, which may represent one of the most complete submissions to date. We look forward to working with the FSA as regulations continue to evolve within the UK. This submission firmly establishes HempFusion as a future leader within the UK market, continued Dr. Mitchell. The novel food application's primary function is to assess CBD product safety, including detailed toxicology studies. HempFusion places significant importance on safety for its consumers as evidenced by its participation and co-sponsoring of many studies and clinical trials, such as the Companys participation in ValidCares liver and reproductive toxicity study, believed to be the largest CBD human observational study to date. The Company has recently entered Europe through Ireland and looks forward to maintaining its long track record of compliance by meeting the requirements of the FSA ahead of its broader planned expansion throughout the UK and the EU to further establish it as a global leader. ABOUT HEMPFUSION HempFusion is a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition. HempFusion distributes its family of brands, including HempFusion, Probulin Probiotics, Biome Research, and HF Labs, to approximately 4,000 retail locations across all 50 states of the United States and select international locations. Built on a foundation of regulatory compliance and human safety, HempFusions diverse product portfolio comprises 48 SKUs including tinctures, proprietary FDA Drug Listed Over-The-Counter (OTC) Topicals, Doctor/Practitioner Lines and more. With a strong focus on research and development, HempFusion has an additional 30 products under development. HempFusion is a board member of the US Hemp Roundtable, and HempFusions wholly-owned subsidiary, Probulin Probiotics, is one of the fastest-growing probiotics companies in the United States, according to SPINs reported data. HempFusions CBD products are based on a proprietary Whole Food Hemp Complex and are available in-store or by visiting HempFusion online at www.hempfusion.com or www.probulin.com. Follow HempFusion on Twitter, Facebook and Instagram and Probulin on Twitter, Facebook and Instagram. FORWARD-LOOKING STATEMENTS This news release contains forward-looking statements and forward-looking information within the meaning of Canadian securities legislation (collectively, forward-looking statements) that relate to HempFusions current expectations and views of future events. Any statements that express, or involve discussions as to, expectations, beliefs, plans, objectives, assumptions or future events or performance (often, but not always, through the use of words or phrases such as will likely result, are expected to, expects, will continue, is anticipated, anticipates, believes, estimated, intends, plans, forecast, projection, strategy, objective and outlook) are not historical facts and may be forward-looking statements and may involve estimates, assumptions and uncertainties which could cause actual results or outcomes to differ materially from those expressed in such forward-looking statements. No assurance can be given that these expectations will prove to be correct and such forward-looking statements included in this news release should not be unduly relied upon. These statements speak only as of the date of this news release. In particular and without limitation, this news release contains forward-looking statements relating to the Companys continued sales within the UK, preparation for anticipated EU regulations, compliance with the requirements of the FSA, planned expansion throughout the UK and the EU and the Companys other plans, focus and objectives. Forward-looking statements are based on a number of assumptions and are subject to a number of risks and uncertainties, many of which are beyond HempFusions control, which could cause actual results and events to differ materially from those that are disclosed in or implied by such forward-looking statements. Such risks and uncertainties include, but are not limited to, the impact and progression of the COVID-19 pandemic and other factors set forth under Forward-Looking Statements and Risk Factors in the final long form prospectus of the Company dated December 17, 2020 and available under the Companys profile on SEDAR at www.sedar.com. HempFusion undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required by law. New factors emerge from time to time, and it is not possible for HempFusion to predict all of them or assess the impact of each such factor or the extent to which any factor, or combination of factors, may cause results to differ materially from those contained in any forward-looking statement. Any forward-looking statements contained in this news release are expressly qualified in their entirety by this cautionary statement. Neither the TSX nor its Regulation Services Provider (as that term is defined in the policies of the TSX) accepts responsibility for the adequacy or accuracy of this release.", "role": "user" }, { "content": "HempFusion Wellness Submits Novel Foods Dossier to the United Kingdoms Regulatory Food Safety Agency", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: LONDON, Jan. 21, 2021 /PRNewswire/ -- In response to the ongoing COVID-19 pandemic, Erba today launched the ErbaMDx SARS-CoV-2 RT-PCR Kit for detection of SARS-CoV-2. To overcome challenges in older COVID-19 molecular tests, Erba's Cambridge(UK)-based development team has carefully engineered a new assay to improve detection and ease of use with a single tube multiplex mastermix, compatible with room-temperature storage and transportation. The new assay offers 200 copies/ml LoD, using universally trusted gene targets highly specific for SARS-CoV-2 and updated primer sequencesto maximise long term performance. Sample types include both nasopharyngeal and oropharyngeal swabs as well as saliva. Nikhil Vazirani, MD of Erba, said: \"We are proud and excited to add a highly sensitive RT-PCR test to our growing range of immunoassay and molecular solutions. The new ErbaMDx SARS-CoV-2 test perfectly complements our successful COVID-19 IgG and IgM ELISA assays to offer customers a state-of-the-art molecular test in addition to antibody testing which will offer clinicians valuable insight into the immune response to infection or vaccination.\" The CE-marked kit will be available through Erba's global distribution network. Learn more: https://covid19.erbamannheim.com/ About Erba MannheimErba Mannheim is a global company focused on delivering innovative, affordable and sustainable diagnostic solutions to labs everywhere. Established in over 100 countries, Erba group uses a combination of cutting-edge R&D in 4 continents with efficient low-cost manufacturing to make diagnostic technologies accessible in all resource settings. SOURCE Erba Mannheim", "role": "user" }, { "content": "ERBA Mannheim Launches 2nd Generation SARS-CoV-2 RT-PCR Assay with room temperature storage USA - English USA - English France - Franais Deutschland - Deutsch Espaa - espaol USA - English USA - English", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: CHICAGO--(BUSINESS WIRE)--Arturo, an AI-powered platform that derives property insights and predictive analytics from aerial and satellite imagery, raised $25 million in a Series B funding round led by Atlantic Bridge Capital, with participation from RPS Ventures and existing investors Crosslink Capital and IAG Firemark Ventures the venture capital fund for IAG, Australias largest general insurer. With the capital in hand, Arturo plans to expand its technical team to refine its industry-leading technology, which extracts valuable property data from the latest satellite, stratospheric, aerial and ground-level imagery, as well as unique proprietary data sources, in as little as five seconds. The round will also enable the company to further establish partnerships with imagery providers to offer coverage in Europe and Southeast Asia and expand its client base of leading property and casualty insurers. In the coming months, the company also aims to roll out its offering to the commercial property sector and other businesses that engage with the built environment, including banks, other financial institutions, asset managers, among others. In conjunction with the funding round, the company appointed two new members to its board: Sunir Kapoor of Atlantic Bridge, who brings a background in growing technology businesses to enterprise scale; and Samantha Wang of RPS, a board observer, who brings expertise working with technology companies in the U.S. and Asia. Over the past twelve months, Arturo increased its revenue over 300%, which speaks directly to the tangible value it offers to leading insurers, said Sunir Kapoor, Operating Partner, Atlantic Bridge. With these new client wins, Arturo now counts among its clients two of the top five P&C insurers in the US, in addition to the two leading insurers in the Australian market. With the success that jC and his team have had onboarding several new clients fully remotely over the past year, were confident in Arturos continued expansion in bringing AI to the insurance industry and beyond. Arturo is a deep learning spin-out from American Family Insurance that delivers highly accurate physical property characteristic data and predictive analysis for residential and commercial properties for use in the property & casualty (P&C) insurance, reinsurance, lending and securities markets. Since spinning out from American Family Insurance to become commercially available in 2018, Arturo has completed over 35 million on-demand property analyses for customers in North America and Oceania. As it has rolled out its platform to a growing number of leading clients, the company has also refined its technology, which increased the number of property attributes it can extract from aerial photographs to 71 within the past 18 months. The company recently announced partnerships with stratospheric imagery providers Urban Sky and Near Space Labs to bolster the frequency of its high-resolution image collection and to expand coverage in remote areas. It also announced the appointment of Roman Buegler to VP of research and development and Daniela Moody to VP of artificial intelligence. Arturos vision is to revolutionize the way businesses interact with properties by providing greater transparency into a buildings physical make-up, and we believe were only scratching the surface in terms of the level of value we can bring to our customers, said John-Isaac jC Clark, CEO, Arturo. Our insurance clients are already using our technology to bolster their quoting, underwriting, and claims processes, but with an increasingly granular level of property information available in real time, we can envision insurers improving their customer responsiveness, offering things like a safe driver discount-type bonus for a client whose propertys condition is well-maintained. A deeper property understanding stands to benefit virtually every building stakeholder, and this capital infusion will enable us to accelerate our product roll-out to serve a growing array of business sectors and geographic markets. About Arturo Arturo is a deep learning spin-out from American Family Insurance relentlessly committed to delivering highly accurate physical property characteristic data and predictive analysis for residential and commercial properties for use in the Property & Casualty (P&C) Insurance, Reinsurance, Lending, and Securities markets. Leveraging the latest satellite, aerial, and ground-level imagery, as well as unique proprietary data sources, Arturos deep learning models provide differentiated property data unparalleled by any other provider - often in as little as 5 seconds. To learn more about Arturo, Inc., visit: www.arturo.ai or follow on Twitter @arturo_ai. About Atlantic Bridge Capital Atlantic Bridge is a 1 Billion Pan European Technology Growth Firm founded in 2004 by successful technology entrepreneurs and executives. With offices in London, Dublin, Munich, Paris, Palo Alto, and Beijing, Atlantic Bridge invests in deep tech sustainable sectors such as Artificial Intelligence, Digital Health and Computer Vision. With 8 Funds under management, the Firm leverages its deep operational experience and unrivalled networks to help build deep technology companies into global market leaders across Europe, the US and Asia. For further information, please visit www.abven.com. About RPS Ventures RPS Ventures is a venture capital firm focused on investing in revolutionary technology companies led by exceptional teams. RPS is a dedicated group of investment professionals who think outside the box and specialize in helping companies navigate the global environment in later-stage company growth, with access to a key network of some of the world's most successful entrepreneurs. RPS investments include such notable companies as RentTheRunway, Molekule, Meesho, and Glovo. For more, visit www.rpsventures.com. About Crosslink Capital Crosslink Capital is a leading early-stage investor based in Menlo Park, investing in emerging growth companies since 1989. They are a proven team of early-stage business builders investing out of their ninth fund ($350M) and managing over $3.6 billion. Crosslink partners with ambitious entrepreneurs who are reshaping markets with disruptive technology. For more information, visit crosslinkcapital.com. About IAG IAG is the parent company of a general insurance group (the Group) with controlled operations in Australia and New Zealand. The Groups businesses underwrite over $12 billion of premium per annum, selling insurance under many leading brands, including: NRMA Insurance, CGU, SGIO, SGIC, Swann Insurance and WFI (Australia); and NZI, State, AMI and Lumley (New Zealand). IAG also has an interest in a general insurance joint venture in Malaysia. For further information, please visit www.iag.com.au. Firemark Ventures is IAGs strategic $75m venture capital fund. Its purpose is to bring the outside world into IAG, by strategically partnering with and investing in startups that have the potential to reinvent the insurance customer experience. This is IAGs second investment in Arturo. Firemark Ventures investments include Airtasker, Life360, HyperAnna, UpGuard and ActivePipe.", "role": "user" }, { "content": "Arturo Raises $25 Million in Series B Funding for AI Platform to Help P&C Insurers and Banks Better Understand Physical Properties Already serving several leading property and casualty insurers globally, Arturo aims to further expand its geographic reach, while breaking into lending and other business sectors", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: DUBLIN, Aug. 21, 2020 /PRNewswire/ -- The \"Sodium Persulfate Market Insights 2020, Analysis and Forecast Global and Chinese Market to 2025, by Manufacturers, Regions, Technology, Application\" report has been added to ResearchAndMarkets.com's offering. This report is a professional and in-depth study on the current state of the global Sodium Persulfate market with a focus on the Chinese market. The report provides key statistics on market of Sodium Persulfate. It is a valuable source of guidance and direction for companies and individuals interested in Sodium Persulfate industry.Key points of Sodium Persulfate Market Report: The report provides a basic overview of Sodium Persulfate industry including: definition, applications and manufacturing technology. The report explores Global and Chinese major players in Sodium Persulfate market. In this part, the report presents the company profile, product specifications, capacity, production value, and 2015-2020 market shares for each company. The report depicts the global and Chinese total Sodium Persulfate market including: capacity, production, production value, cost/profit, supply/demand and Chinese import/export, by statistical analysis. The global Sodium Persulfate market is further divided by company, by country, and by application/type for the competitive landscape analysis. The report then estimates 2020-2025 development trends, analyse upstream raw materials, downstream demand, and current market dynamics of Sodium Persulfate market. The report makes some important proposals for a new project of Sodium Persulfate Industry before evaluating its feasibility. Overall, the report provides an in-depth insight of 2015-2025 global and Chinese Sodium Persulfate market covering all important parameters. Main Parameters for this report:Application Segment: Printed Circuit Board Polymer Initiators Metal Surface Treatment Textile Paper & Pulp Water Treatment & Disinfectant Others Companies Covered: United Initiators PeroxyChem/Evonik RheinPerChemie GmbH Adeka Mitsubishi Gas Chemical VR Persulfates Ak-Kim Calibre Chemicals Yoyo Chemicals Yatai Electrochemistry Shaanxi Baohua Key Topics Covered: 1.: Introduction of Sodium Persulfate Industry1.1 Brief Introduction of Sodium Persulfate1.2 Development of Sodium Persulfate Industry1.3 Status of Sodium Persulfate Industry2.: Manufacturing Technology of Sodium Persulfate2.1 Development of Sodium Persulfate Manufacturing Technology2.2 Analysis of Sodium Persulfate Manufacturing Technology2.3 Trends of Sodium Persulfate Manufacturing Technology3.: Analysis of Global Key Manufacturers 3.1 United Initiators3.1.1 Company Profile3.1.2 Product Information3.1.3 Capacity Production Price Cost Production Value3.1.4 Contact Information3.2 PeroxyChem/Evonik3.2.1 Company Profile3.2.2 Product Information3.2.3 Capacity Production Price Cost Production Value3.2.4 Contact Information3.3 RheinPerChemie GmbH3.3.1 Company Profile3.3.2 Product Information3.3.3 Capacity Production Price Cost Production Value3.3.4 Contact Information3.4 Adeka3.4.1 Company Profile3.4.2 Product Information3.4.3 Capacity Production Price Cost Production Value3.4.4 Contact Information3.5 Mitsubishi Gas Chemical3.5.1 Company Profile3.5.2 Product Information3.5.3 Capacity Production Price Cost Production Value3.5.4 Contact Information3.6 VR Persulfates3.6.1 Company Profile3.6.2 Product Information3.6.3 Capacity Production Price Cost Production Value3.6.4 Contact Information3.7 Ak-Kim3.7.1 Company Profile3.7.2 Product Information3.7.3 Capacity Production Price Cost Production Value3.7.4 Contact Information3.8 Calibre Chemicals3.8.1 Company Profile3.8.2 Product Information3.8.3 Capacity Production Price Cost Production Value3.8.4 Contact Information3.9 Yoyo Chemicals3.9.1 Company Profile3.9.2 Product Information3.9.3 Capacity Production Price Cost Production Value3.9.4 Contact Information3.10 Yatai Electrochemistry3.10.1 Company Profile3.10.2 Product Information3.10.3 Capacity Production Price Cost Production Value3.10.4 Contact Information3.11 Shaanxi Baohua3.11.1 Company Profile3.11.2 Product Information3.11.3 Capacity Production Price Cost Production Value3.11.4 Contact Information4.: 2015-2020 Global and Chinese Market of Sodium Persulfate4.1 Market Size4.1.1 2015-2020 Global Capacity, Production and Production Value of Sodium Persulfate Industry4.1.2 2015-2020 Chinese Capacity, Production and Production Value of Sodium Persulfate Industry4.2 2015-2020 Sodium Persulfate Industry Cost and Profit Estimation4.3 Market Comparison of Global and Chinese Sodium Persulfate Industry4.4 2015-2020 Global and Chinese Supply and Consumption of Sodium Persulfate4.5 2015-2020 Import and Export of Sodium Persulfate5.: Market Status of Sodium Persulfate Industry5.1 Market Competition of Sodium Persulfate Industry by Company5.2 Market Competition of Sodium Persulfate Industry by Region5.3 Market Analysis of Sodium Persulfate Industry by Application5.4 Market Analysis of Sodium Persulfate Industry by Type6.: Market Forecast of 2020-2025 Global and Chinese Sodium Persulfate Industry6.1 2020-2025 Global and Chinese Capacity, Production, and Production Value of Sodium Persulfate6.2 2020-2025 Sodium Persulfate Industry Cost and Profit Estimation6.3 2020-2025 Global and Chinese Market Share of Sodium Persulfate6.4 2020-2025 Global and Chinese Supply and Consumption of Sodium Persulfate6.5 2020-2025 Import and Export of Sodium Persulfate7.: Analysis of Sodium Persulfate Industry Chain7.1 Industry Chain Structure7.2 Upstream Raw Materials7.3 Downstream Industry8.: Global and Chinese Economic Impact on Sodium Persulfate Industry8.1 Global and Chinese Macroeconomic Environment Analysis8.2 Global and Chinese Macroeconomic Environment Development Trend8.3 Effects to Sodium Persulfate Industry9.: Market Dynamics and Policy of Sodium Persulfate Industry9.1 Sodium Persulfate Industry News9.2 Sodium Persulfate Industry Development Challenges9.3 Sodium Persulfate Industry Development Opportunities10.: Proposals for New Project10.1 Market Entry Strategies10.2 Countermeasures of Economic Impact10.3 Marketing Channels10.4 Feasibility Studies of New Project Investment11.: Research Conclusions of Global and Chinese Sodium Persulfate IndustryFor more information about this report visit https://www.researchandmarkets.com/r/mv29s8 Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. Media Contact: Research and Markets Laura Wood, Senior Manager [emailprotected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 SOURCE Research and Markets Related Links http://www.researchandmarkets.com", "role": "user" }, { "content": "Sodium Persulfate Market Insights (2020 to 2025) - Analysis and Forecasts for the Global and Chinese Markets", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: COLUMBIA, S.C., Aug. 6, 2020 /PRNewswire/ -- Obsidio, Inc., a pre-clinical stage medical materials developer, today announced the closing of a $3 million round led by IAG Capital Partners. Returning investors included Good Growth Capital and other angel investors.In addition, The National Science Foundation (NSF) awarded Obsidio with a $225k Phase I Small Business Innovation Research (SBIR) grant. Obsidio plans to use the proceeds for clinical development of its embolic hydrogel material. \"Obsidio will deploy these funds to advance the gel embolic material into pilot trials to address applications in peripheral, neurovascular, and tumor embolization and enhance the performance of the biomaterial,\" said Dr. Ehsan Jabbarzadeh, Obsidio's Chief Executive Officer. \"Today, there is a major gap in the standard of care, including high rebleeding rates, non-target embolization, unpredictable economics, and most importantly, dependence on patients' ability to clot. Our technology provides a significant opportunity to advance the embolization industry and improve patient outcomes.\" Obsidio is developing a shear-thinning biomaterial that has significant advantages over existing products for transcatheter intravascular embolization. Deploying the biomaterial is a minimally invasive procedure used to control bleeding, close off vessels supplying blood to a tumor, eliminate abnormal connections between arteries and veins, and treat aneurysms.\"This shear-thinning biomaterial is also easy to use and will cut down procedure-time and radiation exposure to the patient and operator, enhancing the over-all physician experience,\" said Dr. Rahmi Oklu, an interventional radiologist and the Chief Medical Officer of Obsidio. Obsidio's embolization material can be used for a broad range of indications, is injectable via a wide range of catheters, is compatible with most imaging techniques, and will be available off-the-shelf, eliminating the inventory costs associated with embolic devices such as coils used today. \"Obsidio's technology provides an elegant solution for managing embolization, a serious and difficult-to-treat problem,\" said Dennis Sacha, Principal at IAG Capital Partners. \"We are excited to work with this experienced team as they begin clinical testing.\" Additionally, Obsidio appointed Jeffrey Gold to the Board of Directors. Gold brings significant experience, having led successful companies and participated as director or advisor to several public and private venture-backed medical device companies. Good Growth Capital's Dr. Maureen Stancik Boyce says, \"Jeffrey Gold brings a wealth of experience in the embolization space to Obsidio's Board of Directors as the company brings its life-saving technology to the clinic. His expertise in vascular systems adds excellent value as Obsidio prepares for pilot studies and further develops its shear-thinning biomaterial for therapeutic embolization.\" About Obsidio, Inc. Obsidio, Inc. is a venture capital-funded medical device start-up dedicated to the research, development, and commercialization of breakthrough embolotherapy products. http://obsidiomed.com About IAG Capital Partners IAG Capital Partners is based in Charleston, South Carolina. The firm invests in a variety of companies from early-stage to recapitalization and restructuring. http://www.iagcapitalpartners.com/ About Good Growth Capital Good Growth Capital (GGC) is an early-stage venture capital firm with offices in Charleston, SC and Boston, MA that finds and funds transformative technology-based start-ups. Good Growth Capital is the most active venture fund in the state of South Carolina. GGC also invests a fund focused primarily on pre-seed and seed-stage companies with an MIT affiliation, GGC's Infinite Corridor Fund. GGC is majority women-owned and managed. https://www.goodgrowthvc.com/ About the National Science Foundation's Small Business Programs America's Seed Fund powered by NSF awards $200 million annually to start-ups and small businesses, transforming scientific discovery into products and services with commercial and societal impact. https://seedfund.nsf.gov/ SOURCE Obsidio, Inc. Related Links http://obsidiomed.com/", "role": "user" }, { "content": "Obsidio, Inc. Closes $3 Million Round, Receives Grant from The National Science Foundation and Welcomes New Board Member Funds allocated to support pilot studies of its universal biomaterial for transcatheter embolization", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: NEW YORK--(BUSINESS WIRE)--Equitable, a leading financial services organization and principal franchise of Equitable Holdings, Inc. (NYSE: EQH), today unveiled Equitable Retirement VisionSM, a new platform for ERISA and non-ERISA retirement plans. Equitable Retirement VisionSM offers new features and services for plan sponsors and participants, including: We know plan sponsors across various sectors and industries want best-in-class, mutual fund-based retirement plan platforms. We also recognize that financial market conditions are driving an increased need for guidance and support among plan sponsors and their employees, said Steve Scanlon, head of Group Retirement, Equitable. We designed Equitable Retirement VisionSM with enhanced features and benefits to meet these needs, including customizable strategies, administrative support and participant advice, to help them achieve their goals for their plan and support retirement readiness for employees. Equitable Retirement VisionSM is designed for small-to-medium sized businesses, K-12, higher education, governmental, healthcare and not-for-profit sectors. Equitable** will continue to offer its other group retirement plan products including the Retirement Gateway and EQUI-VEST variable annuities. Fiduciary services are offered through SWBC Retirement Plan Services, Wilshire and NBS. Managed account services are offered through Stadion Money Management. About Equitable Equitable, a principal franchise of Equitable Holdings, Inc. (NYSE: EQH), has been one of Americas leading financial services providers since 1859. With the mission to help clients secure their financial well-being, Equitable provides advice, protection and retirement strategies to individuals, families and small businesses. Equitable has more than 8,000 employees and Equitable Advisors financial professionals and serves 2.8 million clients across the country. Please visit equitable.com for more information. Equitable Advisors is the brand name of Equitable Advisors, LLC (member FINRA, SIPC) (Equitable Financial Advisors in MI & TN). * The Equitable Fixed AccountSM does not include the mutual fund investments available in the Equitable Retirement VisionSM defined contribution plan. The investments in this program are subject to risk, including possible loss of the principal invested. They are not insured by the Federal Deposit Insurance Corporation nor are they deposits to, obligations of, or guaranteed by any bank. ** Equitable in this context refers exclusively to Equitable Financial Life Insurance Company (Equitable Financial), New York, NY (which was established in 1859), issuer of the Retirement Gateway and EQUI-VEST variable annuity products. Mutual funds are sold by prospectus only. Be sure to review the current prospectus that contains complete information on charges, risks, expenses and investment objectives before investing or sending money. Contact your financial professional or the company for a prospectus. Retirement plans offered through the Equitable Retirement VisionSM defined contribution program consists of a custodial account offered through Benefit Trust Company, within which plan participants chosen mutual fund shares are held, as well as a group fixed annuity contract (generic form number 2016FA-MFrev, 2016FA-MF403b) issued by Equitable Financial Life Insurance Company (Equitable Financial). Mutual funds made available through the program are distributed by Equitable Distributors, LLC (Equitable Distributors). Equitable Financial and Equitable Distributors are located at 1290 Avenue of the Americas, NY, NY 10104, (212) 314-4600. Equitable Financial is solely responsible for meeting the obligations of the group fixed annuity contract. Offered by affiliated and unaffiliated entities, the Equitable Retirement Plan ServicesSM platform includes recordkeeping, trading and custodial services to plan sponsors for the program. Benefit Trust Company serves as custodian of mutual funds selected by plan participants. PlanConnect, LLC serves as the platforms recordkeeper. Equitable Retirement Plan ServicesSM and Equitable Retirement VisionSM are service marks of the contractual arrangements between affiliated and/or unaffiliated entities within the platform; PlanConnect is a registered service mark of PlanConnect, LLC (100 Madison Street, Syracuse, NY 13202. (800) 923-6669). Equitable Financial, Equitable Distributors and PlanConnect, LLC are separate, but affiliated companies. Benefit Trust Company, SWBC Retirement Plan Services, Wilshire, National Benefit Services, LLC (NBS), and Stadion are not owned by or affiliated with Equitable Holdings, Inc. or any of its affiliates and subsidiaries. GE-3440606(02/21)(exp.02/23)", "role": "user" }, { "content": "Equitable Retirement VisionSM Launches with Enhanced Features and Services New Open Architecture, Mutual Fund-Based Retirement Plan Platform Features Fiduciary Support for Plan Sponsors", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: SAN FRANCISCO--(BUSINESS WIRE)--Wells Fargo & Company (NYSE: WFC) announced today that Mark A. Chancy has been elected to the companys board of directors, effective immediately. Chancy will serve on the boards Audit Committee and Risk Committee. Chancy was most recently vice chairman and co-chief operating officer at SunTrust Banks, Inc., where he led SunTrusts consumer segment, which included consumer banking, mortgage and consumer lending, private wealth management, deposits and virtual channels, and consumer operations. Chancy has more than 30 years of banking and financial services experience, including 18 years at SunTrust where he served in a broad range of leadership roles spanning consumer and commercial banking, investment banking, and financial management until retiring in December 2019. We are delighted to welcome Mark to the board, said Charles Noski, Wells Fargos chairman of the board. He is an experienced banker with risk and regulatory expertise, a deep financial services background, a record of proven business results, and a customer-first mindset. Mark brings an impressive combination of business, operational, and finance experience in the banking industry to our board, said Wells Fargo CEO Charlie Scharf. His leadership of consumer and commercial businesses, his experience as a chief financial officer, including during the 2008 financial crisis, and his strategic expertise will provide valuable insight to our board. Biographical information Chancy served as vice chairman and consumer segment executive of SunTrust from April 2017 and co-chief operating officer from February 2018 until he retired in December 2019. Previously, Chancy led the wholesale banking segment from April 2011 to April 2017, which included corporate and investment banking, commercial and business banking, commercial real estate, and treasury and payment solutions. Chancy served as chief financial officer of SunTrust from August 2004 to April 2011, which included oversight of the treasury, investor relations, strategic finance, controllers, mergers and acquisitions, tax, and insurance functions. He also previously served as treasurer of SunTrust and CFO of The Robinson-Humphrey Company Inc., which was purchased by SunTrust in 2001. Chancy serves on the board of directors of EVO Payments Inc. He received his MBA in finance from Northwestern Universitys J.L. Kellogg Graduate School of Management, and his BBA in finance from Southern Methodist University. About Wells Fargo Wells Fargo & Company (NYSE: WFC) is a diversified, community-based financial services company with $1.97 trillion in assets. Wells Fargos vision is to satisfy our customers financial needs and help them succeed financially. Founded in 1852 and headquartered in San Francisco, Wells Fargo provides banking, investment and mortgage products and services, as well as consumer and commercial finance, through 7,300 locations, more than 13,000 ATMs, the internet (wellsfargo.com) and mobile banking, and has offices in 31 countries and territories to support customers who conduct business in the global economy. With approximately 266,000 team members, Wells Fargo serves one in three households in the United States. Wells Fargo & Company was ranked No. 30 on Fortunes 2020 rankings of Americas largest corporations.", "role": "user" }, { "content": "Mark A. Chancy Elected to Wells Fargos Board of Directors", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: CHICAGO--(BUSINESS WIRE)--Two of Eversprings partners, the Santa Clara University Leavey School of Business and William & Marys Raymond A. Mason School of Business, have been recognized in Poets&Quants fourth annual ranking of The Best Online MBA Programs of 2021. Making a ranking debut, the Santa Clara University Leavey School of Business online MBA has earned an overall #10 ranking, and William & Marys Mason School of Business online MBA garnered a #19 ranking, placing both among the best programs, nationwide. Both programs placed at the top of the career outcomes category, with William & Marys online MBA coming in first and Santa Claras coming in third. With these new rankings, two of the nations most historic universities are reaffirmed as leaders and innovators in online education. Poets&Quants focuses its ranking on three core measures: quality of incoming students, academic experiences offered by the MBA program and career outcomes of graduates. Everspring has worked with both Santa Clara and William & Mary to build online MBA programs that are outstanding in each of these areas. Everspring brings powerful technology, a unique design-thinking approach, and an extensive set of instructional design, multi-media and marketing capabilities to their university partners programs. Eversprings methodology ensures their partners online programs reflect each universitys traditions and standards of academic excellenceproviding an engaging online experience that leads to successful outcomes. We founded Everspring to bring together the power of technology, advanced instructional design techniques and cutting-edge marketing, said Beth Hollenberg, president of Everspring. Santa Clara and William & Mary each had unique objectives for their online MBA programs and trusted Everspring to bring their programs to life online, with the quality that has long characterized their on-campus programs. We are proud of what we have created together. This years Poets&Quants rankings recognize what we set out to achieve: stellar online programs that deliver an outstanding student experience and great outcomes. Launched in 2018 in partnership with Everspring, Santa Claras online MBA offers students a unique experience by leveraging the innovation and technology of its Silicon Valley location while focusing on the universitys strong tradition of ethics and social responsibility. The success of Leaveys online MBA is reflected in its retention and student satisfaction numbers: The program boasts a 99% term-to-term retention rate and a 92% student satisfaction rate. Prospects have taken note, with enrollment for the fall 2020 cohort more than doubling year-over-year. Similarly, Everspring has been a trusted partner to William & Marys Raymond A. Mason School of Business since 2015. The highly ranked MBA program, co-developed with Everspring, is rooted in William & Marys tradition of teaching excellence and their desire to position its graduates at the forefront of innovation. The result is a high-touch, academically rigorous program that has achieved outstanding outcomes: More than 90% of the programs matriculated students have graduated or remain active in the program, with a 95% student satisfaction rate. About Everspring Everspring creates sophisticated digital solutions that help leading higher education institutions deliver their legacy online, with excellence. Our exceptional technology and services empower universities to focus on teaching engaging content that transforms lives. Everspring offers a range of full-service turnkey solutions and fee-for-service offerings, as well as a set of innovative standalone products. Based in Chicago, Everspring serves a growing number of colleges and universities. Visit www.everspringpartners.com for more information. About Santa Clara University and the Leavey School of Business Founded in 1851, Santa Clara University sits in the heart of Silicon Valleythe worlds most innovative and entrepreneurial region. With undergraduate programs in arts and sciences, business, and engineering, and graduate programs in six disciplines, the curriculum blends high-tech innovation with social consciousness grounded in the 450-year tradition of Jesuit, Catholic education. Santa Clara Universitys Leavey School of Business offers one of the nation's best graduate business programs, ranked No. 11 Executive MBA by U.S News & World Report, No. 25 Evening MBA by U.S News & World Report, and No. 25 Online MBA by The Princeton Review. For more information, visit www.scu.edu/business. About William & Mary and the Raymond A. Mason School of Business William & Mary is a premier public research university located in Williamsburg, Virginia. Founded in 1693, the university is widely recognized for its academic excellence and strong historical tradition. William & Marys Raymond A. Mason School of Business is rebuilding the global economy by training the next generation of revolutionary business leaders. It offers undergraduate and graduate instruction, including full-time, part-time, evening, executive and online MBA degree programs, as well as one-year masters programs in accounting, business analytics and marketing. The school develops successful business leaders by providing world-class instruction and unparalleled opportunities for mentorship and experiential learning. The Raymond A. Mason School of Business online MBA is ranked by U.S. News & World Report as the 28th online MBA and by The Princeton Review as the 21st online MBA. For more information, visit mason.wm.edu.", "role": "user" }, { "content": "Two Everspring Partner Universities Top Poets&Quants Best Online MBA Rankings for Career Outcomes Santa Clara Universitys Leavey School of Business and William & Marys Raymond A. Mason School of Business achieve top rankings for online MBA programs", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: CAMBRIDGE, Mass.--(BUSINESS WIRE)--Acceleron Pharma Inc. (Nasdaq: XLRN), a leading biopharmaceutical company in the discovery, development, and commercialization of TGF-beta superfamily therapeutics to treat serious and rare diseases, today presented a set of preliminary interim data from the ongoing SPECTRA Phase 2 trial of sotatercept in patients with pulmonary arterial hypertension (PAH). Initial data from the trial, which is designed to assess resting and exercise hemodynamics and peak oxygen uptakeas recorded by invasive cardiopulmonary exercise testing (iCPET)show that patients treated with sotatercept experienced substantial improvements in multiple hemodynamic measures as well as in exercise tolerance and exercise capacity. These early outcomes, obtained from the first 10 patients participating in the trial, were shared as part of an Invited Talk entitled, SPECTRA and Beyond: Signs of Disease Modification? presented virtually during the American Heart Association (AHA) 2020 Scientific Sessions. Among the largest resting hemodynamic improvements observed were reductions in pulmonary vascular resistance (PVR; as measured in dynes-sec/cm5) from a mean of 576 at baseline to 369 at week 24 (35.9% reduction) and mean pulmonary arterial pressure (mPAP) as measured in mmHg from 43.4 to 30.6 (29.5% reduction). The SPECTRA trials innovative design is meant to help us better understand and detect sotatercepts potential effects on underlying disease pathology, said Aaron Waxman, M.D., Ph.D.*, Director, Pulmonary Vascular Disease Program at Bostons Brigham and Womens Hospital, who delivered the Invited Talk at the AHA. Despite the limited number of patients evaluated to date, its difficult not to be encouraged by the range and extent of positive changes seen in key hemodynamic and exercise capacity measures thus far. In this single-arm, open-label multi-center exploratory study, a total of up to 25 patients with advanced PAH (classified as WHO functional class III) on stable combination background therapy are to be treated with an initial cycle of 0.3 mg/kg of sotatercept delivered subcutaneously, followed by subsequent cycles of 0.7 mg/kg of sotatercept through a 24-week treatment period. The protocol includes iCPET at baseline and at week 24 to assess change from in peak oxygen uptake or VO2 max (the primary endpoint) as well as changes from baseline in a range of secondary endpoints, including mPAP and VO2 at anaerobic threshold. During his AHA talk, Dr. Waxman also provided an in-depth profile of the first patient treated in the SPECTRA trial: a 25-year-old woman diagnosed with idiopathic PAH nearly five years prior to enrollment. This patient, who was classified as WHO functional class III and on combination background therapy, experienced substantial hemodynamic and functional improvements. Perhaps most notably, this patient was reclassified from WHO functional class III at baseline to class I at week 24. The patient retained functional class I status in follow-up testing at 48 weeks. Sotatercept was generally well tolerated in the trial. Adverse events observed in the study were generally consistent with previously published data on sotatercept in PAH and in other diseases. Were thrilled to see such positive preliminary outcomes from the SPECTRA trial, which serves as another important exploration of sotatercept and the potential of its unique mechanism to alter the course and treatment of PAH, said Habib Dable, President and Chief Executive Officer of Acceleron. These results, combined with new PULSAR trial data presented at AHA and the topline PULSAR findings announced earlier this year, position us well to initiate a robust Phase 3 development program to realize our vision of sotatercept as a backbone therapy for patients with PAH across all stages of disease. Sotatercept is an investigational therapy that is not approved for any use in any country. The presentation referenced above is available on the Publications page under the Science & Pipeline section of Accelerons website, www.acceleronpharma.com. *Dr. Waxman is the principal investigator of the SPECTRA trial and a paid consultant to Acceleron. About the SPECTRA Trial The SPECTRA Phase 2 trial is a single arm, open-label, multi-center exploratory study to determine the effects of sotatercept plus standard of care in adults with WHO functional class III PAH. The primary endpoint of the trial is the change from baseline in peak oxygen uptake (VO2 max) at 24 weeks, as recorded by invasive cardiopulmonary exercise testing (iCPET). Secondary hemodynamic endpoints as well as endpoints of exercise capacity and tolerance assessed via iCPET and right heart catheterization include change from baseline at 24 weeks in: ventilatory efficiency (VE/VCO2 slope); cardiac index (L/min/m2); mean pulmonary artery pressure (mPAP); pulmonary vascular resistance (PVR); arteriovenous oxygen content difference (Ca-vO2); ventilatory efficiency; dead space assessment (VE/VCO2 slope); and oxygen consumption at anaerobic threshold (VO2 at AT). A total of up to 25 patients are to receive stable background combination PAH therapy plus sotatercept at a starting dose level of 0.3 mg/kg delivered subcutaneously for one cycle, escalating to 0.7 mg/kg at cycle 2 for the remainder of the treatment period. Following the 6-month open-label treatment period, participants in the trial are eligible to continue in the 18-month extension period, which includes iCPET conducted at 48 weeks. Conference Call and Webcast Information The Company will host a webcast and conference call today, November 13, 2020, at 11:00 a.m. EST, to review the presentations of sotatercept at AHA. The webcast will be accessible under Events & Presentations in the Investors/Media page of the company's website at www.acceleronpharma.com. Individuals can participate in the live conference call by dialing 877-312-5848 (domestic) or 253-237-1155 (international) and referring to the AHA Sotatercept Conference Call. A replay of the webcast will be available on the Acceleron website approximately two hours after the event. About Sotatercept Sotatercept is an investigational reverse-remodeling agent designed to be a selective ligand trap for members of the TGF-beta superfamily to rebalance BMPR-II signaling, which is a key molecular driver of PAH. The PULSAR Phase 2 trial evaluating sotatercept in combination with approved PAH-specific medicines in patients with PAH achieved its primary endpoint of improvement in pulmonary vascular resistance and its key secondary endpoint of improvement in 6-minute walk distance. Sotatercept was generally well tolerated in the trial. Adverse events observed in the study were generally consistent with previously published data on sotatercept in other diseases. Following the PULSAR results, sotatercept was granted Breakthrough Therapy designation from the FDA and Priority Medicines designation from the EMA in PAH. Sotatercept is also being evaluated in the SPECTRA Phase 2 exploratory trial. In preclinical research published in Science Translational Medicine, sotatercept exhibited consistent effects across multiple components of disease, including suppressed proliferation of pulmonary arterial smooth muscle and microvascular endothelial cells, reduced pulmonary pressures, lessened right ventricular hypertrophy, improved right ventricular function, and attenuated vascular remodeling. The Company recently presented details of its Phase 3 development plan, including the design for the registrational STELLAR trial, which is expected to be initiated before the end of 2020. Acceleron is planning two additional Phase 3 studies in patients with PAH: the HYPERION trial, exploring early intervention with sotatercept, and the ZENITH trial assessing later-stage intervention. Sotatercept is an investigational therapy that is not approved for any use in any country. Sotatercept is part of a licensing agreement with Bristol Myers Squibb. About PAH PAH is a rare and chronic, rapidly progressing disorder characterized by the constriction of small pulmonary arteries and elevated blood pressure in the pulmonary circulation. PAH results in significant strain on the heart, often leading to limited physical activity, heart failure, and reduced life expectancy. The 5-year survival rate for patients with PAH is approximately 57%. Available therapies generally act by promoting the dilation of pulmonary vessels without addressing the underlying cause of the disease. As a result, PAH often progresses rapidly for many patients despite standard of care treatment. A growing body of research has implicated imbalances in BMP and TGF-beta signaling as a primary driver of PAH in familial, idiopathic, and acquired forms of the disease. About Acceleron Acceleron is a biopharmaceutical company dedicated to the discovery, development, and commercialization of therapeutics to treat serious and rare diseases. Accelerons leadership in the understanding of TGF-beta superfamily biology and protein engineering generates innovative compounds that engage the body's ability to regulate cellular growth and repair. Acceleron focuses its commercialization, research, and development efforts in hematologic and pulmonary diseases. In hematology, REBLOZYL (luspatercept-aamt) is the first and only erythroid maturation agent approved in the United States, Europe, and Canada for the treatment of anemia in certain blood disorders. REBLOZYL is part of a global collaboration partnership with Bristol Myers Squibb. The Companies co-promote REBLOZYL in the United States and are also developing luspatercept for the treatment of anemia in patient populations of MDS, beta-thalassemia, and myelofibrosis. In pulmonary, Acceleron is developing sotatercept for the treatment of pulmonary arterial hypertension (PAH), having recently presented positive topline results of the PULSAR Phase 2 trial. The Company is currently planning multiple Phase 3 trials with the potential to support its long-term vision of establishing sotatercept as a backbone therapy for patients with PAH at all stages of the disease. For more information, please visit www.acceleronpharma.com. Follow Acceleron on Social Media: @AcceleronPharma and LinkedIn. Forward-Looking Statements This press release contains forward-looking statements about Accelerons strategy, future plans and prospects, including statements regarding the development of sotatercept in PAH, the timeline for clinical development and regulatory approval of sotatercept in PAH, the expected timing for reporting of data from ongoing clinical trials, and the potential of Accelerons compounds as therapeutic drugs. The words \"anticipate,\" \"believe,\" \"could,\" \"estimate,\" \"expect,\" \"goal,\" \"intend,\" \"may,\" \"plan,\" possible,\" \"potential,\" \"project,\" \"should,\" \"target,\" \"will,\" \"would,\" and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Actual results could differ materially from those included in the forward-looking statements due to various factors, risks and uncertainties, including, but not limited to, that preclinical testing of Accelerons compounds and data from clinical trials may not be predictive of the results or success of ongoing or later clinical trials, that regulatory approval of Accelerons compounds in one indication or country may not be predictive of approval in another indication or country, that the development of Accelerons compounds will take longer and/or cost more than planned, that Acceleron will be unable to successfully complete the clinical development of Accelerons compounds, that Acceleron may be delayed in initiating, enrolling or completing any clinical trials, that Accelerons compounds will not receive regulatory approval or become commercially successful products, and that Breakthrough Therapy or PRIME designation may not expedite the development or review of sotatercept. These and other risks and uncertainties are identified under the heading Risk Factors included in Accelerons most recent Annual Report on Form 10-K, Quarterly Report on Form 10-Q, and other filings that Acceleron has made and may make with the SEC in the future. The forward-looking statements contained in this press release are based on management's current views, plans, estimates, assumptions, and projections with respect to future events, and Acceleron does not undertake and specifically disclaims any obligation to update any forward-looking statements.", "role": "user" }, { "content": "Acceleron Presents Preliminary Interim Data from the SPECTRA Phase 2 Trial of Sotatercept in Pulmonary Arterial Hypertension (PAH) at the 2020 American Heart Association Scientific Sessions Treatment with sotatercept in first set of patients in the ongoing SPECTRA Phase 2 trial was associated with substantial improvements in hemodynamics, exercise tolerance and exercise capacity at week 24 Sotatercept was generally well tolerated, consistent with the previously reported safety profile in PAH and in other diseases Acceleron to host investor and analyst conference call and webcast with guest PAH key opinion leaders today, Friday, November 13, at 11:00 a.m. EST", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: BEIJING, April 3, 2020 /PRNewswire/ --To support SMEs to better survive the epidemic, 36Kr, a well-recognized New-Economy brand,has recentlylaunched a special enterprise service initiativethe Winter Warmth Program. The beginning of 2020 has seen material interruptions on the operation of a spectrum of industries and enterprises by COVID-19 epidemic outbreak. While large and established companies are better prepared to weather the financial impact, small-to-medium enterprises (SMEs), with less cash on the balance sheet, are more vulnerable. The initiative seeks to link up local governments, large enterprises, investment institutions, and companies in Enterprise Service sector to help SMEs in need, centering around the results of the impacts of the uncertain revenue, heightened cost, insufficient financing, difficulties in realizing customer growth, management maintenance, and acquiring supportivepolicies. The initiative has established effective connections with more than 1,500 companies, 180 of which can provide assistance to SMEs. 36Kr also has lined up with the government of Xihu district in Hangzhou, Zhejiang, and Alibaba Cloud Innovation Center to hold a series of Cloud events. 36Kr launched the Super-growth Campaign (under 36Kr Winter Warmth Program), which held 6 online sharing sessions in two weeks to help thousands of SMEs in terms of management efficiency improvement and resources introduction. In November 2019, the company went public on Nasdaq with the ticker of KRKR. Founded in 2010, 36Kr has become a a pioneering and well-recognized brand in New Economy space of China. Bolstered by the premium content and resources, 36Kr has expanded its types of business, including online advertising services, enterprise value-added services, as well as subscription services. While leveraging the premium content to naturally acquire customers at a low cost, the enterprise service constantly helps 36Kr's business to be expanded into a greater market. At the same time, in the process of providing services to the enterprises, 36Kr has accumulated a large number of enterprise data. And this enterprise database can further strengthen its capability to provide more diversified and satisfying enterprise services, and on the other hand to better facilitate the production of content. And the premium content will help to expand the customer base. It is a flywheel model and it keeps running. Besides the data analysis capabilities to serve the New-Economy space, 36Kr also plays as a pioneer who established a new economic community full of vitality and self-reinforcement. And there are six roles in this community: startups, TMT giants, traditional enterprises, institutional investors, local governments, and individuals. What 36Kr doing is to build and promote the connections among the six roles, to accelerate the flows of information, funds, talents and business opportunities, and further to promote the rapid, stable and sustainable development of the new economy. According to its unaudited financial results for the fourth quarter and fiscal year 2019, 36Kr's total revenues increased by 119.2% to RMB655.6 million (US$94.2 million) in the fiscal year of 2019, of which enterprise value-added services revenues increased by 218.7% to RMB319.5 million (US$45.9 million) in the fiscal year of 2019. Besides, the Non-GAAP adjusted net income increased by 43.0% to RMB65.3 million (US$9.4 million) in the fiscal year of 2019. According to the CIC Report, the GDP for China's New Economy is expected to grow at a CAGR of approximately 23.3% from 2018 to reach US$5.7 trillion in 2023, and the GDP for New Economy as a percentage of the overall GDP is expected to increase from 16.1% in 2018 to 33.5% in 2023. \"There is great market potential for our comprehensive services offered to the vibrant new-economy community. We are dedicated to being the prioritized partner of the New-Economy participants and empowering them to achieve more business success,\" said Feng Dagang, 36Kr'sco-chairman and CEO. SOURCE 36Kr", "role": "user" }, { "content": "36Kr Launches a Special Enterprise Service Initiative to Support SMEs Impacted by COVID-19", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: KEENE, N.H., March 24, 2020 /PRNewswire/ --C&S Wholesale Grocers, Inc., the largest wholesale grocery supply company in the U.S., along with US Foods Holding Corp. (NYSE: USFD), have partnered to combat job and food insecurities amid the coronavirus (COVID-19) pandemic's impact on the supply chain. \"We are very excited about our partnership with US Foods, which will keep the food supply chain strong despite challenges resulting from the COVID-19 pandemic,\" said Mike Duffy, Chief Executive Officer, C&S Wholesale Grocers. \"We are taking the steps necessary to onboard and train members of US Foods' workforce to ensure our warehouses are staffed and deliveries are on the road, enabling families access to food across the country.\" US Foods, one of America's leading foodservice distributors, partners with approximately 300,000 restaurants and foodservice operators to help their businesses succeed. However, increasing restrictions imposed by the federal and state government in response to the coronavirus are reshaping American's consumption behaviors, resulting in more grocery purchases and significantly fewer dine-out opportunities. \"We are proud to be working with C&S Wholesale Grocers as their role in our communities increases in importance,\" said Pietro Satriano, Chairman and Chief Executive Officer of US Foods. \"This partnership is an excellent example of the ways in which we are leveraging our distribution capabilities in new ways to support our nation's retailers and we value this important opportunity.\" The partnership will allow C&S Wholesale Grocers to alleviate a potential worker shortage stemming from increased food retail demands, while transferring US Foods personnel to similar job functions wherein demand is lacking in the foodservice industry. \"For more than 100 years, it has been our mission to keep communities fed. We are vigilantly monitoring this situation around the clock and are in constant communication with government authorities and industry associations to ensure that we are doing everything possible to make sure everyone has access to food,\" said Duffy. \"We're thankful to have members of the US Foods team join us in keeping operations moving and store shelves stocked.\" About C&S Wholesale Grocers, Inc. C&S Wholesale Grocers, Inc. is the largest wholesale grocery supply company in the U.S. and the industry leader in supply chain innovation. Founded in 1918 as a supplier to independent grocery stores, C&S now services customers of all sizes, supplying more than 7,700 independent supermarkets, chain stores, military bases and institutions with over 137,000 different products. We are an engaged corporate citizen, supporting causes that positively impact our communities. To learn more, please visitwww.cswg.com. About US FoodsUS Foods is one of America's great food companies and a leading foodservice distributor, partnering with approximately 300,000 restaurants and foodservice operators to help their businesses succeed. With 28,000 associates and more than 70 locations, US Foods provides its customers with a broad and innovative food offering and a comprehensive suite of e-commerce, technology and business solutions. US Foods is headquartered in Rosemont, Ill., and generates more than $28 billion in annual revenue. Visit usfoods.comto learn more. SOURCE C&S Wholesale Grocers, Inc. Related Links http://www.cswg.com", "role": "user" }, { "content": "C&S Wholesale Grocers and US Foods Tackle The Feat To Feed America Together", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: DALLAS, April 29, 2020 /PRNewswire/ -- The U.S. Court of Appeals for the Eighth Circuit unanimously affirmed Infogroup's judgments against DatabaseUSA and Vinod Gupta, Infogroup announced today. In August 2018, a jury unanimously found Gupta and DatabaseUSA liable on all seven counts, including infringement of Infogroup's database copyright and trademarks, unfair competition, false advertising and breach of various contracts. The trial court concluded that Gupta and DatabaseUSA acted \"in bad faith, intentionally and with a desire to suppress the truth, destroyed evidence\" and willfully and deliberately violated federal laws. The trial court entered judgments against DatabaseUSA for $11.2 million and Gupta for $10 million, and ordered both to pay interest and Infogroup's attorney fees and costs, and permanently enjoined them from using Infogroup's tradenames, making false advertising statements and participating in future unfair competitive practices. Unable to pay the judgment, DatabaseUSA filed for Chapter 11 bankruptcy protection in Nevada, where Infogroup is seeking to hold Gupta, his family office Everest Group, LLC and other conspirators liable for the DatabaseUSA judgment. In addition, DatabaseUSA and Gupta appealed parts of the judgments to the 8th Circuit. The 8th Circuit found that the trial court and jury correctly found Gupta and DatabaseUSA liable and upheld the judgments in all respects. \"The jury and courts agree that Infogroup's industry-leading techniques of database management (data selection, refinement, verification, updating and user-friendly arrangement) were so sophisticated and value-enhancing, that such database qualified for copyright protection and Gupta and DatabaseUSA had unlawfully passed Infogroup's proprietary database off as their own. Moreover, the courts found enforceable the confidentiality and non-disparagement provisions in Infogroup's employment contracts,\" said Greg Scaglione, lead trial counsel for Infogroup who heads the National Litigation Practice at Koley Jessen. \"We are thrilled with all of the successful rulings we have secured against Gupta and DatabaseUSA over the years, and Infogroup will continue to tenaciously protect its databases, copyrights, trademarks and the marketplace from competitors' misconduct.\" \"Our team continues to work tirelessly to build databases of the highest quality and accuracy,\" said Infogroup Chairman and CEO Michael Iaccarino. \"We will immediately collect the judgment by drawing on a letter of credit Vinod Gupta issued for our benefit and continue to pursue collection of the Database 101 judgment against DatabaseUSA and its conspirators through the bankruptcy court. We are confident that we will receive full payment from Vinod Gupta.\" All questions regarding the outcome or status of the case should be referred to Infogroup's counsel of record, Greg Scaglione at Koley Jessen. About Infogroup Infogroup is a leading provider of data and real-time business intelligence solutions for enterprise, small business, nonprofit and political organizations. The company's solutions enable clients to acquire and retain customers, and enhance their user experiences through proprietary business and consumer data, artificial intelligence/machine learning models, innovative software applications and expert professional services. Infogroup's cloud-based Data Axle platform delivers data and data updates in real-time via APIs, CRM integrations, SaaS, and managed services. Infogroup has 45+ years of experience helping organizations exceed their goals. For more information, visitwww.infogroup.com. SOURCE Infogroup Related Links https://www.infogroup.com", "role": "user" }, { "content": "Appeals Court Upholds Judgments in Favor of Infogroup: DatabaseUSA, Vinod Gupta Owe More Than $22 Million Eighth Circuit Court of Appeals affirms Infogroup's database copyright protection and honors confidentiality and non-disparagement provisions in Infogroup's employment contracts", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: SAN DIEGO, Nov. 4, 2020 /PRNewswire/ --Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage targeted oncology company, today reported financial results for the third quarter ended September 30, 2020 and recent business highlights. \"The third quarter was notable for significant progress and we have begun the fourth quarter with positive momentum. At the 32nd EORTC-NCI-AACR Symposium on Molecular Targets and Therapeutics last week, we presented preliminary adagrasib (MRTX849) data across multiple tumors, which highlighted the potential for this exciting and differentiated program. We have completed enrollment in our Phase 2 potentially registration-enabling monotherapy trial in 2nd or 3rd line non-small cell lung cancer patients, which will enable our anticipated NDA filing to the FDA for accelerated approval in the second half of 2021.\" said Dr. Charles M. Baum, President and Chief Executive Officer at Mirati Therapeutics, Inc. \"We presented the first preclinical data for MRTX1133, a potentially first in class, potent, selective and reversible inhibitor of KRAS G12D in both its active and inactive states. MRTX1133 demonstrated significant tumor regression in several preclinical tumor models, and we anticipate filing an IND in the first half of 2021. Our recent public offering provides the resources to accelerate and expand development across our pipeline, including sitravatinib, adagrasib, MRTX1133 and discovery programs, as we continue to build our organization, prepare for commercialization and strive to bring novel therapies to cancer patients and their families.\" Recent Corporate Updates: Adagrasib (MRTX849, KRAS G12C Selective Inhibitor) Presented preliminary updated data in non-small cell lung cancer (NSCLC), colorectal cancer (CRC) and other solid tumors at the EORTC-NCI-AACR virtual conference Completed enrollment in the single-agent Phase 2 registrational arm in 2nd or 3rd line therapy in NSCLC Announced clinical collaboration with Boehringer Ingelheim to study BI 1701963, a SOS1::pan-KRAS inhibitor, in combination with adagrasib MRTX1133 (KRAS G12D Selective Inhibitor) Reported initial preclinical data demonstrating significant tumor regression in several tumor models Sitravatinib Presented updated clinical results from Phase 2 clinical trial evaluating sitravatinib in combination with nivolumab (OPDIVO) in patients with advanced or metastatic urothelial carcinoma at the ESMO Virtual Congress Enrollment is on-going in the Phase 3 SAPPHIRE clinical trial in combination with nivolumab (OPDIVO)in 2nd or 3rd line NSCLC patients Operational Update Ended the third quarter with $579.1 million in cash, cash equivalents, and short-term investments and, in addition, strengthened our balance sheet by completing a public offering of common stock on October 30, 2020 that provided estimated net proceeds of $879.7 million Financial Results for the Third Quarter 2020 License and collaboration revenues for the three months ended September30, 2020, were $11.4 million, and relate to a license agreement with ORIC Pharmaceuticals, Inc. (\"ORIC\") pursuant to which the Company granted to ORIC an exclusive, worldwide license to develop and commercialize the Company's allosteric polycomb repressive complex 2 (PRC2) inhibitors for all indications. License and collaboration revenues for the nine months ended September30, 2020 were $11.7 million and related primarily to the ORIC license transfer described above, as well as $0.3 million related to the manufacturing supply services agreement with BeiGene. License and collaboration revenues for the three and nine months ended September30, 2019 were $1.0 million and $2.8 million, respectively, and relate to the manufacturing supply services agreement with BeiGene. Research and development expenses for the third quarter of 2020 were $79.9 million, compared to $47.4 million for the same period in 2019. Research and development expenses for the nine months ended September 30, 2020 were $216.6 million, compared to $119.9 million for the same period in 2019. The increase in research and development expenses is due to an increase in expense associated with the development of adagrasib (MRTX849), MRTX1133, and other preclinical and early discovery activities, as well as an increase in salaries and related expense, including an increase in share-based compensation expense. The Company recognized research and development-related share-based compensation expenses of $12.6 million during the third quarter of 2020, compared to $8.6 million for the same period in 2019, and $35.9 million during the nine months ended September 30, 2020, compared to $20.4 million for the same period in 2019. General and administrative expenses for the third quarter of 2020 were $20.2 million, compared to $10.7 million for the same period in 2019. General and administrative expenses for the nine months ended September 30, 2020 were $58.1 million, compared to $30.3 million for the same period in 2019. The increase is due primarily to an increase in share-based compensation expense and an increase in employee-related expenses and professional service expense. The Company recognized general and administrative-related share-based compensation expenses of $9.2 million during the third quarter of 2020, compared to $6.5 million for the same period in 2019, and $28.2 million during the nine months ended September 30, 2020, compared to $18.4 million for the same period in 2019. Net loss for the third quarter of 2020 was $87.3 million, or $1.96 per share basic and diluted, compared to net loss of $54.3 million, or $1.38 per share basic and diluted for the same period in 2019. Net loss for the nine months ended September 30, 2020 was $256.9 million, or $5.87 per share basic and diluted, compared to net loss of $140.9 million, or $3.83 per share basic and diluted for the same period in 2019. Cash, cash equivalents, and short-term investments were $579.1 million at September 30, 2020. About Mirati Therapeutics Mirati Therapeutics (NASDAQ: MRTX) is a San Diego-based late-stage biotechnology company relentlessly focused on translating drug discovery and research into new treatments for patients by advancing and delivering novel therapeutics that target the genetic and immunologic drivers of cancer. Mirati is advancing a novel pipeline to treat large patient populations across multiple programs and tumor types, including two programs, adagrasib and sitravatinib, in registration-enabling studies to treat non-small cell lung cancer (NSCLC). Adagrasib is an investigational small molecule and selective KRAS G12C inhibitor in clinical development as a monotherapy and in combinations. MRTX1133 is an investigational small molecule, potentand selective KRAS G12D inhibitor in preclinical development. Sitravatinib is an investigational spectrum-selective inhibitor of receptor tyrosine kinases (RTK) designed to enhance immune responses through the inhibition of immunosuppressive signaling. Sitravatinib is being evaluated in multiple clinical trials to treat patients who are refractory to prior immune checkpoint inhibitor therapy, including a Phase 3 trial of sitravatinib in combination with nivolumab in NSCLC. For more information, visit www.mirati.com. Forward Looking Statements This press release contains forward-looking statements regarding the business of Mirati Therapeutics, Inc. (\"Mirati\"). Any statement describing Mirati's goals, expectations, financial or other projections, intentions or beliefs, development plans and the commercial potential of Mirati's drug development pipeline, including without limitation adagrasib (MRTX849), sitravatinib and MRTX1133, is a forward-looking statement and should be considered an at-risk statement. Such statements are subject to risks and uncertainties, particularly those challenges inherent in the process of discovering, developing and commercialization of new drug products that are safe and effective for use as human therapeutics, and in the endeavor of building a business around such drugs. Mirati's forward-looking statements also involve assumptions that, if they never materialize or prove correct, could cause its results to differ materially from those expressed or implied by such forward-looking statements. Although Mirati's forward-looking statements reflect the good faith judgment of its management, these statements are based only on facts and factors currently known by Mirati. As a result, you are cautioned not to rely on these forward-looking statements. These and other risks concerning Mirati's programs are described in additional detail in Mirati's quarterly reports on Form 10-Q and annual reports on Form 10-K, which are on file with the U.S. Securities and Exchange Commission (the \"SEC\") available at the SEC's Internet site (www.sec.gov).These forward-looking statements are made as of the date of this press release, and Mirati assumes no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements, except as required by law. Mirati Therapeutics, Inc. Consolidated Balance Sheets (in thousands) September 30,2020(unaudited) December 31,2019 Assets Current assets Cash, cash equivalents and short-term investments $ 579,050 $ 415,050 Other current assets 16,341 9,357 Total current assets 595,391 424,407 Property and equipment, net 5,901 1,776 Long-term investment 11,400 Other long-term assets 7,159 6,017 Total assets $ 619,851 $ 432,200 Liabilities and Shareholders' Equity Current liabilities Accounts payable and accrued liabilities $ 66,670 $ 48,082 Deferred revenue and other current liabilities 697 824 Total current liabilities 67,367 48,906 Other long-term liabilities 1,541 999 Total liabilities 68,908 49,905 Shareholders' equity 550,943 382,295 Total liabilities and shareholders' equity $ 619,851 $ 432,200 Mirati Therapeutics, Inc. Consolidated Statements of Operations and Comprehensive Loss (in thousands) Three Months Ended September 30, Nine Months Ended September 30, 2020 2019 2020 2019 (unaudited) (unaudited) Revenues License and collaboration revenues $ 11,424 $ 988 $ 11,690 $ 2,809 Total Revenue 11,424 988 11,690 2,809 Operating Expenses Research and development 79,853 47,362 216,644 119,925 General and administrative 20,249 10,685 58,074 30,340 Total operating expenses 100,102 58,047 274,718 150,265 Loss from operations (88,678) (57,059) (263,028) (147,456) Other income, net 1,342 2,786 6,178 6,576 Net loss $ (87,336) $ (54,273) $ (256,850) $ (140,880) Unrealized (loss) gain on available-for-sale investments (827) 103 568 412 Comprehensive loss $ (88,163) $ (54,170) $ (256,282) $ (140,468) Basic and diluted net loss per share $ (1.96) $ (1.38) $ (5.87) $ (3.83) Weighted average number of shares used in computing net loss per share, basic and diluted 44,614 39,197 43,779 36,799 SOURCE Mirati Therapeutics, Inc. Related Links http://www.mirati.com", "role": "user" }, { "content": "Mirati Therapeutics Reports Third Quarter 2020 Financial Results And Recent Business Highlights", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: LONDON--(BUSINESS WIRE)--Technavio has been monitoring the clientless remote support software market and it is poised to grow by USD 1.06 billion during 2020-2024, progressing at a CAGR of over 15% during the forecast period. The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment. Although the COVID-19 pandemic continues to transform the growth of various industries, the immediate impact of the outbreak is varied. While a few industries will register a drop in demand, numerous others will continue to remain unscathed and show promising growth opportunities. Technavios in-depth research has all your needs covered as our research reports include all foreseeable market scenarios, including pre- & post-COVID-19 analysis. Download a Free Sample Report on COVID-19 Impacts Frequently Asked Questions- The market is concentrated, and the degree of concentration will accelerate during the forecast period. BeyondTrust Corp., Cisco System Inc., Citrix System Inc., ConnectWise LLC, LogMeIn Inc., NinjaRMM LLC, RSUPPORT Co. Ltd., SolarWinds Worldwide LLC, TeamViewer Group, and VMware Inc. are some of the major market participants. The advantage of superior customer experience will offer immense growth opportunities. To make most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments. Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free. View market snapshot before purchasing Technavio's custom research reports offer detailed insights on the impact of COVID-19 at an industry level, a regional level, and subsequent supply chain operations. This customized report will also help clients keep up with new product launches in direct & indirect COVID-19 related markets, upcoming vaccines and pipeline analysis, and significant developments in vendor operations and government regulations. Clientless Remote Support Software Market 2020-2024: Segmentation Clientless Remote Support Software Market is segmented as below: To learn more about the global trends impacting the future of market research, download a free sample: https://www.technavio.com/talk-to-us?report=IRTNTR40497 Clientless Remote Support Software Market 2020-2024: Scope Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources. The clientless remote support software market report covers the following areas: This study identifies rise in the need for clientless remote support across various organizations as one of the prime reasons driving the clientless remote support software market growth during the next few years. Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Technavios in-depth research has direct and indirect COVID-19 impacted market research reports. Register for a free trial today and gain instant access to 17,000+ market research reports. Technavio's SUBSCRIPTION platform Clientless Remote Support Software Market 2020-2024: Key Highlights Table of Contents: Executive Summary Market Landscape Market Sizing Five Forces Analysis Market Segmentation by Application Market Segmentation by End-user Customer landscape Geographic Landscape Drivers, Challenges, and Trends Vendor Landscape Vendor Analysis Appendix About Us Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavios report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavios comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.", "role": "user" }, { "content": "Clientless Remote Support Software Market- Roadmap for Recovery from COVID-19 | Advantage of Superior Customer Experience to Boost the Market Growth | Technavio", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: WEST CHESTER, Pa., July 30, 2020 /PRNewswire/ --Wealthcare is pleased to announce that its total assets under management (\"AUM\") for its two registered investment advisors (\"RIAs\"), Wealthcare Capital Management LLC and Wealthcare Advisory Partners LLC, (collectively \"Wealthcare\") has eclipsed $3 billion at the conclusion of the second quarter for the first time in its history. Now servicing over 140 advisors and advisory groups across the country, Wealthcare continues to attract advisors who are interested in leveraging its technology-enabled RIA services. \"Our success needs to be shared with many individuals, not only the dedicated Wealthcare team, including our technology, operations and support personnel, but also our advisors, who continue to adopt our framework and take full advantage of our outsourced solution in order to focus on their clients and helping them to achieve their life goals,\" said Matt Regan, President of Wealthcare. \"We began to hone our focus solely on recruiting advisors to our platform in 2016, so to reach this level of AUM is satisfying,\" he continued. \"While $3 billion in AUM is a commendable milestone, we are even more pleased seeing the rate of our advisors organic growth. We continue to observe that the advisors who have joined us in the last four years are growing their business at nearly twice the industry averages, a testament of our platform's effectiveness.\" Wealthcare provides its patented GDX360 process, the industry's only fully integrated goals-based planning, asset management, and trading engine to advisors who are seeking a partner in their journey to independence. Wealthcare advisors and clients benefit from planning, operations, marketing, and practice management support. \"We look forward to continuing this period of growth and success,\" said Regan. \"Our advisors have validated the value delivered by our solution, and we will continue to work hard to ensure that they have the tools that they need to enhance their clients' financial lives.\" About Wealthcare Wealthcare, a business unit of Financeware, architected its original goals-based planning and investing methodology more than 18 years ago and holds 12 patents on this established goals management process. Powered by its patented Comfort Zone, Wealthcare's approach features innovative, personalized experiences and step-by-step tools that create deeper relationships between advisors and investors. Wealthcare empowers firms and advisors to grow their advisory businesses by providing GDX360 Wealthcare's proven fiduciary process that seamlessly integrates planning, investing and trading and a full-suite of practice-management services. Wealthcare Advisory Partners LLC is the firm's Hybrid RIA, which was created in 2014. Wealthcare is a Financeware portfolio company with over $3 billion in AUM across both RIAs, and serving more than 140 affiliated advisors. Learn more at www.wealthcaregdx.com. About Financeware Financeware is the industry's leading fintech platform company focused on driving strategic growth and expansion of innovative companies across the new wealth management space. Established by NewSpring Holdings in 2018, Financeware was born of a need to connect winning solution sets to the fast-moving targets, partners and market relationships playing out across the entire wealth management sector. With a deep history of game-changing wins driven by broad and deep market leadership, the group drives strategic growth of portfolio companies focused in key areas of wealth management, financial advisory, and data management. Financeware's growing portfolio includes Wealthcare, VMS and QUODD. Learn more at www.financeware.com. About NewSpring Holdings NewSpring Holdings, the dedicated, diversified holding company within NewSpring, with a strategy focused on control buyouts and platform builds, brings a wealth of knowledge, experience, and resources to take profitable, growing companies to the next level through acquisitions and proven organic methodologies. Founded in 1999, NewSpring partners with the innovators, makers, and operators of high-performing companies in dynamic industries to catalyze new growth and seize compelling opportunities. The Firm manages approximately$2 billionacross four distinct strategies covering the spectrum from growth equity and control buyouts to mezzanine debt. Partnering with management teams to help develop their businesses into market leaders, NewSpring identifies opportunities and builds relationships using its network of industry leaders and influencers across a wide array of operational areas and industries. Visit NewSpring atwww.newspringcapital.com. SOURCE Wealthcare Related Links https://www.wealthcaregdx.com", "role": "user" }, { "content": "Wealthcare Eclipes $3 Billion in Assets Under Management", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: MIAMI, Feb. 12, 2021 /PRNewswire/ --Spanish Broadcasting System, Inc. (the \"Company\", \"we\", \"us\", or \"SBS\") announced today that it has priced an offering of $310 millionin aggregate principal amount of its senior secured notes due 2026 (the \"Notes\"). The Notes will bear interest semi-annually at a rate of 9.75% per annum and were offered at par value. The Notes will be fully and unconditionally guaranteed on a senior secured basis by certain of the Company's subsidiaries, and secured, subject to certain exceptions and permitted liens, on a first-priority basis by the Notes collateral. The closing of the offering is anticipated to take place February 17,2021, subject to the satisfaction of customary closing conditions. The Company intends to use the net proceeds of this offering along with cash on hand (i) to repay its 12.5% senior secured notes due 2017, (ii) along with certain other consideration, to repurchase and/or redeem all of its outstanding 10 3/4% Series B cumulative exchangeable redeemable preferred stock, $0.01 par value (the \"Series B Preferred Stock\") and (iii) to pay related fees and expenses. The Notes and the related guarantees are being offered in the United States to persons reasonably believed to be \"qualified institutional buyers\" pursuant to Rule 144A under the Securities Act of 1933, as amended (the \"Securities Act\"), and to persons outside of the United States in compliance with Regulation S under the Securities Act. The Notes and the related guarantees have not been registered under the Securities Act, or any state securities laws, and unless so registered, may not be offered or sold in the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and applicable state securities laws. This press release is for informational purposes only and is neither an offer to sell nor a solicitation of an offer to buy any security and shall not constitute an offer, solicitation or sale in any jurisdiction in which such offering, solicitation or sale would be unlawful. This press release does not constitute a redemption notice for the Series B Preferred Stock and is not an offer to purchase or a solicitation of an offer to sell the Series B Preferred Stock. About Spanish Broadcasting System, Inc. Spanish Broadcasting System, Inc. (SBS) owns and operates radio stations located in the top U.S. Hispanic markets of New York, Los Angeles, Miami, Chicago, San Francisco and Puerto Rico, airing the Tropical, Regional Mexican, Spanish Adult Contemporary, Top 40 and Urbano format genres. SBS also operates AIRE Radio Networks, a national radio platform of over 290 affiliated stations reaching 95% of the U.S. Hispanic audience. SBS also owns MegaTV, a network television operation with over-the-air, cable and satellite distribution and affiliates throughout the U.S. and Puerto Rico, produces a nationwide roster of live concerts and events, and owns a stable of digital properties, including La Musica, a mobile app providing Latino-focused audio and video streaming content and HitzMaker, a new-talent destination for aspiring artists. For more information, visit us online at www.spanishbroadcasting.com. Forward Looking Statements This press release contains forward-looking statements that involve risks and uncertainties. In some cases, you can identify forward-looking statements by the words \"anticipate,\" \"believe,\" \"continue,\" \"could,\" \"estimate,\" \"expect,\" \"intend,\" \"may,\" \"might,\" \"objective,\" \"ongoing,\" \"plan,\" \"predict,\" \"project,\" \"potential,\" \"should,\" \"will,\" or \"would,\" and/or the negative of these terms, or other comparable terminology intended to identify statements about the future. They appear in this press release and include statements regarding our intentions, beliefs or current expectations. These statements, by their nature, involve substantial risks and uncertainties, certain of which are beyond our control, and actual results may differ materially depending on a variety of important factors, including, but not limited to, our substantial indebtedness and high leverage, our highly competitive industry, our ongoing response to the COVID-19 pandemic, our dependency on revenue and operating income from a limited number of markets, unpredictability of sales in the advertising industry, our ability to attract listeners, viewers and advertisers to our broadcast radio and television operations, the popularity and appeal of our content, our ability to maintain and renew distribution agreements, impact from tax reform and any new tax legislation, our ability to respond to rapid changes in technology, content creation, services and standards, our ability to protect our business from cybersecurity risks, performance of key employees, on-air talent and program hosts, reputational damage to our brands and legal or governmental proceedings and regulatory and other legislative compliance, including compliance with the Federal Communications Commission. All forward-looking statements made herein are qualified by these cautionary statements and risk factors and there can be no assurance that the actual results, events or developments referenced herein will occur or be realized. We do not have any obligation to publicly update any forward-looking statements to reflect subsequent events or circumstances. Contacts: Analysts and Investors Jos I. Molina Chief Financial Officer (305) 441-6901 SOURCE Spanish Broadcasting System, Inc. Related Links http://www.spanishbroadcasting.com", "role": "user" }, { "content": "Spanish Broadcasting System, Inc. Announces Pricing Of $310 Million Senior Secured Notes USA - English USA - espaol", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: SAN BERNARDINO, Calif.--(BUSINESS WIRE)--Country Archer Provisions, the leading grass-fed meat snack brand, today announced it has partnered with Chef Will Horowitz of New York Citys Ducks Eatery on a month-long initiative called #BringHomeTheBacon. Comprised of 16 local restaurants and executive chefs, the give back program aims to support small businesses and hospitality employees that have been impacted by COVID-19. According to the latest Yelp Economic Average Report, more than 16,000 restaurants nationwide have permanently shuttered a number that represents 60% of all temporary closures since the pandemic began. The powerhouse collective of participating chefs and restaurants represent the richly diverse community that is the foundation of the New York City restaurant scene. Country Archer donated over 19,000 lbs. of bacon and grass-fed beef to the participating eateries to be used in dishes available for order locally. Between September 12 and October 10, New Yorkers can order these bacon-centric dishes and help local restaurants #BringHomeTheBacon. After working closely with Chef Will Horowitz to bring our line of Zero Sugar Jerky to life, we had the opportunity to learn more about the incredible chefs and restaurants that are part of his culinary family in the city, said CEO and co-founder of Country Archer Provisions, Eugene Kang. At Country Archer our mission is to craft real food to craft a better world, and we wanted to keep up our end of the bargain by helping to preserve the diversity and spirit that these restaurants bring to the city. We hope that this contribution will provide some relief to these businesses and most importantly encourage customers to come out and buy locally. New Yorkers can order bacon-inspired dishes at participating restaurants, spanning across different boroughs, including acclaimed meat-centric and heritage technique focused Ducks Eatery; Top Chef contestant Leah Cohens Filipino-Thai-inspired Pig & Kao; the iconic, family-run East Village pierogi restaurant Veselka; and the dim sum hot spot and longest-lasting restaurant in Chinatown Nom-Wah Tea Parlor. Additional restaurants include Hearth, Wildair, La Palapa, Cheeky Sandwich, Sunday in Brooklyn, Jeepney, Goodnight Sonny, Ivan Ramen, Ops Pizza, Rethink NYC, Boulton & Watt, and Bar Primi. Offerings will include pizza, brunch, cocktails, and dishes like the grilled thick-cut 5-spice bacon tacos that will be available exclusively at Chef Horowitzs Ducks Eatery. We all know COVID-19 has hit the restaurant industry especially hard, and weve unfortunately seen many establishments already close their doors, said Chef Horowitz. Not only is New York City my home, but those here in the industry are my family, so when Country Archer approached me to help support them in a unique way, I was thrilled to be a part of it. Customers who order throughout the campaign are encouraged to spread the word and help show their support by sharing a picture of their dish using the hashtag #BringHomeTheBacon. Additional information on the participating restaurants can be found at CountryArcher.com. About Country Archer Provisions Country Archer Provisions is a leading producer of delicious real ingredient, grass-fed jerky and meat sticks crafted with high-quality, premium, and clean ingredients. Made for outdoor adventurers, busy parents, athletes, and all the humble hustlers who want more from their food, Country Archer pushes the envelope with innovative and mouthwatering flavors, high protein content, and responsibly sourced, real ingredients. The brand is committed to sustainable farming practices, and sources its protein exclusively from grass-fed and -finished pasture-raised cattle that are never confined to feed lots. Each meat snack is crafted with tender cuts of USDA-inspected 100 percent grass-fed and -finished beef, antibiotic-free turkey, or pork. All Country Archer products are free of preservatives, nitrites, MSG, and gluten. Country Archer meat snacks are available at fine retailers nationwide, including Starbucks, Whole Foods Market, Sprouts, Costco, The Fresh Market, Wegmans, Walmart, Target, Kroger, Albertsons, Safeway, Walgreens, 7-Eleven, and more. To learn more about Country Archer, visit www.countryarcher.com, or follow the brand on Instagram (@CountryArcher) and Facebook (@CountryArcher).", "role": "user" }, { "content": "Country Archer Provisions and Chef Will Horowitz Help #BringHomeTheBacon for New York City Restaurants Affected by COVID-19 Leading grass-fed beef jerky brand donates over 19,000 lbs. of bacon and grass-fed beef to beloved eateries to help generate additional revenue through bacon-centric dishes", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: LAKELAND, Fla.--(BUSINESS WIRE)--Publix will distribute COVID-19 vaccinations at 108 Publix pharmacies across the state of Georgia thanks to a collaboration with the State of Georgia and Governor Brian Kemp. Vaccinations are provided by appointment only and are for first responders, health care workers, individuals ages 65 and older and their caregivers, and residents and staff of long-term care facilities. Eligible individuals can make appointments beginning Friday, Jan. 15, using the online reservation system at publix.com/covidvaccine, with vaccinations starting Saturday, Jan. 16. At Publix, we know how important it is to be there, especially in times of need, said Publix CEO Todd Jones. We are grateful for the opportunity to provide this critical service to the Georgia community. Vaccinations are provided to eligible individuals, by appointment only, while supplies last, and at no cost to the individual. Customers with health insurance will need to bring their insurance card to their scheduled appointment. Medicare members should bring their red, white and blue Medicare Part B card. Customers without health insurance will need to provide their drivers license or Social Security number. Publix Pharmacy will administer the vaccine at the following locations: COUNTY CITY STORE ADDRESS Barrow Winder #480, Winder Corners Shopping Center 17 Monroe Highway, Suite A Bibb Macon #1700, Publix at Tobesofkee Crossing 5581 Thomaston Road Bryan Richmond Hill #1154, Publix at Richmond Hill Plantation 12800 Highway 144 Camden Kingsland #455, Camden Woods Shopping Center 1601 Georgia Highway 40 E. Carroll Carrollton #608, McIntosh Plaza 1109 S. Park St. Suite 600 Catoosa Ringgold #1641, Boynton Ridge Plaza 3775 Battlefield Parkway Chatham Pooler #1364, Pooler Marketplace 467 Pooler Parkway #1584, Publix At Blue Moon Crossing 101 Blue Moon Crossing Savannah #521, Island Towne Centre 4717 Highway 80 E., Suite B #1186, Largo Plaza 11701 Abercorn St. Cherokee Canton #42, Freehome Village 12424 Cumming Highway #624, Riverstone Plaza Shopping Center 1451 Riverstone Parkway #1064, Paradise Shoppes of Prominence Point 120 Prominence Point Parkway #1248, Laurel Canyon Village 15 Laurel Canyon Village Circle, Suite 118 Woodstock #636, The Centre at Woodstock 12165 Highway 92 #880, Village Shoppes of East Cherokee 6236 Holly Springs Parkway Clarke Athens #1146, Georgetown Square 1860 Barnett Shoals Road Clayton Morrow #461, Publix at Mt. Zion 2035 Mount Zion Road Cobb Acworth #566, Brookstone Village 1727 Mars Hill Road NW #1096, Governors Towne Square 6110 Cedarcrest Road NW Kennesaw #146, Wade Green Village 4430 Wade Green Road NW, Suite 100 #764, Orchard Square Shopping Center 4290 Bells Ferry Road NW Marietta #280, Piedmont Commons Shopping Center 1050 E. Piedmont Road, Suite 130 #548, Towne Center Prado 50 Barrett Parkway, Suite 1000 #561, West Cobb Marketplace 2500 Dallas Highway SW, Suite 300 #672, Sandy Plains Exchange 1860 Sandy Plains Road Powder Springs #670, Publix at Powder Springs 3721 New Macland Road, Suite 300 Roswell #86, Publix at Shallowford 4401 Shallowford Road Smyrna #753, Highland Station 4480 S. Cobb Drive SE Columbia Evans #1286, Riverwood Town Center 5119 Washington Road Martinez #534, Fury's Ferry Plaza 403 Furys Ferry Road Coweta Newnan #1143, Stillwood Pavilion at Summer Grove 1111 Lower Fayetteville Road Dawson Dawsonville #1542, Dawson Crossroads 145 Forest Blvd., Suite 100 DeKalb Atlanta #691, Briarcliff Village Shopping Center 2162 Henderson Mill Road NE #783, Publix at East Lake 2235 Glenwood Ave. SE Decatur #665, Shamrock Plaza 3870 N. Druid Hills Road #723, Emory Commons 2155 N. Decatur Road Lithonia #752, Centre at Panola 3045 Panola Road Douglas Douglasville #1139, The Shoppes at Deer Creek 4300 Chapel Hill Road Fayette Fayetteville #579, Fayette Pavilion 108 Pavilion Parkway #1087, Summit Point 840 Glynn St. S. Peachtree City #546, Publix at Peachtree East 130 Peachtree East Court, Suite 4 #799, Wilshire Pavillion 1200 Highway 74 S., Suite 20 Tyrone #892, South Hampton Village 1512 Highway 74 N. Floyd Rome #1403, Charles Hight Square 435 Turner McCall Blvd. NE Forsyth Alpharetta #616, Midway Shopping Center 4900 Atlanta Highway #1089, The Village at Flynn Crossing 5180 McGinnis Ferry Road Cumming #49, Lanier Commons 3480 Keith Bridge Road #1130, Castleberry - Southard Crossing 5475 Bethelview Road #1690, Matt Town Center 5310 Matt Highway Suwanee #565, The Shops at Laurel Springs 3245 Peachtree Parkway, Suite A #1091, Shakerag Shopping Center 7780 McGinnis Ferry Road #1227, The Village Shoppes at Windermere 3120 Mathis Airport Parkway Fulton Alpharetta #762, Bethany Village 13800 Highway 9 N., Suite E Atlanta #282, The Peach 2900 Peachtree Road NW #503, Cascade Crossing Shopping Center 3695 Cascade Road SW #599, Ansley Mall 1544 Piedmont Ave. NE #664, Lenox Marketplace 3535 Peachtree Road NE #718, Chastain Square 4279 Roswell Road NE, Suite 300 #1044, Cheshire Square 2325 Cheshire Bridge Road NE #1056, Publix at Princeton Lakes 3730 Carmia Drive SW, Suite 200 #1061, The Plaza Midtown 950 W. Peachtree St. NW #1119, Howell Mill Village 2020 Howell Mill Road NW, Suite A #1647, Madison Yards 905 Memorial Drive SE #1718, Sandtown Crossing 5829 Campbellton Road SW, Suite 110 Fairburn #1183, Parkway Village 5370 Campbellton Fairburn Road Johns Creek #226, Medlock Corners 5805 State Bridge Road Roswell #626, King Plaza 885 Woodstock Road, Suite 100 Sandy Springs #646, Trowbridge Crossing 7525 Roswell Road #647, Publix at Perimeter 1100 Hammond Drive, Suite 300 Greene Greensboro #853, Lake Oconee Village 6350 Lake Oconee Parkway, Suite 106 Gwinnett Dacula #803, Dacula Village 720 Dacula Road Duluth #505, Promenade at Pleasant Hill 1625 Pleasant Hill Road, Suite 200 #585, Duluth Station 2750 Buford Highway Lawrenceville #612, Sugarloaf Crossing 4850 Sugarloaf Parkway #859, Village Shoppes of Sugarloaf 3370 Sugarloaf Parkway #863, The Shops at Huntcrest 1030 Old Peachtree Road NW #1078, The Village Shoppes at Simonton 930 New Hope Road Lilburn #564, Five Forks Corner Shopping Center 4045 Five Forks Trickum Road SW Loganville #789, Grayson Village 2715 Loganville Highway SW Snellville #508, Presidential Market Center 1905 Scenic Highway N., Suite 4000 #539, Publix at Centerville 3550 Centerville Highway, Suite 201 Sugar Hill #596, Sugar Hill Corners 5885 Cumming Highway Suwanee #615, McGinnis Crossing 1000 Peachtree Industrial Blvd. Hall Buford #706, Golden Park Village 4840 Golden Parkway Flowery Branch #634, Robson Crossing 3446 Winder Highway #844, Village Shops of Flowery Branch 5900 Spout Springs Road #1279, Friendship Springs Village 7334 Spout Springs Road Gainesville #1110, Village Shoppes of Gainesville 879 Dawsonville Highway Henry Locust Grove #1052, The Shops at Locust Grove 2730 Highway 155 McDonough #816, Paradise Pointe at Lake Dow 920 Highway 81 E. #1054, The Shops at Westridge 2158 Highway 20 W. Houston Byron #1291, Publix at Gunn Battle 6015 Watson Blvd. Kathleen #1008, Paradise Shoppes of Warner Robins 1114 Georgia Highway 96 Perry #1233, Paradise Shoppes of Perry 275 Perry Parkway Lowndes Valdosta #430, Baytree Village 1741 Gornto Road #1435, Publix at Perimeter Park 3330 Inner Perimeter Road Muscogee Columbus #474, Bradley Park Square 1639 Bradley Park Drive, Suite 600 #562, Milgen Plaza 5435 Woodruff Farm Road #650, Parkway Centre 7600 Schomburg Road #1390, Cross Country Plaza 3201 Macon Road, Suite 201 Newton Covington #744, Salem Road Station 13015 Brown Bridge Road Oconee Watkinsville #617, Butler's Crossing 2061 Experiment Station Road Paulding Dallas #1063, Paradise Shoppes of New Hope 51 E. Paulding Drive #1217, The Village at New Georgia 7953 Villa Rica Highway Rockdale Conyers #1071, Smyrna Crossing 2880 Georgia Highway 212 SW Thomas Thomasville #1498, Publix at Park Place 13775 U.S. Highway 19 S. Walton Loganville #603, Loganville Town Centre 4325 Atlanta Highway Publix is also offering COVID-19 vaccines in 12 Florida counties and continues to communicate with the states in its operating area to provide COVID-19 vaccinations as part of their distribution efforts. Publix, the largest employee-owned company in the U.S. with more than 225,000 associates, currently operates 1,264 stores in Florida, Georgia, Alabama, Tennessee, South Carolina, North Carolina and Virginia. For 23 consecutive years, the company has been recognized by Fortune as a great place to work. In addition, Publixs dedication to superior quality and customer service is recognized among the top in the grocery business. For more information, visit the companys website, corporate.publix.com.", "role": "user" }, { "content": "COVID-19 Vaccinations Coming to 108 Publix Pharmacies in Georgia", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: LONDON--(BUSINESS WIRE)--Technavio has been monitoring the artificial intelligence platforms market and it is poised to grow by $ 12.51 bn during 2020-2024, progressing at a CAGR of over 33% during the forecast period. The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment. Although the COVID-19 pandemic continues to transform the growth of various industries, the immediate impact of the outbreak is varied. While a few industries will register a drop in demand, numerous others will continue to remain unscathed and show promising growth opportunities. Technavios in-depth research has all your needs covered as our research reports include all foreseeable market scenarios, including pre- & post-COVID-19 analysis. We offer $1000 worth of FREE customization The market is concentrated, and the degree of concentration will accelerate during the forecast period. Alibaba Group Holding Ltd., Alphabet Inc., Amazon Web Services Inc., International Business Machines Corp., Microsoft Corp., Palantir Technologies Inc., Salesforce.com Inc., SAP SE, SAS Institute Inc., and Tata Consultancy Services Ltd. are some of the major market participants. To make the most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments. Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free. View market snapshot before purchasing Rise in demand for ai-based solutions has been instrumental in driving the growth of the market. However, the rise in data privacy issues might hamper the market growth. Technavio's custom research reports offer detailed insights on the impact of COVID-19 at an industry level, a regional level, and subsequent supply chain operations. This customized report will also help clients keep up with new product launches in direct & indirect COVID-19 related markets, upcoming vaccines and pipeline analysis, and significant developments in vendor operations and government regulations. Download a Free Sample Report on COVID-19 Impacts Artificial Intelligence Platforms Market 2020-2024: Segmentation Artificial Intelligence Platforms Market is segmented as below: Artificial Intelligence Platforms Market 2020-2024: Scope Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources. The artificial intelligence platforms market report covers the following areas: This study identifies the rise in investments in AI start-ups as one of the prime reasons driving the artificial intelligence platforms market growth during the next few years. Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Technavios in-depth research has direct and indirect COVID-19 impacted market research reports. Register for a free trial today and gain instant access to 17,000+ market research reports. Technavio's SUBSCRIPTION platform Artificial Intelligence Platforms Market 2020-2024: Key Highlights Table of Contents: Executive Summary Market Landscape Market Sizing Five Forces Analysis Market Segmentation by Deployment Customer landscape Geographic Landscape Vendor Landscape Vendor Analysis Appendix About Us Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavios report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavios comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.", "role": "user" }, { "content": "COVID-19 Recovery Analysis: Artificial Intelligence Platforms Market | Rise In Demand For AI-based Solutions to boost the Market Growth | Technavio", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: NEW YORK, Feb. 17, 2021 /PRNewswire/ -- The rise of a whole new form of sports entertainment has made esports the fastest growing segment of the sports betting industry. At the same time, the hype surrounding this year's Super Bowl has made it clear that traditional sports are still going strong and so is traditional sports betting. Companies focused on sports betting are finding a huge opportunity to seamlessly integrate esports into their existing platforms, while new players that have so far focused on esports are finding opportunities in traditional sports as well. As companies like Skillz (NASDAQ:SKLZ)and Enthusiast Gaming (TSX:EGLX) (OTCQB:ENGMF)move esports forward, companies like Real Luck Group Ltd, \"Luckbox\" (TSXV:LUCK), DraftKings Inc (NASDAQ:DKNG),and Penn National Gaming (NASDAQ:PENN) are bringing esports and traditional sports betting together. Sports Betting's Most Comprehensive Platform Gets Even Bigger Among the most recent companies to bring esports and traditional sports betting together is Real Luck Group Ltd, \"Luckbox\" (TSXV:LUCK). Luckbox is a fully licensed sports betting and streaming platform with some of the most complete esports coverage in the sports betting industry. The company's platform offers legal real-money betting pre-match and mid-game, along with live streams of 90% of Esports matches featured on the platform. The company's service is live in more than 80 countries and has more esports matches than almost any other esports betting platform. Luckbox was named a Rising Star at the 2020 EGR Operator Awards. While the company established its place in the online betting space by focusing on esports, the fastest growing segment of the sports entertainment industry, Luckbox's platform was also built to seamlessly integrate traditional sports betting once the company decides it is ready to branch out. On February 3, in the leadup to Super Bowl LV, Luckbox announced that the company is ready to take that step, partnering with Business-to-Business software development company EveryMatrix Ltd to add the functionality. Luckbox is set to add more than 105 traditional sports to the platform, with 85,000 pre-match events, 70,000 live events each month, and 450 types of bets. \"Our partnership with EveryMatrix allows us to roll out the functionality with the Australian Open tennis and rugby union's Six Nations on to the Luckbox platform following Super Bowl LV. Luckbox is a destination for esports betting, but we know most of our players also love traditional sports. This new functionality means they can bet on hugely popular sports such as soccer, basketball and hockey from the convenience of Luckbox - a single and secure platform that now integrates esports and traditional sports betting,\" Luckbox CEO Quentin Martin said in the company's release. \"On behalf of Luckbox, I want to thank EveryMatrix for helping us integrate traditional sports betting into the Luckbox platform.\" Sports Betting Companies Embrace Esports Luckboxbegan with esports before branching out with traditional sports, but some established traditional sports betting companies are doing just the opposite as they realize the momentum behind esports. Fantasy sports platform DraftKings Inc (NASDAQ:DKNG) has added a number of esports-related services in recent years, including announcing in March last year that the company would run daily fantasy Counter Strike: Global Offensive esports events. Legacy gaming giant Penn National Gaming (NASDAQ:PENN) stepped into the sports betting and fantasy sports space in a big way last year with the purchase of sports media company Barstool Sports and the subsequent establishment of a Barstool-branded sports betting platform. Penn Interactive VP of strategic marketing said in May last year that esports \"will be a big part of gambling's future\" after the company hosted betting on the eNASCAR iRacing Pro Invitational Series. Esports is the Hottest Segment in Sports Entertainment Over the past few years, emerging technology companies have found massive opportunity by focusing on esports. Enthusiast Gaming (TSX:EGLX) (OTCQB:ENGMF) has built the largest gaming network in North America by managing esports media and live esports events while working with some of the biggest esports teams in the world. Enthusiast now reaches an audience of 300 million monthly visitors with 4.2 billion page views per month. Esports company Skillz (NASDAQ:SKLZ) has been named by Forbes as one of the next billion-dollar startups and one of the fastest growing companies in America after building a leading platform for hosting casual esports tournaments for real cash prizes. On February 4, the company announced that it had signed a multi-year gaming agreement with the National Football League to host NFL mobile esports events, starting with a global game developer challenge. Esports has quickly become an important part of the overall sports entertainment landscape, and companies like Real Luck Group are maximising their userbases by bringing esports together with the traditional sports entertainment experience. Click hereto find out more about Real Luck Group, \"Luckbox\". Disclaimer: Microsmallcap.com (MSC) is the source of the Article and content set forth above. MSC owns Streetsignals.com. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. FN Media Group (FNM) is a third-party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. FNM is NOT affiliated with MSC or any company mentioned herein. The commentary, views and opinions expressed in this release by MSC are solely those of MSC and are not shared by and do not reflect in any manner the views or opinions of FNM. Readers of this Article and content agree that they cannot and will not seek to hold liable MSC and FNM for any investment decisions by their readers or subscribers. MSC and FNM and their respective affiliated companies are a news dissemination and financial marketing solutions provider and are NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security. The Article and content related to the profiled company represent the personal and subjective views of the Author (MSC), and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author (MSC) has not independently verified or otherwise investigated all such information. None of the Author, MSC, FNM, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer's filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer's securities, including, but not limited to, the complete loss of your investment. FNM was not compensated by any public company mentioned herein to disseminate this press release but was compensated twenty five hundred dollars by MSC, a non-affiliated third party to distribute this release on behalf of Real Luck Group Ltd FNM HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE. This release contains \"forward-looking statements\" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. \"Forward-looking statements\" describe future expectations, plans, results, or strategies and are generally preceded by words such as \"may\", \"future\", \"plan\" or \"planned\", \"will\" or \"should\", \"expected,\" \"anticipates\", \"draft\", \"eventually\" or \"projected\". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and MSC and FNM undertake no obligation to update such statements. Media Contact: FN Media Group, LLC[emailprotected]+1(561)325-8757 SOURCE Microsmallcap.com", "role": "user" }, { "content": "Online Sports Betting Expands With Additions of More Traditional Sports and Esports - FN Media Group Presents Microsmallcap.com Market Commentary", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: OTTAWA, Ontario--(BUSINESS WIRE)--Avivagen Inc. (TSXV:VIV, OTCQB:VIVXF) (Avivagen), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that enhance feed intake and safely support immune function, thereby supporting general health and performance, is pleased to announce that it has chosen Meyenberg International Group to lead expansion efforts in key regions in Central and South America. Meyenberg has been critical to Avivagens recent success in Mexico and will begin by overseeing the process to seek registrations for OxC-beta Livestock in Costa Rica, Colombia, Peru, Uruguay and Argentina. Meyenberg International Group has been instrumental in both the approval for, and rapid adoption of OxC-beta Livestock in Mexico over the past 18 months, says Kym Anthony, Chief Executive Officer, Avivagen, Inc. Were very excited to have founder Alejandro Meyenberg and his team expand on that success in other important livestock regions throughout Central and South America. The combined annual livestock feed consumption in Costa Rica, Colombia, Peru, Uruguay and Argentina was approximately 40 million tonnes in 2020, on par with the 38 million tonnes consumed in Mexico each yeari. Meyenberg International Group With a client base across North America and a well-earned reputation for enabling rapid growth for clients expanding into LATAM, Meyenbergs experience in Mexico has enabled Avivagen to quickly establish and grow sales in the country since securing regulatory approval in August 2019. Meyenberg has been central to establishing key client relationships in Mexico including Industrias Melder, which increased purchase order size rapidly from an initial 50 kg order to a 10 tonne order in a six-month span, and Transformadora Agricola, which placed a six tonne order in January 2021. The strategic working relationship with Meyenberg also enabled Avivagen to join Asociacin Nacional de Fabricantes de Alimentos Para Consumo Animal. S.C (ANFACA) and Asociacin Mexicana de Productores de Alimentos, A.C. (AMEPA) in Mexico, two of the most important and influential feed and dairy production associations in the country. About Avivagen Avivagen is a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications. By unlocking an overlooked facet of -carotene activity, a path has been opened to safely and economically support immune function, thereby promoting general health and performance in animals. Avivagen is a public corporation traded on the TSX Venture Exchange under the symbol VIV and on the OTCQB Exchange in the U.S. under the symbol VIVXF, and is headquartered in Ottawa, Canada, based in partnership facilities of the National Research Council of Canada and Charlottetown, Prince Edward Island. For more information, visit www.avivagen.com. The contents of the website are expressly not incorporated by reference in this press release. About OxC-beta Technology and OxC-beta Livestock Avivagens OxC-beta technology is derived from Avivagen discoveries about -carotene and other carotenoids, compounds that give certain fruits and vegetables their bright colours. Through support of immune function, the technology provides a non-antibiotic means of promoting health and growth. OxC-beta Livestock is a proprietary product shown to be an effective and economic alternative to the antibiotics commonly added to livestock feeds. The product is currently available for sale in the United States, Philippines, Mexico, Taiwan, New Zealand, Thailand, Brazil, Australia and Malaysia. Avivagens OxC-beta Livestock product is safe, effective and could fulfill the global mandate to remove all in-feed antibiotics as growth promoters. Numerous international livestock trials with poultry and swine using OxC-beta Livestock have proven that the product performs as well as, and, sometimes, in some aspects, better than in-feed antibiotics. Forward Looking Statements This news release includes certain forward-looking statements that are based upon the current expectations of management. Forward-looking statements involve risks and uncertainties associated with the business of Avivagen Inc. and the environment in which the business operates. Any statements contained herein that are not statements of historical facts may be deemed to be forward-looking, including those identified by the expressions aim, anticipate, appear, believe, consider, could, estimate, expect, if, intend, goal, hope, likely, may, plan, possibly, potentially, pursue, seem, should, whether, will, would and similar expressions. Statements set out in this news release relating to Avivagens plans to seek registration and its expectations as to growth and success of its business in new jurisdictions, continued distribution and acceptance of Avivagens technology, anticipated growth in demand for Avivagens products, the anticipated date of fulfillment for the orders described, the possibility for OxC-beta Livestock to replace antibiotics in livestock feeds as well as fill a critical need for health support in certain livestock applications where antibiotics are precluded and the size of market opportunities are all forward-looking statements. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. For instance, the efforts and expansion described may not result in new orders for Avivagens products, , demand for Avivagens products may not continue to grow and could decline, Avivagens products may not gain market acceptance or regulatory approval in new jurisdictions or for new applications, including human applications, and may not be widely accepted as a replacement for antibiotics in livestock feeds, new market access may not occur in the timeline or manner expected by Avivagen, timing of fulfillment of the orders may be delayed beyond current expectation for a number of reasons which would push fulfillment and recognition of revenues into a future quarter and the market opportunities may not be as large as Avivagen anticipates, in each case due to many factors, many of which are outside of Avivagens control. Readers are referred to the risk factors associated with the business of Avivagen set out in Avivagens most recent managements discussion and analysis of financial condition available at www.SEDAR.com. Except as required by law, Avivagen assumes no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those reflected in the forward-looking statements. Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. Copyright 2021 Avivagen Inc. OxC-beta is a trademark of Avivagen Inc. i Alltech 2021 Global Feed Survey", "role": "user" }, { "content": "Avivagen Selects Meyenberg International Group to Spearhead Expansion Efforts in Central and South America", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: DUBLIN, April 14, 2021 /PRNewswire/ -- The \"Photoacoustic Imaging Market Research Report: By Product (Imaging Systems, Software and Other Accessories), Application (Pre-Clinical, Clinical), Indication (Oncology, Cardiology) - Global Industry Analysis and Growth Forecast to 2030\" report has been added to ResearchAndMarkets.com's offering. The global photoacoustic imaging market reached a valuation of $39.8 million in 2019 and is predicted to generate a revenue of $279.3 million by 2030, progressing at a CAGR of 20.3% between 2020 and 2030. The increasing incidence of cancer and the rising popularity of advanced medical treatments around the world are the main factors fueling the growth of the market.The surging geriatric population is another important market growth driver. As per the 2019 World Population Ageing report produced by the UN, the total population of the people in the age bracket- 65 years and above is predicted to rise from 703 million to 1.5 billion from 2019 to 2050. This will massively push up the requirement for photoacoustic imaging as the geriatric people are highly vulnerable to various diseases, on account of their low immunity levels.The rising prevalence of chronic diseases is also driving the advancement of the photoacoustic imaging market across the world. In recent years, cancer has emerged as one of the major causes of death across the globe. According to the Global Cancer Observatory (GLOBOCAN), the disease was responsible for the deaths of as many as 9.6 million people in 2018. Furthermore, as per the World Health Organization (WHO), cardiovascular diseases (CVDs) are the primary cause of death around the world.They are responsible for the deaths of 17.9 million people every year. Additionally, as per the Centers for Disease Control and Prevention (CDC), in the U.S., coronary heart disease is the most prevalent heart disease. In 2017, the disease claimed the lives of 365,914 people. Depending on product, the photoacoustic imaging market is divided into software and other accessories and software. Between these, the imaging systems category recorded higher growth in the market in the past years.When application is taken into consideration, the market is divided into clinical and pre-clinical. Of these, the clinical category is predicted to register faster growth in the market in the upcoming years. This would be because of the rising incidence of cancer all over the world, the soaring geriatric population, the increasing usage of technologically advanced and innovative products in healthcare settings, and the ballooning healthcare expenditure in many countries around the world.Hence, it can be said with surety that the market will grow substantially all over the world in the future years, primarily because of the rising incidence of cancer and the soaring geriatric population in various countries around the world.Key Topics Covered: Chapter 1. Research Background1.1 Research Objectives1.2 Market Definition1.3 Research Scope1.3.1 Market Segmentation by Product1.3.2 Market Segmentation by Application1.3.3 Market Segmentation by Indication1.3.4 Market Segmentation by Region1.3.5 Analysis Period1.3.6 Market Data Reporting Unit1.3.6.1 Value1.4 Key StakeholdersChapter 2. Research MethodologyChapter 3. Executive SummaryChapter 4. Introduction4.1 Definition of Market Segments4.1.1 By Product4.1.1.1 Imaging systems4.1.1.2 Software and other accessories4.1.2 By Application4.1.2.1 Pre-clinical4.1.2.2 Clinical4.1.3 By Indication4.1.3.1 Oncology4.1.3.2 Cardiology4.1.3.3 Others4.2 Market Dynamics4.2.1 Trends4.2.1.1 Acquisitions and mergers done for the photoacoustic imaging technique4.2.2 Market Drivers4.2.2.1 Surging geriatric population4.2.2.2 Increasing incidence of chronic diseases4.2.2.3 Technological advancements4.2.2.4 Impact analysis of drivers on market forecast4.2.3 Restraints4.2.3.1 Stringent regulations4.2.3.2 Expensive and high maintenance cost4.2.3.3 Impact analysis of restraints on market forecast4.2.4 Opportunities4.2.4.1 Increasing patient pool in emerging economies4.3 Impact of COVID-194.4 Porter's Five Forces AnalysisChapter 5. Global Market Size and Forecast5.1 By Product5.2 By Application5.3 By Indication5.4 By RegionChapter 6. North America Market Size and ForecastChapter 7. Europe Market Size and ForecastChapter 8. APAC Market Size and ForecastChapter 9. LATAM Market Size and ForecastChapter 10. MEA Market Size and ForecastChapter 11. Competitive Landscape11.1 Product Offerings of Key Players11.2 Strategic Development Activities of Key Players11.2.1 Partnerships and Collaborations11.2.2 Product Approvals and Launches11.2.3 Other DevelopmentsChapter 12. Company Profiles EKSPLA FUJIFILM VisualSonics Inc. illumiSonics Inc. InnoLas Laser GmbH PhotoSound Technologies Inc. Seno Medical Instruments Inc. Teem Photonics TomoWave Laboratories Inc. Verasonics Inc. Vibronix Inc. iThera Medical GmbH kibero GmbH OPOTEK LLC PA Imaging R&D B.V. For more information about this report visit https://www.researchandmarkets.com/r/rbfxec Media Contact: Research and Markets Laura Wood, Senior Manager [emailprotected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 SOURCE Research and Markets Related Links http://www.researchandmarkets.com", "role": "user" }, { "content": "Global Photoacoustic Imaging Market Report 2020-2030: Acquisitions and Mergers Done for the Photoacoustic Imaging Technique Gaining Prominence", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: WASHINGTON--(BUSINESS WIRE)--Easterly Government Properties, Inc. (NYSE:DEA) (the Company or Easterly), a fully integrated real estate investment trust (REIT) focused primarily on the acquisition, development and management of Class A commercial properties leased to the U.S. Government, announced today that management will participate in virtual investor meetings at the Jefferies 2020 Virtual Office & Industrial REIT Summit on December 8, 2020. Electronic copies of the written materials to be provided to investors in connection with the meetings can be found in the Presentation section of the Companys Investor Relations website at ir.easterlyreit.com. About Easterly Government Properties, Inc. Easterly Government Properties, Inc. (NYSE:DEA) is based in Washington, D.C., and focuses primarily on the acquisition, development and management of Class A commercial properties that are leased to the U.S. Government. Easterlys experienced management team brings specialized insight into the strategy and needs of mission-critical U.S. Government agencies for properties leased to such agencies either directly or through the U.S. General Services Administration (GSA). For further information on the company and its properties, please visit www.easterlyreit.com.", "role": "user" }, { "content": "Easterly Government Properties to Participate in Jefferies 2020 Virtual Office & Industrial REIT Summit", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: NEW YORK, March 16, 2021 /PRNewswire/ --The Topps Company, Inc., a global leader in sports and entertainment trading cards and collectibles, today announced its international expansion into the Japanese market. To better serve the Japanese and Asian market's increasing demand for trading cards, Topps has opened a new office in Tokyo. With its presence in Tokyo, Topps will increase its support to local customers and collectors in Japan and across the Asia region. Since the 1930s, Topps has continued to innovate products to include experiential, one-of-a-kind events and unique promotions and to appeal to its global consumers with localized offerings. Through partnerships with proven local talent and Topps' long-standing partnerships with global licensing partners like Major League Baseball, UEFA, Bundesliga, and Star Wars, this expansion in Japan is designed to support the creative culture of trading cards and continue Topps' heritage of empowering collectors and new fans across the globe. \"With 80 years of card creating history under our belt, we're thrilled to continue growing our brand with this exciting expansion into Japan,\" said David Leiner, Topps' VP & Global General Manager of Sports & Entertainment. \"Our long-standing mission is to celebrate memorable moments and iconic superstars in sports, entertainment and pop culture, while giving fans a chance to get closer to their favorite teams, shows, and players. We're excited to bring even more trading card magic to Japan and Asia with a new office we can call home.\" Topps' new sports and entertainment office in Tokyo will mark its first in Japan. This location will add to Topps' global footprint, with its official headquarters in New York City, multiple locations across Europe and offices in India and Brazil. For more information on Topps products and expansion, please visit Topps.com. About ToppsFounded in 1938, The Topps Company, Inc. is the preeminent creator and brand marketer of physical and digital sports cards, entertainment cards and collectibles, and distinctive confectionery products. Topps' leading sports and entertainment products include Major League Baseball, Major League Soccer, UEFA Champions League, National Hockey League, Bundesliga, Formula 1, Star Wars, WWE, Wacky Packages, Garbage Pail Kids, Mars Attacks and other trading cards, sticker album collections and collectibles. Topps' digital trading card apps portfolio, which has been a hit with millions of fans around the world, currently includes Topps BUNT, TOPPS KICK, Topps Star Wars: Card Trader, Topps WWE Slam, Topps NHL SKATE, The Walking Dead: Card Trader, Marvel Collect! by Topps and Disney Collect! by Topps! Topps' confectionery brands include Ring Pop, Push Pop, Baby Bottle Pop, Juicy Drop Pop, and Bazooka bubble gum. Topps was acquired by Michael Eisner's Tornante Company and Madison Dearborn Partners in October 2007. For additional information, visitTopps.comandCandymania.com. SOURCE The Topps Company Related Links https://www.topps.com", "role": "user" }, { "content": "Topps Announces Further Expansion in Japan Global Leader of Trading Cards Expands Presence in Tokyo", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: SEONGNAM,SouthKorea, April 6, 2021 /PRNewswire/ -- Bridge Biotherapeutics Inc.(288330 KQ), a clinical-stage biotech company headquartered in Seongnam, Republic of Korea, announced that the company has initiated the Phase 1/2 clinical trial assessing safety, tolerability, and anti-tumor activity of BBT-176 in non-small cell lung cancer (NSCLC) patients who acquired osimertinib-resistant EGFR triple mutations. BBT-176, a novel epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) is designed to inhibit the signaling pathway of EGFR with C797S mutations, which arises due to osimertinib (Tagrisso)-resistant mutations in NSCLC. The mutation results in a cysteine to serine change on amino acid 797 within the kinase domain sequence of the EGFR. From the pre-clinical studies, BBT-176 exhibited anti-tumor efficacy in mouse xenograft models and anti-brain metastases in patient-derived orthotopic xenograft models. The Phase 1/2 study, an open-label study to assess the safety, tolerability, pharmacokinetics, and anti-tumor activity of BBT-176 in patients with NSCLC who progressed following prior therapy with an EGFR TKI agent (NCT identifier: NCT04820023), is expected to enroll approximately 90 participants separated into two parts: a dose escalation phase (Part 1) and a dose expansion phase (Part 2). In the first part of the study, which has been initiated in the Republic of Korea, the RP2D (Recommended Phase 2 Dose) will be identified based on the evaluation of drug safety and tolerability in the treatment group. In the subsequent part of the study, which will be conducted both in the U.S. and Korea this year, primary and secondary outcome measures will include assessments of overall anti-tumor activity with objective response rate (ORR), duration of response (DoR), and progression-free survival (PFS), based on Response Evaluation Criteria in Solid Tumors (RECIST) version 1.1. In addition, detailed mutation profiles collected through liquid and tumor biopsy procedures will be analyzed after the study. \"We are highly encouraged to be able to initiate the first-in-patient study of BBT-176, which is expected to address high unmet medical needs of advanced NSCLC patients with C797S mutations across the globe,\" and \"our Business Development team will be exploring strategic partnership opportunities as the clinical study progresses,\" said James Lee, CEO of Bridge Biotherapeutics. Additional information about the clinical trial may be found at ClinicalTrials.gov, using identifier NCT: 04820023. Lung cancer is the leading cause of cancer death, accounting for about one-fifth of all cancer deaths. Lung cancer is classified into two main groups: non-small cell lung cancers (NSCLC) and small cell lung cancers (SCLC), where NSCLC accounts for approximately 85% of all lung cancer diagnoses. In 2019, there were a combined 0.79 million diagnosed cases of NSCLC in men and women, aged 18 years and older, across the US, France, Germany, Italy, Spain, the UK, Japan, and urban China. The incidence of NSCLC is expected to increase at an annual growth rate (AGR) of 3.01% from 2019 to 2029, reaching 1.03 million cases in 2029[1]. [1] GlobalData, Non-Small Cell Lung Cancer Epidemiology Forecast Report to 2029, December 2020 About Bridge Biotherapeutics Bridge Biotherapeutics Inc., based in the Republic of Korea, US, and China, is a publicly-traded clinical-stage biotech company founded in 2015. Bridge Biotherapeutics is engaged in the discovery and development of novel therapeutics, focusing on therapeutic areas with high unmet needs such as ulcerative colitis, fibrotic diseases, and cancers. The company is developing BBT-401, the first-in-class Pellino-1 inhibitor for the treatment of ulcerative colitis currently in Phase II, BBT-877, a novel autotaxin inhibitor for the treatment of fibrotic diseases including idiopathic pulmonary fibrosis (IPF), and BBT-176, a potent targeted cancer therapy for non-small cell lung cancer (NSCLC) with C797S EGFR mutations. SOURCE Bridge Biotherapeutics, Inc.", "role": "user" }, { "content": "Bridge Biotherapeutics Announces Initiation of Phase 1/2 Clinical Trial of BBT-176 in EGFR-Mutant NSCLC with C797S", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: NEW YORK, Nov. 24, 2020 /PRNewswire/ --On November 17, 2020, HSBC Holdings plc (the 'Company,' 'we' or 'us') launched nine separate offers to purchase for cash any and all of the outstanding series of notes listed in the tables below. We refer to the outstanding notes listed in the tables below collectively as the 'Notes' and separately as a 'series' of Notes. We refer to each offer to purchase a series of Notes as an 'Offer', and collectively as the 'Offers.' The Offers are made upon the terms and are subject to the conditions set forth in the Offer to Purchase dated November 17, 2020 relating to the Notes (the 'Offer to Purchase') and the related notice of guaranteed delivery (together with the Offer to Purchase, the 'Offer Documents'), including the Financing Condition (as defined below). The Offer Documents are available at the following link: https://www.gbsc-usa.com/hsbc/. The Company today announces that on the terms and subject to the conditions in the Offer to Purchase, set forth in the table below is the 'Consideration' for each series of Fixed Rate Notes, as calculated at 11:00am (New York City time) on the date hereof (the 'Price Determination Date') in accordance with the Offer to Purchase. The Consideration for each series of Floating Rate Notes is equal to the applicable 'Fixed Price' specified in the Offer Documents and copied in the table below. References to '$' are to U.S. dollars. Fixed Rate Notes Acceptance Priority Level(1) Title of Notes(2) CUSIP Maturity Date Principal Amount Outstanding Reference Security Reference Yield Fixed Spread Consideration(4) 1 4.000% Senior Unsecured Notes due March 2022 404280AN9 March 30, 2022 $2,000,000,000 UST 0.375% due March 31, 2022 (US912828ZG82) 0.140% +10 basis points (\"bps\") $1,050.02 2 2.950% Senior Unsecured Notes due May 2021 404280AY5 May 25, 2021 $1,541,839,000 UST 2.625% due May 15, 2021 (US9128284P22) 0.093% +10 bps $1,013.39 3 2.650% Senior Unsecured Notes due January 2022 404280BF5 January 5, 2022 $638,128,000 UST 1.625% due December 31, 2021 (US912828YZ72) 0.118% +10 bps $1,026.64 4 4.875% Senior Unsecured Notes due January 2022 404280AL3 January 14, 2022 $417,483,000 UST 1.625% due December 31, 2021 (US912828YZ72) 0.118% +10 bps $1,052.17 6 3.400% Senior Unsecured Notes due March 2021 404280AV1 March 8, 2021 $978,489,000 UST 1.125% due February 28, 2021 (US912828P873) 0.112% +5 bps $1,008.81 7 5.100% Senior Unsecured Notes due April 2021 404280AK5 April 5, 2021 $848,554,000 UST 1.250% due March 31, 2021 (US912828Q376) 0.110% +5 bps $1,017.14 Floating Rate Notes Acceptance Priority Level(1) Title of Notes(3) CUSIP Maturity Date Principal Amount Outstanding Fixed Price(3) Consideration(4) 5 Floating Rate Senior Unsecured Notes due January 2022 404280BG3 January 5, 2022 $755,193,000 $1,015.70 $1,015.70 8 Floating Rate Senior Unsecured Notes due May 2021 404280AZ2 May 25, 2021 $570,318,000 $1,008.00 $1,008.00 9 Floating Rate Senior Unsecured Notes due March 2021 404280AX7 March 8, 2021 $511,535,000 $1,006.10 $1,006.10 (1) We will accept Notes in the order of their respective Acceptance Priority Level specified in the table above, subject to the satisfaction of the Financing Condition. It is possible that the Financing Condition might not be met with respect to any series of Notes with any Acceptance Priority Level, and such series of Notes will not be accepted for purchase, even if one or more series of Notes with a lower Acceptance Priority Level is accepted for purchase. If any series of Notes is accepted for purchase under the Offers, all Notes of that series that are validly tendered and not validly withdrawn will be accepted for purchase. As a result, no series of Notes accepted for purchase will be prorated. (2) The 3.400% Senior Unsecured Notes due March 2021, the 5.100% Senior Unsecured Notes due April 2021, the 2.950% Senior Unsecured Notes due May 2021, the 2.650% Senior Unsecured Notes due January 2022, the 4.875% Senior Unsecured Notes due January 2022 and the 4.000% Senior Unsecured Notes due March 2022 are collectively referred to as the 'Fixed Rate Notes'. (3) The Floating Rate Senior Unsecured Notes due March 2021, the Floating Rate Senior Unsecured Notes due May 2021 and the Floating Rate Senior Unsecured Notes due January 2022 are collectively refered to as the 'Floating Rate Notes'. (4) Per $1,000 principal amount. Each Offer will expire at 5:00pm (New York City time) today, unless extended or earlier terminated by the Company in its sole discretion (such date and time with respect to an Offer, as the same may be extended, the 'Expiration Time'). Notes tendered for purchase may be validly withdrawn at any time at or prior to 5:00pm (New York City time) today (such date and time with respect to an Offer, as the same may be extended, the 'Withdrawal Date'), but not thereafter, unless extended or earlier terminated with respect to an Offer by the Company in its sole discretion. The settlement date is expected to be the third business day after the Expiration Time, or November 30, 2020, unless extended or earlier terminated in respect of an Offer by the Company in its sole discretion (such date with respect to an Offer, as the same may be extended, the 'Settlement Date'). Each Offer is independent of the other Offers, and we may terminate, modify or waive the conditions of any Offer without terminating, modifying or waiving the conditions of any other Offer. Upon the terms and subject to the conditions set forth in the Offer Documents, holders who (i) validly tender Notes at or prior to the Expiration Time or (ii) validly tender Notes at or prior to the Guaranteed Delivery Date pursuant to the Guaranteed Delivery Procedures (each as defined in the Offer Documents), and whose Notes (i) have not been validly withdrawn at or prior to the Withdrawal Date and (ii) are accepted for purchase by us, will receive the Consideration specified in the tables above for each $1,000 principal amount of such Notes, which will be payable in cash on the Settlement Date as described below. In the case of the Fixed Rate Notes validly tendered and accepted by us pursuant to the Offers, the Consideration has been determined in accordance with the formula set forth in the Offer to Purchase and with standard market practice, using the applicable 'Offer Yield,' which is equal to the sum of: (x) the applicable 'Reference Yield' specified in the table above that corresponds to the bid-side yield of the applicable 'Reference Security' specified in the table above for such series of Notes on the Bloomberg reference page PX3 or PX4, plus (y) the 'Fixed Spread' specified in the table above for such series of Notes. Accordingly, the Consideration payable by us for each $1,000 principal amount of each series of Fixed Rate Notes accepted by us is equal to: (i) the present value on the Settlement Date of $1,000 principal amount of such Fixed Rate Notes due on the maturity date of such Fixed Rate Notes and all scheduled interest payments on such $1,000 principal amount of such Fixed Rate Notes to be made from (but excluding) the Settlement Date up to and including such maturity date, discounted to the Settlement Date at a discount rate equal to the applicable Offer Yield, minus (ii) the Accrued Interest per $1,000 principal amount of such Fixed Rate Notes; such total amount being rounded to the nearest cent per $1,000 principal amount of such Notes, and the above calculation has been made in accordance with standard market practice as described by the formula set forth in the Offer to Purchase. In addition to the Consideration, holders whose Notes of a given series are accepted for purchase will also be paid a cash amount equal to accrued and unpaid interest on such Notes from, and including, the last interest payment date for such Notes to, but not including, the Settlement Date, rounded to the nearest cent (such amount in respect of a series of Notes, 'Accrued Interest'). Accrued Interest will be payable on the Settlement Date. For the avoidance of doubt, interest will cease to accrue on the Settlement Date for all Notes accepted in the Offers. Under no circumstances will any interest be payable to holders because of any delay on the part of Global Bondholder Services Corporation, as depositary, The Depository Trust Company ('DTC') or any other party in the transmission of funds to holders. The Offers are subject to the terms and conditions described in the Offer Documents. In particular, the Company's obligation to complete an Offer with respect to a particular series of Notes is conditioned on satisfaction of the 'Financing Condition', meaning (1) the proposed new issuance of senior unsured debt securities that priced on November 17, 2020 has been successfully completed on terms and conditions satisfactory to the Company in its sole discretion and (2) the 'Total Available Amount' of $2,000,000,000 is sufficient to fund the sum of (a) the Consideration (excluding Accrued Interest) for all validly tendered and not validly withdrawn Notes of such series plus (b) the aggregate Consideration (excluding Accrued Interest) for all validly tendered and not validly withdrawn Notes of each series having a higher 'Acceptance Priority Level' (as specified in the above table, with 1 being the highest Acceptance Priority Level and 9 being the lowest Acceptance Priority Level), other than Excluded Notes (as defined below). Notwithstanding any other provision in the Offer to Purchase to the contrary, if the Financing Condition is not satisfied for a particular series of Notes, at any time at or prior to the Expiration Time, then (1) we will not be obligated to accept for purchase such series of Notes and will terminate the Offer with respect to such series of Notes (such series of Notes, 'Excluded Notes'), and (2) if there is any series of Notes having a lower Acceptance Priority Level for which the Financing Condition is satisfied, meaning the Total Available Amount is equal to or greater than the sum of: a) the Consideration necessary to purchase all validly tendered and not validly withdrawn Notes of such series (excluding Accrued Interest), plus b) the aggregate Consideration necessary to purchase all validly tendered and not validly withdrawn Notes of all series having a higher Acceptance Priority Level than such series of Notes, other than the Excluded Notes (in each case, excluding Accrued Interest), then all Notes of such series having a lower Acceptance Priority Level will be accepted for purchase, and the Financing Condition will be applied at each subsequent Acceptance Priority Level until there is no series of Notes with a lower Acceptance Priority Level to be considered for purchase for which the Financing Condition is met. It is possible that any series of Notes with any Acceptance Priority Level will fail to meet the Financing Condition and therefore will not be accepted for purchase even if one or more series with a lower Acceptance Priority Level is accepted for purchase. If any series of Notes is accepted for purchase under the Offers, all Notes of that series that are validly tendered and not validly withdrawn will be accepted for purchase. As a result, no series of Notes accepted for purchase will be prorated. The Company reserves the right to amend or waive any of the conditions of the Offers, in whole or in part, at any time or from time to time, in its sole discretion, subject to applicable law. If any of the conditions are not satisfied at the Expiration Time with respect to an Offer, the Company may, in its sole discretion and without giving any notice, subject to applicable law, (a) terminate such Offer, (b) extend such Offer, on the same or amended terms, and thereby delay acceptance of any validly tendered Notes, or (c) continue to accept tenders. Holders of Notes are advised to read carefully the Offer to Purchase for full details of and information on the procedures for participating in the Offers. The Company has retained HSBC Bank plc as Dealer Manager for the Offers (the 'Dealer Manager'). Questions and requests for assistance related to the Offers may be directed to the Dealer Manager at UK: +44 (0)20 7992 6237, US: +1 (212) 525-5552 (Collect) or +1 (888) HSBC-4LM (Toll Free), or by email at [emailprotected]. Global Bondholder Services Corporation is acting as the information agent (the 'Information Agent'). Questions or requests for assistance related to the Offers or for additional copies of the Offer Documents may be directed to the Information Agent at (866) 470-4300 (toll free) or (212) 430-3774 (banks and brokers).You may also contact your broker, dealer, custodian bank, trust company or other nominee for assistance concerning the Offers. If the Company terminates an Offer, all Notes tendered pursuant to such Offer will be returned promptly to the tendering holders thereof. Holders of Notes are advised to check with any bank, securities broker or other intermediary through which they hold Notes as to when such intermediary would need to receive instructions from a beneficial owner in order for that beneficial owner to be able to participate in, or withdraw their instruction to participate in, an Offer before the deadlines specified herein and in the Offer to Purchase. The deadlines set by any such intermediary and DTC for the submission and withdrawal of tender instructions will also be earlier than the relevant deadlines specified herein and in the Offer to Purchase. ..... This announcement is for informational purposes only and does not constitute an offer to purchase or sell, or a solicitation of an offer to purchase or sell, any security. No offer, solicitation, or sale will be made in any jurisdiction in which such an offer, solicitation, or sale would be unlawful. The Offers are only being made pursuant to the Offer to Purchase. Holders of the Notes are urged to carefully read the Offer to Purchase before making any decision with respect to the Offers. United Kingdom. This communication and any other documents or materials relating to the Offers are not being made and such documents and/or materials have not been approved by an authorized person for the purposes of section 21 of the Financial Services and Markets Act 2000. Accordingly, this communication and such documents and/or materials are not being distributed to, and must not be passed on to, persons in the United Kingdom other than (i) to those persons in the United Kingdom falling within the definition of investment professionals (as defined in Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the 'Financial Promotion Order')), (ii) to those persons who are within Article 43(2) of the Financial Promotion Order, including existing members and creditors of HSBC Holdings, (iii) to those persons who are outside the United Kingdom, or (iv) to any other persons to whom it may otherwise lawfully be made under the Financial Promotion Order (all such persons together being referred to as 'Relevant Persons') and the transactions contemplated by the Offer to Purchase will be available only to, and engaged in only with, Relevant Persons. Any person who is not a Relevant Person should not act on or rely on this communication or any of its contents. Belgium. Neither this communication nor any other documents or materials relating to the Offers have been submitted to or will be submitted for approval or recognition to the Financial Services and Markets Authority ('Autorit des services et marches financiers / Autoriteit financile diensten en markten') and, accordingly, the Offers may not be made in Belgium by way of a public offering, as defined in Articles 3 and 6 of the Belgian Law of 1 April 2007 on public takeover bids (the 'Belgian Takeover Law') as amended or replaced from time to time. Accordingly, the Offers may not be advertised and the Offers will not be extended, and neither this communication nor any other documents or materials relating to the Offers (including any memorandum, information circular, brochure or any similar documents) has been or shall be distributed or made available, directly or indirectly, to any person in Belgium other than (i) to 'qualified investors' in the sense of Article 10 of the Belgian Law of 16 June 2006 on the public offer of placement instruments and the admission to trading of placement instruments on regulated markets, acting on their own account or (ii) in any circumstances set out in Article 6, 4 of the Belgian Takeover Law. This communication has been issued only for the personal use of the above qualified investors and exclusively for the purpose of the Offers. Accordingly, the information contained in this communication may not be used for any other purpose or disclosed to any other person in Belgium. Italy. None of the Offers, this communication or any other document or materials relating to the Offers have been or will be submitted to the clearance procedures of the Commissione Nazionale per le Societ e la Borsa ('CONSOB') pursuant to Italian laws and regulations. The Offers are being carried out in the Republic of Italy as exempted offers pursuant to article 101-bis, paragraph 3-bis of the Legislative Decree No. 58 of 24 February 1998, as amended (the 'Financial Services Act') and article 35-bis, paragraph 4 of CONSOB Regulation No. 11971 of 14 May 1999, as amended. Holders or beneficial owners of the Notes that are located in Italy can tender the Notes for purchase in the Offers through authorized persons (such as investment firms, banks or financial intermediaries permitted to conduct such activities in the Republic of Italy in accordance with the Financial Services Act, CONSOB Regulation No. 20307 of 15 February 2018, as amended from time to time, and Legislative Decree No. 385 of 1 September 1993, as amended) and in compliance with applicable laws and regulations or with requirements imposed by CONSOB or any other Italian authority. Each intermediary must comply with the applicable laws and regulations concerning information duties vis--vis its clients in connection with the Notes and/or the Offers. Hong Kong. This communication and any other documents or materials relating to the Offers and/or the debt securities is not being made in Hong Kong, by means of any document, other than (i)in circumstances which do not constitute an offer to the public within the meaning of the Companies (Winding Up and Miscellaneous Provisions) Ordinance (Cap. 32, Laws of Hong Kong) (the 'CWUMPO'), or (ii) to 'professional investors' as defined in the Securities and Futures Ordinance (Cap. 571, Laws of Hong Kong) (the 'SFO') and any rules made thereunder, or (iii) in other circumstances which do not result in the document being a 'prospectus' as defined in the CWUMPO. No invitation, advertisement or document relating to the Offers and/or the Notes has been or will be issued, or has been or will be in the possession of any person for the purpose of issue (in each case whether in Hong Kong or elsewhere), which is directed at, or the contents of which are likely to be accessed or read by, the public in Hong Kong (except if permitted to do so under the securities laws of Hong Kong) other than with respect to the Offers and/or the Notes which are or are intended to be disposed of only to persons outside Hong Kong or only to 'professional investors' as defined in the SFO and any rules made thereunder. Canada. Any offer or solicitation in Canada must be made through a dealer that is appropriately registered under the laws of the applicable province or territory of Canada, or pursuant to an exemption from that requirement. Where the Dealer Manager or any affiliate thereof is a registered dealer or able to rely on an exemption from the requirement to be registered in such jurisdiction, the Offers shall be deemed to be made by such Dealer Manager, or such affiliate, on behalf of the relevant company in that jurisdiction. France. None of the Offers are being made, directly or indirectly, to the public in the Republic of France ('France'). This communication and any other document or material relating to the Offers has been or shall be distributed to the public in France and only (i) providers of investment services relating to portfolio management for the account of third parties (personnes fournissant le service d'investissement de gestion de portefeuille pour compte de tiers) and/or (ii) qualified investors (investisseurs qualifis), other than individuals, acting for their own account, all as defined in, and in accordance with, Articles L.411-1, L.411-2 and D.411-1 of the French Code montaire et financier, are eligible to participate in the Offer. This communication has not been and will not be submitted for clearance to nor approved by the Autorit des Marchs Financiers. ..... Cautionary Statement Regarding Forward-Looking Statements In this communication the Company has made forward-looking statements. All statements other than statements of historical fact are, or may be deemed to be, forward-looking statements. Forward-looking statements may be identified by the use of terms such as 'believes,' 'expects,' 'estimate,' 'may,' 'intends,' 'plan,' 'will,' 'should,' 'potential,' 'reasonably possible' or 'anticipates' or the negative thereof or similar expressions, or by discussions of strategy. We have based the forward-looking statements on current expectations and projections about future events. These forward-looking statements are subject to risks, uncertainties and assumptions about us, as described under 'Risk Factors' in our Offer to Purchase. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. In light of these risks, uncertainties and assumptions, the forward-looking events discussed herein might not occur. You are cautioned not to place undue reliance on any forward-looking statements, which speak only as of their dates. Note to editors: HSBC Holdings plc HSBC Holdings plc, the parent company of the HSBC Group, is headquartered in London. HSBC serves customers worldwide from offices in 64 countries and territories in our geographical regions: Europe, Asia, North America, Latin America, and Middle East and North Africa. With assets of US$2,956bn at 30 September 2020, HSBC is one of the world's largest banking and financial services organisations. SOURCE HSBC Holdings plc", "role": "user" }, { "content": "HSBC Holdings plc Announces Pricing Terms of its Tender Offers for Nine Series of Notes", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: PALO ALTO, Calif.--(BUSINESS WIRE)--BitGo Prime, the first digital asset financial services company to offer a deeply integrated solution with lending, trading and custody, announces new value-added Capital Introduction Services (Cap Intro) for its premier clients who seek to optimize their investment strategies. Through a series of invitation only, quarterly roundtables, BitGo Prime will bring together the institutional investment community, such as asset managers, family offices, sovereign funds, pension funds, endowments and high-net-worth individuals, with hedge fund managers. Today, BitGo Holdings, Inc. (BitGo) hosted the first Cap Intro Roundtable in the series. Mike Belshe, CEO, BitGo and Nick Carmi, CEO, BitGo Prime spoke on Investing in Cryptothe Future of Cryptocurrency Hedge Funds. Presenting managers included: Cap Intro Services have been an integral part of traditional prime brokerage offerings for many years and our ability to connect our hedge fund clients with target investors further establishes BitGo Prime as a true, fully-integrated prime broker for digital assets, said Carmi. We at Pantera welcome BitGos initiative to launch cap intro for digital assets and we were delighted to participate, said Dan Morehead, CEO, Pantera. This is yet another step forward in merging digital assets with the traditional finance world and providing the education, tools and solutions institutional investors need to participate in this growing asset class. Launched in May 2020, BitGo Prime raised the bar in the crypto industry by being the first to offer a full suite solution with lending, trading and custody combined with reporting, portfolio and tax management. BitGo Prime provides institutional investors with best-in-class service, increased liquidity, fast execution and competitive aggregate pricing. The next roundtable in the series will be hosted in Q1 2021 in Asia, followed by Europe in Q2. Please contact [email protected] for more information. About BitGo BitGo is the leader in digital asset financial services, providing institutional investors with liquidity, custody, and security solutions. In 2020, BitGo launched Prime Trading and Lending, as well as BitGo Portfolio and Tax, providing clients with a full-stack solution for digital assets. In 2018, it launched BitGo Trust Company, the first qualified custodian purpose-built for storing digital assets. BitGo processes over 20% of all global Bitcoin transactions, and supports over 300 coins and tokens. BitGos customer base includes the world's largest cryptocurrency exchanges and institutional investors and spans more than 50 countries. BitGo is backed by Goldman Sachs, Craft Ventures, Digital Currency Group, DRW, Galaxy Digital Ventures, Redpoint Ventures, and Valor Equity Partners. For more information, please visit https://bitgo.com. Disclosures The information in this press release is not an offer to sell or solicitation of an offer to buy an interest in any investment or for the provision of any investment management or advisory services. Custody services are offered through BitGo Trust Company, a South Dakota chartered trust company. BitGo is not registered with the SEC as an investment advisor or custodian, and does not offer legal, tax, investment, or other advice. Digital asset holdings involve a high degree of risk, and can fluctuate greatly on any given day. Accordingly, your digital asset holdings may be subject to large swings in value and may even become worthless. Please consult your legal/tax/investment professional for questions about your specific circumstances. BitGo Trust Company, BitGo Inc., and BitGo Prime LLC are separately operated, wholly-owned subsidiaries of BitGo Holdings, Inc., a Delaware corporation headquartered in Palo Alto, CA. Website | Blog | Twitter | LinkedIn", "role": "user" }, { "content": "BitGo Prime Launches First Capital Introduction Services for Digital Assets Enhances its Full Suite of Prime Broker Offerings Kicks off First in a Series of Quarterly Roundtables for Hedge Fund Managers and Prospects", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: NEW YORK--(BUSINESS WIRE)--Fiverr International Ltd. (NYSE: FVRR), the company that is changing how the world works together, today announced that Micha Kaufamn, founder and Chief Executive Officer, and Ofer Katz, Chief Financial Officer, will present at the upcoming Needham Virtual Internet Services Conference and UBS Global Virtual TMT Conference. Needham Virtual Internet Services Conference Date: Monday, November 16th Time: 10:45 a.m. Eastern Time UBS Global Virtual TMT Conference Date: Tuesday, December 8th Time: 10:15 a.m. Eastern Time Live webcasts of the presentations will be accessible from the Events & Presentations section of Fiverrs investor relations website, https://investors.fiverr.com. Archived replays of the audio webcasts will be available following the live presentations from the same website. About Fiverr Fiverrs mission is to change how the world works together. For over 10 years, the Fiverr platform has been at the forefront of the future of work connecting businesses of all sizes with skilled freelancers offering digital services in more than 400 categories, across 8 verticals including graphic design, digital marketing, programming, video and animation. In the twelve months ended September 30, 2020, over 3 million customers bought a wide range of services from freelancers across more than 160 countries. We invite you to become part of the future of work by visiting us at fiverr.com, read our blog and follow us on Facebook, Twitter and Instagram.", "role": "user" }, { "content": "Fiverr to Present at Upcoming Investor Conferences", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: MENLO PARK, Calif.--(BUSINESS WIRE)--KKR, a leading global investment firm, and Duke Rohlen, a 20-year medical device veteran, today announced the formation of Zeus Health (Zeus), a $100 million platform focused on investing in and operating a portfolio of emerging medical device companies. Zeus marks the continuation of a long-standing relationship between KKR and Mr. Rohlen. Throughout his career, Mr. Rohlen has successfully led, grown and exited multiple medical device companies, including alongside KKR. In 2016, KKR invested in Spirox, an ENT-focused medical device company led by Mr. Rohlen as CEO. Spirox was sold to Entellus Medical in 2017, and the combined business was sold to Stryker shortly thereafter in 2018. In 2017, KKR and Mr. Rohlen formed Ajax Health, a medical device platform company whose primary asset EpiX Therapeutics was sold to Medtronic in 2019. We are excited to have the opportunity to work with Duke and his team again, now for the third time following our previous success with Ajax Health and Spirox. Duke is a proven leader in the medical device field, as are his team of industry and operational experts. We look forward to working together to identify and scale much-needed next-generation medical technologies, said Ali Satvat, Global Head of KKR Health Care Strategic Growth and Co-Head of Health Care within KKRs North America Private Equity platform. With the formation of Zeus Health, I am thrilled to further deepen my relationship with KKR, whose unmatched reputation, scale and depth of health care expertise will continue to open new doors for us as we look to bring innovative medical devices to patients in need, said Mr. Rohlen. For KKR, the investment in Zeus Health is being funded through the firms Health Care Strategic Growth Fund, which is focused on investing in high-growth health care-related companies for which KKR can be a unique partner in helping reach scale. KKR has established a strong track record of supporting health care companies, having invested approximately $14 billion across the sector since 2004. About KKR KKR is a leading global investment firm that manages multiple alternative asset classes, including private equity, credit and real assets, with strategic partners that manage hedge funds. KKR aims to generate attractive investment returns for its fund investors by following a patient and disciplined investment approach, employing world-class people, and driving growth and value creation with KKR portfolio companies. KKR invests its own capital alongside the capital it manages for fund investors and provides financing solutions and investment opportunities through its capital markets business. References to KKRs investments may include the activities of its sponsored funds. For additional information about KKR & Co. Inc. (NYSE: KKR), please visit KKRs website at www.kkr.com and on Twitter @KKR_Co.", "role": "user" }, { "content": "KKR Partners with Duke Rohlen to Create Medical Device Platform", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: SHENZHEN, China--(BUSINESS WIRE)--DeepRoute.ai, a global level 4 self-driving solution provider, today announced it will be showcasing innovative technologies at the 2021 Consumer Electronics Show (CES), including an inference engine, DeepRoute-Engine, its second-generation all-in-one sensing solution, and human-like planning. DeepRoute has made exciting progress over the past year, and we look forward to presenting our latest solutions to a world-class audience at CES, said Nianqiu Liu, Vice President of DeepRoute.ai. Weve perfected our level 4 self-driving technology both in software and hardware, and have strengthened our partnerships with OEMs and ride-hailing companies, to continually build the future of smart mobility. At CES, the company is debuting DeepRoute-Engine, an inference engine that speeds up the neural network computation, allowing algorithms to run on an energy-efficient computing platform. This results in a 6x faster inference process than that of widely used open source deep learning frameworks (e.g. TensorFlow, PyTorch, Caffe) and is compatible with GPU of various brands, including NVIDIA, Intel, and AMD, to greatly minimize the computation needed for level 4 self-driving technology. Because of this powerful inference engine, DeepRoutes level 4 self-driving technology can run on its 45-watt computing platform, DeepRoute-Tite, which is extremely power-efficient, consuming only 1/9 of the power, compared with traditional level 4 self-driving solutions. View the demo video of DeepRoute-Engine on YouTube. https://youtu.be/XaxOf-eUgio Along with the debut of the inference engine, DeepRoute will also showcase its second-generation all-in-one sensing solution, DeepRoute-Sense II. It houses three LiDAR sensors, seven HDR cameras (DeepRoute-Vision), Global Navigation Satellite System (GNSS), inertial measurement unit (IMU), and a synchronization controller (DeepRoute-Syntric). This powerful combination leads to an accurate object detection range of 140m (153 yards). Notably, the compact roof-box design minimizes the additional drag to only 7%, a huge decrease from the 20% on traditional sensing solutions, allowing for low energy consumption. DeepRoute will also highlight its cutting-edge human-like planning at CES through a video of a fully autonomous road test in Shenzhens heavy traffic. We call it human-like because rather than pre-planned paths, our vehicle adopts a real-time planning method, just like a human driver who constantly thinks about how to drive safely and efficiently. This human-like planning enables a car to smoothly pass by an unplanned construction zone and choose the fastest lane through perceived traffic dynamics, said Nianqiu Liu. Despite the downturn brought by COVID-19, DeepRoute has strengthened its long-term partnerships in China and hopes to resume international partnerships soon. For example, DeepRoute has been working with Dongfeng Motor to build the largest robotaxi fleet in China by 2022. This $90M project led by Dongfeng Motor will bring more than 200 robotaxis to Wuhan. In addition, DeepRoute continues to test out robotaxis with Geely-backed Cao Cao Mobility in Hangzhou, aiming to provide hundreds of robotaxis during the 2022 Asian Games. About DeepRoute.ai Founded in 2019, DeepRoute.ai is a global level 4 self-driving solution provider to OEMs, Tier 1 suppliers, and ride-hailing and logistics companies. DeepRoutes technology covers the entire R&D chain of self-driving technology, including Hardware, Perception, Planning & Control, HD Mapping & Localization, Infrastructure, Operations, and Cloud Platform. With a vision to build the future of smart mobility, DeepRoute is committed to making driving safer, more reliable, and more intelligent.", "role": "user" }, { "content": "DeepRoute.ai Showcases Groundbreaking Inference Engine for Autonomous Vehicles at CES Autonomous vehicle startup to debut new technology that will improve efficiency and advance self-driving solutions", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: NANJING, China, May 18, 2020 /PRNewswire/ -- On May 18, Suzhou held the \"Suzhou Online Dialogue on Global Industrial Chain Collaboration\". Microsoft, Adidas, Roche and other internationally well-known enterprises signed a cooperation contract with the local and make progress together, according to the Organizing Committee of Suzhou Online Dialogue on Global Industrial Chain Collaboration. This collaboration focused on the five major industrial chains of biomedicine and high-end medical apparatus, intelligent equipment, new-type display, automotive and parts, software and integrated circuit, with a total contract value of 400 billion yuan. The Inforgraphic Guide to Investment in Suzhou - Global Cooperation Inforgraphic of Suzhou Industrial Chain was released on the same day. This is the 5th map after the \"Recommended Routes For On-site Investment Survey, Map of Development Platforms and Premises, Map of Industrial Lands and Investment and cooperation opportunities\" which were released on Jan 1, and it is to show Suzhou's determination and courage to open up. Suzhou is an important central city and high-tech industrial base in the Yangtze River Delta. As one of the most complete cities in China's manufacturing system, Suzhou attracts nearly 160,000 industrial enterprises to grow here, including more than 400 World Top 500 projects and 26 China's Top 500 private manufacturing companies. In 2019, Suzhou's industrial output value was 3.36 trillion yuan, and trading partners cover more than 200 countries and regions in the world. The total number of imports and exports is beyond 319 billion dollars. Nowadays, Suzhou is relying on its unique chain of production and supply to accelerate the construction of a modern industrial system with international competitiveness and strive to build the world's \"head factory\". SOURCE The Organizing Committee of Suzhou Online Dialogue on Global Industrial Chain Collaboration", "role": "user" }, { "content": "Collaborate in cloud, Suzhou is going to be \"pacemaker\" of the world's manufacturing industry English Deutschland - Deutsch", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: DUBLIN--(BUSINESS WIRE)--The \"U.S. Truck Trailer Market Analysis and Forecast to 2025\" report has been added to ResearchAndMarkets.com's offering. The report provides on an in-depth study of the U.S. truck trailer market. It reveals the latest data of the market size and volume, domestic production, exports and imports, price dynamics and turnover in the industry. In addition, the report contains insightful information about the industry, including industry life cycle, business locations, productivity, employment and many other crucial aspects. The Company Profiles section contains existing data on the largest players in the industry. Product coverage: Companies mentioned: Data coverage: Key Topics Covered: 1. Introduction Making Data-Driven Decisions To Grow Your Business 1.1 Report Description 1.2 Research Methodology And Ai Platform 1.3 Data-Driven Decisions For Your Business 1.4 Glossary And Specific Terms 2. Executive Summary A Quick Overview Of Market Performance 2.1 Key Findings 2.2 Market Trends 3. Market Overview Understanding The Current State Of The Market And Its Prospects 3.1 Market Size 3.2 Market Structure 3.3 Trade Balance 3.4 Per Capita Consumption 3.5 Market Forecast To 2025 4. Most Promising Products Finding New Products To Diversify Your Business 4.1 Top Products To Diversify Your Business 4.2 Best-Selling Products Worldwide 4.3 Most Consumed Product Worldwide 4.4 Most Traded Product 4.5 Most Profitable Product For Export 5. Most Promising Supplying Countries Choosing The Best Countries To Establish Your Sustainable Supply Chain 5.1 Top Countries To Source Your Product 5.2 Top Producing Countries 5.3 Top Exporting Countries 5.4 Low-Cost Exporting Countries 6. Most Promising Overseas Markets Choosing The Best Countries To Boost Your Exports 6.1 Top Overseas Markets For Exporting Your Product 6.2 Top Consuming Markets 6.3 Unsaturated Markets 6.4 Top Importing Markets 6.5 Most Profitable Markets 7. Production The Latest Trends And Insights Into The Industry 7.1 Production Volume And Value 8. Imports The Largest Importers On The Market And How They Succeed 8.1 Imports From 2007-2017 8.2 Imports By Country 8.3 Import Prices By Country 9. Exports The Largest Exporters On The Market And How They Succeed 9.1 Exports From 2007-2017 9.2 Exports By Country 9.3 Export Prices By Country 10. Profiles Of Major Producers For more information about this report visit https://www.researchandmarkets.com/r/5hwvca", "role": "user" }, { "content": "United States Truck Trailer Market Analysis and Forecast Report 2021-2025 - ResearchAndMarkets.com", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: TAMPA, Fla., May 28, 2020 /PRNewswire/ --Tampa General Hospital and the Cancer Center of South Florida have formed a new alliance, enabling cancer patients in Palm Beach and the Treasure Coast to receive the world-class care and complex services that a major academic medical center provides right in their own back yard. The Cancer Center of South Florida's two locations in Palm Beach County will become the Tampa General Hospital Cancer Institute, marking the first time that Tampa General, nationally ranked by US News and World Report and one of Florida's leading academic medical centers, has opened a location on the east coast of Florida. Tampa General's expansion plans across the state will continue as the institute builds relationships with additional local physicians in Palm Beach and the Treasure Coast, aggregating more specialists into the Tampa General network to provide comprehensive treatment options across multiple specialties. Palm Beach and Treasure Coast residents can now receive world-class cancer treatment and services provided by a leading academic medical center paired with hometown convenience. Tampa General surgical oncologists and specialists will work in collaboration with local physicians to provide the most comprehensive treatment options in a seamless, coordinated manner. Cancer specialists will travel to Palm Beach County to consult with local patients, working closely with their referring physicians to create a comprehensive treatment plan. Patients will be able to receive case evaluations from multi-disciplinary panels of TGH experts, participate in a broader array of cutting-edge clinical trials, and benefit from new services, such as palliative care and genetic counseling. And those patients who need complex, specialized surgeries will have a new option right here in Florida; instead, they'll benefit from a convenient, streamlined process to have surgeries in Tampa with pre-and post-surgery care performed in Palm Beach. These patients will benefit from a hybrid model that allows them to have pre- and post-surgical care in Palm Beach and the Treasure Coast. Nurse navigators with specialized cancer expertise will coordinate their visit to Tampa for surgery with specialists who are leaders in their fields. Patient ambassadors will help coordinate with travel and accommodations. \"We're excited to provide enhanced world-class cancer care that residents in Palm Beach and the Treasure Coast can access close to home,\" said John Couris, Tampa General's president and CEO. \"Our specialists will serve as an extension of the great healthcare that exists in Palm Beach and the Treasure Coast today. Our team of specialists, combined with the high caliber of local care, will allow residents across Florida to be able to receive the highest quality of care with the latest technologies and treatments, including extensive clinical trial opportunities.\" Current patients can still receive care and treatment planning from CCSF's current skilled and compassionate providers, who all trained or taught at top-tier medical programs, such as Harvard University. Patients will now be able to receive palliative care consultations that offer a holistic approach to care, offering patients resources to help with pain management, nutrition, mental health and other issues. They also can receive chemotherapy, radiation and other care in Palm Beach County. \"CCSF is excited that this new agreement brings our patients expanded access to the very best cancer treatment options as we continue our tradition of providing care that is tailored for each patient providing care for each patient, one patient at a time,\" said Dr. Abraham Schwarzberg, chief of Oncology at CCSF and senior vice president for Oncology Services and Network Development at Tampa General. New services that patients can benefit from include: Access to a broader variety of clinical research trials, offering the newest treatments in cancer care Enhanced personal oncology treatment plans Access to complex, minimally invasive surgical management Innovative personalized medicine Advanced immunotherapy treatment options Expertise in rare cancers requiring complex surgeries Patients can make appointments at the new Tampa General Hospital Cancer Institute locations in Palm Beach County by contacting 561-253-3980. Media Contact: Karen Barrera Assistant Director, Communications 813-844-8725 (direct) 813-928-1603 (cell) [emailprotected] SOURCE Florida Health Sciences Center, Inc. d/b/a Tampa General Hospital Related Links http://www.tgh.org", "role": "user" }, { "content": "Tampa General Hospital, Cancer Center of South Florida Form New Alliance to Provide World-Class Care in Palm Beach and the Treasure Coast The new locations for Tampa General Hospital Cancer Care will be TGH's first locations on the east coast of Florida.", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: DENVER, July 20, 2020 /PRNewswire/ --According to a new survey by ROI Rocket, a leading provider of market research-based consulting services, the number of Americans highly concerned about the virus has increased dramatically since the end of Maywhen community re-openings began in earnest. High levels of concern are most pervasive in the South, the region hit hardest by COVID-19 in recent weeks. About two in three Southerners (63%) are concerned about contracting the virus themselves and another 70% worry for someone in their family. These fears extend to the workplace and the additional risk of infection returning to work on-site entails. About two in five Southerners (44%) express strong reservations about resuming their precoronavirus work routines compared to only about one in four workers (28%) in other regions of the country. The resurgent virus and the lack of clear and consistent direction from various levels of government have driven virus management approval ratings to new lows. Confidence in President Trump's handling of the pandemic has most recently bottomed out at about 22% nationally. What's worse for Trump's reelection plans is the fact he's steadily losing support on the issue among his base. Only about one in two Republicans (52%) now approve of the President's response to the crisis. Southerners are likewise holding their governors to account. Only about two in five Southerners (39%) have confidence their governors can manage the pandemic compared to 56% in the Northeast where reopenings have been more guarded than in the South. The nature and pace of re-opening the nation's economy remain hotly-contested partisan issues. Fewer than one in ten Democrats (9%) want re-openings to continue versus about one in three Republicans (35%). By the same token, about four in five Democrats (78%) believe governments should reimpose stay-at-home mandates, only about two in five Republicans (44%) feel the same. With many, if not most, Americans lacking confidence in government to provide the necessary guidance on how to best combat the virus, it's hard to see which institution or politician can bring Americans together on the issue. ABOUT THIS RESEARCH This study of 1,009 U.S. residents aged 18 and older was fielded between June 29 and July 3, 2020. The results have an associated margin of error of +/- 3.1% at the 95% confidence level in the most conservative case. This means the results come within plus or minus 3.1% of the results that would have been obtained given a census of all qualified individuals. Sample collection was balanced to U.S. Census figures for gender, age, race/ethnicity and household income. ABOUT ROI ROCKET Founded in 2007, ROI Rocket is a leading provider of full-service market research, marketing and sales automation, and digital agency support with offices in Denver, CO, Vancouver, WA, and Jacksonville, FL. PRESS CONTACTS For additional information about this study, please contact David McGrath, CEO ([emailprotected]) or Libby Perkins, General Counsel ([emailprotected]). SOURCE ROI Rocket", "role": "user" }, { "content": "ROI Rocket: COVID-19 Resurgence Has Americans Rethinking Fast-Track Re-Openings About one in five Americans (18%) want re-openings to continue and 62% support re-imposing previously mandated countermeasures", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: RESEARCH TRIANGLE PARK, N.C., Nov. 2, 2020 /PRNewswire/ --David Spitz, CEO ofChannelAdvisorCorporation (NYSE: ECOM), a leading provider of cloud-based e-commerce solutions thatenable brands and retailers to increase global sales, was recently featured on NBC's The Today Show to discuss e-commerce trends during the pandemic and the anticipated impact of holiday demand on fulfillment demand. In the national network broadcast, Spitz shared industry insights, including growing concern over \"Shipageddon\", a term widely used by e-commerce observers and shipping experts to describe the potential for holiday delivery delays. In an interview with NBC's Vicky Nguyen, Spitz offered viewers ways to circumvent logistical challenges as more consumers shop online during the holiday season. \"'Shipageddon' could be the Grinch that steals Christmas this year,\" explained Spitz when asked whether consumers in the US should adopt a proactive buying strategy for the holidays. \"Getting most of your shopping done before the Thanksgiving holiday is probably the safest thing to do.\" A recent survey conducted by ChannelAdvisor and Dynata indicates that 47% of shoppers in the US anticipate delivery delays. In comparison, 78% of survey respondents say they are willing to wait longer for holiday deliveries. The survey results suggest that the shift in consumer behavior combined with increased fulfillment demand could influence the e-commerce strategies of brands and retailers. Spitz told NBC's Today Show, \"You could see a lot more promotional activity to get consumers to purchase earlier in the season.\" For more details about ChannelAdvisor, visit ChannelAdvisor's blog, follow ChannelAdvisor on Twitter @ChannelAdvisor, like ChannelAdvisor on Facebook and connect with ChannelAdvisor on LinkedIn. About ChannelAdvisorChannelAdvisor (NYSE: ECOM) is a leading e-commerce cloud platform whose mission is to connect and optimize the world's commerce. For nearly two decades, ChannelAdvisor has helped brands and retailers worldwide improve their online performance by expanding sales channels, connecting with consumers, optimizing their operations for peak performance, and providing actionable analytics to improve competitiveness. Thousands of customers depend on ChannelAdvisor to securely power their sales and optimize fulfillment on channels such as Amazon, eBay, Google, Facebook, Walmart, and hundreds more. For more information, visitwww.channeladvisor.com. ChannelAdvisor Media Contact:Tamara Gibbs[emailprotected]919-249-9798 SOURCE ChannelAdvisor Corporation Related Links www.channeladvisor.com", "role": "user" }, { "content": "ChannelAdvisor CEO Featured on NBC's Today Show David Spitz, head of leading e-commerce platform, discusses e-commerce and shipping trends ahead of holiday shopping season", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: SANTA CLARA, Calif., April 7, 2021 /PRNewswire/ --TiEcon 2021 announced today new additions to the line up of some of the brightest global stars with extraordinary successes building multi-billion dollar ventures. The perfect constellation of founders, funders, a public lister, and global media personalities are coming together during the three day event to engage and inspire every attendee. For free conference registration, use promo code CISION21. Dr. Geeta Gupta-Fisker, Co-Founder & CFO, Fisker Inc.Dr Geeta Gupta-Fisker is a self-made billionaire, along with her husband Henrik Fisker, the visionary car designer. Geeta is playing a pivotal role in the next revolution to hit the automotive industry: developing emotionally desirable electric vehicles that bring together design, technology, and sustainability delivered through an ultra-convenient and digital-first ownership strategy. The company had a successful IPO on October 30, 2020. Geeta is joined in conversation with Jillian Manus, Managing Partner, Structure Capital and frequent commentator at CNBC's Squawk Alley and Bloomberg Business news. She also co-hosts Spotify's Media's business podcast \"The Pitch\". Daniel Dines, UiPath Co-founder and CEODaniel Dines is Co-founder and CEO of UiPath, a leading enterprise automation software company. Dines started UiPath in 2005 with the goal of building a technology that could help humans reduce the time and stress that come from menial, administrative business tasks. In September 2019, he was featured as Boss of the Bots on the cover of Forbes magazine. Daniel is also being honored as Entrepreneur of the Year by TiE. The company is currently in pre-IPO status. Daniel is joined in conversation with Abhi Arun, Managing Partner at Alkeon Capital and heads the private investments group. Adena Friedman, CEO, NASDAQAdena Friedman was named the CEO of Nasdaq in January 2017, the first woman to lead a global exchange. Forbes has repeatedly listed Friedman as one of the world's most powerful women on their annual Power Women list. Adena is joined in conversation with Don Callahan, Executive chairman, TIME. Razat Gaurav, CEO, LLamasoft is a leader in AI-based supply chain design and decisioning software. Driving an expanded product vision combined with a purpose-driven culture enabled the company to more than double its revenue in 3 years and resulted in a successful $1.5 billion acquisition by Coupa in November 2020. Nehal Raj,Partner, TPG co-leads the firm's investment activities in software and enterprise technology across its private equity platforms- TPG Capital, TPG Growth, The Rise Fund, and TPG Tech Adjacencies, where he serves as Co-Managing Partner. For more information, visit TiEcon 2021. About TiE Silicon ValleyTiE Silicon Valley (sv.tie.org) is a not-for-profit organization dedicated to fostering entrepreneurship. TiE hosts TiEcon to create an entrepreneurial ecosystem under one roof for C-level executives, investors, and entrepreneurs. SOURCE TiE Silicon Valley Related Links https://www.tiecon.org/", "role": "user" }, { "content": "TiEcon 2021: From Startup to IPO - Founders, Funders, Public Lister, and Storytellers Will Engage a Global Audience At Silicon Valley's Annual Flagship Conference on May 6-8, 2021", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: DUBLIN--(BUSINESS WIRE)--The \"Collagen Market by Product (Gelatin, Collagen Peptide, Native Collagen, Synthetic Collagen), Source (Porcine, Bovine, Chicken, Sheep, Other Sources), and Application (Food and Beverages, Pharmaceuticals, Nutraceuticals, Cosmetics, Healthcare) - Global Forecasts to 2027\" report has been added to ResearchAndMarkets.com's offering. This report provides in-depth analysis of the collagen market in six major geographies and emphasizes on the current market trends, market size, market share, recent developments, and forecast till 2027. In terms of value, the collagen market is expected to grow at a CAGR of 6.9% to reach $7.5 billion by 2027, while in terms of volume, the market is expected to grow at a CAGR of 5.1% reach 683.8 KT by 2027. The growth of this market is mainly attributed to the growing use of collagen in food industries, growing inclination towards protein consumption & nutricosmetics, increasing application in healthcare, and growing use of collagen based on biomaterials. The collagen market is mainly segmented by type (gelatin, collagen peptide, native collagen, and synthetic collagen), source (bovine, porcine, fish, chicken, sheep, and other sources), application (food and beverage {beverage, confectionery, dairy, meat and fish products, and other applications}, pharmaceuticals {hard gel capsules, soft gel capsules, and microencapsulation}, nutraceuticals {sports nutrition and weight management}, healthcare {wound dressing, tissue regeneration, medical implants, cardiology, research, and drug delivery}, cosmetics, and technical applications), and geography. The study also evaluates industry competitors and analyses the market at a country level. Companies Mentioned Key questions answered in the report: Key Topics Covered: 1. Introduction 2. Research Methodology 3. Executive Summary 4. Market Insights 4.1. Introduction 4.2. Drivers 4.2.1. Growing Use of Collagen in Food Industries 4.2.2. Growing Protein and Nutricosmetics Consumption 4.2.3. Increasing Application in Healthcare 4.2.4. Increasing Technical Applications 4.2.5. Growing Use of Collagen Based Biomaterials 4.3. Restraints 4.3.1. Safety Concerns 4.4. Religious Constraints 4.4.1. Growing Use of Alternatives 4.5. Opportunities 4.5.1. Rise In Per Capita Income Opens Untapped Geographies 4.5.2. Growing Food Processing Industry 4.6. Challenges 4.6.1. Safety Concerns 4.6.2. Improving the Processing Technology 4.7. Regulatory Analysis 4.7.1. North America 4.7.2. Europe 4.7.3. Asia-Pacific 5. Impact of Covid-19 On Collagen Market 6. Global Collagen Market, by Type 6.1. Introduction 6.2. Gelatin 6.3. Collagen Peptide (Hydrolyzed Collagen) 6.4. Native Collagen 6.5. Synthetic Collagen 7. Global Collagen Market, by Source 7.1. Introduction 7.2. Bovine 7.3. Porcine 7.4. Fish 7.5. Chicken 7.6. Sheep 7.7. Other Sources 8. Global Collagen Market, by Application 8.1. Introduction 8.2. Food and Beverage 8.2.1. Beverage 8.2.2. Confectionery 8.2.3. Dairy 8.2.4. Meat and Fish Products 8.2.5. Other Applications (Sauces, Dressing, & Desserts) 8.3. Pharmaceuticals 8.3.1. Hard Gel Capsules 8.3.2. Soft Gel Capsules 8.3.3. Microencapsulation 8.4. Nutraceuticals 8.4.1. Sports Nutrition 8.4.2. Weight Management 8.5. Healthcare 8.5.1. Wound Dressing 8.5.2. Tissue Regeneration 8.5.3. Medical Implants 8.5.4. Cardiology 8.5.5. Research (Cell Culture & Cell Behavior) 8.5.6. Drug Delivery 8.6. Cosmetics 8.7. Technical Applications (Photography & Ballistic) 9. Geographic Analysis 9.1. Introduction 9.2. North America 9.3. Europe 9.4. Asia-Pacific 9.5. Rest of The World 10. Competitive Landscape 10.1. Introduction 10.2. Key Growth Strategies 10.3. Competitive Benchmarking 11. Company Profiles 12. Appendix For more information about this report visit https://www.researchandmarkets.com/r/rtf2x3", "role": "user" }, { "content": "Worldwide Collagen Industry to 2027 - Impact Analysis of COVID-19 - ResearchAndMarkets.com", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: AUBURN, Calif.--(BUSINESS WIRE)--Riskalyze, the company that serves tens of thousands of financial advisors with risk alignment and portfolio analytics, has launched a brand-new financial technology innovation designed to facilitate the ease of integrating the vast landscape of financial technology available to financial advisors. The Build My Tech Stack tool provides financial advisors with step-by-step instructions on assembling and optimizing their technology stack within Riskalyze to fit their practice best. A firm believer in the concept of technology integrations, Riskalyze is keenly aware of advisors' pain points regarding the technology they use to run their business, communicate with clients and prospects, research and manage investments, and the myriad additional responsibilities of the modern advisor. Riskalyze believes that wealth-tech integrations should simply work, and the Build My Tech Stack tool gives advisors more time to focus on what they do best serve the needs of their clients. Every advisor knows the disappointment of choosing what they think could work for them, only to produce a FinTech Frankenstein that does not function as it should. Advisors tell us all the time its great that Riskalyze integrates with every major wealth-tech product, but I really need help making sense of all of these integrations and how to configure them for optimal workflow and data flow, said Aaron Klein, Chief Executive Officer at Riskalyze. Our team realized we had the ability to make it incredibly easy for advisors to generate a customized tech stack integration plan that they and their staff can implement quickly and easily. This industry-first tool will empower advisors to pre-select various integrations, whether they are current customers or not. It will then generate a personalized report showing step-by-step instructions, automatically prioritizing the ones to set up first, including an overview of what the integration does and the necessary steps to set up each piece of software to Riskalyze. All Riskalyze technology partners are available to choose from in a simple, clean menu, whereby the advisor selects their existing or desired tech from a list of key categories: The Build My Tech Stack tool is available immediately at riskalyze.com/tech-stack. About Riskalyze Riskalyze is the company that invented the Risk Number, which powers the world's first Risk Alignment Platform and was built on top of a Nobel Prize-winning academic framework. Advisors, broker-dealers, RIAs, and asset managers use the Riskalyze platform to create alignment between clients and portfolios, leverage sophisticated analytics to increase the quality of their advice, automate trading and client account management, and access world-class models and research in the Riskalyze Partner Store all with the mission of empowering the world to invest fearlessly. To learn more, visit www.riskalyze.com.", "role": "user" }, { "content": "Riskalyze Launches \"Build My Tech Stack\" Tool: Industrys First Step-by-Step Guide for Advisors to Design Their FinTech Integrations \"Integrations\" has been loosely bandied about as a buzz-word for far too long, offering a lot of \"what\" but scarcely any \"how\" Using Riskalyze's new proprietary tool, advisors can quickly assemble their ideal tech solutions, saving countless hours of frustration", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: NEW YORK--(BUSINESS WIRE)--iHeartMedia, Inc. (NASDAQ: IHRT) announced today that Bob Pittman, Chairman and Chief Executive Officer, and Rich Bressler, President, Chief Operating Officer & Chief Financial Officer, will participate in a question and answer session during the Goldman Sachs 29th Annual Communacopia Conference on Wednesday September 16, 2020, at 1:15 p.m. ET. A replay of the event will be available in the Events & Presentation section of iHeartMedias Investors homepage (https://investors.iheartmedia.com/). About iHeartMedia, Inc. iHeartMedia (NASDAQ: IHRT) is the number one audio company in the United States, reaching nine out of 10 Americans every month and with its quarter of a billion monthly listeners, has a greater reach than any other media company in the U.S. The companys leadership position in audio extends across multiple platforms, including more than 850 live broadcast stations in over 160 markets nationwide; through its iHeartRadio digital service available across more than 250 platforms and 2,000 devices; through its influencers; social; branded iconic live music events; other digital products and newsletters; and podcasts as the #1 commercial podcast publisher. iHeartMedia also leads the audio industry in analytics, targeting and attribution for its marketing partners with its SmartAudio product, using data from its massive consumer base. Visit iHeartMedia.com for more company information.", "role": "user" }, { "content": "iHeartMedia Chairman and Chief Executive Officer Bob Pittman and President, Chief Operating Officer & Chief Financial Officer Rich Bressler to Participate in Goldman Sachs 29th Annual Communacopia Conference", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: WESTERLY, R.I., Dec. 1, 2020 /PRNewswire/ --Washington Trust Bancorp, Inc. (Nasdaq: WASH) today announced that the Corporation's Board of Directors adopted a stock repurchase program (\"Stock Repurchase Program\"), which authorizes the repurchase of up to 850,000 shares, or approximately 5%, of the Corporation's common stock. This authority may be exercised from time to time and in such amounts as market conditions warrant, and subject to regulatory considerations. The timing and actual number of shares repurchased will depend on a variety of factors including price, corporate and regulatory requirements, market conditions, and other corporate liquidity requirements and priorities. The Stock Repurchase Program expires on October 31, 2021 and may be modified, suspended, or discontinued at any time. The Corporation had approximately 17.3 million shares outstanding as of November 30, 2020. BackgroundWashington Trust Bancorp, Inc. is the parent of The Washington Trust Company. Founded in 1800, Washington Trust is the oldest community bank in the nation, the largest state-chartered bank headquartered in Rhode Island and one of the Northeast's premier financial services companies. Washington Trust offers a full range of financial services, including commercial banking, mortgage banking, personal banking and wealth management and trust services through its offices located in Rhode Island, Connecticut and Massachusetts. The Corporation's common stock trades on NASDAQ under the symbol WASH. Investor information is available on the Corporation's web site at http://ir.washtrust.com. Forward-Looking StatementsThis press release contains statements that are \"forward-looking statements\". We may also make forward-looking statements in other documents we file with the SEC, in our annual reports to shareholders, in press releases and other written materials, and in oral statements made by our officers, directors or employees. You can identify forward-looking statements by the use of the words \"believe,\" \"expect,\" \"anticipate,\" \"intend,\" \"estimate,\" \"assume,\" \"outlook,\" \"will,\" \"should,\" and other expressions that predict or indicate future events and trends and which do not relate to historical matters. You should not rely on forward-looking statements, because they involve known and unknown risks, uncertainties and other factors, some of which are beyond our control. These risks, uncertainties and other factors may cause our actual results, performance or achievements to be materially different from the anticipated future results, performance or achievements expressed or implied by the forward-looking statements. Some of the factors that might cause these differences include the following: the negative impacts and disruptions of the COVID-19 pandemic and measures taken to contain its spread on our employees, customers, business operations, credit quality, financial position, liquidity and results of operations; the length and extent of the economic contraction as a result of the COVID-19 pandemic; continued deterioration in local, regional, national or international economic conditions or conditions affecting the banking or financial services industries, financial capital markets and the customers and communities we serve; changes in consumer behavior due to changing political, business and economic conditions, including increased unemployment, or legislative or regulatory initiatives; the possibility that future credits losses are higher than currently expected due to changes in economic assumptions or adverse economic developments; volatility in national and international financial markets; reductions in net interest income resulting from interest rate volatility as well as changes in the balance and mix of loans and deposits; reductions in the market value or outflows of wealth management assets under administration; decreases in the value of securities and other assets; reductions in loan demand; changes in loan collectability, increases in defaults and charge-off rates; changes in the size and nature of our competition; changes in legislation or regulation and accounting principles, policies and guidelines; operational risks including, but not limited to, cybersecurity incidents, fraud, natural disasters and future pandemics; reputational risk relating to our participation in the Paycheck Protection Program and other pandemic-related legislative and regulatory initiatives and programs; and changes in the assumptions used in making such forward-looking statements. In addition, the factors described under \"Risk Factors\" in Item 1A of our Annual Report on Form 10-K for the fiscal year ended December 31, 2019, as updated by our Quarterly Reports on Form 10-Q and other filings submitted to the SEC, may result in these differences. You should carefully review all of these factors and you should be aware that there may be other factors that could cause these differences. These forward-looking statements were based on information, plans and estimates at the date of this report, and we assume no obligation to update any forward-looking statements to reflect changes in underlying assumptions or factors, new information, future events or other changes. SOURCE Washington Trust Bancorp, Inc. Related Links www.washtrust.com", "role": "user" }, { "content": "Washington Trust Bancorp, Inc. Announces New Stock Repurchase Program", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: NEW YORK, May 21, 2020 /PRNewswire/ --Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against RTI Surgical Holdings, Inc.(\"RTI\" or the \"Company\"). If you invested in RTI stock or options and would like to discuss your legal rights, click here: www.faruqilaw.com/RTIX. There is no cost or obligation to you. You can also contact us by calling Richard Gonnello toll freeat 877-247-4292 or at 212-983-9330 or by sending an e-mail to [emailprotected] CONTACT:FARUQI & FARUQI, LLP685 Third Avenue, 26th FloorNew York, NY 10017Attn: Richard Gonnello, Esq.[emailprotected]Telephone: (877) 247-4292 or (212) 983-9330 Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner. SOURCE Faruqi & Faruqi, LLP Related Links www.faruqilaw.com", "role": "user" }, { "content": "RTI INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In RTI Surgical Holdings, Inc. To Contact The Firm", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: PITTSBURGH and GLENVIEW, Ill., May 14, 2020 /PRNewswire/ --WESCO International, Inc. (NYSE: WCC) (\"WESCO International\") announced today the early results of the previously announced tender offers (each, an \"Offer\" and together, the \"Offers\") by WESCO Distribution, Inc. (\"WESCO\") to purchase for cash any and all of Anixter Inc.'s (\"Anixter\") outstanding (i) 5.50% Senior Notes due 2023 (the \"2023 Notes\") and (ii)6.00% Senior Notes due 2025 (the \"2025 Notes\" and, together with the 2023 Notes, the \"Notes,\" each such series of the Notes, a \"Series\"). In connection with the Offers, WESCO announced the early results of its consent solicitations with respect to each Series of Notes (the \"Offer Consent Solicitations\") to amend the applicable indenture establishing the 2023 Notes and 2025 Notes (each, the \"Indenture,\" and together, the \"Indentures\"). For any Notes of a Series that a Holder (as defined below) tendered or will tender in either Offer, the Holder is deemed to have delivered consents (\"Offer Exit Consents\") to amend the applicable Indenture to, among other things, eliminate substantially all of the restrictive covenants, eliminate certain \"Events of Default\" and eliminate any requirement to make a change of control offer or restrictions in the Indenture that limit Anixter International (as defined below) or Anixter from consolidating with or merging with or into any other person or selling or conveying all or substantially all of its properties and assets to any person, in each case in the applicable Indenture (as further described in the Offer to Purchase and Consent Solicitation Statement (the \"Offer to Purchase\")) (the \"Offer Exit Proposed Amendments\"). Concurrently, Anixter International Inc. (\"Anixter International\") (NYSE: AXE) announced today the expiration and final results of Anixter's previously announced consent solicitations (the \"Anixter Consent Solicitations\"), whereby Anixter solicited, with respect to the applicable Series of Notes, consents (\"Solicitation Change of Control Consents\") of Holders of such Series of notes to certain proposed amendments (the \"Change of Control Proposed Amendments\") to the Indenture governing such Series of Notes, which such amendments, among other things, (i) amend the definition of \"Change of Control\" under the applicable Indenture to exclude the Merger and related transactions and (ii) expressly permit a merger between Anixter International and Anixter which Anixter survives. At the expiration of the Anixter Consent Solicitations, less than a majority of the Holders of each Series of Notes had delivered Solicitation Change of Control Consents. The Offers are, and Anixter Consent Solicitations were, conducted in connection with the merger agreement, dated as of January 10, 2020 (as it may be amended from time to time, the \"Merger Agreement\"), pursuant to which WESCO International has agreed to acquire Anixter International (the \"Merger\"). The Offers are, and the Anixter Consent Solicitations were, open to all registered holders of the Notes (individually, a \"Holder,\" and collectively the \"Holders\"). The Offers are, and Anixter Consent Solicitations were, made pursuant to the Offer to Purchase, dated April 30, 2020, which sets forth a more detailed description of the Offers and Anixter Consent Solicitations. The Offers As of 5:00 p.m., New York City time on May 13, 2020 (both the \"Early Tender Deadline\" and the \"Withdrawal Deadline\"), the following principal amounts of 2023 Notes and 2025 Notes were validly tendered and not validly withdrawn: Title of Security CUSIP Numbers PrincipalAmount Tendered PercentageTendered Tender OfferConsideration(1) Early Tender Payment(1)(3) Total TenderOfferConsideration (1)(2) 5.50% SeniorNotes due 2023 035287AG6 $291,356,000 83.24% $962.50 $50.00 $1,012.50 6.00% SeniorNotes due 2025 035287AJ0 $245,827,000 98.33% $962.50 $50.00 $1,012.50 (1) Per $1,000 principal amount of Notes that are accepted for purchase.(2) The Total Tender Offer Consideration consists of the Tender Offer Consideration and the Early Tender Payment. (3) Payable, subject to the terms and conditions described in the Offer to Purchase, only to Holders who validly tendered (and did not validly withdraw) Notes prior to the Early Tender Deadline. Holders may no longer withdraw any 2023 Notes or 2025 Notes previously or hereafter validly tendered. The Offers will expire at 11:59 p.m., New York City time, on May 28, 2020, unless extended or earlier terminated by WESCO (the \"Expiration Time\"). Each Offer is conditioned upon, among other things, the substantially concurrent or prior closing of the Merger. WESCO International and Anixter International expect to complete the Merger in the second or third calendar quarter of 2020, but the Merger Agreement provides for the outside date thereunder to be automatically extended to as late as January 11, 2021 under certain circumstances and the parties could mutually agree to extend the outside date under the Merger Agreement beyond that date. WESCO intends to extend the Expiration Time with respect to each Offer, without extending the Withdrawal Deadline (unless required by law), to have the payment of the consideration in respect of such Offer occur concurrently with, or promptly after, the closing of the Merger. Accordingly, any Holder who tendered Notes (and did not validly withdraw such Notes prior to the Withdrawal Deadline), or who tenders Notes following the date hereof, may not receive payment of the Total Tender Offer Consideration or the Tender Offer Consideration, as applicable, and may be unable to validly withdraw or trade its Notes, in each case for a substantial duration. Only Notes that were validly tendered (and not validly withdrawn) at or prior to the Early Tender Deadline and accepted by WESCO for purchase will receive the applicable Total Tender Offer Consideration (as set forth above) which includes an Early Tender Payment (as set forth above). Notes that are validly tendered (and not validly withdrawn) after the Early Tender Deadline and on or prior to the Expiration Time and accepted by WESCO for purchase will receive only the applicable Tender Offer Consideration (as set forth above). Payment for Notes accepted by WESCO for purchase will include accrued and unpaid interest from the last payment date applicable to the Notes up to, but excluding, the settlement date for the Offers (\"Accrued Interest\"). As of 5:00 p.m., New York City time on May 13, 2020, WESCO had received validly delivered Offer Exit Consents (as an immediate consequence of tendering) from the Holders of a majority of the aggregate principal amount outstanding of each Series of Notes (for each Series, the \"Offer Requisite Exit Consent Condition\"). Consequently, Anixter, Anixter International, as guarantor, and Wells Fargo Bank, National Association, as trustee (the \"Trustee\"), have entered into a supplemental indenture for each Series of Notes (each an \"Offer Exit Supplemental Indenture\") to the corresponding Indenture that gives effect to the Offer Exit Proposed Amendments. The Offer Exit Proposed Amendments with respect to each Series of Notes will only become operative, and thereby apply to all Notes of such Series remaining outstanding, immediately prior to the consummation of the Merger. The obligation to accept for purchase and to pay (or cause to be paid) the Total Tender Offer Consideration or the Tender Offer Consideration, as applicable, for any and all Notes validly tendered and not validly withdrawn pursuant to each of the Offers is conditioned on the satisfaction of certain conditions that may be waived by WESCO if they are not satisfied, as more fully described in the Offer to Purchase. WESCO reserves the right in its sole discretion, subject to applicable law, to terminate any Offer if the conditions to such Offer have become incapable of being satisfied at the Expiration Time. The Anixter Consent Solicitations As of 5:00 p.m., New York City time on May 13, 2020 (the \"Consent Solicitation Deadline\"), the following principal amounts of 2023 Notes and 2025 Notes have consented to the Change of Control Proposed Amendments: Title of Security CUSIP Numbers Principal AmountDelivered Percentage Delivered Change of ControlConsent SolicitationPayment(1) 5.50% Senior Notes due2023 035287AG6 $55,538,000 15.87% $2.50 6.00% Senior Notes due2025 035287AJ0 $556,000 0.22% $2.50 (1) Per $1,000 principal amount of Notes. Since the Offer Exit Supplemental Indentures have been executed, Anixter, Anixter International and the Trustee will not enter into a supplemental indenture for each Series of Notes to the corresponding Indenture to give effect to the Change of Control Proposed Amendments. Anixter has accepted any Solicitation Change of Control Consents validly delivered and not validly revoked prior to the Consent Solicitation Deadline and Holders who participated in the Anixter Consent Solicitations by delivering such Solicitation Change of Control Consents at or prior to the Consent Solicitation Deadline will be eligible to receive the Change of Control Consent Solicitation Payment (as set forth above). Among other things, WESCO's obligation to pay the Consent Solicitation Payment to such Holders is conditioned on the Merger being consummated at or prior to the later of (i) 5:00 p.m., New York City time, on April 1, 2021, or (ii) the outside date in the Merger Agreement. WESCO will pay or cause to be paid the Change of Control Consent Solicitation Payment to Holders who participated in the Anixter Consent Solicitations by validly delivering and not validly revoking their Solicitation Change of Control Consents at or prior to the Consent Solicitation Deadline, subject to and on or promptly following the closing of the Merger. Holders who receive the Change of Control Consent Solicitation Payment will not be entitled to any accrued or unpaid interest. Other Information The Offers with respect to one or both series of Notes may be terminated or withdrawn at any time and for any reason, including if certain conditions described in the Offer to Purchase are not satisfied, subject to applicable law. WESCO is making the Offers only by, and pursuant to, the terms of the Offer to Purchase. None of WESCO, WESCO International, Anixter, Anixter International, the Dealer Manager (as defined below), the trustee under each Indenture, the Tender and Information Agent (as defined below), nor any of their respective affiliates, makes any recommendation as to whether or not Holders of the Notes shouldtender or refrain from tendering their Notes with regard to the Offers. This announcement does not constitute an offer to sell any securities or the solicitation of an offer to purchase any securities. The Offers are being made only pursuant to the Offer to Purchase. The Offers are not being made to Holders of Notes in any jurisdiction in which the making or acceptance thereof would not be in compliance with the securities, blue sky or other laws of such jurisdiction. In any jurisdiction in which the securities laws or blue sky laws require the Offers to be made by a licensed broker or dealer, the Offers will be deemed to be made on behalf of WESCO or Anixter, as applicable, by one or more registered brokers or dealers that are licensed under the laws of such jurisdiction. Barclays Capital Inc. is acting as dealer manager and solicitation agent (the \"Dealer Manager\") for the Offers and was Dealer Manager for Anixter Consent Solicitations. D.F. King & Co., Inc. is acting as the tender agent and information agent (the \"Tender and Information Agent\") for the Offers and was Tender and Information Agent for the Anixter Consent Solicitations. Requests for the Offer to Purchase may be directed to D.F. King & Co., Inc. at (212) 269-5550 (for brokers and banks) or (877) 361-7966 (for all others) or email [emailprotected]. Questions or requests for assistance in relation to the Offers may be directed to Barclays Capital Inc. at (212) 528-7581 (collect) or (800) 438-3242 (toll-free). About WESCO WESCO International, Inc. (NYSE: WCC), a publicly traded FORTUNE 500holding company headquartered inPittsburgh, Pennsylvania, is a leading provider of electrical, industrial, and communications maintenance, repair and operating (MRO) and original equipment manufacturer (OEM) products, construction materials, and advanced supply chain management and logistic services. 2019 annual sales were approximately$8.4 billion. The company employs approximately 9,500 people, maintains relationships with approximately 30,000 suppliers, and serves approximately 70,000 active customers worldwide. Customers include commercial and industrial businesses, contractors, government agencies, institutions, telecommunications providers, and utilities. WESCO operates 11 fully automated distribution centers and approximately 500 branches inNorth Americaand international markets, providing a local presence for customers and a global network to serve multi-location businesses and multi-national corporations. About Anixter Anixter International is a leading global distributor of Network & Security Solutions, Electrical & Electronic Solutions and Utility Power Solutions. The company helps build, connect, protect, and power valuable assets and critical infrastructures. From enterprise networks to industrial MRO supply to video surveillance applications to electric power distribution, Anixter International offers full-line solutions, and intelligence, that create reliable, resilient systems that sustain businesses and communities. Through Anixter International's unmatched global distribution network along with its supply chain and technical expertise, the company helps lower the cost, risk and complexity of its customers' supply chains. Anixter International adds value to the distribution process by providing over 100,000 customers access to 1) innovative supply chain solutions, 2) nearly 600,000 products and over$1.0 billionin inventory, 3) over 300 warehouses/branch locations with over 9 million square feet of space and 4) locations in over 300 cities in approximately 50 countries. Founded in 1957 and headquartered nearChicago, Anixter International trades on the New York Stock Exchange under the symbol AXE. Forward-Looking Statements All statements made herein that are not historical facts should be considered as forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results to differ materially. These statements include, but are not limited to, statements regarding the expected completion and timing of the proposed transaction between WESCO International and Anixter International, expected benefits and costs of the proposed transaction, and management plans relating to the proposed transaction, statements that address each company's expected future business and financial performance, statements regarding the impact of natural disasters, health epidemics and other outbreaks, especially the outbreak of COVID-19 since December 2019, which may have a material adverse effect on each company's business, results of operations and financial conditions, and other statements identified by words such as anticipate, plan, believe, estimate, intend, expect, project, will and similar words, phrases or expressions. These forward-looking statements are based on current expectations and beliefs of the management of WESCO International and Anixter International (as the case may be), as well as assumptions made by, and information currently available to, such management, current market trends and market conditions, and involve risks and uncertainties, many of which are outside of each company's and each company's management's control, and which may cause actual results to differ materially from those contained in forward-looking statements. Accordingly, you should not place undue reliance on such statements. Certain of these risks are set forth in WESCO International's Annual Report on Form10-K for the fiscal year ended December31, 2019 and Anixter International's Annual Report on Form 10-K for the fiscal year ended January 3, 2020, as applicable, as well as each company's other reports filed with the U.S. Securities and Exchange Commission (the \"SEC\"). Those risks, uncertainties and assumptions also include the timing, receipt and terms and conditions of any required governmental and regulatory approvals of the proposed transaction between WESCO International and Anixter International that could reduce anticipated benefits or cause the parties to abandon the proposed transaction, the occurrence of any event, change or other circumstances that could give rise to the termination of the merger agreement, the risk that the parties may not be able to satisfy the conditions to the proposed transaction in a timely manner or at all, risks related to disruption of management time from ongoing business operations due to the proposed transaction, the risk that any announcements relating to the proposed transaction could have adverse effects on the market price of WESCO International's common stock, the risk of any unexpected costs or expenses resulting from the proposed transaction, the risk of any litigation relating to the proposed transaction, the risk that the proposed transaction and its announcement could have an adverse effect on the ability of WESCO International or Anixter International to retain customers and retain and hire key personnel and maintain relationships with their suppliers, customers and other business relationships and on their operating results and businesses generally, the risk that the pending proposed transaction could distract management of both entities and they will incur substantial costs, the risk that problems may arise in successfully integrating the businesses of the companies, which may result in the combined company not operating as effectively and efficiently as expected, the risk that the combined company may be unable to achieve synergies or other anticipated benefits of the proposed transaction or it may take longer than expected to achieve those synergies or benefits and other important factors that could cause actual results to differ materially from those projected. All such factors are difficult to predict and are beyond each company's control. Additional factors that could cause results to differ materially from those described above can be found in WESCO International's Annual Report on Form 10-K for the fiscal year ended December31, 2019 and Anixter International's Annual Report on Form 10-K for the fiscal year ended January 3, 2020, as applicable, as well as in each company's other reports filed with the SEC. SOURCE WESCO International, Inc. Related Links http://www.wesco.com", "role": "user" }, { "content": "WESCO Distribution, Inc. announces early tender results with respect to offers to purchase for cash any and all of Anixter Inc.'s 5.50% Senior Notes due 2023 and 6.00% Senior Notes due 2025 and related consent solicitations and Anixter Inc. announces expiration and final results of its consent solicitations related to its 5.50% Senior Notes due 2023 and 6.00% Senior Notes due 2025", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: CAMBERLEY, England, Dec. 18, 2020 /PRNewswire/ - Cennox announces the acquisition of StrongPoint's Swedish based Cash Security business. The deal, which completed on 18th December 2020, enables Cennox to offer customers with a comprehensive cash protection solution unrivalled in the industry. The integration of the StrongPoint Cash Security business positions Cennox as the transformational lead in the Banking and Retail markets. Now capable of offering the widest scope of security products across the world, cements Cennox as the benchmark organization able to provide a fully integrated, end-to-end security solution alongside its existing suite of innovative security products. Cennox is seen as the leading multi-vendor solutions business and trusted 'go-to' partner for many of the world's leading financial and retail organizations looking to innovate their businesses. \"The diversity of our service offering gives Cennox the competitive edge when engaging with customers. We believe our acquisition of the StrongPoint Cash Security business will enable us to connect our customers to a level of service which isn't available anywhere else\". Clive Nation, Group CEO, Cennox StrongPoint have grown their presence across Europe and Russia and will continue to focus on the retail technology side of their business, giving Cennox the opportunity to integrate the Cash Security business into their portfolio. Having a national footprint in the USA, Cennox expects significant growth in this market, with further exciting plans to expand into the Middle East and Asia. \"We are now optimizing and streamlining our portfolio to enable us to focus on the retail technology segment, in particular in-store technologies and ecommerce solutions where we see long-term growth opportunities.\" Jacob Tveraabak, Chief Executive Officer of StrongPoint The acquisition will see StrongPoint staff based in Sweden, Norway, Russia, France and Belgium, join the Cennox Group with immediate effect. The deal also includes their manufacturing facilities in Sweden coming under the care of Cennox to ensure a speedy and seamless transition with no interruption of service and enable the teams to continue the fantastic work they have been doing. \"Our colleagues at Cennox are excited to welcome the teams at StrongPoint. We are confident that our combined resources and talent will benefit our customers across the region and signal the start of new opportunities in the coming months\". Chetan Patil, Managing Director, Cennox Europe ABOUT CENNOX Cennox delivers strategic solutions for customers worldwide and across many sectors. From consultation to implementation, Cennox is the go-to partner for the world's leading brands. From innovation through technology, ease through installation, safety through security to brand transformation. Cennox embraces the diversity of different industries, challenge the status quo, and help customers drive change. SOURCE Cennox", "role": "user" }, { "content": "Cennox acquires The StrongPoint Cash Security business in a deal that provides retail and banking customers with an industry leading, fully end-to-end cash protection solution.", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: PITTSBURGH, June 25, 2020 /PRNewswire/ --\"I often think of ways to improve various products and wanted to bring one of these ideas to life,\" said an inventor from Lancaster, New York. \"This inspired me to develop a means to store lures to prevent them from prematurely rusting.\" He developed the patent pending DRIP DRY LURE LOCKER to prevent rust and corrosion on fishing lures by ensuring they would not remain covered with salt, algae, slime, seaweed and sand. This convenient and easy to use invention could increase the life of expensive fishing lures. Additionally, it would be lightweight to ensure that it could easily be transported. The original design was submitted to the national sales office of InventHelp. It is currently available for licensing or sale to manufacturers or marketers. For more information, write Dept. 18-KOC-1371, InventHelp, 217 Ninth Street, Pittsburgh, PA 15222, or call (412) 288-1300 ext. 1368. Learn more about InventHelp's Invention Submission Services at http://www.InventHelp.com. SOURCE InventHelp Related Links http://www.inventhelp.com", "role": "user" }, { "content": "InventHelp Inventor Develops Rust Free Lure Storage (KOC-1371)", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: NANAIMO, British Columbia--(BUSINESS WIRE)--Tilray, Inc. (NASDAQ: TLRY), a global pioneer in cannabis research, cultivation, production, and distribution, today announced that the company has been included in the inaugural list of TIMEs 100 Most Influential Companies. The new list an expansion of the annual TIME100 franchise highlights 100 businesses making an extraordinary impact around the world. Brendan Kennedy, Tilray's Chief Executive Officer, said, On behalf of every Tilray employee, we feel extremely honored by TIMEs recognition as it provides validation for the myriad accomplishments and milestones that have marked Tilrays status as a pioneer in the global cannabis industry. Now, as we finalize our merger with Aphria, the new Tilray will leverage our combined strengths in geographic scale, product range, and brand expertise to meet our consumers' and patients' needs with attendant benefits for all of our stakeholders over the long term. We feel proud of all weve accomplished, grateful to our employees for their indispensable contributions, and passionate in our belief that the best is yet to come. To assemble the list, TIME solicited nominations across every sectorincluding health care, entertainment, transportation, technology, and morefrom its global network of editors and correspondents, as well as from industry experts. Each company was then evaluated on key factors, including relevance, impact, innovation, leadership, ambition, and success. See the full list here: time.com/100companies About Tilray Tilray is a global pioneer in the research, cultivation, production, and distribution of cannabis and cannabinoids, currently serving tens of thousands of patients and consumers in 18 countries spanning five continents. CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS Certain information in this communication constitutes forward-looking information or forward-looking statements (together, forward-looking statements) under Canadian securities laws and within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, which are intended to be covered by the safe harbor created by such sections and other applicable laws. The forward-looking statements are expressly qualified by this cautionary statement. Forward-looking statements are provided for the purpose of presenting information about managements current expectations and plans relating to the future, and readers are cautioned that such statements may not be appropriate for other purposes. Any information or statements that are contained in this communication that are not statements of historical fact may be deemed to be forward-looking statements, including, but not limited to, statements in this communication with regards to: (i) statements relating to the strategic business combination of Aphria and Tilray and the expected timing and closing of the Transaction; the Transaction including, receipt of required shareholder approvals, court approvals and satisfaction of other closing customary conditions; (ii) estimates of pro-forma financial information of the Combined Company, including in respect of expected revenues and production of cannabis; (iii) the expected strategic and financial benefits of the business combination, including estimates of future cost reductions, synergies, including expected pre-tax synergies, savings and efficiencies; (iv) statements that the Combined Company anticipates having scalable medical and adult-use cannabis platforms expected to strengthen the leadership position in Canada, internationally and, eventually in the United States; (v) statements that the Combined Company is expected to offer a diversified and branded product offering and distribution footprint, state-of-the-art cultivation, processing and manufacturing facilities; (vi) statements in respect of operational efficiencies expected to be generated as a result of the Transaction in the amount of approximately C$100 million of pre-tax annual cost synergies; (vii) statements regarding the value and returns to shareholders expected to be generated by the business combination; (viii) expectations of future balance sheet strength and future equity; (ix) expectations regarding the Combined Companys future M&A strategy; and (x) the expectation that the Combined Companys shares will be listed on the Toronto Stock Exchange concurrently with, or as soon as possible after, the closing of the Transaction. Aphria and Tilray use words such as forecast, future, should, could, enable, potential, contemplate, believe, anticipate, estimate, plan, expect, intend, may, project, will, would and the negative of these terms or similar expressions to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Certain material factors or assumptions were used in drawing the conclusions contained in the forward-looking statements throughout this communication, including the ability of the parties to receive, in a timely manner and on satisfactory terms, the necessary shareholder and court approvals for the Transaction, the ability of the parties to satisfy, in a timely manner, the conditions to closing of the Transaction and other expectations and assumptions concerning the Transaction. Forward-looking statements reflect current beliefs of management of Aphria and Tilray with respect to future events and are based on information currently available to each respective management team including the reasonable assumptions, estimates, analysis and opinions of management of Aphria and Tilray considering their experience, perception of trends, current conditions and expected developments as well as other factors that each respective management believes to be relevant as at the date such statements are made. Forward-looking statements involve significant known and unknown risks and uncertainties. Many factors could cause actual results, performance or achievement to be materially different from any future forward-looking statements. Factors that may cause such differences include, but are not limited to, risks assumptions and expectations described in Aphrias and Tilrays critical accounting policies and estimates; the adoption and impact of certain accounting pronouncements; Aphrias and Tilrays future financial and operating performance; the competitive and business strategies of Aphria and Tilray; the intention to grow the business, operations and potential activities of Aphria and Tilray; the ability of Aphria and Tilray to complete the Transaction; Aphrias and Tilrays ability to provide a return on investment; Aphrias and Tilrays ability to maintain a strong financial position and manage costs, the ability of Aphria and Tilray to maximize the utilization of their existing assets and investments and that the completion of the Transaction is subject to the satisfaction or waiver of a number of conditions as set forth in the Arrangement Agreement. There can be no assurance as to when these conditions will be satisfied or waived, if at all, or that other events will not intervene to delay or result in the failure to complete the Transaction. There is a risk that some or all the expected benefits of the Transaction may fail to materialize or may not occur within the time periods anticipated by Aphria and Tilray. The challenge of coordinating previously independent businesses makes evaluating the business and future financial prospects of the Combined Company following the Transaction difficult. Material risks that could cause actual results to differ from forward-looking statements also include the inherent uncertainty associated with the financial and other projections a well as market changes arising from governmental actions or market conditions in response to the COVID-19 public health crisis; the prompt and effective integration of the Combined Company; the ability to achieve the anticipated synergies and value-creation contemplated by the Transaction; the risk associated with Aphrias and Tilrays ability to obtain the approval of the proposed transaction by their shareholders required to consummate the Transaction and the timing of the closing of the Transaction, including the risk that the conditions to the Transaction are not satisfied on a timely basis or at all; the risk that a consent or authorization that may be required for the Transaction is not obtained or is obtained subject to conditions that are not anticipated; the outcome of any legal proceedings that may be instituted against the parties and others related to the Arrangement Agreement; unanticipated difficulties or expenditures relating to the Transaction, the response of business partners and retention as a result of the announcement and pendency of the Transaction; risks relating to the value of Tilrays common stock to be issued in connection with the transaction; the impact of competitive responses to the announcement of the Transaction; and the diversion of management time on transaction-related issues. Readers are cautioned that the foregoing list of factors is not exhaustive. Other risks and uncertainties not presently known to Aphria and Tilray or that Aphria and Tilray presently believe are not material could also cause actual results or events to differ materially from those expressed in the forward-looking statements contained herein. For a more detailed discussion of risks and other factors, see the most recently filed annual information form of Aphria and the annual report filed on form 10-K of Tilray made with applicable securities regulatory authorities and available on SEDAR and EDGAR. The forward-looking statements included in this communication are made as of the date of this communication and neither Aphria nor Tilray undertake any obligation to publicly update such forward-looking statements to reflect new information, subsequent events or otherwise unless required by applicable securities laws. ADDITIONAL INFORMATION ABOUT THE TRANSACTION AND WHERE TO FIND IT This communication is not intended to and does not constitute an offer to sell or the solicitation of an offer to subscribe for or buy or an invitation to purchase or subscribe for any securities or the solicitation of any vote or approval in any jurisdiction, nor shall there be any sale, issuance or transfer of securities in any jurisdiction in contravention of applicable law. This communication is being made in respect of the proposed transaction involving Aphria and Tilray pursuant to the terms of an arrangement agreement by and among Aphria and Tilray and may be deemed to be soliciting material relating to the proposed transaction. In connection with the Transaction, Tilray has filed a joint proxy statement/management information circular (the Circular) containing important information about the Transaction and related matters. The Circular has also been made available by Aphria and Tilray on their respective SEDAR profiles. Additionally, Aphria and Tilray will file other relevant materials in connection with the Transaction with the applicable securities regulatory authorities. Investors and security holders of Aphria and Tilray are urged to carefully read the entire Circular (including any amendments or supplements to such documents), respectively, before making any voting decision with respect to the Transaction because they contain important information about the Transaction and the parties to the Transaction. The Circular will be mailed to the Aphria Shareholders and Tilray Stockholders and is accessible on the SEDAR and EDGAR profiles of the respective companies. Investors and security holders of Tilray can obtain a free copy of the Circular, as well as other relevant filings containing information about Tilray and the Transaction, including materials incorporated by reference into the Circular, without charge, at the U.S. Securities and Exchange Commissions website (www.sec.gov) or from Tilray by contacting Tilrays Investor Relations at (203) 682-8253, by email at [email protected], or by going to Tilrays Investor Relations page on its website at https://ir.tilray.com/investor-relations and clicking on the link titled Financials. Investors and security holders of Aphria are able to obtain a free copy of the Circular, as well as other relevant filings containing information about Aphria and the Transaction, including materials incorporated by reference into the Circular, without charge, under Aphrias profile on SEDAR at www.sedar.com or from Aphria by contacting Aphrias investor relations at [email protected].", "role": "user" }, { "content": "Tilray Named to Times Inaugural List of the Time100 Most Influential Companies", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: CHICAGO, March 24, 2021 /PRNewswire/ -- Fuel Me, the first-of-its-kind cloud-based technology platform for fuel delivery and roadside assistance, is excited to announce a number of key partnerships to both expand its customer base and solidify its position as a disruptive technology solution in the energy distribution industry. Fuel Me's cutting-edge solutions for energy distribution infuse contemporary technological advances in an antiquated and unoptimized industry. (PRNewsfoto/Fuel Me) (PRNewsfoto/Fuel Me) (PRNewsfoto/Fuel Me) Check out Fuel Me's newly announced strategic partnerships! Tweet this As Fuel Metargets a variety of customers, it has dedicated extensive resources to disrupting fueling services for the transportation industry, which accounts for 75% of the U.S. diesel fuel consumption. Fuel Me has solidified exclusive partnerships to allow trucks to fuel while they are taking mandatory rest at parking locations without having to stop at truck stops, decreasing accident risks and saving upwards of $0.40 per gallon by reducing stoppage time which often exceeds 1 hour. To secure nationwide fueling services for truckers while they are stopped at parking locations, Fuel Me has partnered with TruckPark, the largest truck parking reservation platform. Fuel Me capitalizes on the hundreds of parking locations that Truck Park has secured across the U.S. with a number of large partners such as ParkMyFleet, an innovative nationwide vehicle parking solution, to deliver customers seamless fueling services while trucks are parked or stopped for mandatory rest. Anthony Petitte, CEO of TruckPark stated \"The TruckPark and Fuel Me partnership provides long-haul truckers a reliable means to secure safe parking, fueling and repair services in close proximity to their route. This is a real game changer for this industry, and we are proud to play an important role in enhancing driver experience.\" By aggregating trucks in one location Fuel Me is able to offer competitive coop fuel purchasing as the Fuel Me algorithm finds the closest truck stop from the parking locations where the fuel is ordered and decreases the price to $0.05 under the nearest pump price. Further leveraging the nationwide parking network, Fuel Me has partnered with Dock411, a distribution center service and dispatch company, to provide dispatch services from Fuel Me parking locations to distribution centers, mills, and ports - allowing companies to significantly decrease wait times and liabilities while enabling trucks to receive fueling services while they wait to drop off or pick up their cargo. This program helps a variety of industries remove long dangerous truck lines on the side of the highway and roads without incurring any costs as Fuel Me provides these services for free while monetizing on aggregating trucks for fueling in one location at discounted pricing. Fuel Me CEO, Carlo Passacantando mentioned that \"Fuel Me is at the forefront of discovering innovative solutions for companies across the U.S. to decrease costs, improve efficiency, all while providing invaluable fueling services to customers\".Thanks to these key partnerships, Fuel Me customers have the ability to receive around the clock fuel delivery services and parking assistance to make their jobs easier and increase operational efficiency.Fuel Me is continuing to work and expand its services as it solidifies strategic partnerships to offer efficient and cost-effective solutions to customers in the transportation and industrial sectors with any energy product need.The Fuel Me App available on Fuel.me, as well as in the Android and IOS app stores:https://fuel.me/services/application/For those seeking further information on the Fuel Me mobile app, or would like to schedule an on-boarding meeting for any company, please feel free to contact:Website:https://fuel.me Phone: (833) 838-3563 Email:[emailprotected] Facebook -https://www.facebook.com/OfficialFuelMe Instagram -https://www.instagram.com/officialfuelme Twitter -https://twitter.com/OfficialFuelMe LinkedIn -https://www.linkedin.com/company/fuel-me/SOURCE Fuel Me Related Links http://www.fuel.me/", "role": "user" }, { "content": "Fuel Me Continues To Build Momentum with New Strategic Partnerships", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: ENGLEWOOD, Colo., March 29, 2020 /PRNewswire/ --WOW! Internet, Cable & Phone (NYSE: WOW), a leading broadband provider, today issued the following statement: WOW! CEO Teresa Elder, was admitted to a local Denver hospital on Friday, March 27, after testing positive for COVID-19. Ms. Elder had been working remotely since March 16, following WOW!'s decision to transition all non-essential positions to work-from-home status. \"All of WOW! is united in wishing Teresa a quick and full recovery,\" said Jeff Marcus, board chairman for WOW!. \" The board, her leadership team and every WOW! employee offers their support and prayers to her and her family.\" While Ms. Elder recovers, Bill Case, chief information officer, will serve as acting CEO. Additionally, cable pioneer and WOW! board chairman, Jeff Marcus, will temporarily take on a formal leadership role as executive chairman. About WOW! Internet, Cable & Phone WOW! is one of the nation's leading broadband providers, with an efficient, high-performing fiber network that passes three million residential, business and wholesale consumers. WOW! provides services in 19 markets, primarily in the Midwest and Southeast, including Illinois, Michigan, Indiana, Ohio, Maryland, Alabama, Tennessee, South Carolina, Florida and Georgia. With an expansive portfolio of advanced services, including high-speed Internet services, cable TV, streaming, phone, business data, voice, and cloud services, the company is dedicated to providing outstanding service at affordable prices. WOW! also serves as a leader in exceptional human resources practices, having been recognized by the National Association for Business Resources' for six years as a Best & Brightest Company to Work For, winning the award for the last two consecutive years. Visit wowway.com for more information. SOURCE WideOpenWest, Inc. Related Links http://www.wowway.com", "role": "user" }, { "content": "WOW! CEO Hospitalized with COVID-19", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: NEW YORK--(BUSINESS WIRE)--As previously announced, the JPMorgan Chase & Co. annual meeting of shareholders will be held on Tuesday, May 18, 2021 at 10:00 a.m. (Eastern). The meeting will be held virtually. Attending the annual meeting To participate in the virtual meeting, visit www.virtualshareholdermeeting.com/JPM2021 and enter the 16-digit control number included on your proxy card, voting instruction form or notice you previously received. Shareholders may submit questions either before the meeting, from May 3 to May 14, 2021, or during a portion of the meeting. If you wish to submit a question before the meeting, you may log into www.proxyvote.com using your 16-digit control number and follow the instructions to submit a question. Alternatively, if you wish to submit a question during the meeting, log into the virtual meeting platform at www.virtualshareholdermeeting.com/JPM2021 using the 16-digit control number and follow the instructions to submit a question. Questions pertinent to meeting matters will be answered during the meeting, subject to time limitations. Access for the general public A live audio webcast of the event will also be available at www.jpmorganchase.com under Investor Relations, Events & Presentations. The general public can also listen to the meeting by dialing (866) 324-3683 in the U.S. and Canada or (509) 844-0959 for international participants; use Conference ID #5690697. Please dial in 10 minutes prior to the start of the meeting. JPMorgan Chase & Co. (NYSE: JPM) is a leading global financial services firm with assets of $3.7 trillion and operations worldwide. The Firm is a leader in investment banking, financial services for consumers and small businesses, commercial banking, financial transaction processing, and asset management. A component of the Dow Jones Industrial Average, JPMorgan Chase & Co. serves millions of customers in the United States and many of the world's most prominent corporate, institutional and government clients under its J.P. Morgan and Chase brands. Information about JPMorgan Chase & Co. is available at www.jpmorganchase.com.", "role": "user" }, { "content": "JPMorgan Chase 2021 Annual Meeting of Shareholders", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: WOODLAND HILLS, Calif., Oct. 13, 2020 /PRNewswire/ -- DealPoint Merrill, LLC, an owner and operator of value-added real estate opportunities and sponsor of real estate investment offerings, acquired a 69,275 square foot former Kroger Shopping Center on 7 acres located in the retail corridor of Sterling Heights, Michigan. Continue Reading Closed-Escrow-Kroger-Sterling-Heights-MI The property is in a growing community on the corner of Dequindre Rd.and 18 Mile Rd. with excellent visibility and adjacent to major national retail chains, with co-anchors McDonald's and Mobile gas station and across the street from the newly relocated Super Kroger grocery. DealPoint Merrill plans to redevelop the property into a new 138,000 square-foot development. DealPoint Merrill's executives, David Frank, CEO, negotiated the transaction, and Sterling McGregor, President, handled the due diligence and financing of the purchase. Jason Limbert, Director of acquisitions, and Tyler Bendicksen, head of investment underwriting, participated in the DealPoint' s acquisition. For more information, visit our website at www.dealpointmerrill.com. Contact: Danielle Watson, CommunicationsDealPoint Merrill310-671-3900[emailprotected] SOURCE DealPoint Merrill", "role": "user" }, { "content": "DealPoint Merrill Announces the Acquisition of a Kroger Shopping Center, a 69,275 Square Foot Building on 7 Acres in Sterling Heights, Michigan", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: DUBLIN--(BUSINESS WIRE)--The \"Nigeria Oil & Gas Market - Growth, Trends, and Forecasts (2020 - 2025)\" report has been added to ResearchAndMarkets.com's offering. The Nigeria oil and gas market is expected to grow at a CAGR of less than 5% during the forecast period of 2020 - 2025 Major factors driving the market are the increasing investments in the upstream and downstream sectors of the oil & gas industry. Oil and gas production had been hampered in Nigeria in the past few years, due to the attack on oil and gas infrastructure by militants. Further, oil theft has been one of the major issues faced by the oil & gas market in Nigeria, which resulted in huge losses to operating companies in the country. Nigeria's offshore oil and gas industry continues to expand, albeit not very fast, opening more market opportunities. The growth of Nigeria's offshore exploration and production activities has been mainly driven by the efforts of governments in their region. Lack of infrastructure, uncertainties in regulations, and security concerns have led Nigeria to under-utilize its refining capacities, thereby pushing the country to become a net importer of refined petroleum products. However, Nigeria is on the edge of altering refined products' supply dynamics in the region with the help of the upcoming Dangote Refinery and is expected to become the regional refining hub in the coming years. Given the country's huge gas reserve and its advantage as a clean fuel, gas has already witnessed a massive surge in its domestic consumption in the recent years. Further, the country is steadily moving away from oil and exploring different ways to replace the oil consumption with gas in power as well as the transportation sector. The shift to gas is also supported by the fact that major oil reserves are likely to get dry in coming three to four decades. Hence, the oil market is considered to be one of the most vulnerable markets where natural gas has the highest potential to penetrate. Moreover, gas production has become a major focus for the oil & gas companies, in response to strong investment in gas-to-power projects, across the region. Key Market Trends Offshore Segment to be Fastest Growing Market Nigeria's offshore oil and gas industry continues to expand, albeit not very fast, opening up more market opportunities. The growth of Nigeria's offshore exploration and production activities has been mainly driven by the efforts of governments in their region, such as providing key incentives and supporting policies to unlock the investment opportunity, as well as a growing list of international oil and gas companies interested in exploring alternative fields to replace the maturing offshore producing sites. Competitive Landscape The Nigeria oil & gas market is moderately consolidated with top 5-6 players accounting for the majority of the share. Some of the major players include Nigerian National Petroleum Corporation (NNPC), Royal Dutch Shell PLC, Total SA, Chevron Corporation, and Exxon Mobil Corporation. Key Topics Covered: 1 INTRODUCTION 2 RESEARCH METHODOLOGY 3 EXECUTIVE SUMMARY 4 MARKET OVERVIEW 4.1 Introduction 4.2 Oil and Gas Reserves, 2010-2018 4.3 Upstream Spending in USD billion, by Category, 2020-2025 4.4 Crude Oil Production in billion barrels per day, till 2025 4.5 Natural Gas Production in billion cubic feet per day, till 2025 4.6 Oil Breakeven Prices in USD/bbl for Key Unsanctioned Projects 4.7 Active Rig Count Historic Trend in Nigeria 4.8 Recent Trends and Developments 4.9 Government Policies and Regulations 4.10 Market Dynamics 4.11 PESTLE ANALYSIS 5 MARKET SEGMENTATION 5.1 Sector 5.1.1 Upstream 5.1.2 Midstream 5.1.3 Downstream 5.2 Location 5.2.1 Onshore 5.2.2 Offshore 6 COMPETITIVE LANDSCAPE 6.1 Mergers & Acquisitions, Joint Ventures, Collaborations, and Agreements 6.2 Strategies Adopted by Leading Players 6.3 Company Profiles 6.3.1 Nigerian National Petroleum Corporation (NNPC) 6.3.2 Royal Dutch Shell PLC 6.3.3 Total SA 6.3.4 Chevron Corporation 6.3.5 Exxon Mobil Corporation 7 MARKET OPPORTUNITIES AND FUTURE TRENDS For more information about this report visit https://www.researchandmarkets.com/r/dizdue", "role": "user" }, { "content": "Nigeria Oil & Gas Market Report 2020-2025: Growth, Trends, and Forecasts - ResearchAndMarkets.com", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: Launching Highly Dutch across Canada in the second half of September Bringing innovative products to market, including expanded RIPPLE suite of products Appointed new head of operations Signed distribution agreements for international exports to Australia/NZ TORONTO, Aug. 28, 2020 /PRNewswire/ -The Green Organic Dutchman Holdings Ltd. (the \"Company\" or \"TGOD\") (TSX: TGOD) (US: TGODF), a leading producer of premium certified organically grown cannabis, is pleased to provide an update on the progress of its corporate initiatives. Highly Dutch ExpansionTGOD successfully launched its mainstream brand, Highly Dutch, in Quebec at the end of May. Given strong sales, the Company looks forward to expanding to the balance of Canada in late September once it can build sufficient finished goods inventory to provide consistent supply to the market. TGOD also started production of Highly Dutch's 2.0 line-up with concentrates expected to be launched, beginning in Quebec, at the end of September. Product PortfolioTGOD introduced multiple 2.0 products during the second quarter, including RIPPLE dissolvables, teas and vapes. Based on the popularity of certain SKUs, the Company accelerated its innovation pipeline by signing an expanded licensing agreement with Colorado-based Stillwater Brands to bring their entire RIPPLE product suite to Canada, including RIPPLE Gummies and RIPPLE QuickSticks. By leveraging Stillwater Brands' proven formulations and intellectual property, TGOD has been able to develop products that are compliant to Canadian regulations at a much faster pace. Commercialization of RIPPLE Gummies is expected in the fourth quarter. TGOD also leveraged consumer insights to develop new product formats, including balanced CBD/THC and CBD only versions. Some of these new products are already in market, with the balance expected to be commercialized during the fourth quarter. Valleyfield Processing HubThe Company has reconfigured its Valleyfield facility, which is fully licensed, into a processing hub to support its product innovation pipeline and reduce its reliance on third parties. Processing of production has already commenced. In light of some capacity challenges with third party processing, the Company has chosen to now bringits production of premium organic teas and Ripple dissolvable powders in-house to its Valleyfield facility. This will allow for better control of quality, agility in shift staffing and capacity and importantly over the longer term should enable cost reduction allowing for better gross margins. This along with hash and chewables production is expected to help with capacity utilization and fixed cost absorption in its Valleyfield facility during Q4 2020. The transfer of equipment is planned during September.The Company anticipates modest start up costs in connection with this in-sourcing of the production of certain of its 2.0 products. TGOD has also signed co-packing and sales agreements with two licensed producers, further increasing the utilization and fixed cost absorption of Valleyfield. Operations and Leadership ChangesStart-up commissioning and calibrations challenges within the energy center at the company's Ancaster facility led to inconsistent climate controls in the hybrid greenhouse during the very hot weather in late July and early August which led to several recent August harvests not meeting the Company's strict premium flower specifications. As a result, most of the flower from these harvests will now be used for extraction. The Company along with its equipment vendors have since significantly reduced the energy center downtimes resulting in improved climate controls and the Company expects future harvests to meet its specifications. Some of the delays experienced by the Company resulted in lower than expected flower availability and a shifting of the national Highly Dutch expansion from Quebec to the balance of the country from August until the latter part of September. This is partially offset by further cost reductions identified by the Company, and the Company continues to expect to reach a monthly revenue run rate that delivers positive Canadian operating cash flow by the end of 2020. TGOD has recently made changes to its operations leadership structure and appointed Michel Gagn as Vice President, Operations. Mr. Gagn brings over 30 years of experience in the food and natural health products industries, having occupied leadership roles at Cargill and Maple Leaf Foods. International ExportsIn July, TGOD obtained a European Union Good Manufacturing Practice (\"EU-GMP\") certificate enabling it to commence exports to Germany for validation purposes. This process is expected to be completed by the end of the year, following which TGOD plan to begin exporting medical cannabis to Europe and other jurisdictions. In parallel, TGOD signed an exclusive distribution agreement for international exports to Australia and New Zealand with LeafCann. The Australian distributor will act as TGOD's exclusive agent for the Company's range of medical cannabis products in both countries. The Company expects its first commercial shipment during the first quarter of 2021. About The Green Organic Dutchman Holdings Ltd.The Green Organic Dutchman Holdings Ltd. (TSX:TGOD) (US-OTC: TGODF) is a premium certified organically grown cannabis company focused on the health and wellness market. Its organic cannabis is cultivated in living soil, as nature intended. The Company is committed to cultivating a better tomorrow by producing its products responsibly, with less waste and impact on the environment. Its two Canadian facilities have been builtto LEED certification standards and its products are sold in recyclable packaging. InCanada, TGOD sells dried flower and oil, and recently launched a series of next-generation cannabis products such as organic teas, dissolvables and vapes. Through its European subsidiary, HemPoland, the Company also distributes premium hemp CBD oil and CBD-infused topicals inEurope. By leveraging science and technology, TGOD harnesses the power of nature from seed to sale. TGOD's Common Shares and warrants issued under the indentures datedNovember 1, 2017 and December 19, 2019trade on the TSX under the symbol \"TGOD\", \"TGOD.WT\", \"TGOD.WS\" and \"TGOD.WR\", respectively, and TGODF trades in the US on the OTCQX. For more information on The Green Organic Dutchman Holdings Ltd., pleasevisit www.tgod.ca. Cautionary StatementsThis news release includes statements containing certain \"forward-looking information\" within the meaning of applicable securities law (\"forward-looking statements\"). Forward looking statements in this release include, but are not limited to, statements about new product launches, statements about the completion of validation of the Company's products for European export, statements about the export of the Company's medical products for commercial purposes to Europe and other jurisdictions, statements about the timing of international sales of the Company's products, statements about the Company's ability to offer certain products in certain jurisdictions and statements about the Company's ability to reach certain financial and operational milestones. Forward-looking statements are frequently characterized by words such as \"plan\", \"continue\", \"expect\", \"project\", \"intend\", \"should\", \"believe\", \"anticipate\", \"estimate\", \"may\", \"will\", \"potential\", \"proposed\" and other similar words, or statements that certain events or conditions \"may\" or \"will\" occur. These statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this news release. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made and are subject to a variety of risks and uncertainties (including market conditions) and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements, including those risk factors described in the Company's most recently filed Annual Information Form available on SEDAR. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law. Neither the TSX nor the TSX's Regulation Services Provider (as that term is defined in the policies of Toronto Stock Exchange) accept responsibility for the adequacy or accuracy of this release. SOURCE The Green Organic Dutchman Holdings Ltd. Related Links www.tgod.ca", "role": "user" }, { "content": "The Green Organic Dutchman Provides Corporate Update and Confirms Product Innovation Pipeline Expansion", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: NEW YORK, July 28, 2020 /PRNewswire/ --Silvercrest Asset Management Group Inc. (NASDAQ: SAMG) announced today it will host a teleconference at 8:30 am Eastern Time on August 4, 2020, to discuss the company's financial results for the second quarter ended June 30, 2020. A news release containing the results will be issued before the open of the U.S. equity markets and will be available on http://ir.silvercrestgroup.com/. Chairman, Chief Executive Officer and President Richard R. Hough III and Chief Financial Officer Scott A. Gerard will review the quarterly results during the call. Immediately after the prepared remarks, there will be a question and answer session for analysts and institutional investors. Analysts, institutional investors and the general public may listen to the call by dialing 1-844-836-8743 or for international callers please dial 1-412-317-5723. An archived replay of the call will be available after the completion of the live call on the Investor Relations page of the Silvercrest website at http://ir.silvercrestgroup.com/. The Company's Board of Directors today declared a quarterly dividend of $0.16 per share of Class A common stock.The dividend will be paid on or about September 18, 2020 to shareholders of record as of the close of business on September 11, 2020. About Silvercrest Silvercrest was founded in April 2002 as an independent, employee-owned registered investment adviser. With offices in New York, Boston, Virginia, New Jersey, California and Wisconsin, Silvercrest provides traditional and alternative investment advisory and family office services to wealthy families and select institutional investors. As of March 31, 2020, the firm reported assets under management of $20.6 billion. SOURCE Silvercrest Asset Management Group Inc. Related Links http://ir.silvercrestgroup.com", "role": "user" }, { "content": "Silvercrest Asset Management (SAMG) to Announce Second Quarter 2020 Results and Host Investor Conference Call", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: NEW YORK, Oct. 29, 2020 /PRNewswire/ --KEY FINDINGSThe global tampon market is estimated to project a CAGR of 4.52% in terms of revenue, and 4.83% in terms of volume, during the forecast period, 2021-2028. The factors propelling the market growth are the untapped opportunities in developing countries, the rising awareness regarding feminine hygiene products, and the availability of organic tampons.Read the full report: https://www.reportlinker.com/p05978376/?utm_source=PRN MARKET INSIGHTSTampons are considered to be one of the most affordable solutions for feminine hygiene protection, offering leakage protection and comfort in comparison to other alternatives.They are made of grade cotton and rayon.There is an increasing prioritization of the manufacture of tampons with 100% organic cotton.The growth of organic cotton does not entail synthetic pesticides or fertilizers.An organic cotton is a favorable option, given the increasing environmental concerns and growing focus on environment-friendly measures.Organic tampons are projected to be beneficial, since they are devoid of bleach and harmful chemicals.Thus, the rising concerns regarding female hygiene and the environment, are set to contribute to market growth. At the same time, the cost of tampons and the availability of substitutes are set to hinder the market growth.REGIONAL INSIGHTSThe geographical segmentation of the global tampon market includes the analysis of Europe, Asia Pacific, North America, and rest of world.North America is anticipated to dominate the global market with regard to revenue and volume by 2028.The rising awareness regarding the availability and benefits of tampons is the essential factor propelling market growth prospects in North America.COMPETITIVE INSIGHTSThe market has the presence of major international players.These players have huge product offerings, strong distribution network, and provide quality products in the market.Some of these big players in the market include Corman SPA, First Quality Enterprises Inc, Body Wise International, Edgewell Personal Care Company, Cohitech-Cotton High Tech SL, etc.Our report offerings include: Explore key findings of the overall market Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges) Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions Market Segmentation cater to a thorough assessment of key segments with their market estimations Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc. Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc. Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developmentsCompanies mentioned1. BODY WISE INTERNATIONAL2. CORMAN SPA3. COHITECH-COTTON HIGH TECH S.L4. EDGEWELL PERSONAL CARE COMPANY5. FIRST QUALITY ENTERPRISES INC6. JOHNSON & JOHNSON7. KAO CORPORATION8. KIMBERLY CLARK CORPORATION9. UNICHARM CORPORATION10. PROCTER & GAMBLE11. TZMO SA12. ESSITY AB13. CORA14. LIL LETS UK LTD15. UNILEVER PLCRead the full report: https://www.reportlinker.com/p05978376/?utm_source=PRN About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________ Contact Clare: [emailprotected] US: (339)-368-6001 Intl: +1 339-368-6001 SOURCE Reportlinker Related Links www.reportlinker.com", "role": "user" }, { "content": "The global tampon market is estimated to project a CAGR of 4.52% in terms of revenue, and 4.83% in terms of volume, during the forecast period, 2021-2028", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: DES MOINES, Iowa, April 7, 2020 /PRNewswire/ --Kemin Industries, a global ingredient manufacturer that strives to sustainably transform the quality of life every day for 80 percent of the world with its products and services,has launched a $1 million bonus program to express gratitude to its employees required to work on-site at Kemin facilities during the coronavirus (COVID-19) pandemic. As a manufacturer that produces ingredients and solutions used to protect the health and safety of our food supply, as well as humans, pets and animals, Keminis part of a \"Critical Infrastructure Sector\" as outlined by the U.S. Department of Homeland Security, permitting the company to continue operating with exemption during shelter-in-place and stay-at-home orders. \"Our work is vital to the world's food supply and we have continued operating and producing ingredients to make sure that our customers companies that are keeping grocery stores stocked have what they need to keep their products safe, healthy and available to consumers,\" said Dr. Chris Nelson, President and CEO, Kemin. \"We could not do this without the many individuals who show up to work every day, seven days a week, even as they manage the same uncertainty and stress surrounding us all during this unprecedented time.\" This bonus initative was created to show appreciation and thank team members in North America including Canada and Mexico whocannot work from home during stay-at-home mandates and shelter-in-place orders. Many of the essential jobs include handling inventory and equipment, production, research requiring a laboratory, security, facilities, process transactions, and those who facilitate the ability of other workers to do their jobs remotely. \"Despite the challenges that COVID-19 has brought us, Kemin team members have demonstrated infallible work ethic and a deep dedication to their role in protecting our food supply during this crisis,\" said Nelson. \"I'll never be able to fully convey how truly grateful I am for the effort these individuals put in every day. On behalf of the Nelson family, we hope this signifies how important our teams are to Kemin, our appreciation and how much they matter to our company.\" Kemin has implemented other bonus programs and initiatives to support teams at its global locations, including Europe, China and Singapore. About Kemin Industries Kemin Industries (www.kemin.com) is a global ingredient manufacturer that strives to sustainably transform the quality of life every day for 80 percent of the world with its products and services. The company supplies over 500 specialty ingredients for human and animal health and nutrition, pet food, aquaculture, nutraceutical, food technologies, crop technologies and textile industries. For over half a century, Kemin has been dedicated to using applied science to address industry challenges and offer product solutions to customers in more than 120 countries. Kemin provides ingredients to feed a growing population with its commitment to the quality, safety and efficacy of food, feed and health-related products. Established in 1961, Kemin is a privately held, family-owned-and-operated company with more than 2,800 global employees and operations in 90 countries, including manufacturing facilities in Belgium, Brazil, China, India, Italy, Russia, San Marino, Singapore, South Africa and the United States. Media Contact:Lauren M.G. Burt, Head of Worldwide Communications, [emailprotected], +1 515-249-4219 SOURCE Kemin Industries Related Links http://www.kemin.com", "role": "user" }, { "content": "Kemin Industries Announces $1 Million in Bonuses for Essential Employees During COVID-19 Pandemic North America employees in manufacturing, laboratory research and other essential on-site roles to receive special bonus", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: NEW YORK, April 6, 2021 /PRNewswire/ --The e-invoicing market is expected to grow by USD 15.49 billion during 2021-2025, according to Technavio. The report offers a detailed analysis of the impact of COVID-19 pandemic on the e-invoicing market in optimistic, probable, and pessimistic forecast scenarios. Enterprises will go through the Response, Recovery, and Renew phases.Download a Free Sample Report The e-invoicing market will witness a neutral impact during the forecast period owing to the widespread growth of the COVID-19 pandemic. As per Technavio's pandemic-focused market research, market growth is likely to increase as compared to 2020.With the continuing spread of the novel coronavirus pandemic, organizations across the globe are gradually flattening their recessionary curve by leveraging technology. Many businesses will go through response, recovery, and renewal phases. Building business resilience and enabling agility will aid organizations to move forward in their journey out of the COVID-19 crisis towards the Next Normal.This post-pandemic business planning research will aid clients to: Adjust their strategic planningto move ahead once business stability kicks in. Build Resilience bymaking effective resource and investment choicesfor individual business units, products, and service lines. Conceptualize scenario-based planningto mitigate future crisis situations. Download the Post-Pandemic Business Planning StructureKey Considerations for Market Forecast: Impact of lockdowns, supply chain disruptions, demand destruction, and change in customer behavior Optimistic, probable, and pessimistic scenarios for all markets as the impact of pandemic unfolds Pre- as well as post-COVID-19 market estimates Quarterly impact analysis and updates on market estimates Related Report on Information Technology Include: GlobalData Integration and Data Quality Tools Market- Global data integration and data quality tools market is segmented byend-user (large enterprises, government organizations, and SME) and geography (North America, Europe, APAC, South America, and MEA).Receive an Exclusive Free Sample ReportGlobalTechnical Support Outsourcing Market- Global technical support outsourcing market is segmented bytype (helpdesk and call center) and (APAC, Europe, MEA, North America, and South America).Receive an Exclusive Free Sample ReportMajor Three E-invoicing Market Participants: Basware Corp. The company offers invoice sending, invoice receiving, and supplier management solutions to meet a wide range of end-user requirements.Cegedim SA The company offers products such asGIS e-invoicing andjFSE.Comarch SA The company offers e-invoicing services that enable cost-effective handling of the invoice-related flow of electronic and paper in one integrated suite.If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE! Get a free sample report for adetailed market share analysis of market participants during COVID-19 lockdown:www.technavio.com/talk-to-us?report=IRTNTR41123E-invoicing Market 2021-2025: Segmentation E-invoicing market is segmented as below: End-user B2B B2C Geographic Europe APAC North America South America MEA The e-invoicing market is driven by the convenience and easy accessibility of mobile payment systems. In addition, the shift from capital expenditure model to operational expenditure model are expected to trigger the e-invoicing market toward witnessing a CAGR of over 28% during the forecast period.Get more insights into the global trends impacting the future of the e-invoicing marketRequest Free Sample ReportMarket DriversMarket ChallengesMarket TrendsVendor Landscape Vendors covered Vendor classification Market positioning of vendors Competitive scenario About UsTechnavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.ContactTechnavio ResearchJesse MaidaMedia & Marketing ExecutiveUS: +1 844 364 1100UK: +44 203 893 3200Email: [emailprotected]Website: www.technavio.com/Free Sample Report: www.technavio.com/report/e-invoicing-market-industry-analysisSOURCE Technavio Related Links http://www.technavio.com", "role": "user" }, { "content": "$ 15.49 Billion growth in Global E-invoicing Market featuring Basware Corp., Cegedim SA, and Comarch SA among others | Technavio Shape strategic responses through the phases of industry recovery", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: CHICAGO--(BUSINESS WIRE)--The Small Exchange, a futures exchange offering smaller, simpler products aimed toward retail customers, has launched Small Treasury Yield (S10Y) futures - the first product to afford customers the ability to trade treasury futures in yield not price. S10Y follows the 10-Year U.S. Treasury Yield, the most quoted interest rate in the US. Small Treasury Yield futures simplify variables in an otherwise complex asset class down to a single, succinct interest rate so traders can skip the calculations that translate yield to price. S10Y gives easy access to trade interest rates at their lowest levels in the history of Treasuries, creating a simple trade on the return to normal or fall to negative, where many global rates already are. We believe the Small 10YR US Treasury Yield is a true differentiator in the futures space, and nothing like this is available for traders in the equity or ETF world, said Don Roberts, the Small Exchange President and CEO. Our whole mission is to continue creating new products for investors that enable more opportunities within the futures marketplace. We wouldnt be able to do this without market participants like Interactive Brokers and MarketAxess. Interactive Brokers (Nasdaq: IBKR), an automated global electronic broker and a minority investor to the Small Exchange, is now offering S10Y to its customer base. Interactive Brokers focuses on providing our clients with superior pricing, advanced technology and breadth of product around the globe, said Interactive Brokers CEO Milan Galik. We serve more than a million clients worldwide and strive to provide them with innovative products. We look forward to offering them access to the Small Exchanges new interest rate future. The Small Treasury Yield is based on real-time U.S. Treasury data provided by MarketAxess, the operator of a leading electronic trading platform for fixed-income securities, and the provider of market data and post-trade services for the global fixed-income markets. As a leading fixed income trading marketplace and offering in-depth market data, our focus aligns with Small Exchanges vision to develop solutions that drive liquidity in the U.S. Treasury market, said Kat Tatochenko, Global Head of Data, MarketAxess. By enabling traders to uncover new trading opportunities through robust data, we are putting traders in the drivers seat and reshaping the bond markets. As of December 1, 2020, the Small Exchange has 21 partners including some of the worlds largest trading firms and market makers. It has launched 5 products including a suite of Equity indices, Global Dollar Index, and Precious Metals Index. To learn more about the Small Exchanges offering, visit www.thesmallexchange.com. About Small Exchange: Based in Chicago, The Small Exchange - backed by award-winning industry innovators and powered by a proprietary trade matching engine - is a registered Designated Contract Market (DCM) with the Commodity Futures Trading Commission (CFTC). The Small Exchanges mission is to become the worlds largest customer-centric futures exchange, bringing products that bridge the product gap for investors of all sizes by providing futures products that are smaller, capital efficient, simple to use, and easy to understand for all participants. The company will facilitate the trading of exchange-created proprietary products for all types of market participants including, but not limited to market-makers/liquidity providers, Introducing Brokers (IBs), Futures Commission Merchants (FCMs), proprietary trading firms and hedge funds, all with a primary focus on the public retail customer. Please visit www.thesmallexchange.com for more information. About Interactive Brokers Group, Inc.: Interactive Brokers Group provides automated trade execution and custody of securities, commodities and foreign exchange around the clock on over 135 markets in numerous countries and currencies, from a single IBKR Integrated Investment Account to clients worldwide. The platform services individual investors, hedge funds, proprietary trading groups, financial advisors and introducing brokers. Our four decades of focus on technology and automation has enabled us to equip our clients with a uniquely sophisticated platform to manage their investment portfolios. We strive to provide our clients with advantageous execution prices and trading, risk and portfolio management tools, research facilities and investment products, all at low or no cost, positioning them to achieve superior returns on investments. About MarketAxess: MarketAxess operates a leading, institutional electronic trading platform delivering expanded liquidity opportunities, improved execution quality and significant cost savings across global fixed-income markets. A global network of over 1,700 firms, including the worlds leading asset managers and institutional broker-dealers, leverages MarketAxess patented trading technology to efficiently trade bonds. MarketAxess award-winning Open Trading marketplace is regarded as the preferred all-to-all trading solution in the global credit markets, creating a unique liquidity pool for a broad range of credit market participants. Drawing on its deep data and analytical resources, MarketAxess provides automated trading solutions, market data products and a range of pre- and post-trade services. MarketAxess is headquartered in New York and has offices in London, Amsterdam, Boston, Chicago, Los Angeles, Miami, San Francisco, So Paulo, Hong Kong and Singapore. For more information, please visit www.marketaxess.com.", "role": "user" }, { "content": "The Small Exchange Launches New 10-Year Treasury Yield Future Small Treasury Yield / S10Y Is the First Product that Allows Trading of Treasury Futures in Yield", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: JACKSONVILLE, Fla., Jan. 21, 2021 /PRNewswire/ --Entrepreneurmagazine hasnamedBrightway Insuranceto its Franchise 500list for the eighth time. Recognized as an invaluable resource for potential franchisees, the Franchise 500 ranks Brightway No. 190 for its outstanding performance in areas including unit growth, financial strength and stability and brand power. The national insurance distribution company climbed 64 spots in the ranking from last year. View Brightway's profile on Entrepreneur.com. (PRNewsfoto/Brightway Insurance) \"We're honored to earn a place on Entrepreneur's Franchise 500 once again asone of the top franchises in North America,\" said BrightwayPresident and CEO, Michael Miller, who co-founded Brightway with his brother, David, in 2008. \"While tragic, the pandemic gave us an opportunity to continue to innovate and, in June, we launched a brand-new franchise model that reduces many barriers for people who want to build their own business and legacy with Brightway. This new, lower investment model was extremely well received and led to record franchise sales for the company in 2020. We are very well positioned to nearly double our Agency footprint across the U.S. in 2021.\" The key factors that go into Entrepreneur's evaluation include costs and fees, size and growth, support, brand strength and financial strength and stability. Each franchise is given a cumulative score based on an analysis of more than 150 data points from information collected in late July 2020, and the 500 franchises with the highest cumulative scores become the Franchise 500 in ranking order. \"2020 was a challenging year for everyone, but it was also a year of unusual opportunity,\" said Jason Feifer, Entrepreneur editor-in-chief. \"Franchises were able to be nimble and innovative, serving the needs of franchisees and customers in ways that will resonate for many years to come. We believe that, when we eventually look back on this time, we'll see it as a moment when many brands defined themselves for the future.\"To view Brightway in the full ranking, visit Entrepreneur.com/Franchise500. Results can also be seen in the January/February 2021 issue of Entrepreneur, available on newsstands Jan. 26.Brightway'slow-risk, high-reward business opportunities allow people from a wide variety of backgrounds to prosper. Nearly 400 insurance experts provide training and support in areas including Customer Service, Accounting, Marketing, Distribution, Business Analytics, Carrier Relations and Appointments, Licensing, Onboarding, Training, Hiring and Retaining personnel. The company's signature after-the-sale service empowers franchisees to focus on new business sales and provides their customers the personalized service they deserve. Here is what some Franchise Owners had to say about franchising with Brightway.\"Brightway continues to exceed and excel with any promised benefits in the platform,\" said Multi-unit Owner, Ken Toney. \"I am very satisfied with Brightway.\" \"Training was excellent, and the support has been great as well,\" said Rebecca Nadelhoffer, who co-owns a Brightway Agency in Warrenville, Illinois, with her husband, Matt Nadelhoffer. If you are interested in becoming a Brightway Franchise Owner, please complete this online form or email [emailprotected]. About Brightway InsuranceBrightway Insurance is a national property/casualty insurance distribution company with more than $750 million in annualized written premium, making it one of the largest Personal Lines agencies in the U.S. Brightway's focus is on producing Win, Win, Win outcomes for consumers by offering customized insurance solutions and for people wishing to sell insurance by providing business opportunities that span from single Agent to multi-unit enterprises. Regardless of the path taken, Brightway provides the support necessary to consistently outsell other insurance agents. Brightway got its start in 2008 and has since grown to more than 900 people in 283 officesacross 24 states serving customers in all 50 states. Consumers seeking a better insurance buying experience may visit Brightway.com, and people wishing to learn more about franchise ownership with Brightway may visit BrightwayDifference.com. SOURCE Brightway Insurance", "role": "user" }, { "content": "Brightway Insurance jumps 64 spots on Entrepreneur's top franchises list, makes list eighth time - National insurance distribution company garnered recognition 13 times in 2020 as a best-in-class franchise. -", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: RICHMOND, Va., Dec. 15, 2020 /PRNewswire/ -- Essex Bank, the banking subsidiary of Community Bankers Trust Corporation (NASDAQ: ESXB), announced today that Patricia M. Davis, the Bank's Executive Vice President and Chief Credit Officer, will resign from the Bank effective February 28, 2021. Her decision to resign is due to a relocation outside of the Bank's market area for family reasons. Rex L. Smith, III, President and Chief Executive Officer of Community Bankers Trust Corporation and Essex Bank, stated, \"On behalf of our Board of Directors and the management team, we are very grateful for everything that Patti has improved in our credit function, especially over the past six years. Her leadership has been integral in enhancing our credit structure and otherwise maintaining our high standards for safety and soundness. Patti has also overseen the Bank's handling of troubled borrowers during this year's pandemic, and we find ourselves in as good a position as possible through the strong customer relationships on which we pride ourselves. Patti has created a strong team that has put in place a credit culture that will allow for an easy transition to her successor.\" The Bank will appoint a new Chief Credit Officer following internal and external executive searches. About Community Bankers Trust Corporation and Essex Bank Community Bankers Trust Corporation is the holding company for Essex Bank, a Virginia state bank with 24 full-service offices, 18 of which are in Virginia and six of which are in Maryland. The Bank also operates two loan production offices. Additional information on the Bank is available on the Bank's website at www.essexbank.com. For information on Community Bankers Trust Corporation, please visit its website at www.cbtrustcorp.com. Forward-Looking Statements This press release contains forward-looking statements about the Company's goals and objectives. These statements are made on the basis of the Company's views and assumptions as of this time, and the Company undertakes no obligation to update these statements unless required by law. These statements are not a guarantee of future performance, and actual events or results may differ materially from these statements. Investors should consult the periodic and other reports that the Company files from time to time with theSecurities and Exchange Commission(including the information set forth under the caption \"Risk Factors\" in each of the Company's Annual Report on Form 10-K for the year endedDecember 31, 2019 and its Quarterly Report on Form 10-Q for the period ended September 30, 2020) for information about certain factors, risks and uncertainties that could cause such differences. Copies of these filings may be obtained by visiting the Company's website atwww.cbtrustcorp.com. SOURCE Community Bankers Trust Corporation Related Links http://www.cbtrustcorp.com", "role": "user" }, { "content": "Essex Bank Announces Resignation of Chief Credit Officer", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: SHANGHAI, April 30, 2020 /PRNewswire/ -- Global leading semiconductor microsystem integration packaging and test provider, JCET Group (SH: 600584) reported the financial results for Q1 2020, ended March 31, 2020. Q1 2020 financial highlights: Revenue was RMB 5,708 million, a record high in the first quarter. On a comparable basis, taking into account the accounting change in revenue recognition, it was an increase of 44.2% year on year (see note*). Generated RMB 1,149 million cash from operations, up 579% year on year. With net capex investments of RMB 671 million, the free cash flow for the quarter was RMB 478 million. Net profit was RMB 133.8 million, a record first quarter high in the past five years. Earnings per share was 0.08 RMB, as compared to -0.03 in Q1 2019. Note*:During the reporting period, we optimized the business model for the purchase and sale of certain packaged products, of which JCET Group no longer bears the general inventory risk on the main raw materials. In accordance with PRC GAAP, both revenue and costs of goods sold were recorded on the net basis and decreased by RMB 803 million respectively in the reporting period. This change had no impact on the company's net profit. Assuming that revenue was still recognized by the gross method (should be recorded on the net basis according to PRC GAAP), it would be RMB 6,511 million, an increase of 44.2% over the same period last year. JCET Group CFO Ms. Janet Chou said, \"JCET Group has been a leading innovator in System in Package, Wafer Level and Flip Chip advanced microsystem integration technologies for years. The ramping up of 5G market segments provided a perfect match for JCET Group's advanced technologies and manufacturing capabilities. JCET Group overcame the impact of Covid-19 and went against the industry trend, with revenues of RMB 5,708 million which was a record high for the first quarter.\" About JCET Group: JCET Group is a leading global semiconductor microsystem integration packaging and test provider, offering a full range of turnkey services that include semiconductor package integration design and characterization, R&D, wafer probe, wafer bumping, package assembly, final test and drop shipment to vendors around the world. Our comprehensive portfolio covers a wide spectrum of semiconductor applications such as mobile, communication, compute, consumer, automotive and industry etc., through advanced wafer level packaging, 2.5D/3D, System-in-Packaging, and reliable flip chip and wire bonding technologies. JCET Group has three R&D centers, six manufacturing locations in China, Singapore and Korea, and sales centers around the world, providing close technology collaboration and efficient supply-chain manufacturing to customers in China and around the world. CONSOLIDATED BALANCE SHEET (Unaudited) 31 March 2020 Expressed in Renminbi Yuan ASSETS 31 March 2020 31 December 2019 Current assets Currency funds 2,667,287,264.14 2,569,393,396.00 Derivative financial assets 180,674.37 4,119,413.24 Accounts receivable 3,004,234,491.07 3,349,731,893.13 Receivables financing 39,363,670.87 67,584,630.96 Prepayments 212,443,068.51 187,863,377.10 Other receivables 9,293,025.43 10,944,727.48 Inventories 2,581,182,782.87 2,730,914,425.68 Current portion of non-current assets 137,458,152.98 137,458,152.98 Other current assets 366,923,222.68 501,350,372.47 Total current assets 9,018,366,352.92 9,559,360,389.04 Non-current assets Long-term receivables 38,975,986.44 40,222,976.53 Long-term equity investments 966,281,402.61 971,660,594.36 Other equity investments 526,890,056.51 517,049,881.56 Investment properties 98,957,148.36 99,877,458.60 Fixed assets 17,630,171,071.32 17,798,818,045.91 Construction in progress 1,543,924,889.46 1,664,082,709.03 Intangible assets 592,018,291.59 586,737,281.83 Goodwill 2,261,147,119.92 2,213,786,772.01 Long-term prepaid expenses 1,034,770.80 1,256,235.80 Deferred tax assets 122,964,117.85 128,106,315.77 Other non-current assets 738,596.31 934,907.57 Total non-current assets 23,783,103,451.17 24,022,533,178.97 Total assets 32,801,469,804.09 33,581,893,568.01 CONSOLIDATED BALANCE SHEET (CONTINUED) (Unaudited) 31 March 2020 Expressed in Renminbi Yuan LIABILITIES AND EQUITY 31 March 2020 31 December 2019 Current liabilities Short-term borrowings 6,788,675,448.76 9,098,056,842.77 Derivative financial liabilities 129,247,374.07 160,941,443.47 Notes payable 652,010,110.73 958,145,682.25 Accounts payable 4,024,475,573.16 4,617,703,102.89 Receipts in advance 0.00 112,646,926.13 Contract liabilities 73,173,140.74 0.00 Employee benefits payable 505,569,143.68 586,441,964.86 Taxes and surcharges payable 60,748,543.35 53,226,873.84 Other payables 207,479,982.69 235,425,281.38 Current portion of non-current liabilities 1,841,259,569.03 1,826,772,611.88 Total current liabilities 14,282,638,886.21 17,649,360,729.47 Non-current liabilities Long-term borrowings 3,037,255,169.36 1,584,384,891.47 Bonds payable 1,000,000,000.00 0.00 Long-term payables 1,071,924,846.56 1,215,622,628.92 Long-term employee benefits payable 2,045,009.96 1,405,672.34 Deferred income 327,442,496.71 336,470,799.39 Deferred tax liabilities 176,941,252.41 156,293,450.06 Total non-current liabilities 5,615,608,775.00 3,294,177,442.18 Total liabilities 19,898,247,661.21 20,943,538,171.65 Equity Paid-in capital 1,602,874,555.00 1,602,874,555.00 Surplus reserves 10,242,039,552.06 10,242,039,552.06 Accumulated other comprehensive income 559,711,303.19 428,946,927.71 Specialised reserves 122,283,975.32 122,283,975.32 Unappropriated profit 365,073,592.09 231,285,970.34 Total equity attributable to owners of the parent 12,891,982,977.66 12,627,430,980.43 Minority shareholders 11,239,165.22 10,924,415.93 Total equity 12,903,222,142.88 12,638,355,396.36 Total liabilities and equity 32,801,469,804.09 33,581,893,568.01 CONSOLIDATED INCOME STATEMENT (Unaudited) For The Three Months Ended 31 March 2020 Expressed in Renminbi Yuan For The Three Months Ended of March 31 2020 2019 Revenue 5,708,103,216.96 4,514,773,490.97 Less: Cost of sales 4,960,479,797.74 4,148,858,484.70 Taxes and surcharges 8,496,390.50 8,427,302.31 Selling expenses 56,415,920.92 64,459,043.18 Administrative expenses 209,175,100.75 245,961,758.35 Research and development expenses 214,447,183.03 172,776,325.03 Finance expenses 146,866,963.10 247,960,718.09 Including: Interest expenses 153,627,683.35 197,226,529.98 Interest income 8,963,046.00 7,448,691.54 Add:Other income 34,096,572.65 143,267,973.38 Investment income -1,355,424.01 -1,366,630.50 Including: Income from investments in associates and joint ventures (loss is expressed by\"-\") -1,355,424.01 -1,366,630.50 Loss on the net position hedging (loss is expressed by\"-\") -1,677,212.22 0.00 Credit impairment losses (loss is expressed by\"-\") 4,897,177.94 1,461,773.07 Impairment losses (loss is expressed by\"-\") 3,476,919.20 3,001,528.85 Profit/Loss on disposal of assets (loss is expressed by\"-\") 3,595,368.41 -64,624.42 Operating profit/(loss) 155,255,262.89 -227,370,120.31 Add: Non-operating income 129,297.09 472,293.14 Less: Non-operating expenses 5,920,556.72 3,532,845.12 Profit/(loss) before income taxes 149,464,003.26 -230,430,672.29 Less: Income tax expenses 15,361,632.22 -184,374,430.08 Net Profit/(loss) 134,102,371.04 -46,056,242.21 Classified by continuity of operations Profit/(loss) from continuing operations 134,102,371.04 -46,056,242.21 Classified by ownership Net Profit/(loss) attributable to owners of the parent 133,787,621.75 -46,516,845.29 Net Profit/(loss) attributable to minority shareholders 314,749.29 460,603.08 CONSOLIDATED INCOME STATEMENT (CONTINUED) (Unaudited) For The Three Months Ended 31 March 2020 Expressed in Renminbi Yuan For The Three Months Ended of March 31 2020 2019 Other comprehensive income, net of tax 130,764,375.48 -212,318,509.95 Comprehensive income attributable to owners of the parent 130,764,375.48 -212,318,509.95 Comprehensive income to be reclassified to profit or loss 130,764,375.48 -212,318,509.95 Comprehensive income using the equity method 148,427.34 0.00 Cash flow hedge reserve -2,186,816.98 3,293,829.91 Exchange differences of foreign currency financial statements 132,802,765.12 -215,612,339.86 Total comprehensive income 264,866,746.52 -258,374,752.16 Including: Total comprehensive income attributable to owners of the parent 264,551,997.23 -258,835,355.24 Total comprehensive income attributable to minority shareholders 314,749.29 460,603.08 Earnings per share Basic earnings per share 0.08 -0.03 Diluted earnings per share 0.08 -0.03 CONSOLIDATED CASH FLOW STATEMENT (Unaudited) For The Three Months Ended 31 March 2020 Expressed in Renminbi Yuan For The Three Months Ended of March 31 2020 2019 1 CASH FLOWS FROM OPERATING ACTIVITIES Cash receipts from the sale of goods and the rendering of services 6,034,987,407.22 5,409,211,254.94 Receipts of taxes and surcharges refunds 222,820,490.19 84,045,680.63 Other cash receipts relating to operating activities 292,911,054.91 166,305,244.26 Total cash inflows from operating activities 6,550,718,952.32 5,659,562,179.83 Cash payments for goods and services 4,225,366,613.14 4,274,933,708.31 Cash payments to and on behalf of employees 958,765,445.26 961,621,785.97 Payments of all types of taxes and surcharges 89,648,853.34 118,435,872.25 Other cash payments relating to operating activities 128,353,850.33 135,377,603.19 Total cash outflows from operating activities 5,402,134,762.07 5,490,368,969.72 Net cash flows from operating activities 1,148,584,190.25 169,193,210.11 2 CASH FLOWS FROM INVESTING ACTIVITIES Cash receipts from returns of investments 72,000.00 15,900,000.00 Cash receipts from investment income 36,000.00 23,850,000.00 Net cash receipts from disposal of fixed assets, intangible assets and other long-term assets 6,683,773.20 5,781,022.60 Other cash receipts relating to investing activities 0.00 20,000,000.00 Total cash inflows from investing activities 6,791,773.20 65,531,022.60 Cash payments to acquire fixed assets, intangible assets and other long-term assets 677,493,801.79 589,599,854.74 Total cash outflows from investing activities 677,493,801.79 589,599,854.74 Net cash flows from investing activities -670,702,028.59 -524,068,832.14 CONSOLIDATED CASH FLOW STATEMENT (CONTINUED) (Unaudited) For The Three Months Ended 31 March 2020 Expressed in Renminbi Yuan For The Three Months Ended of March 31 2020 2019 3 CASH FLOWS FROM FINANCING ACTIVITIES Cash receipts from borrowings 5,930,556,630.68 5,861,598,188.73 Total cash inflows from financing activities 5,930,556,630.68 5,861,598,188.73 Cash repayments for debts 5,748,192,045.98 6,827,205,711.73 Cash payments for distribution of dividends or profit and interest expenses 163,937,060.56 301,119,352.01 Other cash payments relating to financing activities 173,393,562.04 432,652,569.27 Total cash outflows from financing activities 6,085,522,668.58 7,560,977,633.01 Net cash flows from financing activities -154,966,037.90 -1,699,379,444.28 4 EFFECT OF EXCHANGE RATE CHANGES ON CASH AND CASH EQUIVALENTS 22,800,903.29 -20,118,766.71 5 NET INCREASE IN CASH AND CASH EQUIVALENTS 345,717,027.05 -2,074,373,833.02 Add: Cash and cash equivalents at beginning of the year 1,865,553,082.53 4,206,347,524.52 6 CASH AND CASH EQUIVALENTS AT END OF THE YEAR 2,211,270,109.58 2,131,973,691.50 SOURCE JCET Group", "role": "user" }, { "content": "JCET Group Records Strong Performance in Q1", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: DALLAS, May 5, 2020 /PRNewswire/ -- RateGain, a leading SaaS company for travel and hospitality, today announced the release of the second edition of the report on assessing the global impact of COVID-19 on the hospitality industry in collaboration with IDeaS and HSMAI Europe. The report tracks week-wise room reservations & cancellation trends from over 20+ countries across the globe, giving a comprehensive view of the current state of the industry and strategies that hospitality professionals can leverage to cope with the crisis. The second edition of the report compares data from February 1st to April 19th 2020, with the previous year to determine if the overall health of the industry was improving compared to the first edition that was released in March, which confirmed a 16% decline in reservations. In the latest edition, 18 destination countries out of 20 show considerable improvement with Argentina (60%), Brazil (45%), Czech Republic (65%), Japan (28%), Mexico (33%), Oman (67%) leading those trends in 'week over week' reservations observed till week ending April 19th. Commenting on the report, Harmeet Singh, CEO-RateGain, said, \"While the outbreak of COVID-19 is affecting hotels' forward reservations, there are recovery efforts being made by industry associations, governments, hotel chains, technology organizations and tourism boards. With all of us working together, we believe that the markets will recover faster,\" said Harmeet Singh, CEO, RateGain. \"However, what's most important between now and the post-corona era is the continuous preparation for the recovery. The second edition of the study COVID-19 & The Hospitality Industry Worldwide is, therefore, an effort to help the industry learn from the country-wise hotel reservation and cancellation trends, to understand the market pulse, respond to critical developments, revisit the short-term revenue management strategies, and prepare for the recovery.\" The report findings also suggest that as a region, except the Asia Pacific, Europe, Americas, and the Middle East are not only seeing a recovery in reservations but also seeing a higher number of reservations as compared to 2019 levels, however, this growth is offset by an increase in cancellations as well, with lockdown measures being extended in some markets. \"During this difficult time, we understand and sympathize with the challenges our clients face today and in the coming months. Our strategic collaboration with RateGain is focused on bringing added value to our common clients to ensurethey can integrate rate shopping data seamlessly with our revenue science. We continue to work with our partners and our customers to provide the industry with tangible advice to help all involved come out of these challenging times together while helpingrevenue managers make informed decisions based on these combined insights. Stay strong, and we will weather this storm together,\" said Ravi Mehrotra, President, Founder & Chief Scientist, IDeaS Revenue Solutions. In addition to providing free analysis and coping strategies, RateGain is also committed to 1000+ hours of free consulting sessions to help travel and hospitality professionals with coping strategies and steps towards a better tomorrow. About RateGain: RateGain is a leading provider of SaaS products, which help travel and hospitality companies with cognitive revenue management, smart e-distribution, and brand engagement to make more revenue every day. For more information, visit www.rategain.com About IDeaS:IDeaS, a SAS company, is the world's leading provider of revenue management software and services. With over 30 years of expertise, IDeaS delivers revenue science to more than 13,000 clients in 129 countries. Discover greater profitability at ideas.com Media contact: Ankit ChaturvediAVP-Marketing [emailprotected]+91-9654502760 SOURCE RateGain", "role": "user" }, { "content": "RateGain's New Global Report on Impact of COVID-19 on Hospitality Shows Recovery in Key Markets", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: LONDON--(BUSINESS WIRE)-- Xtrackers Investment company with variable capital (Socit d'investissement capital variable) Registered office: 49, avenue J.F. Kennedy, L-1855 Luxembourg R.C.S. Luxembourg B-119.899 (the Company) NOTICE TO SHAREHOLDERS OF THE SUB-FUNDS LISTED ON THE LONDON STOCK EXCHANGE Luxembourg, 24 August 2020 The board of directors of the Company (the Board of Directors) hereby informs all shareholders of the sub-funds listed in the table below (each a Sub-Fund, and together the Sub-Funds) (the Shareholders) of the applicable net asset value (the NAV) in respect of each Sub-Fund for the below stated Transaction Day: Sub-Fund ISIN Outstanding Shares Currency Transaction Day NAV LEI Xtrackers CSI300 Swap UCITS ETF 1C LU0779800910 43,783,833 USD 24-Aug-2020 15.6546 549300DUCO0U5J4KFZ65 Xtrackers DAX Income UCITS ETF 1D LU0838782315 4,500,000 EUR 24-Aug-2020 103.7003 549300FN63CGIEPOGE29 Xtrackers DAX UCITS ETF 1C LU0274211480 29,953,192 EUR 24-Aug-2020 125.5429 5493003ZDIEI2DLBMZ44 Xtrackers DBLCI Commodity Optimum Yield Swap UCITS ETF 2C LU0460391732 3,094,968 USD 24-Aug-2020 21.1072 549300UM261GC7JDGU46 Xtrackers DBLCI Commodity Optimum Yield Swap UCITS ETF 3C - GBP Hedged LU0460391906 378,236 GBP 24-Aug-2020 19.9377 549300UM261GC7JDGU46 Xtrackers Euro Stoxx 50 Short Daily Swap UCITS ETF 1C LU0292106753 20,666,868 EUR 24-Aug-2020 11.5583 549300VJTTGNE658W265 Xtrackers Euro Stoxx 50 UCITS ETF 1C LU0380865021 69,992,490 EUR 24-Aug-2020 50.2157 5493007YS2I1OGP7ST09 Xtrackers Euro Stoxx 50 UCITS ETF 1D LU0274211217 69,373,480 EUR 24-Aug-2020 34.9915 5493007YS2I1OGP7ST09 Xtrackers Euro Stoxx Quality Dividend UCITS ETF 1D LU0292095535 9,029,481 EUR 24-Aug-2020 18.3913 549300I932FBWNXRYR96 Xtrackers FTSE 100 Income UCITS ETF 1D LU0292097234 9,944,003 GBP 24-Aug-2020 6.1318 549300XQ6CCZ8UFWF453 Xtrackers FTSE 100 Short Daily Swap UCITS ETF 1C LU0328473581 6,828,698 GBP 24-Aug-2020 4.0622 549300YUDYTSCUJ56A32 Xtrackers FTSE 100 UCITS ETF 1C LU0838780707 7,500,000 GBP 24-Aug-2020 8.0187 549300ZQ0XR3XXOVCN64 Xtrackers FTSE 250 UCITS ETF 1D LU0292097317 2,808,052 GBP 24-Aug-2020 17.1474 549300VOW6BRPSKX2S03 Xtrackers FTSE All-Share UCITS ETF 1D LU0292097747 13,101,270 GBP 24-Aug-2020 3.3398 549300HW2T02FJGTP634 Xtrackers FTSE China 50 UCITS ETF 1C LU0292109856 2,840,696 USD 24-Aug-2020 41.9548 549300QR8I67KKNOQS90 Xtrackers FTSE Developed Europe Real Estate UCITS ETF 1C LU0489337690 17,168,354 EUR 24-Aug-2020 24.9046 549300I6RS87TDT7B025 Xtrackers FTSE Vietnam Swap UCITS ETF 1C LU0322252924 8,296,127 USD 24-Aug-2020 27.7178 549300WSGH3OZP0CTO20 Xtrackers Harvest CSI300 UCITS ETF 1D LU0875160326 44,229,395 USD 24-Aug-2020 13.5044 549300GBJ3MHFG0ZA036 Xtrackers Harvest FTSE China A-H 50 UCITS ETF 1D LU1310477036 350,000 USD 24-Aug-2020 32.6338 549300TI9U1U5PV12W66 Xtrackers LevDAX Daily Swap UCITS ETF 1C LU0411075376 472,340 EUR 24-Aug-2020 109.838 549300ZNH3F02BUTHC48 Xtrackers LPX Private Equity Swap UCITS ETF 1C LU0322250712 2,166,113 EUR 24-Aug-2020 58.8956 549300GBERNOIEVW4626 Xtrackers MSCI AC Asia ex Japan Swap UCITS ETF 1C LU0322252171 10,954,363 USD 24-Aug-2020 50.054 5493008RMHPSOU8YK549 Xtrackers MSCI Africa Top 50 Swap UCITS ETF 1C LU0592217524 4,211,000 USD 24-Aug-2020 6.5797 5493008JIICCGDRJSG92 Xtrackers MSCI Brazil UCITS ETF 1C LU0292109344 3,343,577 USD 24-Aug-2020 36.2927 549300FACBRLQX0QWG34 Xtrackers MSCI Canada UCITS ETF 1C LU0476289540 4,872,400 USD 24-Aug-2020 54.9647 54930044H07NIEDYO740 Xtrackers MSCI China UCITS ETF 1C LU0514695690 70,194,000 USD 24-Aug-2020 22.4916 549300OZ47J75ZDOA820 Xtrackers MSCI EM Asia Swap UCITS ETF 1C LU0292107991 10,031,466 USD 24-Aug-2020 58.4462 549300Z4GYCGHAKKYJ34 Xtrackers MSCI EM Europe, Middle East & Africa Swap UCITS ETF 1C LU0292109005 1,593,728 USD 24-Aug-2020 25.9657 549300MQVYIX98ON7X65 Xtrackers MSCI EM Latin America Swap UCITS ETF 1C LU0292108619 1,465,344 USD 24-Aug-2020 34.322 549300GABFBJGTJ62T14 Xtrackers MSCI Emerging Markets Swap UCITS ETF 1C LU0292107645 23,508,256 USD 24-Aug-2020 48.5424 5493009RXMI1GTHXHW95 Xtrackers MSCI EMU UCITS ETF 1C - USD Hedged LU1127514245 3,970,085 USD 24-Aug-2020 43.4831 549300ALO47Q7LCTU516 Xtrackers MSCI EMU UCITS ETF 1D LU0846194776 48,683,967 EUR 24-Aug-2020 37.4542 549300ALO47Q7LCTU516 Xtrackers MSCI EMU UCITS ETF 2C - GBP Hedged LU1127516455 2,936,923 GBP 24-Aug-2020 21.1981 549300ALO47Q7LCTU516 Xtrackers MSCI Europe Mid Cap UCITS ETF 1C LU0322253732 322,000 USD 24-Aug-2020 122.9969 549300K53ZG6VNCNTO67 Xtrackers MSCI Europe Small Cap UCITS ETF 1C LU0322253906 12,533,106 USD 24-Aug-2020 51.5399 5493001NKFFQ8J34H446 Xtrackers MSCI Europe UCITS ETF 1C LU0274209237 43,509,306 USD 24-Aug-2020 68.1049 549300QWP0OM04U4LX10 Xtrackers MSCI Europe UCITS ETF 2C - USD Hedged LU1184092051 9,367,602 USD 24-Aug-2020 10.5291 549300QWP0OM04U4LX10 Xtrackers MSCI India Swap UCITS ETF 1C LU0514695187 6,851,369 USD 24-Aug-2020 11.4624 549300J934WHEYR4LT41 Xtrackers MSCI Indonesia Swap UCITS ETF 1C LU0476289623 8,249,732 USD 24-Aug-2020 13.0112 549300FSAG1G3WU5LK58 Xtrackers MSCI Japan UCITS ETF 1C LU0274209740 25,527,709 USD 24-Aug-2020 62.7309 549300B0RUOTF8LWQ776 Xtrackers MSCI Japan UCITS ETF 2D - USD Hedged LU0927735406 3,511,530 USD 24-Aug-2020 21.7296 549300B0RUOTF8LWQ776 Xtrackers MSCI Japan UCITS ETF 6C - GBP Hedged LU0659580236 446,203 GBP 24-Aug-2020 22.618 549300B0RUOTF8LWQ776 Xtrackers MSCI Korea UCITS ETF 1C LU0292100046 1,261,413 USD 24-Aug-2020 73.2108 549300Y0H4IVGKEBIM20 Xtrackers MSCI Malaysia UCITS ETF 1C LU0514694370 1,490,480 USD 24-Aug-2020 11.4438 549300BXNTQ5VE1SHW51 Xtrackers MSCI Mexico UCITS ETF 1C LU0476289466 12,675,000 USD 24-Aug-2020 3.4082 549300WGVCCZ68BCH050 Xtrackers MSCI Pacific ex Japan UCITS ETF 1C LU0322252338 8,712,046 USD 24-Aug-2020 59.9229 549300PKYNYSI1CU4632 Xtrackers MSCI Pakistan Swap UCITS ETF 1C LU0659579147 13,294,963 USD 24-Aug-2020 1.01 549300IQ0LV3B2XIAB10 Xtrackers MSCI Philippines UCITS ETF 1C LU0592215403 21,906,233 USD 24-Aug-2020 1.5029 549300KHZS63S3BR2C61 Xtrackers MSCI Russia Capped Swap UCITS ETF 1C LU0322252502 3,175,470 USD 24-Aug-2020 30.8086 54930048GQK613KCU539 Xtrackers MSCI Taiwan UCITS ETF 1C LU0292109187 4,124,760 USD 24-Aug-2020 38.7326 549300BS2LKA0BJFCB15 Xtrackers MSCI Thailand UCITS ETF 1C LU0514694701 1,400,385 USD 24-Aug-2020 20.7897 5493006C4G53ZKBJ4S76 Xtrackers MSCI USA Swap UCITS ETF 1C LU0274210672 29,544,118 USD 24-Aug-2020 96.7251 549300F8SBBH8DIC4B04 Xtrackers MSCI World Swap UCITS ETF 1C LU0274208692 39,891,721 USD 24-Aug-2020 70.7092 5493008RJ2750QYQWH07 Xtrackers Nifty 50 Swap UCITS ETF 1C LU0292109690 765,295 USD 24-Aug-2020 150.9028 5493003HJBEIBPURTQ80 Xtrackers Nikkei 225 UCITS ETF 1D LU0839027447 63,489,099 JPY 24-Aug-2020 2371.0076 549300LVXXR6TCRR8V11 Xtrackers S&P 500 2x Inverse Daily Swap UCITS ETF 1C LU0411078636 117,939,772 USD 24-Aug-2020 0.838 549300EFLCUD3W5Y8L17 Xtrackers S&P 500 2x Leveraged Daily Swap UCITS ETF 1C LU0411078552 1,244,402 USD 24-Aug-2020 93.4639 549300C5VHS640G74S24 Xtrackers S&P 500 Inverse Daily Swap UCITS ETF 1C LU0322251520 38,351,161 USD 24-Aug-2020 10.7824 549300R4YM5JER8OY786 Xtrackers S&P 500 Swap UCITS ETF 1C LU0490618542 98,719,463 USD 24-Aug-2020 64.1546 54930044TWZ26JPZ4913 Xtrackers S&P ASX 200 UCITS ETF 1D LU0328474803 1,831,284 AUD 24-Aug-2020 50.5253 54930013Q3M4XTZK8090 Xtrackers S&P Global Infrastructure Swap UCITS ETF 1C LU0322253229 4,157,726 USD 24-Aug-2020 42.5187 5493008C0SZTHO53K557 Xtrackers S&P Select Frontier Swap UCITS ETF 1C LU0328476410 5,987,184 USD 24-Aug-2020 12.5517 549300XYU8YRYRLW2V30 Xtrackers ShortDAX Daily Swap UCITS ETF 1C LU0292106241 26,225,319 EUR 24-Aug-2020 17.335 549300JBKDYMG1CI8P69 Xtrackers ShortDAX x2 Daily Swap UCITS ETF 1C LU0411075020 75,986,015 EUR 24-Aug-2020 2.2598 5493007QFVQA092DU026 Xtrackers Stoxx Europe 600 Banks Swap UCITS ETF 1C LU0292103651 1,321,598 EUR 24-Aug-2020 23.6221 549300YNIXVMFWOP8P94 Xtrackers Stoxx Europe 600 Basic Resources Swap UCITS ETF 1C LU0292100806 2,891,250 EUR 24-Aug-2020 96.4226 549300WQTIB1NF8TQE37 Xtrackers Stoxx Europe 600 Food & Beverage Swap UCITS ETF 1C LU0292105359 428,516 EUR 24-Aug-2020 132.261 549300TA45MCFPU0C423 Xtrackers Stoxx Europe 600 Health Care Swap UCITS ETF 1C LU0292103222 590,806 EUR 24-Aug-2020 161.8099 54930078RS1ES4P71W58 Xtrackers Stoxx Europe 600 Industrial Goods Swap UCITS ETF 1C LU0292106084 237,061 EUR 24-Aug-2020 104.0499 549300CKZLU243U6UD60 Xtrackers Stoxx Europe 600 Oil & Gas Swap UCITS ETF 1C LU0292101796 655,946 EUR 24-Aug-2020 59.5933 549300MTOEHZINZR8S05 Xtrackers Stoxx Europe 600 Technology Swap UCITS ETF 1C LU0292104469 563,876 EUR 24-Aug-2020 87.1391 549300KIYVPQAF3TNN13 Xtrackers Stoxx Europe 600 Telecommunications Swap UCITS ETF 1C LU0292104030 83,138 EUR 24-Aug-2020 58.3895 549300AGJ1TYQ7FNRT15 Xtrackers Stoxx Europe 600 UCITS ETF 1C LU0328475792 17,502,403 EUR 24-Aug-2020 82.1592 549300ZBFJN4JNFI8P11 Xtrackers Stoxx Europe 600 Utilities Swap UCITS ETF 1C LU0292104899 168,623 EUR 24-Aug-2020 110.2623 549300R2FZ8OLQR2BG66 Xtrackers Stoxx Global Select Dividend 100 Swap UCITS ETF 1D LU0292096186 14,892,646 EUR 24-Aug-2020 22.8117 549300E5G4ZOXUZN8C92 Xtrackers USD Overnight Rate Swap UCITS ETF 1C LU0356591882 74,360 USD 24-Aug-2020 179.555 549300Y460NPHKS56V12 This notice is for information purposes only. Shareholders are not required to take any action. Capitalised terms used in this letter shall have the meaning ascribed to them in the current prospectus of the Company (the Prospectus) unless the context otherwise requires. Further information in relation to this notice may be obtained from the Company on its registered address, the offices of foreign representatives or by sending an email [email protected] Xtrackers The board of directors", "role": "user" }, { "content": "Net Asset Value(s)", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: BOCA RATON, Fla., Oct. 5, 2020 /PRNewswire/ --Tint World Automotive Styling Centers, the leading international auto accessory and window tinting franchise, has been named to the Franchise Times Top 200+ list for 2020. This marks the eighth year the company has been named as a top performing U.S.-based franchise brand. \"This prestigious recognition belongs to every member of the Tint World family,\" said Charles J. Bonfiglio, president and CEO of Tint World. \"The fact that we've achieved this honor every year since 2013 demonstrates the commitment and passion of our corporate staff and Tint World franchisees around the world. They've remained truly dedicated to providing the top auto accessory products and services during a challenging year, and we're proud to see their hard work acknowledged within the industry.\" The Franchise Times Top 200+ list is an annual ranking of the 500 largest franchise systems in the United States by global system-wide sales, based on the previous year's performance. The project is the result of a five-month research and reporting effort each year that results in the most credible and objective franchise ranking available. \"Tint World continues to grow, with several more locations set to open in 2020 and 2021,\" Bonfiglio said. \"Our franchise model and support systems help set our franchisees up for success.\" Tint World Automotive Styling Centers offer sales and installation of auto and marine accessories, mobile electronics, audio video equipment, security systems, custom wheels and tire packages, window tinting, vehicle wraps, paint protection films, detailing services, nano ceramic coatings, maintenance and repair services, and more. Tint World is also the leading provider of residential, commercial and marine computerized window tinting and security film services with locations throughout the U.S. and abroad, with franchise opportunities available worldwide. About Tint World Founded in 1982, Tint World Automotive Styling Centers is America's largest and fastest growing automotive accessories and window tinting international franchise, specializing in car and truck accessories, mobile electronics, audio video equipment, security systems, detailing services, nano ceramic coatings, custom wheel and tire packages, maintenance, and repair services. Tint World services include residential, commercial, and marine window tinting films, solar films, decorative films, safety, and security films. Tint World has locations in the United States, Canada, Saudi Arabia, and the United Arab Emirates, with master franchise opportunities available worldwide. To find out more, please visitwww.TintWorld.comorwww.TintWorldFranchise.com. Tint World Contact: Charles J. Bonfiglio, CEO888-944-8468 [emailprotected] MEDIA CONTACT:Heather RipleyRipley PR865-977-1973[emailprotected] SOURCE Tint World", "role": "user" }, { "content": "Tint World named to Franchise Times Top 200+ Ranking Top trade publication recognizes National Automotive Styling Centers as one of the top U.S.-based franchise brands", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: VENTURA, Calif.--(BUSINESS WIRE)--Nexa3D, the maker of ultrafast polymer production 3D printers, announced today the immediate availability of Ximplify, an automated 3D printing decision support portal powered by CASTOR that accelerates the ability of designers and manufacturers to adopt additive manufacturing at scale. Ximplify is part of Nexa3Ds expanding digital twin software platform NexaX, combining process and geometry algorithms and end-to-end validated workflows to identify, select and optimize tooled plastic parts and assembly candidates that are suitable for polymer additive production. Ximplify is CAD agnostic and can scan through a complete list of materials comprising of thousands of parts in minutes, selecting the ideal candidates for additive manufacturing. In addition to analyzing parts for ideal process, Ximplify will recommend the best 3D printer and material to maximize performance and provide full part cost and return on investment analysis. At the conclusion of each session, Ximplify generates an automatic report to support the entire decision making and implementation process. To learn more about Ximplify, check out this media kit and watch this video, or check out Ximplify at our Nexa3Ds Virtual Booth as part Formnext 2020. To obtain your free pass, click here. We are excited to partner with CASTOR, a leading decision support software provider, to deliver orders of magnitude productivity and cost advantages to companies seeking to simplify their supply chain by quickly identifying opportunities to migrate tooled plastic parts to just-in-time, on-site and on-demand additive polymer production, said Avi Reichental, Co-founder, Chairman and CEO of Nexa3D. Nexa3D is a firm believer in the power of collaborations as force multipliers to democratize access to additive polymer production at scale, and we are very excited to add CASTOR to our growing list of outstanding industry partners. We are thrilled to partner with Nexa3D and combine the power of our decision support software capabilities with Nexa3Ds digital twin software platform for the benefit of designers and engineers seeking to accelerate their additive manufacturing learning curve, and de-risk migration from tooled parts to digital parts with all the benefits of digital inventory, said Omer Blaier, Co-founder and CEO of CASTOR. Since its inception, CASTORs mission is to simplify and demystify the process and knowledge required for product companies to digitize their supply-chain by harvesting the advantages of additive manufacturing. In that respect, we see Nexa3D as a company with similar interests and values, and together we are taking another step towards digitizing the worlds supply chain sustainably. Ximplify is scalable, economical and available for immediate use on the Nexa3D website, providing end-to-end 3D printing decision support and simulation capabilities including: As part of Nexa3Ds Digital Twin Printing (DTP) software NexaX, Ximplify combines process interplay algorithms that ensure part performance and production consistency and higher yields while minimizing material usage and waste, and reducing energy consumption per part. About Nexa3D Nexa3D is digitizing the worlds supply chain sustainably. The company makes ultrafast industrial grade polymer 3D printers affordable for professionals and businesses of all sizes. The company's photoplastic printers are powered by its proprietary Lubricant Sublayer Photo-curing (LSPc) while its thermoplastic printers are powered by Quantum Laser Sintering (QLS), both of which increase print speed and productivity by orders of magnitude. The companys partnerships with world-class material suppliers unlock the full potential of supply-chain approved polymers that are tailored for faster production at scale. Nexa3Ds Digital Twin Printing (DTP) software optimizes the entire additive production cycle through process interplay algorithms to ensure part performance and production consistency delivering higher yields while minimizing material usage and waste to reduce energy and carbon footprints. To learn more, visit www.nexa3d.com. About CASTOR CASTOR is a decision support software which helps manufacturers to reduce the risks and accelerate the process of identifying opportunities for using industrial 3D printing. The software conducts CAD file analysis resulting in an automatic report on a part-by-part basis which includes feedback whether it is beneficial to use 3D printing, or not. The report also includes a recommendation on the most suitable technology and material for the 3D printing while maintaining the system requirements. It estimates the cost and lead-time and connects the manufacturer to a service bureau which can print and supply the part according to the requirements. To learn more, visit www.3dcastor.com", "role": "user" }, { "content": "Nexa3D Launches Ximplify Automated 3D Printing Selector and Design Optimizer, Powered by CASTOR Accelerates the ability of designers and manufacturers to adopt additive manufacturing using automated decision support tools Combines process and geometry algorithms to identify, select and optimize tooled plastic parts for additive polymer production Reduces the cost, risk and lead-time required to successfully implement 3D printing for series production applications", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: HOUSTON, July 28, 2020 /PRNewswire/ -- RCI Hospitality Holdings, Inc. (Nasdaq: RICK) plans to file its 10-Q and report financial results for its Fiscal 3Q20 ended June 30, 2020 after the market closes Monday, August 10, 2020. The company will hold a related conference call that day at 4:30 PM ET. Conference Call Details Monday, August 10, 2020, at 4:30 PM ET Live Participant Phone Number: Toll Free 877-407-9210, International 201-689-8049 To access the live webcast, slides or replay, visit: https://www.webcaster4.com/Webcast/Page/2209/36059 Phone replay: Toll Free 877-481-4010, International 919-882-2331, Passcode: 36059 About RCI Hospitality Holdings, Inc. (Nasdaq: RICK) With more than 40 units, RCI Hospitality Holdings, Inc., through its subsidiaries, is the country's leading company in gentlemen's clubs and sports bars/restaurants. Clubs in New York City, Chicago, Dallas/Ft. Worth, Houston, Miami, Minneapolis, St. Louis, Charlotte, Pittsburgh, and other markets operate under brand names such as Rick's Cabaret, XTC, Club Onyx, Vivid Cabaret, Jaguars Club, Tootsie's Cabaret, and Scarlett's Cabaret. Sports bars/restaurants operate under the brand name Bombshells Restaurant & Bar. Please visit http://www.rcihospitality.com Forward-Looking Statements This press release may contain forward-looking statements that involve a number of risks and uncertainties that could cause the company's actual results to differ materially from those indicated in this press release, including, but not limited to, the risks and uncertainties associated with (i) operating and managing an adult business, (ii) the business climates in cities where it operates, (iii) the success or lack thereof in launching and building the company's businesses, (iv) cyber security, (v) conditions relevant to real estate transactions, (vi) our ability to maintain compliance with the filing requirements of the SEC and the Nasdaq Stock Market, (vii) the impact of the coronavirus pandemic, and (viii) numerous other factors such as laws governing the operation of adult entertainment businesses, competition and dependence on key personnel. The company has no obligation to update or revise the forward-looking statements to reflect the occurrence of future events or circumstances. Contacts: Gary Fishman and Steven Anreder at 212-532-3232 or [emailprotected] and [emailprotected] SOURCE RCI Hospitality Holdings, Inc. Related Links http://www.rcihospitality.com", "role": "user" }, { "content": "RCI to File 3Q20 10-Q and Hold Conference Call on Monday, August 10, 2020", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: CATONSVILLE,Md., Feb. 17, 2021 /PRNewswire/ --Policymakers at all levels of government are racing to vaccinate hundreds of millions of people to save lives and blunt the deadly COVID-19 pandemic.New research published in the INFORMS Journal on Applied Analytics provides a simulated model for drive-through clinics that can be used for mass COVID-19 vaccinations based on the successful use of such a clinic to address H1N1. Researchers Use Data from the H1N1 Pandemic to Model Pathway to Achieve Faster Vaccination to Stem COVID-19 Crisis Tweet this The paper, \"Lessons from Modeling and Running the Worlds Largest Drive-Through, Mass Vaccination Clinic,\" looks at data from The Louisville Metro Public Health and Wellness department during the H1N1 vaccinations. The authors, Sunderesh Heragu of Oklahoma State University and Thomas van de Kracht of Vanderlande Industries, note that a total of 19,318 residents were vaccinated via a drive-through and a walk-up clinic over 1.5 days nearly two-thirds of whom specifically used the drive-through clinic. The authors found that people preferred the convenience of drive-through clinics because they perceived it was safer, more convenient and less contagious. \"As policymakers address how to bolster mass vaccinations for COVID-19, drive-through vaccination sites offer a means to inoculate people faster and with less waiting and confusion as compared to other mass vaccination approaches,\" said Heragu, a Regents professor and head of the School of Industrial Engineering and Management at OSU. \"This could readily be done in literally every single community, transforming the trajectory of the COVID-19 pandemic once and for all.\"Link to full study.About INFORMS and INFORMS Journal on Applied AnalyticsINFORMS Journal on Applied Analyticsis a premier peer-reviewed scholarly journal focused on the practice of operations research and management science and the impact this practice has on organizations throughout the world. It is published by INFORMS, the leading international association for operations research and analytics professionals. More information is available [email protected] INFORMS Related Links http://www.informs.org", "role": "user" }, { "content": "New Research Finds Drive-Through Mass-Vaccination Clinics Could Alter COVID-19 Trajectory", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: LONDON--(BUSINESS WIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the Code) 1. KEY INFORMATION (a) Full name of discloser: Millennium International Management LP (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree Alternative Credit Investments plc (d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: (e) Date position held/dealing undertaken: For an opening position disclosure, state the latest practicable date prior to the disclosure 11th December 2020 (f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state N/A No 2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security. (a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any) Class of relevant security: 1p ordinary (GB00BLP57Y95) Interests Short positions Number % Number % (1) Relevant securities owned and/or controlled: 2,600,000 3.539% - - (2) Cash-settled derivatives: 1,949,940 2.654% (3) Stock-settled derivatives (including options) and agreements to purchase/sell: - - - - TOTAL: 4,549,940 6.193% - - All interests and all short positions should be disclosed. Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions). (b) Rights to subscribe for new securities (including directors and other employee options) Class of relevant security in relation to which subscription right exists: Details, including nature of the rights concerned and relevant percentages: 3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in. The currency of all prices and other monetary amounts should be stated. (a) Purchases and sales Class of relevant security Purchase/sale Number of securities Price per unit (GBP) (b) Cash-settled derivative transactions Class of relevant security Product description e.g. CFD Nature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short position Number of reference securities Price per unit (GBP) GB00BLP57Y95 CFD Increasing a long position 2,377 8.68 (c) Stock-settled derivative transactions (including options) (i) Writing, selling, purchasing or varying Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type e.g. American, European etc. Expiry date Option money paid/ received per unit (ii) Exercise Class of relevant security Product description e.g. call option Exercising/ exercised against Number of securities Exercise price per unit (d) Other dealings (including subscribing for new securities) Class of relevant security Nature of dealing e.g. subscription, conversion Details Price per unit (if applicable) 4. OTHER INFORMATION (a) Indemnity and other dealing arrangements Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer: Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state none NONE (b) Agreements, arrangements or understandings relating to options or derivatives Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state none NONE (c) Attachments Is a Supplemental Form 8 (Open Positions) attached? NO Date of disclosure: 14th December 2020 Contact name: Milos Naumovic Telephone number: +44 203 650 8203 Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at [email protected]. The Panels Market Surveillance Unit is available for consultation in relation to the Codes disclosure requirements on +44 (0)20 7638 0129. The Code can be viewed on the Panels website at www.thetakeoverpanel.org.uk.", "role": "user" }, { "content": "Form 8.3 - Alternative Credit Investments plc", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: CARLSBAD, Calif., Oct. 21, 2020 /PRNewswire/ --Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) announced today that it will host a live webcast on Wednesday, November 4th at 11:30 a.m. Eastern Time to discuss its third quarter 2020 financial results and report on pipeline and business progress. Interested parties may access the webcast at www.ionispharma.com. A webcast replay will be available for a limited time at the same address. About Ionis PharmaceuticalsAs the leader in RNA-targeted drug discovery and development, Ionis has created an efficient, broadly applicable, drug discovery platform called antisense technology that can treat diseases where no other therapeutic approaches have proven effective. Our drug discovery platform has served as a springboard for actionable promise and realized hope for patients with unmet needs. We created the first and only approved treatment for children and adults with spinal muscular atrophy as well as the world's first RNA-targeted therapeutic approved for the treatment of polyneuropathy in adults with hereditary transthyretin amyloidosis. Our sights are set on all the patients we have yet to reach with a pipeline of more than 40 novel medicines designed to potentially treat a broad range of diseases, including neurological, cardiovascular, infectious, and pulmonary diseases. To learn more about Ionis visit www.ionispharma.com and follow us on twitter @ionispharma. SOURCE Ionis Pharmaceuticals, Inc. Related Links http://www.ionispharma.com", "role": "user" }, { "content": "Ionis to hold third quarter 2020 financial results webcast Webcast scheduled for Wednesday, November 4 at 11:30 a.m. Eastern Time", "role": "assistant" } ]

[ { "content": "You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text. \nText: SACRAMENTO, Calif., June 9, 2020 /PRNewswire/ --AECOM-Canyon Partners (\"ACP\"), in a joint venture with The Martin Group, today announced the closing of a $73.3 million senior construction loan from Pacific Western Bank to begin the transit-oriented development of Wexler on 65th, a mid-rise student housing project near California State University, Sacramento (\"Sacramento State\"). The development will bring much needed housing to Sacramento State. Construction of the project is scheduled to commence in June 2020, bringing hundreds of job opportunities to the community, and is scheduled to reach completion by Fall 2022. The property is located less than a 5-minute walk from the university's Hornet Crossing entrance and adjacent to several retail and dining options. It is directly adjacent to Sacramento Regional Transit Authority's (\"SacRT\") University/65th St. Gold Line light rail station, providing direct service to downtown Sacramento in approximately 11 minutes. In March 2020, the joint venture began the reconstruction and modernization of bus stops for the SacRT on 67th and Q streets, as part of the Wexler's off-site improvement plan. The 223-unit project will offer a mix of studio, two-, three-, four-, and five-bedroom units, featuring bedroom-bathroom parity, in addition to numerous tenant amenities, ample parking, and approximately 7,400 square feet of commercial space. With a total enrollment of over 31,000, Sacramento State is the sixth largest university in the California State University (\"CSU\") system, which is the largest four-year public university system in the United States. Over $260 million of projects have been recently completed or are underway at Sacramento State, including a new science center and student activity center. About AECOM-Canyon Partners AECOM-Canyon Partners is a joint venture between AECOM Capital, the real estate investment management arm of global infrastructure firm AECOM, and Canyon Partners, LLC, a global alternative asset management firm with approximately $23 billion in assets under management. AECOM-Canyon Partners was established to develop large-scale, institutional quality commercial real estate projects in top U.S. markets. In addition to capital, AECOM-Canyon Partners provides best-in-class design, construction management and engineering expertise as well as credit support for its development partners. For more information, visithttps://www.aecomcanyon.com/.About The Martin Group The Martin Group is a real estate investment firm developing ground-up and value-add residential and mixed-use properties. We deliver superior returns by focusing on urban infill housing located near durable demand drivers in supply-constrained regions of California. The Martin Group has acquired, developed and managed all types of real estate, resulting in cumulative project experience exceeding 24 million square feet including 20,000 apartments. About Pacific Western Bank Pacific Western Bank is a commercial bank with over $26 billion in assets headquartered in Los Angeles, California, with executive offices in Denver, Colorado.The Bank has 74 full-service branches primarily located in California, with one branch located in Durham, North Carolina, and one branch located in Denver, Colorado. We offernational lending products including asset-based, equipment, and real estate loans and treasury management services to established middle-market businesses. Learn about Pacific Western Bank, visitwww.pacwest.com.Media Contacts:AECOM Capital: Brendan Ranson-Walsh Vice President, Global Communications 213-996-2367 [emailprotected]Canyon Partners Real Estate:Kris Cole Prosek Partners 310-652-1411 [emailprotected]SOURCE AECOM-Canyon Partners", "role": "user" }, { "content": "AECOM-Canyon Partners, The Martin Group Secure Construction Loan from Pacific Western Bank for a Sacramento State Student Housing Development Project", "role": "assistant" } ]